Sentence,class,file
"77 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  group consists of genetic factors as demonstrated  by the literature evidence.5 Tsuang et al.6 evaluated  the influence of genetic, familial, and non-familial  factors over a few types of drugs on 3372 twins in  Vietnam.",OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"Addict Health, Spring 2016; Vol 8, No 2 78 http://ahj.kmu.ac.ir,    3 April  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"79 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  Table 3:  Dermatoglyphics patterns for each hand in the control group  P Finger pattern  Variable  Whorl [n (%)]  Loop [n (%)]  Arch [n (%)]   Right hand   0.24 63 (52.1)  58 (47.9)  - Case  Thumb   - 49 (40.5)  - Control   0.77 47 (29.7)  61 (50.4)  12 (9.9)  Case  Index   44 (36.4)  62 (51.2)  15 (12.4)  Control   0.52 30 (24.8)  86 (71.1)  5 (4.1)  Case  Middle   27 (22.3)  85 (70.2)  9 (7.4)  Control   0.51 67 (55.4)  54 (44.6)  - Case  Ring   72 (59.5)  46 (38.0)  3 (2.5)  Control   0.13 24 (19.8)  97 (80.2)  - Case  Small   24 (19.8)  93 (76.9)  4 (3.3)  Control   Left hand   0.07 54 (44.6)  67 (55.4)  - Case  Thumb   55 (45.5)  61 (50.4)  5 (4.1)  Control   0.76 48 (39.7)  57 (47.1)  16 (13.2)  Case Index   47 (38.8)  54 (44.6)  20 (16.5)  Control   0.79 31 (25.6)  78 (64.5)  12 (9.9)  Case  Middle   34 (28.1)  73 (60.3)  14 (11.6)  Control   0.05 63 (52.1)  58 (47.9)  - Case  Ring   53 (43.8)  63 (52.1)  5 (4.1)  Control   0.35 20 (1.0)  101 (83.5)  - Case  Small   18 (14.9)  101 (83.5)  2 (1.6)  Control   Analysis of the fingerprint patterns has shown  important differences between case and control  groups for the ring finger.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"Addict Health, Spring 2016; Vol 8, No 2 80  http://ahj.kmu.ac.ir,    3 April  In some regions of Iran, especially the eastern  part of Iran and Khorasan Province, there is no  difference between crack and crystal in terms of  ingredients, since both of them are heroin.3 In the  previous study, it was revealed that traditional  drugs (opium, opium residue) were the most  common type of drugs abused in South Khorasan  province,Iran,  followed by newer or modern  drugs (Iranian crack, Iranian crystal, and heroin),  and other drugs were minimally abused such as  tramadol, methadone, diphenoxylate, and  cannabis.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"81 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  our study was confined to a limited region.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"Addict Health, Spring 2016; Vol 8, No 2 82  http://ahj.kmu.ac.ir,    3 April  A.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"1 -  ىايرا داًشگاُ علَم پسشكي بیرجٌد، بیرجٌد،ا، ّ هسوَهیت هركس تحقیقات سَء هصرف هَاد ٍٍ  هركس تحقیقات آترٍاسكلرٍز ٍ عرٍق كرًٍر داًشیار،  2 -  ايراى تْراى، ،ىداًشگاُ علَم پسشكي تْراداًشكدُ پسشكي،  ،ّا ٍ گرٍُ پسشكي قاًًَي ٍ هسوَهیت ّا هسوَهیت ٍ شٌاسي سن تحقیقات هركس ،استاد  3 -  راىٌد، ايبیرج بیرجٌد، يپسشك علَم اُداًشگ ّا، هسوَهیت ٍ هَاد هصرف سَء تحقیقـات پسشک عوَهي، هركس  4 -   اتاٍا، اتاٍا، كاًادا داًشگاُبیوارستاى كَدكاى شرق اًتاريَ، استاديار،  5 -  آباد، ايراى پژٍّشگر، داًشكدُ پرستاری ٍ هاهايي، داًشگاُ علَم پسشكي لرستاى، خرم  6 -  ، داًشگاُ علَم پسشكي كرهاى، كرهاى، ايراىپسشكي رساًي تاديار، گرٍُ هديريت خدهات بْداشتي، داًشكدُ هديريت ٍ اطالعاس  مسؤول:‌‌نویسنده یآزاد خیش ریاردش دكتر Email: sheikhazadi@tums.ac.ir 83 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April   مصرف كنندگان مواد در مقايسه با افراد سالممقايسه اختصاصات كمي و كيفي درماتوگليفيك  مهزپور دیام دکتز 1یآساد خیش زیاردش دکتز ، 2بزسگز افسون دکتز ، 3نیحس افضل دکتز ، 3کیمال ایکلود دکتز ، 4 ،  یآساد خیش الهام 5یانار یصابز نیحس دیس دکتز ، 6 چکیده ‌مقدمه:شَد.",Non-OADS,/arxiv_data1/oa_pdf/0f/f8/AHJ-08-076.PMC5115640.pdf
"1- Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran 2- Sleep Disorders Research Center AND Department of Psychiatric Nursing, School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran Correspondence to: Behnam Khaledi-Paveh MSc, Email: bkhaledipaveh@kums.ac.ir Addict Health, Spring 2016; Vol 8, No 2 84 http://ahj.kmu.ac.ir,    3 April  Sleep Disorders in Methadone Maintenance Treatment Volunteers and  Opium-dependent Patients  Habibolah Khazaie MD1, Farid Najafi MD1, Mohammad Rasoul Ghadami MD1, Atena Azami MD1,  Marzieh Nasouri MS1, Masoud Tahmasian MD1, Behnam Khaledi-Paveh MSc2  Abstract  Background: Th e relationship betwe en substanc e use and sleep i s bidirectional.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"85 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  The main goal of this study is to compare the  frequency of sleep disorders in MMT patients and  opium-dependent individuals.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"Addict Health, Spring 2016; Vol 8, No 2 86  http://ahj.kmu.ac.ir,    3 April  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"87 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  outcome of sleep questionnaire, and the Beck  depression inventory (BDI).",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"[cited 2005 Jul]; Available from: URL: http://www.beckleyfoundation.org/pdf/paper_08.pdf 3.Watson B, Lingford-Hughes A. Pharmacological treatment of addiction.",OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"Addict Health, Spring 2016; Vol 8, No 2 88  http://ahj.kmu.ac.ir,    3 April  11.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"1 -  ، کرمانشاه، ایرانکرمانشاه یدانشگاه علوم پزشک ،خواب اختالالت قاتیتحق مرکز  2 -   ، کرمانشاه، ایرانکرمانشاه یدانشگاه علوم پزشک یی،ماما و یدانشکده پرستار ی،پرستار روان گروهمرکز تحقیقات اختالالت خواب و  مسؤول:‌‌نویسنده پاوه یخالد تهنام Email: bkhaledipaveh@kums.ac.ir 89 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  اختالالت خواب در افراد تحت درمان نگهدارنده با متادون و وابستگان به تریاک ییخزا اله بیحب دکتز 1ینجف دیفز دکتز ، 1یقدم رسول محمد دکتز ، 1یاعظم آتنا دکتز ، 1ینصور هیمزض ، 1 ،  انیطهماس مسعود دکتز 1پاوه یخالد بهنام ، 2 چکیده مقدمه:گردد.",Non-OADS,/arxiv_data1/oa_pdf/c1/cf/AHJ-08-084.PMC5115641.pdf
"1- Senior Researcher, Program of International Research and Training, National Drug and Alcohol Research Centre, School of Public  Health and Community Medicine, University of New South Wales, Sydney, Australia 2- PhD Student, Department of Psychology, School of Psychology and Educational Sciences, Alzahra University, Tehran, Iran 3- Statistician , School of Health, University of Technology Sydney, Sydney, Australia 4- Professor, Department of Psychiatry, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran 5- Professor, Department of Psychology, School of Educational Sciences and Psychology, Ferdowsi University , Mashhad, Iran 6 - Professor, Program of International Research and Training, National Drug and Alcohol Research Centre, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia Correspondence to: Zahra Alam-Mehrjerdi PhD , Email: z.alammehrjerdi@unsw.edu.au Ad dict Health, Spring 2016; Vol 8, No 2 90 http://ahj.kmu.ac.ir,    3 April  Willingness to Receive Treatment for Hepatitis C among Injecting Drug  Users on Methadone Program: Implications for Education and Treatment  Zahra Alam-Mehrjerdi PhD1, Afsaneh Moradi MSc2, Fenglian Xu PhD3, Mehran Zarghami MD4,  Javad Salehi-Fadardi PhD5, Kate Dolan PhD6  Abstract  Background:  Hepatitis C virus (HCV) is common among people who inject drugs (PWID)  on methadone  program in Iran (Persia).",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"91 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  clinic in Tehran, Iran, found that 52% of the  respondents were HCV seropositive.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"Addict Health, Spring 2016; Vol 8, No 2 92 http://ahj.kmu.ac.ir,  3 April  The mean age of the participants was 35.8  [standard deviation (SD) = 7.9] years (the age  range 20-54).",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"93 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"Addict Health, Spring 2016; Vol 8, No 2 94 http://ahj.kmu.ac.ir,    3 April  highlighted high prevalence of HCV among  PWID.3,7,13 The prevalence of HCV among PWID in  this study has important health implications and  should be considered for pharmacological treatment  on methadone program.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"95 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  women.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
[cited 2013]; Available from: URL: http://www.unaids.org/sites/default/files/en/dataanalys is/knowyourresponse/countryprogressreports/2014cou ntries/IRN_narrative_report_2014_fa.pdf [In Persian].,OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"Addict Health, Spring 2016; Vol 8, No 2 96 http://ahj.kmu.ac.ir,  3 April  and willingness to receive treatment among patients  on methadone maintenance.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"1 -   ، سیدًی، استرالیاًیَ سَت ٍیلسّش هَاد ٍ الکل، داًشکدُ سالهت ّوگاًی ٍ پسشکی جاهعِ، داًشگاُ پژٍّش ٍ کارٍرزی، هرکس هلی الوللی پژٍ برًاهِ بیيپژٍّشگر برتر،  2 -  شٌاسی ٍ علَم تربیتی، داًشگاُ السّراء، تْراى، ایراى شٌاسی، داًشکدُ رٍاى رٍاى گرٍُ داًشجَی دکتری،  3 -  استرالیاآٍری سیدًی، سیدًی،  ، داًشگاُ فيبْداشتداًشکدُ گر آهار،  تحلیل  4 -  پسشکی، داًشکدُ پسشکی، داًشگاُ علَم پسشکی هازًدراى، ساری، ایراى رٍاى گرٍُ استاد،  5 -  شٌاسی ٍعلَم تربیتی، داًشگاُ فردٍسی، هشْد، ایراى شٌاسی، داًشکدُ رٍاى رٍاى گرٍُ استاد،  6 -  اداًشکدُ سالهت ّوگاًی ٍ پسشکی جاهعِ، داًشگاُ ًیَ سَت ٍیلس، سیدًی، استرالیالوللی پژٍّش ٍ کارٍرزی، هرکس هلی پژٍّش هَاد ٍ الکل،  برًاهِ بیي ،ستادا  مسؤيل:‌‌وًیسىدٌ زّرا علن هْرجردیدکتر  Email: z.alammehrjerdi@unsw.edu.au Addict Health, Spring 2016; Vol 8, No 2   http://ahj.kmu.ac.ir,    3 April   هپاتیت برای درمان دریافت به تمایل C : متادون درمان در مواد کنندگان تسریق بیه در   درمان و آموزش برای هایی داللت  سهزا علم مهزجزدیدکتز 1، افسانه مزادی2 ایکس یوفنگلیان دکتز ، 3 مهزان ضزغامیدکتز ، 4 ، جواد صالحی فدردیدکتز 5 کیت دالندکتز ، 6  چکیده ‌مقدمٍ:ٍیزٍط ّپاتیت  C (  Hepatitis C virus    یا HCV ّا  تعذاد کوی اس تشریقی اها است،رایج  هتادٍى در ایزاى تا ّا در درهاى ) در تیي تشریقی  در درهاى هتادٍى تزای درهاى ّپاتیت C عَاهل هزتثط تا توایل تِ دریافت ّپاتیت  تزرسی، حاضز هطالعِ اس اًجام دٌّذ.",Non-OADS,/arxiv_data1/oa_pdf/b0/a0/AHJ-08-090.PMC5115642.pdf
"1- Associate Professor, Family Research Institute, Shahid Beheshti University, Tehran, Iran   2- PhD Student, School of Humanities and Social Sciences, University of Queensland, Brisbane, Australia   3- Family Research Institute, Shahid Beheshti University, Tehran, Iran   4- Assistant Professor, Family Research Institute, Shahid Beheshti University, Tehran, Iran   5- Assistant Professor, Department of Social Sciences, School of Criminal Justice and Sociology, Cameron University, Oklahama, USA   Correspondence to: Zohreh Ahmadabadi MSc , Email: z.ahmadabadi@uqconnect.edu.au     98 Addict Health, Spring 201 6; Vol 8, No 2    http://ahj.kmu.ac.ir ,    3 April  Living with Addicted Men and Codependency:   The Moderating Effect of Personality Traits   Leili Panaghi PhD1, Zohreh Ahmadabadi MSc2, Najmeh Khosravi MSc3,   Mansoureh Sadat Sadeghi PhD4, Ali Madanipour PhD5    Abstract   Background:  This study aimed to determine the moderating effect of personality traits on the relationship  between living with an addicted man and codependency.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"Addict Health, Spring 201 6; Vol 8, No 2 99    http://ahj.kmu.ac.ir ,    3 April  is a dysfunctional relationship o r a personality  problem .12-15 Eventually, some studies contradicted  the stereotypical view that a chemically -dependent  spouse has a personality disorder making her to  exhibit codependent behaviors.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"100 Addict Health, Spring 201 6; Vol 8, No 2    http://ahj.kmu.ac.ir ,    3 April  Cronbach’s alpha coefficients of 0.86, 0.77, 0.73,   0.68, and 0.81 for N, E, O, A, and C te sts  respectively.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"Addict Health, Spring 201 6; Vol 8, No 2 101    http://ahj.kmu.ac.ir ,    3 April  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"102 Addict Health, Spring 201 6; Vol 8, No 2    http://ahj.kmu.ac.ir ,    3 April  Findings revealed that except agreeableness,  there were no significant differences in other  personality  traits in women with addicted  spouses and normal women.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"Addict Health, Spring 201 6; Vol 8, No 2 103    http://ahj.kmu.ac.ir ,    3 April  magnitude of negative interactions.39,49 Therefore, it  appears that agreeableness, as a psychological  resource, helps wives of addicts to cope well with  life stressors and adjust their adverse effects such  as codependency.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"104 Addict Health, Spring 201 6; Vol 8, No 2    http://ahj.kmu.ac.ir ,    3 April  Psychother 1998; 12(3): 25 -38.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"Addict Health, Spring 201 6; Vol 8, No 2 105    http://ahj.kmu.ac.ir ,    3 April  bath water.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"1- پژٍّشگر ارشذ، هركس تحقيقات علَم اعصاب، داًشگاُ علَم پسشكي كرهاى، كرهاى، ايراى  2- استاديار، گرٍُ رٍاً شٌاسي، داًشگاُ تاٌّر كرهاى، كرهاى، ايراى   3- عضَ ّيأت علوي ، گرٍُ رٍاًشٌاسي عوَهي، داًشگاُ آزاد اسالهي، ٍاحذ زرًذ، كرهاى، ايراى   4- پژٍّشگر ارشذ، پژٍّشكذُ تعلين ٍ ترتيت ّوذاى، ّوذاى، ايراى  5- داًشجَ، داًشگاُ علوي - كارتردی جْاد كشاٍرزی كرهاى، كرهاى، ايراى  6- پرستار، تخش آًژيَگرافي، تيوارستاى شفا، داًشگاُ علَم پسشكي كرهاى، كرهاى، ايراى  7- پژٍّشگر ارشذ، كويتِ تحقيقات داًشجَيي پسشكي، داًشگاُ علَم پسشكي كرهاى، كرهاى، ايراى  نویسنده‌‌مسؤول: هحوَد زيَری رحواى  Email:  zivari63@yahoo.com       106 Addict Health, Spring 201 6; Vol 8, No 2    http://ahj.kmu.ac.ir ,    3 April    رابطه بین بازي هاي رايانه اي با مشکالت رفتاري نوجوانان    سًلماس شکًهی مقدم1 ،دکتز  وًشیزيان خضزی مقدم2، سیىب جًاومزد3 ، حسه سزمدیاوصار 4 ،مهزان امیىایی 5،  مجید شکًهی مقدم6 ،محمًد سیًری رحمان 7      چکیدٌ  مقدمه:‌بازی‌ّای رایاًِ‌ای بِ عٌَاى یک پذیذُ اجتواعی در کٌار سایر‌رساًِ‌ّای‌صَتی‌ٍ‌تصَیری‌ٍ‌ بِ دلیل رضذ‌چطوگیر في‌آٍری‌ّای ارتباطی  در دًیای اهرٍز،‌با کطص ٍ جاربِ‌ای حیرت‌اًگیس، عوذُ‌تریي هخاطباى خَد را از هیاى کَدکاى ٍ ًَجَاًاى اًتخاب کردُ‌است.‌با افسایص سریع  هحبَبیت ایي‌بازی‌ّا در بیي کَدکاى ٍ ًَجَاًاى، ًگراًی ّوگاًی از تأثیرات زیاى‌بار احتوالی ایي بازی‌ّا فسًٍی گرفتِ‌است.",Non-OADS,/arxiv_data1/oa_pdf/82/b6/AHJ-08-098.PMC5115643.pdf
"1- PhD Candidate, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran 2- Professor, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran 3- Associate Professor, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran 4- Professor, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran Correspondence to: Nouzar Nakhaee MD, Email: nakhaeen@kmu.ac.ir Addict Health, Spring 2016 ; Vol 8, No 2 107  http://ahj.kmu.ac.ir,    3 April  Maternal Separation and the Risk of Drug Abuse in Later Life  Fatemeh Delavari MSc1, Vahid Sheibani PhD2, Saeed Esmaeili-Mahani PhD3, Nouzar Nakhaee MD4  Abstract   Maternal separation (MS) is defined as the termination of the continuity of mother -child relationship after  the relationship is established.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"108 Addict Health, Spring 2016 ; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  Introduction   Brain function is under the influence of  environmental factors, signals, stimuli, and  acquisitive events throughout the entire lifespan.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"Addict Health, Spring 2016 ; Vol 8, No 2 109  http://ahj.kmu.ac.ir,    3 April  Moreover, it should be noted that the effects of  MS can be associated with the child’s age, the  length of separation, type of separation, and  gender.14  The effects of MS on children may have  different physical, mental and social aspects.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"110 Addict Health, Spring 2016 ; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  that although there was no difference in baseline  voluntary alcohol intake between the deprived  and the control groups, after stress exposure, the  deprived rats consumed remarkably greater  ethanol than the control group.31  Neurochemical changes in brain serotonin  systems,32,33 changes in the endocannabinoid  system (ECS),34 and changes in the function of  hypothalamus pituitary axis35 are introduces as  some probable mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"Addict Health, Spring 2016 ; Vol 8, No 2 111  http://ahj.kmu.ac.ir,    3 April  stressors that is the cause of disturbance in  dopaminergic system and change in mesolimbic  dopamine system of the brain.48-50  The vast majority of studies investigating the  effect of MS on mental disorders have been  conducted on diseases such as anxiety and  depression,12 personality disorders,51 and  behavioral problems52 and no exclusive human  study, whether retrospective or prospective, was  found regarding the relationship of MS and drug  abuse in humans.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"112 Addict Health, Spring 2016 ; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  consumption [Thesis].",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"Addict Health, Spring 2016 ; Vol 8, No 2 113  http://ahj.kmu.ac.ir,    3 April  rodents: altered responses to cannabinoid exposure.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"1- ، کرمان، ایران کرمان پزشکی علوم دانشگاه اعصاب، علوم تحقیقات مرکز دکتری، دانشجوی  2- ایران کرمان، ، کرمان پزشکی علوم دانشگاه اعصاب، علوم تحقیقات مرکز استاد،  3- ایران کرمان، ، کرمان پزشکی علوم دانشگاه اعصاب، علوم تحقیقات مرکز دانشیار،  4- ، کرمان، ایران  کرمان پزشکی علوم دانشگاه اعصاب، علوم تحقیقات مرکز استاد،  مسؤول:‌‌نویسنده نخعی نورردکتر  Email: nakhaeen@kmu.ac.ir 114 Addict Health, Spring 2016 ; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  زندگی آینده در مواد مصرف سوء خطر و مادر از محرومیت  دالوسی فاطمه 1شیبانی وحیذدکتش  ، 2ماهانی اسماعیلی سعیذدکتش  ، 3نخعی نورسدکتش  ، 4 چکیذه جدایی از هادر (  Maternal separation  یاMS ) تحت ػٌَاى قطغ استورار ارتباط بیي هادر ٍ کَدک بؼد از استقرار ایي ارتباط تؼریف هی ضَد.",Non-OADS,/arxiv_data1/oa_pdf/31/6f/AHJ-08-107.PMC5115644.pdf
"1- Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran 2- Professor, Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran Correspondence to: Abbas Pardakhty PhD, Email: abpardakhty@kmu.ac.ir Addict Health, Spring 2016; Vol 8, No 2 115 http://ahj.kmu.ac.ir,    3 April  Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists  Administration: A Rapid Overview  Hoda Soltani MSc1, Abbas Pardakhty PhD2  Abstract  Novel  drug  delivery  systems  for controlled-release  of opioid  agonists  as a long  time  painkillers  or opioid  antagonists  for opium,  heroin,  and  alcohol  addiction  are under  development  or in clinical  use today.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"116 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  maximum affinity for the µ-opioid receptors and  has few, if any inherent effects as well its opioid  blocking properties.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"Addict Health, Spring 2016; Vol 8, No 2 117 http://ahj.kmu.ac.ir,    3 April  product Duragesic and the g eneric product.”21  Slatkin et al.22 reported the high efficacy, well  tolerance, and rapid onset of analgesia in  opioid-tolerant patients with chronic cancer pain  after using fentanyl buccal tablet, a new opioid  formulation.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"118 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"Addict Health, Spring 2016; Vol 8, No 2 119  http://ahj.kmu.ac.ir,    3 April  gum which after swallowing become a tight, thick  gel, and slowly releases the drug.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"120 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  Conflict of Interests   The Authors have no conflict of interest.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"Addict Health, Spring 2016; Vol 8, No 2 121  http://ahj.kmu.ac.ir,    3 April  patterns of fentanyl transdermal system and  oxycodone hydrochloride controlled-release among  patients with chronic nonmalignant pain.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
"1 -  ایران کرمان،کرمان،  یعلوم پزشک دانشگاه ی،نوروفارماکولوژ پژوهشکده فارماسیوتیکس، تحقیقات مرکز  2 -  ایران کرمان، کرمان، پزشکی علوم دانشگاه نوروفارماکولوژی، پژوهشکده فارماسیوتیکس، تحقیقات مرکز استاد،  مسؤول:‌‌نویسنذه پرداختی عباس دکتر Email: abpardakhty@kmu.ac.ir 122 Addict Health, Spring 2016; Vol 8, No 2  http://ahj.kmu.ac.ir,    3 April  ‌های‌آنتاگونیست/‌آگونیست‌تجویش‌بزای‌دارویی‌در‌باسار‌موجود‌دارورسانی‌جذیذ‌یها‌سامانه  ‌گذرا‌مزور‌یکمخذر:‌  سلطانی هدی 1پزداختی عباس دکتز ، 2 چکیده مخذر  های آنتاگونیست یبرا یااثر  یطوالن ضذ دردهای عنوان به مخذر های آگونیستکنترل شذه  یشرها یبرا یدارورسان یذجذ های سامانهامروزه   جذیذ های سامانه مطالعه، ین.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/AHJ-08-115.PMC5115645.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 641–642Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 641 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S120438 Proposed learning strategies of medical students  in a clinical rotation in obstetrics and gynecology:  a descriptive study Alok Prasad   Aamer Mughal   Imran Ahmed   Farheen Ebrahim   Syed Mustafa Ali Ahmad Faculty of Medicine, Imperial  College – London, London, UKDear editor We note with great interest the article by Deane and Murphy1 exploring the learning  drivers and strategies of medical students in a clinical rotation in obstetrics and gyne- cology.",Non-OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
"Correspondence: Aamer Mughal 7 Batoum Gardens, London W6 7QB, UKEmail ajm311@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Prasad et alRunning head recto: Proposed learning strategies of medical students in Ob/Gyn rotationDOI: http://dx.doi.org/10.2147/AMEP .S120438",Non-OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 642 Prasad et al Authors’ reply Richard P Deane   Deirdre J Murphy Department of Obstetrics and Gynecology, Trinity College Dublin,   University of Dublin, Coombe Women & Infants University Hospital, Dublin, Republic of Ireland Correspondence: Richard P Deane Department of Obstetrics and Gynecology, Trinity College Dublin, University of Dublin, Coombe Women & Infants University Hospital, Dublin 8, Republic of IrelandTel +353 1 408 5365Email deaneri@tcd.ie Dear editor We are very grateful to Prasad et al for their interest in our  paper “Proposed learning strategies of medical students in a clinical rotation in obstetrics and gynecology: a descriptive study”.",Non-OADS,/arxiv_data1/oa_pdf/99/c4/amep-7-641.PMC5115677.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1031–1038Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1031 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S117959Appearance of fetal pain could be associated with  maturation of the mesodiencephalic structures Slobodan Sekulic¹ Ksenija Gebauer-Bukurov¹ Milan Cvijanovic¹ Aleksandar Kopitovic¹Djordje Ilic²Djordje Petrovic² Ivan Capo³ Ivana Pericin-Starcevic 4 Oliver Christ5 Anastasia T opalidou6  ¹Department of Neurology, Faculty  of Medicine Novi Sad, University of Novi Sad, ²Department of Obstetrics and Gynecology, Faculty of Medicine Novi Sad, University of Novi Sad,  ³Department of Histology and Embryology, Faculty of Medicine Novi Sad, University of Novi Sad,   4Department of Developmental  Neurology and Epilepsy, Institute for Child and Y outh Health Care of Vojvodina, Faculty of Medicine Novi Sad, University of Novi Sad, Novi Sad,  Serbia;  5School of Applied Psychology,   Institute Humans in Complex Systems,  Olten, Switzerland;  6Department  of Orthopaedics and Traumatology,  University Hospital of Heraklion,  Faculty of Medicine, University of Crete, Heraklion, GreeceAbstract: Fetal pain remains a controversial subject both in terms of recognizing its existence  and the time-frame within which it appears.",Non-OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
"2 The traditional standpoint is  that the registering of a nociceptive stimulus with a sensory system and perceiving Correspondence: Slobodan Sekulic Department of Neurology, Clinical Center of Vojvodina, Hajduk Veljkova 1-7, 21000 Novi Sad, SerbiaTel +381 6 4388 6715Email slobodan.sekulic@mf.uns.ac.rs Journal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Sekulic et alRunning head recto: Fetal painDOI: http://dx.doi.org/10.2147/JPR.S117959",Non-OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1038 Sekulic et al,Non-OADS,/arxiv_data1/oa_pdf/e8/66/jpr-9-1031.PMC5115678.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2941–2948Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2941OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11950 6 Posttraumatic stress and depression in Yazidi  refugees Serhat Nasırog ˘lu1 Veysi Çeri2 1Department of child and adolescent  Psychiatry, Faculty of Medicine,   sakarya University, sakarya, T urkey;   2Pendik Training and research  hospital, Department of child and  adolescent Psychiatry, Medical school  of Marmara University, istanbul,   T urkeyAim:  The aim of this investigation was to determine the frequency of mental pathologies in  children and adolescents of the Y azidi minority group who immigrated to Turkey from Iraq.",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
"Traumatic life events for such children before their migration may include  exposure to violence, separation from family and friends, and cessation of studies.2  Separation from their home environment causes traumatic experiences by interrupting  their attachment to home, putting distance between them and their friends, and dam - aging their feelings of individualism toward a place where they have been living for  a long time.3 The needs of refugee children and adolescents during their resettlement  should be satisfied in such a way that they can continue their lives in a safe area.4Correspondence: Serhat Nasıro ğlu Department of child and adolescent  Psychiatry, Faculty of Medicine, sakarya  University, sakarya 54000, Turkey Tel +90 505 568 1072 email serhatnasiroglu@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Nasıro ğlu and Çeri Running head recto: PTSD and depression in Y azidi refugees DOI: http://dx.doi.org/10.2147/NDT.S119506",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/0d/ndt-12-2941.PMC5115679.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1021–1029Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1021 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S117885Improving pain care through implementation of  the Stepped Care Model at a multisite community  health center Daren R Anderson1 Ianita Zlateva1 Emil N Coman2 Khushbu Khatri1 T errence Tian1 Robert D Kerns3 1Weitzman Institute, Community  Health Center, Inc., Middletown,   2UCONN Health Disparities  Institute, University of Connecticut,   Farmington, 3VA Connecticut  Healthcare System, West Haven,  CT, USAPurpose: Treating pain in primary care is challenging.",Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
"Keywords: quality improvement, primary care, chronic pain, community health, FQHC Background There are over 100 million people in the US with chronic pain, costing an estimated  $635 billion each year for medical treatment and lost productivity.1 The majority of  these patients seek help for their pain from a primary care provider (PCP),2 account- ing for up to a third of all visits to primary care.3,4 However, the quality of pain care  in primary care remains poor.5–7 PCPs receive little education about pain management  during medical training5–8 and lack confidence in their ability to manage chronic pain  effectively.3,9–11 Guidelines for the appropriate management of pain have had a limited  impact as evidenced by low rates of adherence to recommendations for documentation12 Correspondence: Daren Anderson Weitzman Institute, Community Health Center, Inc., 631 Main St, Middletown, CT 06457, USATel +1 860 347 6971Email Daren@chc1.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Anderson et alRunning head recto: The stepped care model for pain care in a community health center DOI: http://dx.doi.org/10.2147/JPR.S117885 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
Or use: http://youtu.be/wzQARbrLplU,Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
Available from: http://www.va.gov/painmanagement/docs/cpg_opioi-dtherapy_fulltext.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1029 The stepped care model for pain care in a community health center,Non-OADS,/arxiv_data1/oa_pdf/e6/13/jpr-9-1021.PMC5115680.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/da/f4/ndt-12-2957.PMC5115681.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2957–2962Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2957OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11562 9 The occurrence and predictive factors of sleep  paralysis in university students Monika lišková1,2 Denisa Janečková1 Lucie Klůzová Kráčmarová3 Karolína Mladá1 Jitka Bušková1,2 1institute of sleep Medicine, National  institute of Mental health, Klecany,   2Third Faculty of Medicine, charles  University, Prague, 3Olomouc  University social health institute,   Palacky University, Olomouc,   Czech RepublicAbstract:  The aim of the present study was to assess the occurrence and predictive factors  of sleep paralysis (SP) in Czech university students.",Non-OADS,/arxiv_data1/oa_pdf/da/f4/ndt-12-2957.PMC5115681.pdf
"We were especially interested whether personality traits correspondence: Monika lišková institute of sleep Medicine, National  institute of Mental health, Topolova 748,  Klecany 180 00, Czech Republic Tel +420 283 088 203 Fax +420 283 088 420 email monika.liskova@nudz.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Lišková et al Running head recto: SP in a student sample DOI: http://dx.doi.org/10.2147/NDT.S115629",Non-OADS,/arxiv_data1/oa_pdf/da/f4/ndt-12-2957.PMC5115681.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/da/f4/ndt-12-2957.PMC5115681.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/f4/ndt-12-2957.PMC5115681.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1001–1020Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1001 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S112418Efficacy and tolerability balance of oxycodone/ naloxone and tapentadol in chronic low back pain  with a neuropathic component: a blinded end point  analysis of randomly selected routine data from   12-week prospective open-label observations Michael A Ueberall1 Gerhard H H  Mueller-Schwefe2 1Institute of Neurological  Sciences, Nuernberg, Germany;   2Interdisciplinary Center for Pain and  Palliative Care Medicine, Goeppingen,   GermanyObjective:  To evaluate the benefit–risk profile (BRP) of oxycodone/naloxone (OXN) and  tapentadol (TAP) in patients with chronic low back pain (cLBP) with a neuropathic component  (NC) in routine clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
"Keywords: oxycodone/naloxone, tapentadol, chronic low back pain, neuropathic component,  noninterventional study, German Pain Registry, random data selection, blinded end point  analysis, benefit–risk profile Correspondence: Michael A Ueberall Institute of Neurological Sciences, Nordostpark 51, 90411 Nuernberg, GermanyTel +49 911 2177 3760Fax +49 911 2177 3761Email michael.ueberall@ifnap.deJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ueberall and Mueller-SchwefeRunning head recto: Efficacy and tolerability balance of OXN and TAP in cLBP-NCDOI: http://dx.doi.org/10.2147/JPR.S112418",Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://www.nccn.org/professionals/physician_gls/ pdf/pain.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205777lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://www.dgss.org/deutscher- schmerzfragebogen.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available  at http://www.dgss.org/fileadmin/pdf/12_DSF_Manual_2012.2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available from: https://www.gelbe-liste.de/produkte/palexia-retard-100-mg-retardtabletten_528663/fachinformation.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available  from: https://www.gelbe-liste.de/produkte/targin-10-mg-5-mg-retard-tabletten_486051/fachinformation.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://www.ich.org/filead-min/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1020 Ueberall and Mueller-Schwefe  70.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://www.dgss.org/fileadmin/pdf/12_DSF_Manual_2012.2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
Available at http://daris.kbv.de/daris.asp.,Non-OADS,/arxiv_data1/oa_pdf/bb/91/jpr-9-1001.PMC5115682.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2927–2939Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2927OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10115 1 sex differences in the course of schizophrenia  across diverse regions of the world Diego Novick1 William Montgomery2 Tamas Treuer3 Maria Victoria Moneta4 Josep Maria haro4 1eli lilly and company, Windlesham,   surrey, UK; 2eli lilly australia Pty ltd,   West ryde, N sW, australia; 3eli lilly  and company, Neuroscience research,   Budapest, hungary; 4Parc sanitari sant  Joan de Déu, ciBersaM, Universitat  de Barcelona, Barcelona, spainAbstract:  This study explores sex differences in the outcomes of patients with schizophrenia  (clinical/functional remission and recovery) across diverse regions of the world (Northern  Europe, Southern Europe, Central and Eastern Europe, Latin America, East Asia, and North  Africa and the Middle East).",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
"These include the following tendencies in females:  1) later onset of illness,10–13 2) fewer negative symptoms,14–19 3) a less severe form  of illness,20 4) better premorbid functioning,21–23 5) better social functioning or social correspondence: Diego Novick eli lilly and company, lilly research  centre, erl Wood Manor, sunninghill  road, Windlesham, surrey gU20  6Ph, UK Tel +44 1276 483 832 Fax +44 1276 483 192 email novick_diego@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Novick et al Running head recto: Sex differences in schizophrenia worldwide DOI: http://dx.doi.org/10.2147/NDT.S101151",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
"The  poster’s abstract was published in Schizophrenia Research  Volume 153, Supplement 1, S1-S402 ( http://www.schres- journal.com/issue/S0920-9964(14)X0004-6?page=1 9).",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/d6/ndt-12-2927.PMC5115683.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2949–2956Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2949OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11832 6 altered spontaneous brain activity pattern in  patients with high myopia using amplitude of low- frequency fluctuation: a resting-state fMRI study Xin huang1,2,* Fu-Qing Zhou3,* Yu-Xiang hu1 Xiao-Xuan Xu1 Xiong Zhou4 Yu-lin Zhong1 Jun Wang4 Xiao-rong Wu1 1Department of Ophthalmology, The  First affiliated hospital of Nanchang  University, Nanchang, 2Department  of Ophthalmology, The First People’s  hospital of Jiujiang city, Jiujiang,   3Department of radiology, The First  affiliated hospital of Nanchang  University, Jiangxi Province Medical  imaging research institute, 4second  Department of respiratory Disease,   Jiangxi Provincial People’s hospital,   Nanchang, Jiangxi, People’s republic  of china *These authors contributed equally  to this workObjective:  Many previous reports have demonstrated significant neural anatomy changes in  the brain of high myopic (HM) patients, whereas the spontaneous brain activity changes in the  HM patients at rest are not well studied.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
"A previous study demonstrated using  OCT method that the HM eyes have less retinal nerve fiber thickness compared with  emmetropic eyes.11 Another study reported that the OCT examinations could reveal  the types of abnormalities around the optic disc in HM eyes.12 Meanwhile, OCT correspondence: Xiao-rong Wu Department of Ophthalmology, The  First Affiliated Hospital of Nanchang  University, 17 YongWai Zheng street,  Donghu District, Nanchang 330006,  Jiangxi, People’s republic of china Tel +86 136 1709 3259 email wxr98021@126.co m  Jun Wang second Department of respiratory  Disease, Jiangxi Provincial People’s  hospital, 152 aiguo road, Donghu  District, Nanchang 330006, Jiangxi,  People’s republic of china Tel +86 189 7005 5686 email wangjun5087@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Huang et al Running head recto: ALFF study in high myopic patient DOI: http://dx.doi.org/10.2147/NDT.S118326",Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
"The rest of the data was preprocessed by Data  Processing Asisstant for Resting-State fMRI, version 2.3  (http://rfmri.org/DPARS F) software, including slice timing,  head motion correction, spatial normalization, and smooth - ing with a Gaussian kernel of 6 ×6×6 mm3 full width at half  maximum.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/f1/ndt-12-2949.PMC5115684.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2831–2838International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2831OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10413 6 COPD care delivery pathways in five European  Union countries: mapping and health care  professionals’ perceptions reem Kayyali,1 Bassel  Odeh,1 Inéz Frerichs,2 nikki  Davies,3 eleni Perantoni,4  shona D’arcy,5 anouk W  Vaes,6 John Chang,3 Martijn  a spruit,6 Brenda Deering,7  nada Philip,1 roshan siva,3  evangelos Kaimakamis,8  Ioanna Chouvarda,8 Barbara  Pierscionek,1 norbert Weiler,2  emiel FM Wouters,6 andreas  raptopoulos,9 shereen  nabhani-gebara1 1Faculty of science, engineering and  Computing, Kingston University,   Kingston-Upon-Thames, UK; 2Department  of anaesthesiology and Intensive Care  Medicine, University Medical Centre  schleswig-holstein, Kiel, germany; 3Chest  Clinic and research and Development,   Croydon University hospital, Croydon,   UK; 4Pulmonary Clinic, ahePa University  hospital, Thessaloniki, greece; 5Department  of Medicine, royal College of surgeons  in Ireland, Dublin, Ireland; 6research and  education, CI rO – Centre of expertise  for Chronic Organ Failure, horn,   the netherlands; 7COPD Outreach,   Beaumont hospital, Dublin, Ireland;   8Medical school, aristotle University,   Thessaloniki, 9research and Development,   exodus Information T echnology sa,   athens, greeceBackground:  COPD is among the leading causes of chronic morbidity and mortality in the  European Union with an estimated annual economic burden of €25.1 billion.",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"Keywords:  COPD, comorbidities, care delivery pathway, comparative analysis Introduction COPD is a common preventable and treatable pulmonary disease with symptoms  of dyspnea, cough, and sputum production.1 COPD is among the leading causes of  chronic morbidity and mortality in the European Union (EU) with ~300,000 people  with the condition dying each year.2 The prevalence of COPD has been increasing with  different ratios nationally and even regionally.3,4 Table 1 summarizes COPD statistics  in Germany, Greece, Ireland, the Netherlands, and the UK.5–8 The estimated annual economic burden of COPD in Europe, in terms of direct  (health care) and indirect (lost production) costs, is €25.1 billion.4 In addition, acute  exacerbations increase health care use, accelerate decline in lung function, and reduce  patients’ quality of life (QoL).1 Chronic diseases often develop together, and comorbidities markedly affect  health outcomes in COPD.9 In fact, patients with COPD mainly die of nonrespiratory Correspondence: reem Kayyali Faculty of science, engineering and Computing,  Kingston University, Penrhyn road, Kingston  upon Thames KT1 2ee, United Kingdom Tel +44 208 417 2561 email r.kayyali@kingston.ac.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kayyali et al Running head recto: COPD care delivery pathways in five EU countries DOI: http://dx.doi.org/10.2147/COPD.S104136",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
Methods This was a two-phase study conducted as a part of the  WELCOME project ( http://www.welcome-project.e u).27  It mapped the current COPD patients’ care pathways as a first  stage and then explored HCPs’ perceptions as a second stage.,Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
Available from: http://stats.oecd.org/Index.aspx?DatasetCode=sh a.5  bData from european respiratory society.6,Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"Available from: http://www.europeanlung.org/en/ lung-disease-and-information/lung-diseases/cop d. Accessed December 9,  2014.",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"Available from: http://stats.oecd.org/Index.aspx?DataSetCode=SH A.  Accessed March 20, 2015.",OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"Available from: http://www.europeanlung.org/ en/lung-disease-and-information/lung-diseases/cop d. Accessed  December 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4d/ef/copd-11-2831.PMC5115685.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1631–1644Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1631OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10293 0 effectiveness of the Vital Aging program to  promote active aging in Mexican older adults neyda Ma Mendoza- ruvalcaba1 rocío Fernández- Ballesteros2 1health sciences Department,   University of guadalajara, University  Center of T onalá, T onalá, Jalisco,   Mexico; 2Department of Biological  and health Psychology, Autonomous  University of Madrid, Madrid, spainIntroduction:  Aging is not only a population phenomenon but also an experience and an indi - vidual reality.",Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
com.mx Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Mendoza-Ruvalcaba and Fernández-Ballesteros Running head recto: Vital Aging in Mexico DOI: http://dx.doi.org/10.2147/CIA.S102930,Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
"4) Vital Aging-OCW (Open Course Ware), the course is  supported by the Autonomous University of Madrid in the  website http://ocw.uam.es/cursos/vivirconvitalidad/index.",Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
"Available from: http://www.activeageingaustralia.com.a u. Accessed  May 30, 2016.",OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
Available from: http://rlrw.bnu.edu.cn/NewsImage/   201241011 4358.p df.,Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3f/8d/cia-11-1631.PMC5115686.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/75/opth-10-2271.PMC5115687.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2271–2276Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2271Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11702 2 Comparison of choroidal thickness measurements  between spectral-domain OCT and swept-source  OCT in normal and diseased eyes sidra Zafar1 Ma rehman siddiqui2,3 rida shahzad1 1Medical College, aga Khan  University hospital, 2Department of  Ophthalmology, shahzad eye hospital,   3south City hospital, Karachi, PakistanPurpose:  Sub-foveal choroidal thickness (SFCT) is affected in many ocular diseases.",Non-OADS,/arxiv_data1/oa_pdf/20/75/opth-10-2271.PMC5115687.pdf
"Correspondence: Ma rehman siddiqui Department of Ophthalmology, shahzad  eye hospital, B-2, Block-16, gulshan-e- iqbal, Karachi, Pakistan Tel +92 321 289 4547 email rehman.siddiqui@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zafar et al Running head recto: Comparison of choroidal thickness between SD-OCT and SS-OCT DOI: http://dx.doi.org/10.2147/OPTH.S117022",Non-OADS,/arxiv_data1/oa_pdf/20/75/opth-10-2271.PMC5115687.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/20/75/opth-10-2271.PMC5115687.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/75/opth-10-2271.PMC5115687.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/ef/ijn-11-6035.PMC5115688.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6035–6046International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6035OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11706 6 Preparation and characterization of novel  chitosan–protamine nanoparticles for  nucleus-targeted anticancer drug delivery Xiwei Yu1 Jiahui hou1 Yijie shi1 chang su2 liang Zhao1 1school of Pharmacy, 2school of  Veterinary Medicine, Jinzhou  Medical University, Jinzhou, People’s  republic of chinaAbstract:  It is well known that most anticancer drugs commonly show high toxicity to the  DNA of tumor cells and exert effects by combining with the DNA or associated enzymes in  the nucleus.",Non-OADS,/arxiv_data1/oa_pdf/80/ef/ijn-11-6035.PMC5115688.pdf
"At present, biocompatible  and biodegradable nanoparticles (NPs) as an effective drug delivery device is widely correspondence: liang Zhao school of Pharmacy, Jinzhou Medical  University, No.40, section 3, songpo  road, linghe District, Jinzhou 121000,  People’s republic of china Tel +86 416 467 3439 Fax +86 416 467 3439 email liangzhao79@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yu et al Running head recto: Chitosan–protamine nanoparticles  DOI: http://dx.doi.org/10.2147/IJN.S117066",Non-OADS,/arxiv_data1/oa_pdf/80/ef/ijn-11-6035.PMC5115688.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/80/ef/ijn-11-6035.PMC5115688.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/ef/ijn-11-6035.PMC5115688.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/cia-11-1645.PMC5115689.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1645–1652Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1645OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11815 2 habitual cocoa intake reduces arterial stiffness  in postmenopausal women regardless of intake  frequency: a randomized parallel-group study Takanobu Okamoto1 ryota Kobayashi1 Midori natsume2 Koichi nakazato1 1Department of exercise Physiology,   nippon sport science University,   T okyo, Japan; 2Food sciences  research laboratories, Meiji Co ltd,   Kanagawa, JapanAbstract:  Arterial stiffness is substantially higher in postmenopausal than in premenopausal  women.",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/cia-11-1645.PMC5115689.pdf
"Acute and habitual intake of flavanol-enriched cocoa and/or dark chocolate was  reported to increase flow-mediated vasodilator response, thereby effectively lowering  blood pressure (BP).9,10 In addition, associations have been reported between habitual Correspondence: Takanobu Okamoto Department of exercise Physiology,  nippon sport science University,  7-1-1 Fukasawa, setagaya-ku,  Tokyo 158-8508, Japan Tel/fax +81 3 5706 0966 email tokamoto@nittai.ac.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Okamoto et al Running head recto: Cocoa intake frequency and arterial stiffness in postmenopause DOI: http://dx.doi.org/10.2147/CIA.S118152",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/cia-11-1645.PMC5115689.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e7/5b/cia-11-1645.PMC5115689.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e7/5b/cia-11-1645.PMC5115689.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 279–290International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 279 RevIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S103784 Rodent models of diabetic nephropathy: their  utility and limitations Munehiro Kitada1,2 Y oshio Ogura2 Daisuke Koya1,2 1Division of Anticipatory Molecular  Food Science and T echnology, Medical  Research Institute, 2Department  of Diabetology and endocrinology,   Kanazawa Medical University,  Uchinada, Ishikawa, JapanAbstract: Diabetic nephropathy is the most common cause of end-stage renal disease.",Non-OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
"Therefore, a novel and more Correspondence: Munehiro Kitada Department of Diabetology and endocrinology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japanemail kitta@kanazawa-med.ac.jpJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Kitada et alRunning head recto: Features of rodent models of diabetic nephropathyDOI: http://dx.doi.org/10.2147/IJNRD.S103784",Non-OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 290 Kitada et al  58.,Non-OADS,/arxiv_data1/oa_pdf/e0/8d/ijnrd-9-279.PMC5115690.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/4a/ijn-11-6023.PMC5115692.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6023–6033International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6023OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11528 6 Osseointegration of nanohydroxyapatite- or nano- calcium silicate-incorporated polyetheretherketone  bioactive composites in vivo rui Ma1,2 Zhifeng Yu1 songchao Tang3 Y ongkang Pan3 Jie Wei3 Tingting Tang1 1shanghai Key laboratory of  Orthopedic Implants, Department of  Orthopedic surgery, shanghai Ninth  People’s hospital, shanghai Jiao  T ong  University school of Medicine,   shanghai, People’s republic of china;   2Department of Orthopedic surgery,   The second affiliated hospital of  Xi’an Jiaotong University, Xi’an,   shanxi Province, People’s republic of  china; 3Key laboratory for Ultrafine  Materials of Ministry of education,   school of Materials science and  engineering, east china University  of science and T echnology, shanghai,   People’s republic of chinaAbstract:  Polyetheretherketone (PEEK) exhibits appropriate biomechanical strength as well as  good biocompatibility and stable chemical properties but lacks bioactivity and cannot achieve  highly efficient osseointegration after implantation.",Non-OADS,/arxiv_data1/oa_pdf/9a/4a/ijn-11-6023.PMC5115692.pdf
"In a clinical study, the combined use  of bone morphogenetic protein-2 (BMP-2) with PEEK increased the fusion rate (FR)  to 90.6%,7 while the FR of pure PEEK was only 70.6%.8 However, the use of BMP2 correspondence: Tingting Tang shanghai Key laboratory of Orthopedic  Implants, Department of Orthopedic  surgery, shanghai Ninth People’s hospital,  shanghai Jiao Tong University school of  Medicine, 639 Zhizaoju road, shanghai  200011, People’s republic of china Tel +86 21 2327 1133 Fax +86 21 6313 7020 email tingtingtang@hotmail.co m  Jie Wei Key Laboratory for Ultrafine Materials of  Ministry of education, school of Materials  science and engineering, east china  University of science and Technology,  130 Meilong road, shanghai 200237,  People’s republic of china email jiewei7860@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ma et al Running head recto: Osseointegration of n-HA/PEEK or n-CS/PEEK DOI: http://dx.doi.org/10.2147/IJN.S115286",Non-OADS,/arxiv_data1/oa_pdf/9a/4a/ijn-11-6023.PMC5115692.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9a/4a/ijn-11-6023.PMC5115692.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/4a/ijn-11-6023.PMC5115692.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/5d/dddt-10-3725.PMC5115693.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3725–3736Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3725Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11233 3 Systematic review and meta-analysis of  randomized controlled trials on wenxin keli Xiaoyi wang Ying wang Xiaoyuan Feng Ying Lu Yu Zhang wenwen wang wentao Zhu School of Management, Beijing  University of Chinese Medicine,   Beijing, People’s Republic of ChinaObjective:  The aim of the study was to evaluate the effectiveness, safety, and cost associated  with Wenxin keli in the treatment of cardiovascular diseases based on meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/d8/5d/dddt-10-3725.PMC5115693.pdf
"Wenxin keli has been used clinically in the treat - ment of qi and yin deficiency, systolic blood stasis due to restless heart palpitations, Correspondence: wentao Zhu School of Management, Beijing University  of Chinese Medicine, No 11, Beijing  North Third Ring Road, Chaoyang,  Beijing, People’s Republic of China Tel +86 10 6428 6475 Fax +86 10 6428 6475 email zhuwt@bucm.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: Meta-analysis of the effects of Wenxin keli DOI: http://dx.doi.org/10.2147/DDDT.S112333",Non-OADS,/arxiv_data1/oa_pdf/d8/5d/dddt-10-3725.PMC5115693.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d8/5d/dddt-10-3725.PMC5115693.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/5d/dddt-10-3725.PMC5115693.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2016:7 125–146Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  125 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S101631Psychological consequences of childhood   obesity: psychiatric comorbidity and prevention Jean Rankin1 Lynsay Matthews2 Stephen Cobley3 Ahreum Han3 Ross Sanders3 Huw D Wiltshire4 Julien S Baker5 1Department of Maternal and Child  Health, University of the West of  Scotland, Paisley, 2MRC/CSO Social  and Public Health Sciences Unit,  Institute of Health and Wellbeing,  University of Glasgow, Glasgow,  Scotland;  3Department of Exercise and  Sport Science, University of Sydney,  Sydney, Australia;  4Cardiff School of  Sport/Ysgol Chwaraeon Caerdydd,  Cardiff Metropolitan University,  Cardiff, UK;  5School of Science and  Sport, Institute of Clinical Exercise and Health Science, University of the West of Scotland, Hamilton, ScotlandAbstract:  Childhood obesity is one of the most serious public health challenges of the 21st  century with far-reaching and enduring adverse consequences for health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
"If current trends continue, then Correspondence: Jean Rankin Department of Maternal and Child Health, University of the West of Scotland, High Street, Paisley, Scotland PA1 2BEEmail j.rankin@uws.ac.ukJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: REVIEWY ear: 2016V olume: 7Running head verso: Rankin et alRunning head recto: Psychological consequences of childhood obesityDOI: http://dx.doi.org/10.2147/AHMT.S101631",Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
"Adolescent Health, Medicine and Therapeutics 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
Available from: http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4364.0.55.003main+ features12011-2012.,Non-OADS,/arxiv_data1/oa_pdf/6a/62/ahmt-7-125.PMC5115694.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3717–3724Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3717Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11509 9 Low-dose modified-release prednisone in axial  spondyloarthritis: 3-month efficacy and tolerability Francesca Bandinelli1 Francesco scazzariello1 emanuela Pimenta da  Fonseca2 Mittermayer Barreto  santiago2 claudio Marcassa3 Francesca nacci1 Marco Matucci cerinic1 1Department of experimental and  clinical Medicine, University of  Florence, Florence, italy; 2service of  Rheumatology, Hospital Santa Isabel,   Escola de Medicina e Saúde Pública,   Bahia, Brazil; 3Maugeri clinical and  scientific institutes, irccs, Veruno,   novara, italyBackground:  Oral glucocorticoids (GCs) have been shown to be effective in reducing the  inflammatory symptoms of rheumatoid arthritis, but their use is not supported by evidence in  spondyloarthritis (SpA).",Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
"Psoriasis,  uveitis, and inflammatory bowel disease frequently coexist.4–6correspondence: Francesca Bandinelli Department of experimental and clinical  Medicine, University of Florence, largo  Brambilla 3, IT 50139 Florence, Italy Tel +39 338 747 2303 Fax +39 055 749 9271 email bandin@hotmail.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Bandinelli et al Running head recto: MR prednisone in SpA DOI: http://dx.doi.org/10.2147/DDDT.S115099",Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/aa/dddt-10-3717.PMC5115695.pdf
"An  expert in gene therapy, Brian’s work will  enable the expression of the Neezalin  gene in germ cells, allowing the body to  produce the anti-cancer agent itself—a  trait that can be passed on to subsequent  generations, thereby potentially  eliminating cancer forever.Review of Bugging Cancer A book by Ananda Chakrabarty and the Chicago Oncogroup Roy D Sleator Department of Biological Sciences; Cork Institute of Technology; Cork, Ireland Correspondence to: Roy D Sleator;   Email: roy.sleator@cit.ie Published Online: 06/09/2014  http://dx.doi.org/10.4161/bioe.29530",Non-OADS,/arxiv_data1/oa_pdf/07/e8/kbie-05-04-10929530.PMC5115721.pdf
"The use of  dTPT3,17 an analog of d5SICS, in the in vitro synthesized pINF  provided an efficient means of confirming in vivo replication;  replacement of dTPT3 with d5SICS, supplied exogenously in  Correspondence to: Roy D Sleator; Email: roy.sleator@cit.ie Published Online: 05/21/2014  http://dx.doi.org/10.4161/bioe.29306Genetics just got SEXY Sequences encoding XY roy D Sleator Department of Biological Sciences; Cork Institute of Technology; Cork, Ireland",Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
"While the natural genetic code builds  proteins with just 20 amino acids building blocks,19 Romesberg’s  expanded code incorporates up to 172 amino acids, circumventing  the need to recode the translational functions of existing codons  as proffered by Lajoie et al.20 The obvious commercial potential of the research is not lost  on Romesberg who is co-founder of Synthorx (http://www.synthorx.com), a San Diego based biotech company, the launch  of which coincided with the publication of the Malyshev et al.,  paper.1 A stated aim of Synthorx is to exploit the potential of  UBPs to improve the discovery and development of new drugs,  diagnostics, and vaccines as well as creating innovative products,  including research reagents, aptamers, and nanomaterials.",Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Nature  1953; 171:737-8;  PMID:13054692 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Nature 2014; 509:291-2;   PMID:24805244 ; http://dx.doi.org/10.1038/ nature13335 6.,Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Nature 1992;  356:537-9;  PMID :1560827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J  Am Chem Soc 1995; 117:1863-72;  PMID:20882111 ;  http://dx.doi.org/10.1021/ja00112a001 8.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Nucleic Acids Res 2012; 40:2793-806;   PMID:22121213 ; http://dx.doi.org/10.1093/nar/ gkr1068 10.,Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Am Chem Soc 2011;  133:15105-12 ;  PMID:21842904 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Am Chem Soc 2002; 124:14626- 30; PMID:12465973 ; http://dx.doi.org/10.1021/ ja028050m 12.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Mol Evol  2003; 56:137-50;  PMID:12574860 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Eukaryot Microbiol  2004; 51:509-14;  PMID :15537084 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Proc Natl Acad Sci U S A 2009; 106:3621-6;   PMID:19221027 ; http://dx.doi.org/10.1073/ pnas.0808862106 15.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Nucleic Acids Res 2011; 39:7020-33;   PMID:21622658 ; http://dx.doi.org/10.1093/nar/ gkr15716.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Am Chem Soc  2009; 131:5046-7;  PMID:19351201 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
J Am Chem Soc 2014; 136:826-9;  PMID:24152106 ;  http://dx.doi.org/10.1021/ja408814g 18.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Annu Rev Biochem  2002; 71:17-50;  PMID:12045089 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Bioeng  Bugs 2012; 3:80-5;  PMID:22095055 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
Science  2013; 342:357-60;  PMID:24136966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/7f/kbie-05-04-10929306.PMC5115725.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/esmoopen-2016-000106).,Non-OADS,/arxiv_data1/oa_pdf/0b/4c/esmoopen-2016-000106.PMC5115812.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/Click here to listen to the Podcast Cardoso F. ESMO Open 2016; 1:e000106.,Non-OADS,/arxiv_data1/oa_pdf/0b/4c/esmoopen-2016-000106.PMC5115812.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000113).,Non-OADS,/arxiv_data1/oa_pdf/4b/88/esmoopen-2016-000113.PMC5115814.pdf
To view please visit the journal (http://dx.doi.org/10.1136/esmoopen-2016- 000087).,Non-OADS,/arxiv_data1/oa_pdf/79/bd/esmoopen-2016-000087.PMC5115815.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/bd/esmoopen-2016-000087.PMC5115815.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000103).,Non-OADS,/arxiv_data1/oa_pdf/65/be/esmoopen-2016-000103.PMC5115816.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ esmoopen-2016-000100).,Non-OADS,/arxiv_data1/oa_pdf/04/32/esmoopen-2016-000100.PMC5115817.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/32/esmoopen-2016-000100.PMC5115817.pdf
"8 In addition, the authors state that When to screen and not to screen Nichola Cruickshanks Department of Biochemistry; Virginia Commonwealth University; Richmond, VA USA Keywords:  EGFR, cetuximab, colon  carcinoma, monoclonal antibodies, panitumumab, resistance Submitted: 01/06/2014Accepted: 01/06/2014http://dx.doi.org/10.4161/cbt.27741 Correspondence to: Nichola Cruickshanks;   Email: ncruickshank@vcu.edu Commentary to: Esposito C, Rachiglio AM, La Porta ML, Sacco A, Roma C, Iannaccone A, Tatan - gelo F, Forgione L, Pasquale R, Barbaro A, et al.",Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Cancer Biol Ther 2013; 14:1143-6; PMID:24025416; http://dx.doi.org/10.4161/cbt.26340CommenT ary,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Cancer Treat  Rev 2010; 36(Suppl 3):S56-61; PMID:21129611 ;  http://dx.doi.org/10.1016/S0305-7372(10)70021-9 2.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Trends Cell Biol 2014 ; 24:26-34; PMID:24295852 ;  http://dx.doi.org/10.1016/j.tcb.2013.11.002 3.,OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Front  Oncol  2013 ; 3:281; PMID:24298448 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
N Engl J Med 2004 ;  351:337-45; PMID :15269313 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
BMC Res Notes  2013 ; 6:508; PMID:24304820 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Cancer Chemother Pharmacol  2013 ; 72:397- 403; PMID:23765179 ; http://dx.doi.org/10.1007/ s00280-013-2211-0 8.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Cancer Biol Ther  2013 ; 14:1143 -6; PMID:24025416 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/3c/kcbt-15-02-10927741.PMC5115864.pdf
Available at: http://ed.ted.com/ lessons/why-sitting-is-bad-for-you-murat-dalkilinc (accessed on 30 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/49/ijo2016136a.PMC5116050.pdf
"fALFF calculations The fALFF calculations were carried out using the Rest toolbox (Resting-State fMRI Data Analysis Toolkit V1.8, REST-Group, http://www.restfmri.net).16 First, the signal was linearly detrended to correct for signal drift.",OADS,/arxiv_data1/oa_pdf/04/5e/ijo2016105a.PMC5116051.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Contribution of a ﬁrst-degree FHD to serum A-FABP XH u et al 1654 International Journal of Obesity (2016) 1649 –1654",Non-OADS,/arxiv_data1/oa_pdf/d8/80/ijo2016147a.PMC5116052.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Brown fat in DIT and fat oxidation M Hibi et al 1661 International Journal of Obesity (2016) 1655 –1661",Non-OADS,/arxiv_data1/oa_pdf/e6/80/ijo2016124a.PMC5116053.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)SUMOylation and SENP3 in STAT3 activation Z Zhou et al 5838 Oncogene (2016) 5826 –5838 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/93/29/onc2016124a.PMC5116054.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
We used Bioclim variables (20) available athttp://www.worldclim.org at 30 arc seconds resolution.A table explaining the Bioclim variables has been added as Supplementary File.,OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"(a) Map of the study area showing the location of Baringo County, (b) the sub-county administrative units within Baringo County with the study area shaded out green, and (c) the ecological zones within the study area, sampling sites and the 2006/2007 R VF outbreak points.Rift Valley fever modelling Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"The highest habitat suitability for the R VF vectors is in the lowland area between Lake Baringo and Lake Bogoria.Rift Valley fever modelling Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"Acknowledgements The authors are grateful to the following individuals and institu- tions: the project ﬁeld staff for their role in data collection, Ministryof Health and Department of Veterinary Services in Baringo County for their support during this study, and the local communityRift Valley fever modelling Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
Infect Ecol Epidemiol 2015; 5: 28024. doi: http://dx.doi.org/10.3402/iee.v5.28024 8.,Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
Infect Ecol Epidemiol 2013; 3: 21748. doi: http://dx.doi.org/10.3402/iee.v3.21748 29.,Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"Nairobi: KNBS.Rift Valley fever modelling Citation: Infection Ecology and Epidemiology 2016, 6: 32322 - http://dx.doi.org/10.3402/iee.v6.32322 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/68/61/IEE-6-32322.PMC5116061.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"Lipids were quantified using an in-houselibrary on MultiQuant TMsoftware.High-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"Level of proteins and lipids in exosomes and microvesicles were later normalized to their respective source cells and expressed on a log(2) scale.High-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"MSC- and Huh7-derived EVs increasingly cluster together and segregate from U87 moving from microvesicles to exosomes.High-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"TM, transmembrane; ECM, extracellular matrix; ER, endoplasmic reticulum; CAM, cell adhesion molecule; VLDL, very low density lipoprotein; diS, disulphide.High-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"Since different lipid classes represent vastly different percentage of cells’ or vesicles’ lipid composition, the scale of the y-axes shows a corresponding variability.High-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"Molecular lipidomics of exosomesHigh-resolution proteomic and lipidomic analysis of EVs Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 32570 - http://dx.doi.org/10.3402/jev.v5.32570",OADS,/arxiv_data1/oa_pdf/cb/c2/JEV-5-32570.PMC5116062.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Oxytocin and food intake in obese and lean men M Thienel et al 1714 International Journal of Obesity (2016) 1707 –1714",Non-OADS,/arxiv_data1/oa_pdf/74/7b/ijo2016149a.PMC5116063.pdf
The E-AIM Model II is accessible online at (http://www.aim.env.uea.ac.uk/ aim/model2/model2a.php).,Non-OADS,/arxiv_data1/oa_pdf/b2/c2/ncomms13444.PMC5116067.pdf
https://data.gov.uk/dataset/global-ammonia-emissions-from- seabirds (2012).,OADS,/arxiv_data1/oa_pdf/b2/c2/ncomms13444.PMC5116067.pdf
"Circumpolar Seabird Data Portal, available at http://axiom.seabirds.net/circumpolar_portal.php (last access, 2015).",OADS,/arxiv_data1/oa_pdf/b2/c2/ncomms13444.PMC5116067.pdf
All the authors contributed to the writing of this paper.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/c2/ncomms13444.PMC5116067.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Croft, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/b2/c2/ncomms13444.PMC5116067.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/c5/hepatmon-16-10-38920.PMC5116105.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/b8/hepatmon-16-10-32457.PMC5116124.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/e4/hepatmon-16-10-40140.PMC5116126.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/58/hepatmon-16-10-39909.PMC5116127.pdf
"At ﬁrst, by analysis the HBV genome (GenBank: X70185.1) in sequence search option of Pfam 30.0 (http://pfam.xfam.org/search/sequence), six-frame translation of this gene and their characteristics were obtained.",OADS,/arxiv_data1/oa_pdf/06/58/hepatmon-16-10-39909.PMC5116127.pdf
"On the other hand, by introducing the DNA sequence of HBV (GenBank: X70185.1) into Pfam search tool (http://pfam.xfam.org/search#tabview=tab1), it searches for matching Pfam families.",OADS,/arxiv_data1/oa_pdf/06/58/hepatmon-16-10-39909.PMC5116127.pdf
"For this, these Pfam IDs were introduced in the PFAM Accession ID menu of Sherlocc Finder Interface (http://bcb.med.usherbrooke.ca/sherlocc_ﬁnder.php) and the RCCs of HBV proteins and their properties were de- tected and shown as a table in Sherlocc Finder Interface.",OADS,/arxiv_data1/oa_pdf/06/58/hepatmon-16-10-39909.PMC5116127.pdf
Available from: http://www.citeulike.org/group/340/article/240061 .,Non-OADS,/arxiv_data1/oa_pdf/06/58/hepatmon-16-10-39909.PMC5116127.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/32/hepatmon-16-10-40492.PMC5116128.pdf
Available from: http://www.who.int/csr/disease/hepatitis/ world_hepatitis_day/en /.,Non-OADS,/arxiv_data1/oa_pdf/8f/32/hepatmon-16-10-40492.PMC5116128.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/12/iranjradiol-13-04-28230.PMC5116173.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/ed/iranjradiol-13-04-23636.PMC5116209.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/3e/iranjradiol-13-04-31069.PMC5116225.pdf
"E-mail: bwonkoba@gmail.com Original Article DOI: http://dx.doi.org/10.4314/ovj.v6i3.6 Submitted: 05/04/2016 Accepted: 27/09/2016 Published: 04/11/2016 Metabolic and adaptive immune responses induced in mice infected with  tissue-dwelling nematode Trichinella zimbabwensis N. Onkoba1, 2,*, M.J. Chimbari1, J.M.",Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
http://www.openveterinaryjournal.com N. Onkoba et al.,Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
"2014, Article ID  856749. http://dx.doi.org/10.1155/2014/856749.",Non-OADS,/arxiv_data1/oa_pdf/98/4e/OpenVetJ-6-178.PMC5116437.pdf
6(3): 185-193  ISSN: 2226 -4485 (Print)  Original Article   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v6i3.7     _____________________________________________________________________________________________________ ___  *Corresponding Author: Mario Ricciardi.,Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"MDCT image analysis    For selected patients, MDCT data were retrieved and  restored from picture archiving and communication  systems (PACS) ( Marcel van Herk, “Conquest DICOM  software.” Online Available:  http://ingenium.home.xs4all.nl/dicom.html.)",OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016 ), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016 ), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016 ), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
"http://www.openveterinaryjournal.com   M. Ricciardi  Open Veterinary Journal , (2016 ), Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/9f/OpenVetJ-6-185.PMC5116438.pdf
ARPAN-SA 2008; http://www.arpansa.gov.au/publications/codes/rps14_3.cfm.,OADS,/arxiv_data1/oa_pdf/be/9f/JCB-8-28550.PMC5116448.pdf
Available at: https://www.embracestudy.dk/ About.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a2/36/JCB-8-28602.PMC5116450.pdf
Available from: http://www.nrc.gov/reading-rm/doc-col - lections/nuregs/staff/sr0090/.,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/JCB-8-28638.PMC5116452.pdf
Available from: http://www.estro.org/binaries/con- tent/assets/estro/about/gec-estro/ivd-seminar-2014/1_tanderup_k_seminarintroduction.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/b1/JCB-8-28638.PMC5116452.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on Cancer Gene Therapy website (http://www.nature.com/cgt)Neoadjuvant Ad-REIC for localized prostate cancer H Kumon et al 409 Cancer Gene Therapy (2016), 400 –409",Non-OADS,/arxiv_data1/oa_pdf/2b/47/cgt201653a.PMC5116477.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Volumetric abnormalities in BD DP Hibar et al 1716 Molecular Psychiatry (2016), 1710 –1716",Non-OADS,/arxiv_data1/oa_pdf/e0/41/mp2015227a.PMC5116479.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)VEGF impact on NMDAR synaptic function P De Rossi et al 1780 Molecular Psychiatry (2016), 1768 –1780",Non-OADS,/arxiv_data1/oa_pdf/9d/81/mp2015195a.PMC5116482.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ oemed-2015-103194).,OADS,/arxiv_data1/oa_pdf/5f/05/oemed-2015-103194.PMC5116531.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McRobbie DW.,Non-OADS,/arxiv_data1/oa_pdf/5f/05/oemed-2015-103194.PMC5116531.pdf
2008. http://www.itis.ethz.ch/assets/Downloads/Papers-Reports/Reports/ VT2007017FinalReportv04.pdf (accessed 14 Oct 2015).,OADS,/arxiv_data1/oa_pdf/5f/05/oemed-2015-103194.PMC5116531.pdf
"2016 October;22(4):253-254.  https://doi.org/10.4258/hir.2016.22.4.253pISSN 2093-3681  •  eISSN 2093-369X  Editorial This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
254 www.e-hir.orgYoung-Taek Park https://doi.org/10.4258/hir.2016.22.4.253care industries.,Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
Avail-able from: http://www.healthitoutcomes.com/doc/the-rise-of-mhealth-0001.4.,Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
Available from: http://www.himss.org/news/2016-himss-connected-health-survey-suggests-positive-future-connected-health-technologies-us.,Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
Available from: http://www.pchaconference.org/pro-gram.,Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
Available from: https://www.nibib.nih.gov/news-events/newsroom/nih-supports-develop-ment-mobile-health-research-platform.,Non-OADS,/arxiv_data1/oa_pdf/7c/92/hir-22-253.PMC5116535.pdf
"2016 October;22(4):255-260.  https://doi.org/10.4258/hir.2016.22.4.255pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: September 5, 2016Accepted: October 16, 2016 Corresponding Author  Michael Rigby, PhDLavender Hill, 6 Carrighill Lower, Calverstown, Kilcullen, Co. Kildare, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
"E-mail: m.j.rigby@keele.ac.uk This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
256 www.e-hir.orgMichael Rigby et al https://doi.org/10.4258/hir.2016.22.4.255sential (and arguably the only) means of generating evidence  on which to base informed practice.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
258 www.e-hir.orgMichael Rigby et al https://doi.org/10.4258/hir.2016.22.4.255cerned its extension and adaptation to cover aspects of social  and healthcare integration as well as its application in ac-cordance with HTA methodological recommendations for observational studies.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://www.bcs.org/category/6044.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://hijournal.bcs.org/index.php/jhi.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://theprsb.org.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://www.bcs.org/content/ConWebDoc/38891.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
260 www.e-hir.orgMichael Rigby et al https://doi.org/10.4258/hir.2016.22.4.255ering organizations to improve the safety and effective- ness of electronic health records.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://inahta.episerverhotell.net/upload/HTA_resources/Edu_INAHTA_glossary_July_2006_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://htaglossary.net.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://patientregistries.eu/docu - ments/10184/0/Parent+registies.pdf/3fc47a86-a9aa-47dd-a47d-b8a8d79834cf.,Non-OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
Available from: http://www.oecd.org/els/health-systems/measuring-icts-in-the-health-sector.htm.,OADS,/arxiv_data1/oa_pdf/1f/c3/hir-22-255.PMC5116536.pdf
"2016 October;22(4):261-269.  https://doi.org/10.4258/hir.2016.22.4.261pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: September 6, 2016Revised: September 25, 2016Accepted: September 27, 2016 Corresponding Author  Sunil Kumar Srivastava, PhDMinistry of Electronics & Information Technology, Government of India, Electronics Niketan, 6, Lodi Road, New Delhi, India.",Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
"Tel: +91-1124366293, E-mail: sks@meity.gov.in This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
"262 www.e-hir.orgSunil Kumar Srivastava https://doi.org/10.4258/hir.2016.22.4.261nology (ICT) cannot work as a panacea, it can provide a  cost-effective solution to improve the quality and coverage as demonstrated in other countries.",Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
"264 www.e-hir.orgSunil Kumar Srivastava https://doi.org/10.4258/hir.2016.22.4.261 Regulations have been enacted for privacy protection, en- abling the exchange of health information for the collection  of patient information for use in clinical research and other purposes.",Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
266 www.e-hir.orgSunil Kumar Srivastava https://doi.org/10.4258/hir.2016.22.4.261It is required for exchange of EHR among healthcare pro- viders.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
268 www.e-hir.orgSunil Kumar Srivastava https://doi.org/10.4258/hir.2016.22.4.261 The Ministry of Electronics & IT has been supporting the  development and deployment of digital health solution for  a long time.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://meity.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://mohfw.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://digital.nhs.uk.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://researchbriefings.parliament.uk/ResearchBriefing/Summary/POST-PN-0519.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.healthit-board.health.govt.nz.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.cms.gov.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: https://www.healthit.gov.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.maxhealthcare.in.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.apollohospitals.com.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.sankaranethralaya.org.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.openehr.org/.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.cen.eu/.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.hl7.org.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://dicom.nema.org.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.who.int/whosis/icd10.,OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Avail-able from: http://www.ihtsdo.org.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: https://loinc.org.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.hitsp.org/.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.cchit.org/.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.ehos-pital.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.aiims.edu.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
Available from: http://www.nhp.gov.in.,Non-OADS,/arxiv_data1/oa_pdf/92/d2/hir-22-261.PMC5116537.pdf
"2016 October;22(4):270-276.  https://doi.org/10.4258/hir.2016.22.4.270pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 20, 2016Accepted: September 30, 2016 Corresponding Author  Mona Choi, PhD, RNCollege of Nursing, Mo-Im Kim Nursing Research Institute, Yonsei University, 50 Yonsei-ro, Seodaemoon-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
"Tel: +82-2-2228-3341, E-mail: monachoi@yuhs.ac This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
"272 www.e-hir.orgMeejung Ahn et al https://doi.org/10.4258/hir.2016.22.4.270nursing experience in the current ward, and the shift worked  on the date and days of the week on which the electronic nursing documentation was entered.",OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
"274 www.e-hir.orgMeejung Ahn et al https://doi.org/10.4258/hir.2016.22.4.270difference in the timeliness, with 77.1% occurring during  weekdays and 85.7% on weekends.",OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
276 www.e-hir.orgMeejung Ahn et al https://doi.org/10.4258/hir.2016.22.4.270classification of standard nursing activities in Korea.,Non-OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
Avail-able from: http://Khna.or.kr/web/information/resource.php.,Non-OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
Available from: http://ecminer.com/product.,Non-OADS,/arxiv_data1/oa_pdf/27/ef/hir-22-270.PMC5116538.pdf
"2016 October;22(4):277-284.  https://doi.org/10.4258/hir.2016.22.4.277pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: June 21, 2016Revised: August 3, 2016Accepted: August 9, 2016 Corresponding Author  In Ho Kwon, MD, MPHDepartment of Emergency Medicine, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 49201, Korea.",Non-OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
"Tel: +82-51-240-5590, E-mail: inho.kwon@gmail.com This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
278 www.e-hir.orgYuri Choi et al https://doi.org/10.4258/hir.2016.22.4.277and New Zealand were found [10].,OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
280 www.e-hir.orgYuri Choi et al https://doi.org/10.4258/hir.2016.22.4.277Table 3.,OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
282 www.e-hir.orgYuri Choi et al https://doi.org/10.4258/hir.2016.22.4.277mostly limited to certain age groups or a few hospitals.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
https://doi.org/10.1111/imj.13039.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
284 www.e-hir.orgYuri Choi et al https://doi.org/10.4258/hir.2016.22.4.27717.,OADS,/arxiv_data1/oa_pdf/26/8c/hir-22-277.PMC5116539.pdf
"2016 October;22(4):285-292.  https://doi.org/10.4258/hir.2016.22.4.285pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 17, 2016Revised: September 26, 2016Accepted: September 28, 2016 Corresponding Author  Jeongjin Lee, PhDSchool of Computer Science & Engineering, Soongsil University, 369, Sangdo-ro, Dongjak-gu, Seoul 06978, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
"Tel: +82-2-820-0911, E-mail: leejeongjin@ssu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
"286 www.e-hir.orgHo Chul Kang et al https://doi.org/10.4258/hir.2016.22.4.285 Computed tomography angiography (CTA), magnetic  resonance imaging (MRI), and single-photon-emission com- puted tomography (SPECT) are widely used, non-invasive cardiac imaging modalities.",Non-OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
288 www.e-hir.orgHo Chul Kang et al https://doi.org/10.4258/hir.2016.22.4.285boundary of heart.,Non-OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
290 www.e-hir.orgHo Chul Kang et al https://doi.org/10.4258/hir.2016.22.4.285× 0.70 mm.,OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
Available from: https://hal.archives-ouvertes.fr/hal-00403627v1/.,Non-OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
"292 www.e-hir.orgHo Chul Kang et al https://doi.org/10.4258/hir.2016.22.4.285Paragios N, Chen Y , Faugeras O, editors.",OADS,/arxiv_data1/oa_pdf/d6/6b/hir-22-285.PMC5116540.pdf
"2016 October;22(4):293-298.  https://doi.org/10.4258/hir.2016.22.4.293pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 18, 2016Revised: September 25, 2016Accepted: September 28, 2016 Corresponding Author  Ji-Wook Jeong, PhDElectronics & Telecommunications Research Institute, 218, Gajeong-ro, Yuseong-gu, Daejeon 34129, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f7/08/hir-22-293.PMC5116541.pdf
"Tel: +82-42-860-1056, E-mail: jwj@etri.re.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/08/hir-22-293.PMC5116541.pdf
"294 www.e-hir.orgJi-Wook Jeong et al https://doi.org/10.4258/hir.2016.22.4.293long time to perform conventional breast ultrasonography  for breast cancer screening with some breast regions still left  unscanned; thus, recently various studies have been reported regarding the development of the three-dimensional (3D) breast scanning devices to overcome these shortcomings [7,8].",Non-OADS,/arxiv_data1/oa_pdf/f7/08/hir-22-293.PMC5116541.pdf
"296 www.e-hir.orgJi-Wook Jeong et al https://doi.org/10.4258/hir.2016.22.4.293els on line (lij) between the center points of the i-th and j-th  Hough cubes, Lij is the length of lij described above, and ∆cσi  is the standard deviation of the grey level values of voxels  on lij.",Non-OADS,/arxiv_data1/oa_pdf/f7/08/hir-22-293.PMC5116541.pdf
298 www.e-hir.orgJi-Wook Jeong et al https://doi.org/10.4258/hir.2016.22.4.293Hendrick RE.,OADS,/arxiv_data1/oa_pdf/f7/08/hir-22-293.PMC5116541.pdf
"2016 October;22(4):299-304.  https://doi.org/10.4258/hir.2016.22.4.299pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 7, 2016Revised: September 27, 2016Accepted: September 29, 2016 Corresponding Author  Sun Kook Yoo, PhDDepartment of Medical Engineering, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
"Tel: +82-2-2228-1921, E-mail: sunkyoo@yuhs.ac This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
300 www.e-hir.orgByung Eun Park et al https://doi.org/10.4258/hir.2016.22.4.299sicians usually observe the injury symptoms to make a diag- nosis.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
302 www.e-hir.orgByung Eun Park et al https://doi.org/10.4258/hir.2016.22.4.299from the mean feature (p < 0.0001) and the lowest difference  from the smoothness feature (p < 0.0001).,OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
Avail-able from: https://en.wikipedia.org/wiki/Supraspinatus_muscle.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
"304 www.e-hir.orgByung Eun Park et al https://doi.org/10.4258/hir.2016.22.4.299Cavouras D, Theodoridis S. Mammographic masses  characterization based on localized texture and dataset fractal analysis using linear, neural and support vector machine classifiers.",OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
Available from: https://en.wikipedia.org/wiki/Sensitiv-ity_and_specificity 11.,Non-OADS,/arxiv_data1/oa_pdf/74/4b/hir-22-299.PMC5116542.pdf
"2016 October;22(4):305-315.  https://doi.org/10.4258/hir.2016.22.4.305pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 17, 2016Revised: September 27, 2016Accepted: September 29, 2016 Corresponding Author  Kwang Gi Kim, PhDBiomedical Engineering Branch, Division of Precision Medicine and Cancer Informatics, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea.",Non-OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
"Tel: +82-31-920-2241, E-mail: kimkg@ncc.re.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
306 www.e-hir.orgYoung Jae Kim et al https://doi.org/10.4258/hir.2016.22.4.305the development of a cancer marker capable of detecting  cancer in its early stage is urgently required to improve the treatment and prognosis of lung cancer patients [2].,Non-OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
308 www.e-hir.orgYoung Jae Kim et al https://doi.org/10.4258/hir.2016.22.4.305tion following binarization.,OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
"310 www.e-hir.orgYoung Jae Kim et al https://doi.org/10.4258/hir.2016.22.4.305tion, which was used for quantitative evaluation.",OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
312 www.e-hir.orgYoung Jae Kim et al https://doi.org/10.4258/hir.2016.22.4.305ings with histopathological results.,Non-OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
314 www.e-hir.orgYoung Jae Kim et al https://doi.org/10.4258/hir.2016.22.4.3053.,OADS,/arxiv_data1/oa_pdf/54/4a/hir-22-305.PMC5116543.pdf
"2016 October;22(4):316-325.  https://doi.org/10.4258/hir.2016.22.4.316pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 18, 2016Revised: September 29, 2016Accepted: September 30, 2016 Corresponding Author  Seungryong Cho, PhDDepartment of Nuclear and Quantum Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
"Tel: +82-42-350-3828, E-mail: scho@kaist.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
318 www.e-hir.orgBoyeol Yoo et al https://doi.org/10.4258/hir.2016.22.4.3161.,OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
320 www.e-hir.orgBoyeol Yoo et al https://doi.org/10.4258/hir.2016.22.4.316 A B C DFigure 3.,OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
"322 www.e-hir.orgBoyeol Yoo et al https://doi.org/10.4258/hir.2016.22.4.316confirmed, the image noise level in the outer ROI is higher  than that in the inner ROI.",OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
"324 www.e-hir.orgBoyeol Yoo et al https://doi.org/10.4258/hir.2016.22.4.316system due to the off-axis margin, can be increased to 52  cm by shifting the detector almost all of the way toward the rotation axis.",OADS,/arxiv_data1/oa_pdf/fd/f4/hir-22-316.PMC5116544.pdf
"2016 October;22(4):326-332.  https://doi.org/10.4258/hir.2016.22.4.326pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: June 14, 2016Revised: July 25, 2016Accepted: July 27, 2016 Corresponding Author  Mostafa Langarizadeh, MSc, PhDDepartment of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
"Tel: +98-9198616016, E-mail: Langarizadeh.m@iums.ac.ir This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
328 www.e-hir.orgHaleh Ayatollahi et al https://doi.org/10.4258/hir.2016.22.4.326to satisfaction with the system.,Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
330 www.e-hir.orgHaleh Ayatollahi et al https://doi.org/10.4258/hir.2016.22.4.326that their expectations and the level of meeting their expec- tations were different in both hospitals.,Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
332 www.e-hir.orgHaleh Ayatollahi et al https://doi.org/10.4258/hir.2016.22.4.32618.,Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
http://doi.org/10.1097/CIN.0000000000000293.,Non-OADS,/arxiv_data1/oa_pdf/21/0a/hir-22-326.PMC5116545.pdf
"2016 October;22(4):333-341.  https://doi.org/10.4258/hir.2016.22.4.333pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 7, 2016Revised: September 24, 2016Accepted: September 27, 2016 Corresponding Author  Hwa Jeong Seo, PhDMedical Informatics and Health Technology (MIT), Department of Healthcare Management, College of Social Science, Gachon Univer-sity, 1342 Seongnamdaero, Sujeong-gu, Seongnam 13120, Korea.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
"Tel: +82-31-750-8741, E-mail: hjseo@gachon.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
"334 www.e-hir.orgEun Min Jeon and Hwa Jeong Seo https://doi.org/10.4258/hir.2016.22.4.333the global wearable device market will reach US$ 14 billion  in 2018 [3], while Gartner predicted that the global IoT mar - ket will reach US$ 309.0 billion in 2020 and that healthcare will take up the highest ratio at 15% of the IoT market [4].",Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
"336 www.e-hir.orgEun Min Jeon and Hwa Jeong Seo https://doi.org/10.4258/hir.2016.22.4.333minutes of access to a hospital, and 46 people (15.5%) said  they were more than 30 minutes from a hospital (Table 1).",OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
"338 www.e-hir.orgEun Min Jeon and Hwa Jeong Seo https://doi.org/10.4258/hir.2016.22.4.333management necessity was 0.210 (p  = 0.000), and the correla- tion coefficient between health concerns and acceptability was  0.198 (p  = 0.001); therefore, there were positive correlations.",OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
340 www.e-hir.orgEun Min Jeon and Hwa Jeong Seo https://doi.org/10.4258/hir.2016.22.4.333areas.,Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
Available from: https://healthmanagementacademyin-public.sharepoint.com/attachmentsexternal/publications/The_RBC_Capi-tal_Markets_Consumer_Health_Information_Technol-ogy_Survey2015-07-13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
Available from: http://www.techrepub - lic.com/article/ibm-watson-health-computes-a-pair-of-new-solutions-to-improve-healthcare-data-and-security/.,Non-OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
Available from: http://kostat.go.kr/portal/korea/kor_nw/3/index.board?bmode=read&aSeq=348541.,OADS,/arxiv_data1/oa_pdf/19/dd/hir-22-333.PMC5116546.pdf
"2016 October;22(4):342-350.  https://doi.org/10.4258/hir.2016.22.4.342pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: September 21, 2016Accepted: September 30, 2016 Corresponding Author  Hyejung Chang, PhDSchool of Management, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02453, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
"Tel: +82-2-961-9432, E-mail: hjchang@khu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
344 www.e-hir.orgEun-Seon Kwak and Hyejung Chang https://doi.org/10.4258/hir.2016.22.4.3422.,Non-OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
"346 www.e-hir.orgEun-Seon Kwak and Hyejung Chang https://doi.org/10.4258/hir.2016.22.4.342 Even when MRs receive laptop computers or tablet PCs  from the company, 84.1% and 62.7% still used paper bro- chures.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
"348 www.e-hir.orgEun-Seon Kwak and Hyejung Chang https://doi.org/10.4258/hir.2016.22.4.342formation and effectiveness, had significant impact on inten- tion to use.",OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
350 www.e-hir.orgEun-Seon Kwak and Hyejung Chang https://doi.org/10.4258/hir.2016.22.4.342References 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/f1/hir-22-342.PMC5116547.pdf
"2016 October;22(4):351-354. https://doi.org/10.4258/hir.2016.22.4.351pISSN 2093-3681  •  eISSN 2093-369X  Book Review This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/78/hir-22-351.PMC5116548.pdf
352 www.e-hir.orgKwang Gi Kim https://doi.org/10.4258/hir.2016.22.4.351ing those who are beginning their careers in deep learning  and artiﬁcial intelligence research.,Non-OADS,/arxiv_data1/oa_pdf/0e/78/hir-22-351.PMC5116548.pdf
354 www.e-hir.orgKwang Gi Kim https://doi.org/10.4258/hir.2016.22.4.351tion functions.,Non-OADS,/arxiv_data1/oa_pdf/0e/78/hir-22-351.PMC5116548.pdf
Available from: http://cs229.stanford.edu/mate-rials/ML-advice.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/78/hir-22-351.PMC5116548.pdf
"Correction: Methods of Hematoxylin and Eosin  Image Information Acquisition and Optimization in Confocal Microscopy Woong Bae Yoon, BS, Hyunjin Kim, MS, Kwang Gi Kim, PhD, Yongdoo Choi, PhD,  Hee Jin Chang, MD, PhD, Dae Kyung Sohn, MD, PhD https://doi.org/10.4258/hir.2016.22.3.238 Healthc Inform Res 2016;22(3):238-42 In the article, Methods of Hematoxylin and Erosin Image Information Acquisition and Optimization in Confocal Microscopy,  there was a typographical error in the title.",Non-OADS,/arxiv_data1/oa_pdf/d8/61/hir-22-355.PMC5116549.pdf
"2016 October;22(4):355.  https://doi.org/10.4258/hir.2016.22.4.355pISSN 2093-3681  •  eISSN 2093-369X  Erratum This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/61/hir-22-355.PMC5116549.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Figure 6.Oncogene (2016) 35,6043 www.nature.com/onc",Non-OADS,/arxiv_data1/oa_pdf/9e/70/onc2016140a.PMC5116556.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)FOXC2 determines EMT and stem-cell features in PCa AN Paranjape et al 5976 Oncogene (2016) 5963 –5976 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/27/e3/onc2015498a.PMC5116559.pdf
"EMT heatmap Expression of EMT-associated genes of the CIT data set was imported intoMultiExperiment Viewer (http://www.tm4.org/mev.html).6,31Genes were normalized by rows, median centered, and the gene tree was hierarchically clustered using Pearson correlation.",OADS,/arxiv_data1/oa_pdf/b4/4a/onc2016134a.PMC5116560.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Regulation of the mesenchymal colorectal cancer subtype E Fessler et al 6037 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/b4/4a/onc2016134a.PMC5116560.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)TE-MSCs promotes tumour growth LY Lin et al 6042 Oncogene (2016) 6038 –6042 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/61/db/onc2016131a.PMC5116561.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/cb/iranjradiol-13-04-30929.PMC5116566.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/37/iranjradiol-13-04-31116.PMC5116567.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/60/iranjradiol-13-04-31155.PMC5116578.pdf
"To  view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ EXE cUtiVE SUMM aRY Current management of castration-resistant prostate cancer  ●  Over the last 5 years, treatment options for metastatic castration-resistant prostate cancer (mCRPC) have significantly  advanced, leading to more complex clinical decision-making.",Non-OADS,/arxiv_data1/oa_pdf/46/19/fon-12-2689.PMC5116579.pdf
"http://seer.cancer.gov 2 Scher HI, Solo K, Valant J, Todd MB, Mehra  M. Prevalence of prostate cancer clinical  states and mortality in the United States:  Estimates using a dynamic progression model.",Non-OADS,/arxiv_data1/oa_pdf/46/19/fon-12-2689.PMC5116579.pdf
https://clinicaltrials.gov   15 Clinical trials database: NCT01813370  (2015).,Non-OADS,/arxiv_data1/oa_pdf/46/19/fon-12-2689.PMC5116579.pdf
https://clinicaltrials.gov   16 Clinical trials database: NCT02008058  (2016).,Non-OADS,/arxiv_data1/oa_pdf/46/19/fon-12-2689.PMC5116579.pdf
"https://clinicaltrials.gov 17 Gliklich R, Dreyer N, Leavy M. Registries for  Evaluating Patient Outcomes: A User’s Guide  (3rd Edition).",Non-OADS,/arxiv_data1/oa_pdf/46/19/fon-12-2689.PMC5116579.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Eli Magen, MD,  Medicine C Department,  Allergy and Clinical Immunology Unit, Barzilai Medical Center,  Ben Gurion University of Negev, Ashkelon 78100,  Israel.",Non-OADS,/arxiv_data1/oa_pdf/48/fc/WJG-22-9451.PMC5116590.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.EDITORIALSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9451 9451 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9451-9456  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/48/fc/WJG-22-9451.PMC5116590.pdf
World J Gastroenterol  2016;  22(43): 9451 ­9456  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/48/fc/WJG-22-9451.PMC5116590.pdf
com/1007 ­9327/full/v22/i43/9451.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/fc/WJG-22-9451.PMC5116590.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/48/fc/WJG-22-9451.PMC5116590.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Daniel Ansari, MD, PhD,  Department  of Surgery, Clinical Sciences Lund, Lund University, and Skåne  University Hospital, SE-221 85 Lund,  Sweden.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"daniel.ansari@med.lu.se Telephone:  + 46-46-2224672 Received:  July 24, 2016 Peer-review started:  July 26, 2016 First decision:  September 12, 2016 Revised:  September 18, 2016 Accepted:  October 19, 2016 Article in press:  October 19, 2016 Published online: November 21, 2016 Abstract Novel treatment modalities are necessary for pancreatic REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9457 9457 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9457-9476  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"URL: http://www.wjgnet.com/1007-9327/full/v22/i43/9457.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i43.9457 INTRODUCTION The human immune system is an elaborative bio­ logical system of cellular interactions, structures and  processes that have been evolved to protect the body  from foreign substances.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from:  URL: http://www.cancer.gov/publications/dictionaries/cancer-drug 23 Royal RE , Levy C, Turner K, Mathur A, Hughes M, Kammula  US, Sherry RM, Topalian SL, Yang JC, Lowy I, Rosenberg  SA.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: U RL: https://clinicaltrials.gov/ct2/show/study/Johansson H et al.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT01473940 27 Aglietta M , Barone C, Sawyer MB, Moore MJ, Miller WH,  Bagalà C, Colombi F, Cagnazzo C, Gioeni L, Wang E, Huang B,  Fly KD, Leone F. A phase I dose escalation trial of tremelimumab  (CP-675,206) in combination with gemcitabine in chemotherapy- naive patients with metastatic pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available  from: URL: https://clinicaltrials.gov/ct2/show/NCT02301130 30 O’Reilly EM .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://clinicaltrials.gov/ct2/ show/study/NCT02558894 31 Duffy AG .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/study/NCT02311361 32 O’Hara MH .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/ study/NCT02639026 33 Padmanee S .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/ show/study/NCT02527434 34 Keir ME , Butte MJ, Freeman GJ, Sharpe AH.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/study/NCT02423954 48 Oft M .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/show/study/ NCT02526017 50 Wainberg ZA , Eisenberg PD, Sachdev JC, Weise AM, Kaufman  DR, Hutchinson M, Tong S, Aromin I, Hu-Lieskovan S, Patnaik  A.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/show/ NCT02305186 52 Khemka V , Weiss G. Study of Pembrolizumab Plus Chemotherapy  in Patients With Advanced Cancer (PembroPlus).",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/study/NCT02331251 53 Phase I/IIA Study MK-3475 With Chemotherapy in Patients With  Advanced GI Cancers (MK-3475 GI).,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02268825 54 Zheng L .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/study/NCT02648282 55 Indamdar S .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/study/NCT02546531 57 Chung V .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/study/ NCT02432963 58 Mahalingam D .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://clinicaltrials.gov/ ct2/show/NCT0262042 3 59 Rosenberg SA .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from:  URL: https://clinicaltrials.gov/ct2/show/study/NCT01174121 60 Khleif SN .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://ClinicalTrials.gov/show/ NCT01313416 61 CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/show/study/ NCT01386502 62 Wang L , Ma Q, Chen X, Guo K, Li J, Zhang M. Clinical  significance of B7-H1 and B7-1 expressions in pancreatic  carcinoma.",OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL:  https://clinicaltrials.gov/ct2/show/NCT02669914 78 Sun W .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"Available from: URL: https://clinicaltrials.gov/ct2/show/study/ NCT02583477 79 Brahmer JR , Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu  P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid  O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy  S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM,  Pardoll DM, Gupta A, Wigginton JM.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
Available from: URL: https://clinicaltrials.gov/ct2/show/study/NCT00732082 87 Le DT .,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/WJG-22-9457.PMC5116591.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Zoltán Szepes, MD, PhD,  First Department  of Medicine, University of Szeged, Korányi Fasor 8-10, 6720  Szeged, Hungary.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/WJG-22-9477.PMC5116592.pdf
World J Gastroenterol  2016; 22(43): 9477-9487   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9477.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/a5/8b/WJG-22-9477.PMC5116592.pdf
"i43.9477REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9477 9477 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9477-9487  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/WJG-22-9477.PMC5116592.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/a5/8b/WJG-22-9477.PMC5116592.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ivana Mikolasevic, MD, PhD, Department  of Gastroenterology, UHC Rijeka, Kresimirova 42, 51000 Rijeka,  Croatia.",Non-OADS,/arxiv_data1/oa_pdf/6e/8a/WJG-22-9488.PMC5116593.pdf
"REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9488 9488 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9488-9505  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6e/8a/WJG-22-9488.PMC5116593.pdf
World J Gastroenterol  2016;  22(43): 9488-9505  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/6e/8a/WJG-22-9488.PMC5116593.pdf
com/1007-9327/full/v22/i43/9488.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/8a/WJG-22-9488.PMC5116593.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/6e/8a/WJG-22-9488.PMC5116593.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Danielle Queiroz Calcagno, PhD,  Núcleo de Pesquisas em Oncologia, Hospital Universitário João  de Barros Barreto, Av.",Non-OADS,/arxiv_data1/oa_pdf/f2/b6/WJG-22-9506.PMC5116594.pdf
"danicalcagno@gmail.co m Telephone:  +55-91-32016776 Received:  July 15, 2016 Peer-review started:  July 16, 2016 First decision:  August 19, 2016 Revised:  September 10, 2016 Accepted:  October 10, 2016 Article in press:  October 10, 2016 Published online: November 21, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9506 9506 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9506-9514  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f2/b6/WJG-22-9506.PMC5116594.pdf
"World J Gastroenterol  2016; 22(43): 9506-9514  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i43/9506.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i43.9506INTRODUCTION Gastric cancer (GC) remains a major public health issues,  as it is the fifth most common malignancy and the third  leading cause of cancer death in both sexes worldwide[1].",Non-OADS,/arxiv_data1/oa_pdf/f2/b6/WJG-22-9506.PMC5116594.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/f2/b6/WJG-22-9506.PMC5116594.pdf
"In addition, the effect of SB203580 (SB), an inhibitor  of p38, was investigated in  parallel experiments, and Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9515 9515World J Gastroenterol   2016 November 21; 22(43): 9515-9524  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/10/17/WJG-22-9515.PMC5116595.pdf
"World  J Gastroenterol  2016; 22(43): 9515-9524  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9515 INTRODUCTION Inflammatory bowel disease (IBD), including ulcerative  colitis and Crohn’s disease, is a group of chronic disor - ders characterized by recurrent intestinal inflammation  and overactive immune responses[1,2].",Non-OADS,/arxiv_data1/oa_pdf/10/17/WJG-22-9515.PMC5116595.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/10/17/WJG-22-9515.PMC5116595.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Wei De, PhD, Professor  of Biochemistr y,  Department of Biochemistry and Molecular Biology, Nanjing  Medical University, Nanjing 210029, Jiangsu Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/WJG-22-9525.PMC5116596.pdf
"The RT-PCR  analysis of the NBC1 specific region on rat pancreas Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9525 9525 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9525-9533  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f8/27/WJG-22-9525.PMC5116596.pdf
World J Gastroenterol  2016;  22(43): 9525-9533  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f8/27/WJG-22-9525.PMC5116596.pdf
com/1007-9327/full/v22/i43/9525.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/27/WJG-22-9525.PMC5116596.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/f8/27/WJG-22-9525.PMC5116596.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: De-Ying Tian, PhD, Professor,  Tongji  Hospital, Tongji Medical College, Huazhong University of  Science and Technology, 1037 Luoyu Road, Wuhan 430030,  Hubei Province, China.",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/WJG-22-9534.PMC5116597.pdf
"The expression levels of α-1,2-mannosidase  were higher in AD38 cells than those in ND10 cells,  which were in turn greater than those in G2.2.15 cells,  and positively correlated with the expression of HBsAg Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9534 9534 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9534-9543  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/WJG-22-9534.PMC5116597.pdf
World J Gastroenterol  2016; 22(43): 9534-9543   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9534.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/cb/ff/WJG-22-9534.PMC5116597.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/cb/ff/WJG-22-9534.PMC5116597.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Timothy L Fitzgerald, MD, Associate  Professor,  Department of General Surgery, Division of Surgical  Oncology, East Carolina University Brody School of Medicine,  4S24, 600 Moye Boulevard, Greenville, NC 27834,  United States.",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/WJG-22-9544.PMC5116598.pdf
"RESULTS A total of 94811 patients were identified; the majority  underwent OC (58.7%), were white (76.9%), and Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9544 9544 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9544-9553  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/WJG-22-9544.PMC5116598.pdf
World J Gastroenterol  2016; 22(43): 9544-9553  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i43/9544.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i43.9544 INTRODUCTION Laparoscopy has revolutionized abdominal surgery.,Non-OADS,/arxiv_data1/oa_pdf/c9/f1/WJG-22-9544.PMC5116598.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/c9/f1/WJG-22-9544.PMC5116598.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to: Ralf Jakobs, MD, Medical Director,  Medizinische Klinik C, Klinikum der Stadt Ludwigshafen,  Bremserstraße 79, 67063 Ludwigshafen,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/cb/e7/WJG-22-9554.PMC5116599.pdf
"According to  carcinomatosis status, patients were assigned into  groups with or without evidence of peritoneal disease.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9554 9554 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9554-9561  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cb/e7/WJG-22-9554.PMC5116599.pdf
"World J Gastroenterol  2016; 22(43): 9554-9561   Available from: URL: http://www.wjgnet.com/1007-9327/full/v22/ i43/9554.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.i43.9554 INTRODUCTION Gastric outlet obstruction (GOO) is a frequent complication of advanced gastric and pancreaticobiliary  cancer[1,2].",Non-OADS,/arxiv_data1/oa_pdf/cb/e7/WJG-22-9554.PMC5116599.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/cb/e7/WJG-22-9554.PMC5116599.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Rossano Girometti, MD,  Institute of  Diagnostic Radiology, Department of Medical and Biological  Sciences, University of Udine, University Hospital “S.",Non-OADS,/arxiv_data1/oa_pdf/80/ba/WJG-22-9562.PMC5116600.pdf
"METHODS We retrospectively evaluated 72 patients who under - went, over the period 2006-2016, a total of 318 MRCPs  (mean 4.4) to follow-up incidental, presumed bd- IPMN without signs of malignancy, found or confirmed Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9562 9562 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9562-9570  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/80/ba/WJG-22-9562.PMC5116600.pdf
World  J Gastroenterol  2016; 22(43): 9562-9570  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9562.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9562 INTRODUCTION Branch-duct intraductal papillary mucinous neoplasm  (bd-IPMN) is a subtype of pancreatic cystic tumor  developing from mucin-producing columnar cells lining  the side branches of the main pancreatic duct (MPD).,Non-OADS,/arxiv_data1/oa_pdf/80/ba/WJG-22-9562.PMC5116600.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/80/ba/WJG-22-9562.PMC5116600.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Zhong- Yang Shen,  Institute of Liver  Transplantation, General Hospital of Chinese People’s Armed  Police Forces, 69 Yongding Road, Haidian District, Beijing  100039, China.",Non-OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
"zqy47@sina.com telephone:  +86-10-57976839 Fax:  +86-10-68242910 Received:  June 11, 2016 Peer-review started:  June 17, 2016 First decision:  July 12, 2016 Revised:  August 2, 2016 Accepted:  September 14, 2016 Article in press:  September 14, 2016 Published online: November 21, 2016 Abstract AIM to determine whether diabetes mellitus (DM) affects Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9571 9571 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9571-9585  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
Patient data were obtained from the China Liver transplant Registry ( https://www.cltr.org /).,OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
World J Gastroenterol  2016; 22(43): 9571-9585   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9571.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
"MATERIALS AND METHODS Patient population Between January 2000 and August 2013, 2128  patients were diagnosed with primary HCC and  underwent LT at the General Hospital of Chinese  People’s Armed Police Force, Tianjin First Central  Hospital and First Affiliated Hospital, School of  Medicine, Xi’an Jiaotong University (data from the  China Liver Transplant Registry: https://www.cltr.",Non-OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
These variables were  collected and recorded in the databases of the China  Liver Transplant Registry ( https://www.cltr .org /).,OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/c4/b0/WJG-22-9571.PMC5116601.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Yue-Yong Zhu, MD,  Liver Center,  The First Affiliated Hospital, Fujian Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/WJG-22-9586.PMC5116602.pdf
"Multivariate  analysis revealed that CP levels were significantly Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9586 9586 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9586-9594  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/WJG-22-9586.PMC5116602.pdf
"World  J Gastroenterol  2016; 22(43): 9586-9594  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9586 INTRODUCTION Worldwide, an estimated 2 billion people are infected  by hepatitis B virus (HBV), with approximately 240  million being chronically infected[1].",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/WJG-22-9586.PMC5116602.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/WJG-22-9586.PMC5116602.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Hasan Özen, MD,  Division of Gastro - enterology, Hepatology and Nutrition Unit, Department of  Pediatrics, Hacettepe University Faculty of Medicine, Hacettepe,  Ankara 06100, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/2a/58/WJG-22-9595.PMC5116603.pdf
"METHODS Seventy-five consecutive patients with suspected Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9595 9595 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9595-9603  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/2a/58/WJG-22-9595.PMC5116603.pdf
World J  Gastroenterol  2016; 22(43): 9595-9603  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9595.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9595 INTRODUCTION Gastroesophageal reflux (GER) is defined as the  passage of gastric contents into the esophagus which  is usually physiological and common in childhood[1].,Non-OADS,/arxiv_data1/oa_pdf/2a/58/WJG-22-9595.PMC5116603.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/2a/58/WJG-22-9595.PMC5116603.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Francisco Rodriguez-Frias, PhD, Liver  Pathology Unit, Departments of Biochemistry and Microbiology,  Hospital Universitari Vall d’Hebron, Autonomous University of  Barcelona, Pg Vall d’Hebron 119-129, 08035 Barcelona,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/8e/4e/WJG-22-9604.PMC5116604.pdf
"frarodri@vhebron.ne t Telephone:  +34-93-2746897 Fax:  +34-93-4894032 Received:  July 11, 2016 Peer-review started:  July 13, 2016 First decision:  August 19, 2016 Revised:  August 25, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9604 9604 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9604-9612  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8e/4e/WJG-22-9604.PMC5116604.pdf
"World J  Gastroenterol  2016; 22(43): 9604-9612  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9604.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9604 INTRODUCTION   Chronic hepatitis C virus (HCV) infection, which affects  approximately 160 million individuals worldwide[1] and  has an annual incidence of 3 million new infections[2], is  one of the leading causes of early-stage liver cirrhosis  and hepatocellular carcinoma[3].",Non-OADS,/arxiv_data1/oa_pdf/8e/4e/WJG-22-9604.PMC5116604.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/8e/4e/WJG-22-9604.PMC5116604.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript  Correspondence to: K Rajender Reddy, MD,  Ruimy Family  President’s Distinguished Professor  of Medicine, Professor   of Medicine in Surgery, Director of Hepatology, Director   of the Viral Hepatitis Center, and Medical Director  of Liver  Transplantation, Division of Gastroenterology and Hepatology,  University of Pennsylvania, 2 Dulles, 3400 Spruce Street,  Philadelphia, PA 19104,  United States.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-22-9613.PMC5116605.pdf
"Those co-infected with  hepatitis B received 48 wk of therapy.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9613 9613 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9613-9622  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-22-9613.PMC5116605.pdf
World J Gastroenterol  2016; 22(43): 9613-9622   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9613.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-22-9613.PMC5116605.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/28/8c/WJG-22-9613.PMC5116605.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to: Omer Ozturk, MD,  Department of  Gastroenterology, Hacettepe University School of Medicine,  06100 Ankara, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/f8/22/WJG-22-9623.PMC5116606.pdf
"Mean spleen size  was 22.9 cm (21-28 cm), and severe hypersplenism Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9623 9623 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9623-9630  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f8/22/WJG-22-9623.PMC5116606.pdf
World J Gastroenterol  2016;  22(43): 9623-9630  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f8/22/WJG-22-9623.PMC5116606.pdf
com/1007-9327/full/v22/i43/9623.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/22/WJG-22-9623.PMC5116606.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/f8/22/WJG-22-9623.PMC5116606.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Benedicte Kirkøen, MSc,  Department  of bowel cancer screening, Cancer Registry of Norway, P.O.",Non-OADS,/arxiv_data1/oa_pdf/e5/bb/WJG-22-9631.PMC5116607.pdf
"Benedicte.Kirkoen@kreftregisteret.n o Telephone:  +47-45474009 Received:  August 18, 2016 Peer-review started:  August 21, 2016 First decision:  September 5, 2016 Revised:  September 19, 2016 Accepted:  October 10, 2016 Article in press:  October 10, 2016 Published online: November 21, 2016 Abstract AIM To investigate the possible long-term psychological  harm of participating in colorectal cancer (CRC) Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9631 9631 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9631-9641  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e5/bb/WJG-22-9631.PMC5116607.pdf
World  J Gastroenterol  2016; 22(43): 9631-9641  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9631.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9631 INTRODUCTION Colorectal cancer (CRC) is one of the most frequent  causes of cancer-related deaths in both men and  women in developed countries[1].,Non-OADS,/arxiv_data1/oa_pdf/e5/bb/WJG-22-9631.PMC5116607.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/e5/bb/WJG-22-9631.PMC5116607.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Douglas L Nguyen, MD,  Division of  Gastroenterology and Hepatology, University of California  Irvine, Department of Medicine, 101 The City Drive, Orange, CA  92868, United States.",Non-OADS,/arxiv_data1/oa_pdf/ac/88/WJG-22-9642.PMC5116608.pdf
"There was no significant  difference in cecal intubation rates between the EAC META-ANALYSISSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9642 9642 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9642-9649  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ac/88/WJG-22-9642.PMC5116608.pdf
World J Gastroenterol  2016; 22(43): 9642-9649   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9642.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/ac/88/WJG-22-9642.PMC5116608.pdf
"Available  from: URL: http://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement38/colorectal-cancer- screening 3 Edwards BK , Ward E, Kohler BA, Eheman C, Zauber AG,  Anderson RN, Jemal A, Schymura MJ, Lansdorp-V ogelaar I, Seeff  LC, van Ballegooijen M, Goede SL, Ries LA.",Non-OADS,/arxiv_data1/oa_pdf/ac/88/WJG-22-9642.PMC5116608.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/ac/88/WJG-22-9642.PMC5116608.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: In Gyu Hwang, MD, PhD, Associate  Professor,  Department of Internal Medicine, Division of  Hemato-oncology, Chung-Ang University College of Medicine,  224-1 Heukseok-dong, Dongjak-gu, Seoul 156-861,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/62/6a/WJG-22-9650.PMC5116609.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9650 9650 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9650-9653  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/62/6a/WJG-22-9650.PMC5116609.pdf
"World J  Gastroenterol  2016; 22(43): 9650-9653  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i43/9650.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i43.9650 INTRODUCTION Choroidal and skin metastases from colorectal cancer  are very rare, and it has never been reported in Korea.",Non-OADS,/arxiv_data1/oa_pdf/62/6a/WJG-22-9650.PMC5116609.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/62/6a/WJG-22-9650.PMC5116609.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Wei-Lin Wang, PhD, MD,  Division  of Hepatobiliary and Pancreatic Surgery, Department of  Surgery, First Affiliated Hospital, School of Medicine, Zhejiang  University, No.",Non-OADS,/arxiv_data1/oa_pdf/55/d1/WJG-22-9654.PMC5116610.pdf
"Two inhomogeneous low-CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i43.9654 9654 November 21, 2016 |Volume 22 |Issue 43 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 November 21; 22(43): 9654-9660  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/55/d1/WJG-22-9654.PMC5116610.pdf
World J Gastroenterol  2016; 22(43): 9654-9660   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i43/9654.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/55/d1/WJG-22-9654.PMC5116610.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 454   3",Non-OADS,/arxiv_data1/oa_pdf/55/d1/WJG-22-9654.PMC5116610.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and re- production in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 33:2044–2054 (November 15, 2016) Mary Ann Liebert, Inc.DOI: 10.1089/neu.2015.4229 2044",Non-OADS,/arxiv_data1/oa_pdf/02/02/neu.2015.4229.PMC5116684.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source arecredited.THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 22, Number 11, 2016, pp.",Non-OADS,/arxiv_data1/oa_pdf/a2/b5/acm.2015.0350.PMC5116685.pdf
"The information pathways ofdifferentially expressed messenger RNAs (mRNAs) were analyzed online by using DAVID tools (http://david.abcc .ncifcrf.gov/), and the interactions between them were ana-lyzed by using STRING (http://string.embl.de).",OADS,/arxiv_data1/oa_pdf/a2/b5/acm.2015.0350.PMC5116685.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 25, Number 11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jwh.2016.5895 1086",Non-OADS,/arxiv_data1/oa_pdf/32/0f/jwh.2016.5895.PMC5116700.pdf
"Washington, DC: US Gov- ernment Printing Ofﬁce, 2012. http://udaonline.net/pdf- compendium/Sections/Trackstar-Urologic%20Diseases%20 Chap%2011.pdf Accessed June 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/32/0f/jwh.2016.5895.PMC5116700.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/c4/iranjradiol-13-04-31647.PMC5116748.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/d3/iranjradiol-13-04-31581.PMC5116749.pdf
We gratefully acknowledge the altruism of the participants  and their families and contributions of the DIAN research and support staff at each of the participating sites for their  contributions to this study ( http://www.dian-info.org/institutions_map.htm ).,Non-OADS,/arxiv_data1/oa_pdf/28/1b/nihms-827342.PMC5116769.pdf
The DIAN Expanded Registry ( http://dianxr.org ) welcomes contact from any  ADAD families or treating clinicians interested in research.,Non-OADS,/arxiv_data1/oa_pdf/28/1b/nihms-827342.PMC5116769.pdf
"Colin Masters, MD, Mental Health Research Institute of Victoria, Level 3, Alan Gilbert  Building, University of Melbourne, Victoria 03130 AUS, c.masters@unimelb.edu.au Richard Mayeux, MD, Columbia University, College of Physicians and Surgeons, 630 West  168th Street, New York, NY 10032, USA, rpm2@columbia.edu Eric McDade, DO, Washington University School of Medicine, 660 South Euclid, Campus  Box 8111, Saint Louis, MO 63110, USA, mcdadee@neuro.wustl.edu John Ringman, MD, Keck School of Medicine of University of Southern California, Center  for the Health Professionals, 1540 Alcazar Street, Suite 209F, Los Angeles, CA 90089,  USA, john.ringman@med.usc.edu Martin Rossor, MD, Dementia Research Center, Institute of Neurology, University College  London, Queen Square, London WC1 3BG United Kingdom, m.rossor@drc.ion.ucl.ac.uk Stephen Salloway, MD, Butler Hospital, 245 Blackstone Boulevard, Providence, RI 02906,  USA, SSalloway@Butler.org Peter Schofield, PhD, Neuroscience Research Australia, Barker Street, Randwick, Sydney  02031 Australia, p.schofield@neura.edu.au John Morris, MD, Washington University School of Medicine, 660 South Euclid, Campus  Box 8111, Saint Louis, MO 63110, USA, morrisj@abraxas.wustl.edu Randall Bateman, MD, Washington University School of Medicine, 660 South Euclid,  Campus Box 8111, Saint Louis, MO 63110, USA, batemanr@neuro.wustl.edu DIAN, Washington University School of Medicine, 660 South Euclid, Campus Box 8111,  Saint Louis, MO 63110, USA, http://www.dian-info.org/personnel.htm Abbreviations ADAD autosomal dominant Alzheimer’s disease APOE Apolipoprotein E APP amyloid precursor protein CAA Cerebral amyloid angiopathy CDR Clinical Dementia Rating DIAN Dominantly Inherited Alzheimer’s Network DIAN-OBS DIAN Observational Study FAQ Functional Activities Questionnaire GDS Geriatric Depression Scale HIS Hachinski Ischemic ScoreTang et al.",Non-OADS,/arxiv_data1/oa_pdf/28/1b/nihms-827342.PMC5116769.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/ec/iranjradiol-13-04-31649.PMC5116771.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/62/iranjradiol-13-04-34301.PMC5116772.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/1f/iranjradiol-13-04-31386.PMC5116817.pdf
The figure was generated by images from commercial software (http://www.visi - science.com).,OADS,/arxiv_data1/oa_pdf/13/7e/NRR-11-1579.PMC5116834.pdf
Available from http://www.centerforda.,Non-OADS,/arxiv_data1/oa_pdf/34/8b/IJMR-144-1.PMC5116880.pdf
"Available from: http://apps.who.int/iris/ bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1 ,  accessed on April 2, 2015.",OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available  from: http://www.tbfacts.org/tb-india.html , accessed on  January 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from: http://www.ifpri.org/sites/default/files/ publications/gnr14.pdf , accessed on January 5, 2015.12.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from: http://www.rchiips.org/nfhs/ NFHS-3%20Data/VOL-2/Report-%20Volume-II%281632K%   29.pdf , accessed on January 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
Available from: http://documents.wfp.,Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from: http://www.who.int/tb/publications/global_ report/en , accessed on January 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from:  http://www.unicef.org/india/children_2356.htm , accessed on  January 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from: http://apps.who.int/iris/ bitstream/10665/94836/1/9789241506410_eng.pdf , accessed  on June 7, 2015.",OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from:  http://www.chaikerala.com/activities.php , accessed on May  20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"Available from: http://www.dnaindia.com/mumbai/ report-multi-drug-resistant-tb-patients-to-get-food-support- from-bmc-2056960 , accessed on January 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IJMR-144-11.PMC5116882.pdf
"NM_005575.2, http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/93/1e/IJMR-144-120.PMC5116884.pdf
"Available  from: http://www.path.org/files/WHO_surveillance_ standards_JE.pdf , accessed on September 5, 2016.",OADS,/arxiv_data1/oa_pdf/4b/27/IJMR-144-128.PMC5116886.pdf
ncbi.nlm.nih.gov ) aligned with Clustal W ( http://www.ebi.ac.uk/ Tools/msa/clustalw2/ ) using default parameters.,OADS,/arxiv_data1/oa_pdf/a0/44/IJMR-144-21.PMC5116894.pdf
Nucleotide changes in KPC-2 in  comparison with other variants are compiled with the  help of EMBOSS  tools ( www.http://www.ebi.ac.uk/ Tools/emboss/ ) (Table I).,OADS,/arxiv_data1/oa_pdf/a0/44/IJMR-144-21.PMC5116894.pdf
Nucleotide changes among variants of bla KPC Variant Reference  AF297554.1 601CACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCA A650 KPC-1 47 AF395881.1 796CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTAG 845 KPC-3 32 AY700571.1 295 ATGCGCTGGTTC GGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGC 344 KPC-4 11 AY700571.1 695 CAAAACCGGAACCTGCGGAG GGTATGGCACGGCAAATGACTATGCCGTCG 744 KPC-4 11 EU400222.2 2451 AAAAATGCGCTGGTTC GGTGGTCACCCATCTCGGAAAAATATCTGACAAC 2500 KPC-5 11 EU555534.1 696 CAAAACCGGAACCTGCGGAG GGTATGGCACGGCAAATGACTATGCCGTCG 745 KPC-6 30 EU729727.1 146 TAGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTC 195 KPC-7 10 EU729727.1 796 CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTAG 845 KPC-7 10 FJ234412.1 696 CAAAACCGGAACCTGCGGAG GGTATGGCACGGCAAATGACTATGCCGTCG 745 KPC-8 13 FJ234412.1 796 CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTAG 845 KPC-8 13 FJ624872.1 683 CAAAACCGGAACCTGCGGAG CGTATGGCACGGCAAATGACTATGCCGTCG 732 KPC-9 28 FJ624872.1 783 CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTAG 832 KPC-9 28 GQ140348.1 296 ATGCGCTGGTTC GGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGC 345 KPC-10 45 GQ140348.1 796 CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTAG 845 KPC-10 45 HM066995.1 296 ATGCGCTGGTTC TGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGC 345 KPC-11 27 HQ641421.1 496 CTGGAG ATGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCC 545 KPC-12 29 AEA73284.1 246 CAGCCAGCAGCAGGCCGGCTTGCTGG GCACACCCATCCGTTACGGCAAAA 295 KPC-13 31 AEA73284.1 296 ACGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGC 345 KPC-13 31 AEA73284.1 496 CTGGAGCTGAACTCCGC TATCCCAGGCGATGCGCGCGATACCTCATCGCC 545 KPC-13 31 AEA73284.1 796 CCTAACAAGGATGACAAG TACAGCGAGGCCGTCATCGCCGCTGCGGCTGG 845 KPC-13 31 Nucleotide changes of KPC  gene which resulted in various KPC  variants have been highlighted Source : EMBOSS ( www.http://www.ebi.ac.uk/Tools/emboss/ ) SWATHI et al: KLEBSIELLA PNEUMONIAE CARBAPENEMASE  25,Non-OADS,/arxiv_data1/oa_pdf/a0/44/IJMR-144-21.PMC5116894.pdf
"Available from: http://www.unic.org.in/items/India_ and_the_MDGs_small_web.pdf , accessed on April 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/41/66/IJMR-144-58.PMC5116899.pdf
"Available from: http://data.unicef.org/maternal-health/ antenatal-care#sthash.W01W4q5P .dpuf , accessed on April  17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/41/66/IJMR-144-58.PMC5116899.pdf
"Available from: http://nrhm.gov.in / publications/four-years-of-nrhm-2005-2009.html ,   accessed on  April 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/41/66/IJMR-144-58.PMC5116899.pdf
"Available from: http://www.gadm.org/ , accessed on October  8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/51/24/IJMR-144-76.PMC5116902.pdf
"Available from: http://www.cdc.gov/salmonella/typhimurium- cantaloupe-08-12/index.html?s_cid=cs_852 , accessed on  June 1, 2014.",OADS,/arxiv_data1/oa_pdf/c1/6c/IJMR-144-82.PMC5116903.pdf
"Available from: http://www.hpa.org.uk/NewsCentre/National  PressReleases/2012PressReleases/120202SalmonellaNewpor toutbreak/ , accessed on June 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c1/6c/IJMR-144-82.PMC5116903.pdf
"Available  from: http://www.fda.gov/downloads/MedicalDevices/Device   RegulationandGuidance/GuidanceDocuments/ucm388961.pdf ,  accessed on January 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/80/06/IJMR-144-87.PMC5116904.pdf
"Available from: http://www.ninds.nih.gov/ disorders/post_polio/detail_post_polio.htm , accessed on May  2, 2016.4.",Non-OADS,/arxiv_data1/oa_pdf/22/9e/IJMR-144-9.PMC5116905.pdf
Identification of the compounds was done by  comparing their mass spectra with the reference spectra  in National Institute of Standards and Technology  (NIST) library ( http://chemdata.nist.gov/ ).,OADS,/arxiv_data1/oa_pdf/88/71/IJMR-144-92.PMC5116906.pdf
"6, 373 –380 http://dx.doi.org/10.1080/09286586.2016.1236974 © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
"Data management and analysis In 2012, data were collected using paper-based questionnaires and processed using the TELEFORM System ( http://www.cardiff.com/products/teleform/ )t h a t enabled scanning of completed questionnaires into a database.",OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
"In 2013 and 2014, data were collected electroni- cally using Android tablets and smartphones and the LINKS system ( https://gtmp.linkssystem.org/tanzania ) developed for the GTMP, and processed as described elsewhere.13,15In 2012, data analysis was undertaken using Stata 12 (Stata Corporation, College Park, Texas, USA).",OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://www.who.int/iris/handle/10665/63413 3.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://www.coecsa.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://apps.who.int/iris/handle/ 10665/66842#sthash.DzEHVqrJ.dpuf 12.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://ihi.eprints.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 10 February 2016 from: http://ihi.eprints.org/419/1/ihi_(31).pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://www.trachoma coalition.org/resources/global-trachoma-mapping-pro ject-training-mapping-trachoma 16.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
2013. http://www.stata.com/manuals13/svy.pdf 17. International Coalition for Trachoma Control.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://trachoma.org/ sites/default/files/guidesandmanuals/ICTC_ MDAToolkitEN_0.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
Accessed 15 December 2015 from: http://www.nbs.go.,Non-OADS,/arxiv_data1/oa_pdf/26/8c/iope-23-373.PMC5116913.pdf
"Moreover, we didnot see an effect of Igfbp1 on d-cell regeneration, suggesting that Igfbp1 can promote regeneration of some but not all cell types, eventhough the IGF1R and the insulin receptor are widely expressed inthe pancreas (http://sandberg.cmb.ki.se/pancreas/; Segerstolpeet al, 2016).",Non-OADS,/arxiv_data1/oa_pdf/6b/1d/EMBJ-35-2026.PMC5116948.pdf
"6, 412 –417 http://dx.doi.org/10.1080/09286586.2016.1235206 © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered ,t r a n s f o r m e d ,o rb u i l tu p o ni na n yw a y .",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Data management and analysis Data were collected electronic allyusing Android tablets a n dt h eL I N K Ss y s t e m( https://gtmp.linkssystem.org/zanzi bar) developed for the GTMP.13,14Descriptive statistics were used to examine the sample characteristics, the pre- valence of trachoma signs and proportion of households with key WASH indicators.",OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.who.int/iris/handle/10665/63413 3.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.coecsa.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.artsrn.ualberta.ca/amc douga/Hist347/autumn%202012/resources/MIT% 20Journal.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.lshtm.ac.uk/ library/MSc_CEH/2006-07/470023.pdf 10.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://apps.who.int/iris/han dle/10665/66842#sthash.DzEHVqrJ.dpuf 11.",OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://ihi.eprints.org//1344/416 F. J. OMAR ET AL.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://www.trachomacoalition.org/resources/global-tra choma-mapping-project-training-mapping-trachoma 15. International Coalition for Trachoma Control.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"Accessed December 15, 2015 from: http://trachoma.org/sites/default/files/guidesand manuals/ICTC_MDAToolkitEN_0.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/iope-23-412.PMC5116987.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/50/iranjradiol-13-04-36779.PMC5116988.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/44/iranjradiol-13-04-36271.PMC5116989.pdf
doi:10.1136/bmjsem-2015- 000019 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000019).,Non-OADS,/arxiv_data1/oa_pdf/7c/15/bmjsem-2015-000019.PMC5117007.pdf
4. http://www.amca.uk.com/5.,Non-OADS,/arxiv_data1/oa_pdf/7c/15/bmjsem-2015-000019.PMC5117007.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000021).,Non-OADS,/arxiv_data1/oa_pdf/da/04/bmjsem-2015-000021.PMC5117008.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/da/04/bmjsem-2015-000021.PMC5117008.pdf
2013 cited 2013 Jul 3 http://www.sst.dk/English/Health_promotion/Physical_activity/Recommendations_for_adults.aspx 24.,Non-OADS,/arxiv_data1/oa_pdf/da/04/bmjsem-2015-000021.PMC5117008.pdf
2008. http://www.walk-up.dk/inspiration/skridttaelleren/13-skridttaellerprogrammet 30.,Non-OADS,/arxiv_data1/oa_pdf/da/04/bmjsem-2015-000021.PMC5117008.pdf
doi:10.1136/ bmjsem-2015-000005 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000005).,Non-OADS,/arxiv_data1/oa_pdf/87/e4/bmjsem-2015-000005.PMC5117009.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000020).,Non-OADS,/arxiv_data1/oa_pdf/dd/7b/bmjsem-2015-000020.PMC5117010.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000025).,Non-OADS,/arxiv_data1/oa_pdf/17/a3/bmjsem-2015-000025.PMC5117012.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/17/a3/bmjsem-2015-000025.PMC5117012.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000026).,Non-OADS,/arxiv_data1/oa_pdf/60/ff/bmjsem-2015-000026.PMC5117013.pdf
January 2004:2. http://www.phru.nhs.uk/Doc_Links/cohort% 2012%20questions.pdf9 11. http://www.seniam.org12.,Non-OADS,/arxiv_data1/oa_pdf/60/ff/bmjsem-2015-000026.PMC5117013.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000015).,Non-OADS,/arxiv_data1/oa_pdf/6e/98/bmjsem-2015-000015.PMC5117015.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000008).,Non-OADS,/arxiv_data1/oa_pdf/9d/f2/bmjsem-2015-000008.PMC5117017.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000032).,Non-OADS,/arxiv_data1/oa_pdf/b9/e9/bmjsem-2015-000032.PMC5117018.pdf
Competing interests All authors have completed the Unified Competing Interests form at http://www.icmje.org/coi_disclosure.pdf and declare thatnone of the authors have any non-financial interests that may be relevant to the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/b9/e9/bmjsem-2015-000032.PMC5117018.pdf
2014. http://www.hscic.gov.uk/catalogue/PUB13648/Obes-phys-acti-diet-eng-2014-rep.pdf (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/ea/32/bmjsem-2015-000048.PMC5117019.pdf
doi:10.1136/bmjsem-2015- 000049 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000049).,Non-OADS,/arxiv_data1/oa_pdf/2a/a0/bmjsem-2015-000049.PMC5117020.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000050).,Non-OADS,/arxiv_data1/oa_pdf/a3/95/bmjsem-2015-000050.PMC5117021.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000081).,Non-OADS,/arxiv_data1/oa_pdf/3a/12/bmjsem-2015-000081.PMC5117022.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000060).,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/bmjsem-2015-000060.PMC5117023.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000056).,Non-OADS,/arxiv_data1/oa_pdf/fa/a2/bmjsem-2015-000056.PMC5117024.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000059).,Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
"Speci ﬁcally, there were approximately 1550 Sechelt residents between the ages of 65 and 79 and 600 residents aged 80 and over (http://www.secheltseniors.ca/documents/ReporttotheCommunity.pdf).",Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
http://www.ibisworld.com/industry/ fitness-dvd-production.html.,Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
http://www.webcitation.org/6Vejz8t7f.Secondary IBISWorld Industry Report OD5356 Fitness DVD Productionin the US.,Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
http://www.ibisworld.com/industry/fitness-dvd-production.html.,Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
http://www.webcitation.org/6Vejz8t7f.,Non-OADS,/arxiv_data1/oa_pdf/54/83/bmjsem-2015-000059.PMC5117025.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000072).,Non-OADS,/arxiv_data1/oa_pdf/53/f9/bmjsem-2015-000072.PMC5117026.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/5e/bmjsem-2015-000067.PMC5117028.pdf
2014. http://www.health.gov.au/internet/main/publishing.nsf/content/F01F92328EDADA5BCA257BF0001E720D/$File/Move%20and%20play%20every%20day%200-5yrs.PDF 25.,Non-OADS,/arxiv_data1/oa_pdf/32/5e/bmjsem-2015-000067.PMC5117028.pdf
"United Kingdom, 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213737/dh_128142.pdf 26.",Non-OADS,/arxiv_data1/oa_pdf/32/5e/bmjsem-2015-000067.PMC5117028.pdf
"Canada, 2012. http://www.csep.ca/CMFiles/Guidelines/CSEP_PAGuidelines_early-years_ en.pdf 27.",Non-OADS,/arxiv_data1/oa_pdf/32/5e/bmjsem-2015-000067.PMC5117028.pdf
doi:10.1136/ bmjsem-2015-000071 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000071).,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/bmjsem-2015-000071.PMC5117029.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000012).,Non-OADS,/arxiv_data1/oa_pdf/10/5b/bmjsem-2015-000012.PMC5117030.pdf
Secondary NATA Position Statement Disclaimer 2014. http://www.nata.org/position-statements 6.,Non-OADS,/arxiv_data1/oa_pdf/10/5b/bmjsem-2015-000012.PMC5117030.pdf
Lovell M. Immediate Post-Concussion Assessment Testing (ImPACT) test clinical interpretive manual: online ImPACT 2007 – 2012. https://impacttest.com.,Non-OADS,/arxiv_data1/oa_pdf/10/5b/bmjsem-2015-000012.PMC5117030.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/b5/bmjsem-2015-000017.PMC5117031.pdf
2011. http://www.ircobi.org/downloads/2011-lecture-crandall.pdf 9th June 2012.,Non-OADS,/arxiv_data1/oa_pdf/f8/b5/bmjsem-2015-000017.PMC5117031.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000045).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2566407&tool=pmcentrez&rendertype=abstract (accessed7 Dec 2014).,OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
2001. http://www.pcprg.com/ sym01out.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 24279237 (accessed 4 Mar2014).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 24261055 (accessed 6 Dec2014).,OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
2006. http://www.dropzone.com/safety/Canopy_Control/Body_Language_Helping_Your_Canopy_Open_Better_636.html (accessed 17 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
Published Online First: 1986. http://www.ewp.rpi.edu/hartford/users/papers/engr/ernesto/cedenc/SMRE/Project/shuttlereliability.pdf (accessed 27 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.ncbi.nlm.nih.gov/pubmed/3640358 (accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
http://www.grc.nasa.gov/WWW/K-12/ airplane/rotations.html (accessed 22 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/bmjsem-2015-000045.PMC5117032.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000066).,Non-OADS,/arxiv_data1/oa_pdf/13/d8/bmjsem-2015-000066.PMC5117033.pdf
"Retrieved 1 April 2015. http://list.wada-ama.org/ Trinh KV, et al.BMJ Open Sport Exerc Med 2015; 1:e000066.",Non-OADS,/arxiv_data1/oa_pdf/13/d8/bmjsem-2015-000066.PMC5117033.pdf
2011. http://digitalcommons.usu.edu/cgi/viewcontent.cgi?article=2115&context=etd 27.,Non-OADS,/arxiv_data1/oa_pdf/13/d8/bmjsem-2015-000066.PMC5117033.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000076).,Non-OADS,/arxiv_data1/oa_pdf/39/2b/bmjsem-2015-000076.PMC5117034.pdf
"In the second section, respondents were prompted to visit the of ﬁcial website of the FIFA 11+ (http://f-marc.com/11plus/home/).Subsequent questions focused speci ﬁcally on the 2 O’Brien J, Finch CF.",Non-OADS,/arxiv_data1/oa_pdf/1b/0b/bmjsem-2015-000075.PMC5117035.pdf
"For each survey question, the proportion (%) of respondents indicating each different answer was calculated in Microsoft Excel and 95% CIsfor the sample proportions were calculated with an online calculator (http://www.select-statistics.co.uk).",OADS,/arxiv_data1/oa_pdf/1b/0b/bmjsem-2015-000075.PMC5117035.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjsem-2015-000047.PMC5117036.pdf
http://www.sportsci.org/2006/ wghss.htm (accessed 8 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjsem-2015-000047.PMC5117036.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000054).,Non-OADS,/arxiv_data1/oa_pdf/f4/d1/bmjsem-2015-000054.PMC5117037.pdf
http://www.australianprescriber.com/magazine/18/3/69/71files/621/71.html 12.,Non-OADS,/arxiv_data1/oa_pdf/f4/d1/bmjsem-2015-000054.PMC5117037.pdf
Available from: http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-201408.,Non-OADS,/arxiv_data1/oa_pdf/f4/d1/bmjsem-2015-000054.PMC5117037.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000063).,Non-OADS,/arxiv_data1/oa_pdf/3e/f8/bmjsem-2015-000063.PMC5117038.pdf
2002. http://www.cbsnews.com/news/hockey-dad-found-guilty/ 11.,Non-OADS,/arxiv_data1/oa_pdf/99/1e/bmjsem-2015-000074.PMC5117041.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000043).,Non-OADS,/arxiv_data1/oa_pdf/f1/7e/bmjsem-2015-000043.PMC5117042.pdf
http://nccsir.unc.edu/reports/ (accessed 02 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/99/01/bmjsem-2015-000055.PMC5117044.pdf
https://www.cso.nato.int/pubs/rdp.asp?,Non-OADS,/arxiv_data1/oa_pdf/99/01/bmjsem-2015-000055.PMC5117044.pdf
34. http://www.southwalesargus.co.uk/news/gwentnews/13417922.,Non-OADS,/arxiv_data1/oa_pdf/99/01/bmjsem-2015-000055.PMC5117044.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000062).,Non-OADS,/arxiv_data1/oa_pdf/c0/be/bmjsem-2015-000062.PMC5117045.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000080).,Non-OADS,/arxiv_data1/oa_pdf/99/0f/bmjsem-2015-000080.PMC5117046.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000082).,Non-OADS,/arxiv_data1/oa_pdf/f3/91/bmjsem-2015-000082.PMC5117047.pdf
10.07.2013. http://mrg.net/News-and-Events/ Press-Releases/HIP-ARTHROSCOPY-PROCEDURES-TO-SOAR-THROUGH-2013.aspx 18.,Non-OADS,/arxiv_data1/oa_pdf/f3/91/bmjsem-2015-000082.PMC5117047.pdf
http://www.hscic.gov.uk/hes 22.,Non-OADS,/arxiv_data1/oa_pdf/f3/91/bmjsem-2015-000082.PMC5117047.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000029).,Non-OADS,/arxiv_data1/oa_pdf/5c/7a/bmjsem-2015-000029.PMC5117048.pdf
2013. http://www.hockeycanada.ca/en-ca/news/agm-concludes-in-charlottetown 28.,Non-OADS,/arxiv_data1/oa_pdf/5c/7a/bmjsem-2015-000029.PMC5117048.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/16/bmjsem-2015-000031.PMC5117049.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000013).,Non-OADS,/arxiv_data1/oa_pdf/42/23/bmjsem-2015-000013.PMC5117050.pdf
2014. http://www.health.gov.au/internet/main/publishing.nsf/content/health-pubhlth-strateg-phys-act-guidelines4.,Non-OADS,/arxiv_data1/oa_pdf/42/23/bmjsem-2015-000013.PMC5117050.pdf
http://www.ifsc-climbing.org/.,Non-OADS,/arxiv_data1/oa_pdf/34/b5/bmjsem-2015-000083.PMC5117051.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000036).,Non-OADS,/arxiv_data1/oa_pdf/92/00/bmjsem-2015-000036.PMC5117054.pdf
"Primary outcome measures 1.Physical activity —PA levels were measured by ‘steps ’ (SenseWear accelerometer; http://sensewear.bodymedia.com, Pittsburgh, Pennsylvania, USA).",Non-OADS,/arxiv_data1/oa_pdf/92/00/bmjsem-2015-000036.PMC5117054.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000037).,Non-OADS,/arxiv_data1/oa_pdf/ef/10/bmjsem-2015-000037.PMC5117055.pdf
http://www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/index-fra.php 15.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/bmjsem-2015-000044.PMC5117056.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000086).,Non-OADS,/arxiv_data1/oa_pdf/58/e3/bmjsem-2015-000086.PMC5117058.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000089).,Non-OADS,/arxiv_data1/oa_pdf/d2/e5/bmjsem-2015-000089.PMC5117059.pdf
http://www.hscic.gov.uk/catalogue/PUB13218/HSE2012-Sum-bklet.pdf (accessed 18 May 2015) 4.,Non-OADS,/arxiv_data1/oa_pdf/d2/e5/bmjsem-2015-000089.PMC5117059.pdf
Welsh Health Survey 2012. http://gov.wales/ docs/statistics/2013/130911-welsh-health-survey-2012-en.pdf(accessed 18 May 2015) 5.,Non-OADS,/arxiv_data1/oa_pdf/d2/e5/bmjsem-2015-000089.PMC5117059.pdf
36. http://www.nice.org.uk/guidance/ph54 (accessed 12 May 2015).37.,Non-OADS,/arxiv_data1/oa_pdf/d2/e5/bmjsem-2015-000089.PMC5117059.pdf
http://www.noo.org.uk/core/frameworks/SEF_PA (accessed 12 May2015).,Non-OADS,/arxiv_data1/oa_pdf/d2/e5/bmjsem-2015-000089.PMC5117059.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2015-000034).,Non-OADS,/arxiv_data1/oa_pdf/3e/f0/bmjsem-2015-000034.PMC5117060.pdf
doi:10.1136/bmjsem-2015- 000092 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000092).,Non-OADS,/arxiv_data1/oa_pdf/8e/71/bmjsem-2015-000092.PMC5117063.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/71/bmjsem-2015-000092.PMC5117063.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000100).,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/bmjsem-2015-000100.PMC5117064.pdf
http://geoconvert.mimas.ac.uk/ (accessed: 20 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/bmjsem-2015-000100.PMC5117064.pdf
http://www.nomisweb.co.uk/ (accessed: 20 Jan 2014).14.,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/bmjsem-2015-000100.PMC5117064.pdf
"of aBiomedical Research Project to the Committee System onBiomedical Research Ethics, No 9154, 5 May 2011. http://www.cvk.sum.dk/English/guidelinesaboutnotification.aspx.",Non-OADS,/arxiv_data1/oa_pdf/41/0d/bmjsem-2015-000097.PMC5117065.pdf
2011. http://www.theactigraph.com/ products/gt3x/.,Non-OADS,/arxiv_data1/oa_pdf/41/0d/bmjsem-2015-000097.PMC5117065.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2015- 000098).,Non-OADS,/arxiv_data1/oa_pdf/dd/4b/bmjsem-2015-000098.PMC5117067.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjsem-2015-000105).,Non-OADS,/arxiv_data1/oa_pdf/33/d3/bmjsem-2015-000105.PMC5117068.pdf
"Tackling physical inactivity —a coordinated approach: All Party Commission on Physical Activity, 2014 (cited 29 Febuary 2016).http://parliamentarycommissiononphysicalactivity.files.wordpress.com/2014/04/apcopa-final.pdf 10.",Non-OADS,/arxiv_data1/oa_pdf/33/d3/bmjsem-2015-000105.PMC5117068.pdf
http://researchinstitute.ukactive.com/downloads/managed/Identifying_what_works.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/33/d3/bmjsem-2015-000105.PMC5117068.pdf
"Nesta, 2013. http://www.nesta.org.uk/sites/ default/files/standards_of_evidence.pdf 12.",Non-OADS,/arxiv_data1/oa_pdf/33/d3/bmjsem-2015-000105.PMC5117068.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000107).,Non-OADS,/arxiv_data1/oa_pdf/d0/e5/bmjsem-2015-000107.PMC5117069.pdf
http://www.kindl.org (accessed 20 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/d2/e3/bmjsem-2016-000111.PMC5117070.pdf
2015 Available from http://www.aflcommunityclub.com.au/index.php?id=66 (accessed 11/11/2015).,OADS,/arxiv_data1/oa_pdf/1c/cf/bmjsem-2016-000112.PMC5117071.pdf
1998. http://sma.org.au/wp-content/ uploads/2009/12/datadictionary.pdf 16.,OADS,/arxiv_data1/oa_pdf/1c/cf/bmjsem-2016-000112.PMC5117071.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjsem-2016-000114).,Non-OADS,/arxiv_data1/oa_pdf/d8/89/bmjsem-2016-000114.PMC5117072.pdf
"Umeå: Univ, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-19690 3.",Non-OADS,/arxiv_data1/oa_pdf/fd/66/bmjsem-2015-000108.PMC5117073.pdf
Outl Present 2001 Parachut Ind Assoc Symp Present by Jean Potvin Gary Peek ; 2001. http://www.pcprg.com/sym01out.htm 9.,Non-OADS,/arxiv_data1/oa_pdf/fd/66/bmjsem-2015-000108.PMC5117073.pdf
2006. http://www.dropzone.com/safety/Canopy_Control/Body_Language_Helping_Your_Canopy_Open_Better_636.html (accessed 17 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/fd/66/bmjsem-2015-000108.PMC5117073.pdf
http://www.consort-statement.,Non-OADS,/arxiv_data1/oa_pdf/fd/66/bmjsem-2015-000108.PMC5117073.pdf
https://clinicaltrials.gov/ct2/show/NCT02625896?term=acropose&rank=1 (accessed 30 Dec 2015).,OADS,/arxiv_data1/oa_pdf/fd/66/bmjsem-2015-000108.PMC5117073.pdf
doi:10.1136/bmjsem-2015- 000101 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2015-000101).,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/bmjsem-2015-000101.PMC5117074.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Previousproducts/4156.0.55.001Feature%20Article1May%202009?opendocument&tabname=Summary&prodno=4156.0.55.001&issue=May%202009&num=&view= (accessed 10 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/bmjsem-2015-000101.PMC5117074.pdf
http://www.afl.com.au/laws (accessed 9 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/bmjsem-2015-000101.PMC5117074.pdf
http://www.aflcommunityclub.com.au/fileadmin/user_upload/Play_AFL/Multicultural/AF_2842_1014_Womens_Football_Match_Guide_web_ lores.pdf (accessed 9 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/bmjsem-2015-000101.PMC5117074.pdf
http://www.aflcommunityclub.com.au/index.php?id=66 (accessed 21 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/ce/cf/bmjsem-2015-000101.PMC5117074.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000115).,Non-OADS,/arxiv_data1/oa_pdf/c4/09/bmjsem-2016-000115.PMC5117075.pdf
doi:10.1136/ bmjsem-2016-000118 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000118).,Non-OADS,/arxiv_data1/oa_pdf/4f/10/bmjsem-2016-000118.PMC5117077.pdf
"Secondary State laws on traumatic brain injuries: 2009 –2014, 2014. http://www.ncsl.org/research/health/traumatic-brain-injury-legislation.aspx 4.",Non-OADS,/arxiv_data1/oa_pdf/4f/10/bmjsem-2016-000118.PMC5117077.pdf
https://www.ncaa.,Non-OADS,/arxiv_data1/oa_pdf/4f/10/bmjsem-2016-000118.PMC5117077.pdf
"http://dx.doi.org/ 10.1002/cc.376 Chinn NR, Porter P. BMJ Open Sport Exerc Med 2016; 2:e000118.",Non-OADS,/arxiv_data1/oa_pdf/4f/10/bmjsem-2016-000118.PMC5117077.pdf
doi:10.1136/bmjsem-2016- 000122 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000122).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
PDF available from http://www.lebendige-traditionen.ch (accessed 21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
3. https://www.youtube.com/watch?v=GdIHOV6VGNU (accessed 21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
4. http://www.ehv.ch/hornussen (accessed 21 Aug 2015).5.,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
8. http://www.ehv.ch (accessed 21 Aug 2015).9. http://www.blick.ch/news/schweiz/sportanlagen-in-der-schweiz-die- welschen-haben-keine-lust-auf-hornussen-id2433893.html (accessed21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
10. http://www.ehv.ch/hornussen/schlagen (accessed 21 Aug 2015).11.,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
14. http://www.solothurnerzeitung.ch/sport/solothurn/erblindeter- hornusser-war-mir-nicht-bewusst-dass-es-so-schmerzen-ueberhaupt-gibt-128040888 (accessed 21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
15. http://www.solothurnerzeitung.ch/sport/solothurn/wieso-im- hornussen-immer-mehr-helme-mit-im-spiel-sind-128151961(accessed 21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
16. http://www.watson.ch/Best%20of%20watson/Sport/698304704-Als- Deutscher-beim-Hornussen –Wenn-Schweizer-sich-eine-Sportart- ausdenken –dann-muss-man-schon-mal-den-Kopf-einziehen (accessed 21 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/8b/bmjsem-2016-000122.PMC5117079.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/7d/bmjsem-2016-000134.PMC5117080.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/46/bmjsem-2016-000135.PMC5117081.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000144).,Non-OADS,/arxiv_data1/oa_pdf/97/4d/bmjsem-2016-000144.PMC5117082.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjsem-2016- 000127).,Non-OADS,/arxiv_data1/oa_pdf/8e/7d/bmjsem-2016-000127.PMC5117083.pdf
http://www.mhlw.go.jp/ topics/2009/05/dl/tp0501-1c_0001.pdf (accessed 25 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8e/7d/bmjsem-2016-000127.PMC5117083.pdf
"CoreChair, https://www.corechair.com (CoreChair, Aurora, Ontario, Canada) ( ﬁgure 1 ), is a chair designed to promote activity while a person stays seated.",Non-OADS,/arxiv_data1/oa_pdf/93/d8/bmjsem-2016-000152.PMC5117084.pdf
"One popular example is replacing of ﬁce chairs with large rubber balls (Swiss Balls).32Using a Swiss Ball, anFigure 1 (A) FootFidget, http:// footfidget.com, and (B)CoreChair, https://www.corechair.com.",Non-OADS,/arxiv_data1/oa_pdf/93/d8/bmjsem-2016-000152.PMC5117084.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjsem-2016-000151).,Non-OADS,/arxiv_data1/oa_pdf/f5/70/bmjsem-2016-000151.PMC5117086.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/70/bmjsem-2016-000151.PMC5117086.pdf
"Published with license by Taylor & Francis Group, LLC © Jhun-Chen Chen, Miao-Ju Wei, and Su-Chiung Fang This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
"10, e1237331 (5 pages)http://dx.doi.org/10.1080/15592324.2016.1237331",Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
ORCID Su-Chiung Fang http://orcid.org/0000-0001-6894-5025References 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Physiol 2016; 171:2682-700; PMID:27338813; http://dx.doi.org/10.1104/pp.16.00841 2.,Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Nat Rev Genet 2014; 15:613-24; PMID:25048170;http://dx.doi.org/10.1038/nrg3685 3.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Reprod 2015; 28:73-89; PMID:25761645; http://dx.doi.org/10.1007/s00497- 015-0261-7 4.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Reprod 2016; 29:179-88; PMID:27016359; http://dx.doi.org/10.1007/s00497-016-0280-z 6.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Mol Biol 2014; 84:203-26; PMID:24222213; http://dx.doi.org/ 10.1007/s11103-013-0128-y 7.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Development 2012; 139:3081-98; PMID:22872082; http://dx.doi.org/10.1242/dev.074674 8.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant J 2008; 54:1037-48;PMID:18346189; http://dx.doi.org/10.1111/j.1365-313X.2008.03485.x 9.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Cell 2008; 20:635-47; PMID:18334668; http://dx.doi.org/10.1105/tpc.107.055137 10.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Physiol 2007; 143:447-60;PMID:17071640; http://dx.doi.org/10.1104/pp.106.089805 11.,Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Cell 2013; 25:1288-303; PMID:23613199; http://dx.doi.org/10.1105/tpc.113.110049 12.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
MIKC/C3MADS domain heterodimers are required for pollen maturation and tube growth in Arabidopsis.Plant Physiol 2009; 149:1713-23; PMID:19211705; http://dx.doi.org/10.1104/pp.109.135806 13.,Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
"Zobell O, Faigl W, Saedler H, Munster T. MIKC /C3MADS-box proteins: conserved regulators of the gametophytic generation of land plants.Mol Biol Evol 2010; 27:1201-11; PMID:20080864; http://dx.doi.org/ 10.1093/molbev/msq005 15.",OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Trends Genet 2010; 26:394-9; PMID:20609490;http://dx.doi.org/10.1016/j.tig.2010.06.001Table 2.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Cell 2006; 124:495-506; PMID:16469697; http://dx.doi.org/ 10.1016/j.cell.2005.12.034 17.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Cell 2012; 151:194-205; PMID:23000270; http://dx.doi.org/10.1016/j.cell.2012.09.001 18.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Cell2014; 157:1050-60; PMID:24855943; http://dx.doi.org/10.1016/j.cell.2014.03.056 19.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Science 2001; 292:2077-80;PMID:11349138; http://dx.doi.org/10.1126/science.1059745 20.,Non-OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Curr Biol 2007; 17:379-84; PMID:17239600; http://dx.doi.org/10.1016/j.cub.2007.01.009 21.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Nucleic Acids Res 2006; 34:5461-70; PMID:17020925; http://dx.doi.org/ 10.1093/nar/gkl687 22.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
PLoS Genet2011; 7:e1001325; PMID:21423664; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant J 2009; 58:318-32; PMID:19207215; http://dx.doi.org/ 10.1111/j.1365-313X.2008.03781.x 24.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Dev Cell 2013; 25:310-6; PMID: 23673332; http://dx.doi.org/10.1016/j.devcel.2013.04.001 25.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Nature Plants 2015; 1:15184; PMID:27251719; http://dx.doi.org/10.1038/nplants.2015.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Cell 1993; 5:403-18; PMID:12271070; http://dx.doi.org/10.1105/ tpc.5.4.403 27.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Science 2008; 175:98- 105; http://dx.doi.org/10.1016/j.plantsci.2008.02.011 28.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
J Mol Biol 2005; 348:253-64; PMID:15811366; http://dx.doi.org/10.1016/j.jmb.2005.02.065 29.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
Plant Cell 2009; 21:2563-77; PMID:19767455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/89/kpsb-11-10-1237331.PMC5117094.pdf
"), lacking its N-terminal peptide andC-terminal transmembrane motif (P2NC), was fused to the CONTACT Boon Leong Lim bllim@hku.hk Published with license by Taylor & Francis Group, LLC © Renshan Zhang, Xiaoqian Guan, Yee-Song Law, Feng Sun, Shuai Chen, Kam Bo Wong, and Boon Leong Lim This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.PLANT SIGNALING & BEHAVIOR 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
"10, e1239687 (6 pages)http://dx.doi.org/10.1080/15592324.2016.1239687",Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
ORCID Boon Leong Lim http://orcid.org/0000-0002-2720-2353 References 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Nat Rev Mol Cell Biol 2011; 12:48-59; PMID:21139638; http://dx.doi.org/10.1038/nrm3027 2.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
J Biol Chem 1996; 271:6545-54; PMID:8626459; http://dx.doi.org/10.1074/jbc.271.11.6545PLANT SIGNALING & BEHAVIOR e1239687-5,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Plant Physiol 2015; 169:1344-55; PMID:26304849; http://dx.doi.org/10.1104/pp.15.01115 4.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
J Biol Chem 2006; 281:40216-23; PMID:17090544; http://dx.doi.org/10.1074/jbc.M606580200 5.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Plant Physiol 2011; 157:70-85; PMID:21799034; http://dx.doi.org/10.1104/pp.111.182774 6.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Plant Cell 2000; 12:53-63; PMID:10634907; http://dx.doi.org/10.1105/tpc.12.1.53 7.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Eur J Biochem 1986; 160:563-70; PMID:3780721; http://dx.doi.org/10.1111/j.1432-1033.1986.tb10075.x 8.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
EMBO J 2004; 23:520-30;PMID:14765117; http://dx.doi.org/10.1038/sj.emboj.7600089 9.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
J Mol Biol 2011;405:804-18; PMID:21087612; http://dx.doi.org/10.1016/j.jmb.2010.11.017 10.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Biochim Biophys Acta 2013; 1833:304-13; PMID:22406071; http://dx.doi.org/10.1016/j.bbamcr.2012.02.015 11.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
New Phytol 2012; 194:206-19; PMID:22269069; http://dx.doi.org/10.1111/j.1469-8137.2011.04026.x 12.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Plant Signal Behav2012; 7:927-32; PMID:22751362; http://dx.doi.org/10.4161/ psb.20769 13.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Nat Protoc 2006; 1:1278-86; PMID:17406412; http://dx.doi.org/10.1038/nprot.2006.201 14.,Non-OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Curr Protoc Cell Biol 2003; Chapter 11:Unit11 6: 17:11.16:11.16.1 –11.16.21; PMID:18228418; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Plant J 2001; 27:59-65; PMID:11489183; http://dx.doi.org/ 10.1046/j.0960-7412.2001.01061.x 16.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
Eur J Biochem FEBS 2004; 271:509-16; PMID:14728677; http://dx.doi.org/10.1046/j.1432-1033.2003.03950.x 17.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
FEBS Lett 2015; 589:1301-7; PMID:25935521; http://dx.doi.org/ 10.1016/j.febslet.2015.04.033 18.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
IUCrJ 2014; 1:101-9; PMID:25075326; http://dx.doi.org/10.1107/S205225251400400Xe1239687-6 R. ZHANG ET AL.,OADS,/arxiv_data1/oa_pdf/cb/f0/kpsb-11-10-1239687.PMC5117095.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/2c/iranjradiol-13-04-34712.PMC5117114.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/8d/iranjradiol-13-04-36484.PMC5117115.pdf
Available from: https://mcnpx.lanl.gov .,Non-OADS,/arxiv_data1/oa_pdf/be/8d/iranjradiol-13-04-36484.PMC5117115.pdf
Available at: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/a0/10.1177_0018726716636945.PMC5117123.pdf
"Ein  Leitfaden für die Praxis, 2013, http://www.fmh.ch/files/pdf12/Rechtliche_Grundlagen_2013_D.pdf  5.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/10.1177_0269216316628422.PMC5117124.pdf
http://sru.soc.surrey.,Non-OADS,/arxiv_data1/oa_pdf/99/f1/10.1177_0269216316628422.PMC5117124.pdf
"Braun V and Clarke V. An introduction to the   vignette method, 2013, http://studysites.uk.sagepub.com/ braunandclarke/study/Learning%20Resources/An%20 Introduction%20to%20the%20Vignette%20Method.docx  30.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/10.1177_0269216316628422.PMC5117124.pdf
"SGBEbulletinSSEB 2008; 57: 9–11, http://www.pflegeportal.ch/pflegeportal/Klinische_Ethikberatung_ Machtfreier_Diskurs_im_Spital.php  59.",Non-OADS,/arxiv_data1/oa_pdf/99/f1/10.1177_0269216316628422.PMC5117124.pdf
"Qualitative Research Checklist, http://media.wix.",Non-OADS,/arxiv_data1/oa_pdf/37/c3/10.1177_0269216316648072.PMC5117127.pdf
"Transforming patient experience: the essential guide, https://www.institute.",Non-OADS,/arxiv_data1/oa_pdf/b8/97/10.1177_0269216316649155.PMC5117129.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/44/91/10.1177_2325967116671940.PMC5117156.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7a/9b/10.1177_2054270416660935.PMC5117158.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/10.1177_2054270416663569.PMC5117160.pdf
"Aga Khan University Hospital Karachi, Pakistan, http://www.agakhanhospitals.org/akuh/ (accessed 28 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/10.1177_2054270416663569.PMC5117160.pdf
"40, 2011, 60, http://www.cdc.gov/mmwr/(accessed 5 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/10.1177_2054270416663569.PMC5117160.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/10.1177_2325967116670142.PMC5117161.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(11) 1–5 DOI: 10.1177/2054270416653522",Non-OADS,/arxiv_data1/oa_pdf/4b/39/10.1177_2054270416653522.PMC5117162.pdf
"PIN-ER-t and 95% conﬁdence interval were cal- culated using the relevant online calculator (http://www.phsim.man.ac.uk/pinert/Default.aspx).Although it would theoretically be possible to elim-inate ‘no supplementation with vitamin D’, this isprobably diﬃcult to achieve in practice, therefore, the number of type 1 diabetes cases which could beprevented if current rates of supplementation areimproved were calculated.",Non-OADS,/arxiv_data1/oa_pdf/4b/39/10.1177_2054270416653522.PMC5117162.pdf
"Vitamin D–Advice on supple- ments for at risk groups, https://www.gov.uk/government/uploads/system/uploads/attachment_ data/file/213703/dh_132508.pdf (2012, accessed 29 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/4b/39/10.1177_2054270416653522.PMC5117162.pdf
"Statistical bulletin: Births in England and Wales, 2012, http://www.ons.gov.uk/ons/rel/vsob1/birth-summary-tables–england-and- wales/2012/stb-births-in-england-and-wales-2012.html (2013, accessed 29 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/4b/39/10.1177_2054270416653522.PMC5117162.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c7/8f/10.1177_2325967116671501.PMC5117163.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/24/c5/10.1177_2325967116670376.PMC5117164.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
https://americanyoga.school/ yoga-alliance-ruining-yoga/.,Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
http://www.cdc.gov/brfss/ annual_data/annual_2011.htm.,OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
http://www.cdc.gov/brfss/annual_ data/annual_2014.html.,OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
http://www.cdc.gov/injury/ wisqars/fatal.html.,Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
https://nccih.nih.gov/ health/yoga/introduction.htm .,Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
http://factfinder.census.gov/f aces/tableservices/jsf/pages/ productview.xhtml?src ¼bkmk.,OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
"Intercensal estimates of the resident population by single year of age, sex, race, and Hispanic origin for the US: April 1, 2000 to July 1, 2010. https://www.census.gov/popest/data/ intercensal/national/nat2010.html.",OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
https://www.cpsc.gov/ s3fs-public/pdfs/blk_media_ 2001d011-6b6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
https://www.cpsc.gov/s3fs-public/pdfs/blk_ media_2000d015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/b4/10.1177_2325967116671703.PMC5117171.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/d9/main.PMC5117185.pdf
"He  denied  nausea,  post-prandial  discomfort  or  pain,  diar- http://dx.doi.org/10.1016/j.ijscr.2016.10.077 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/65/d9/main.PMC5117185.pdf
"Association Diabète Québec, http://www.diabete.qc.ca/en/ diabetes-quebec (accessed 17 July 2016).",Non-OADS,/arxiv_data1/oa_pdf/70/b6/10.1177_2050312116674850.PMC5117245.pdf
"SPSS, SAS, MATLAB, and R programs for  determining the number of components and factors using par- allel analysis and Velicer’s MAP test, https://people.ok.ubc.ca/brioconn/nfactors/nfactors.html (accessed 4 January 2016).",OADS,/arxiv_data1/oa_pdf/70/b6/10.1177_2050312116674850.PMC5117245.pdf
"Author contribution All authors have agreed on the final version and meet at least one of  the following criteria (recommended by the ICMJE (http://www.icmje.org/recommendations/)): (1) substantial contributions to con- ception and design, acquisition of data or analysis and interpreta- tion of data and (2) drafting the article or revising it critically for important intellectual content.",Non-OADS,/arxiv_data1/oa_pdf/5c/42/10.1177_2050312116676033.PMC5117247.pdf
"The Finnish Psychogeriatric Association and the Finnish Association of general practice, http://www.kaypahoito.fi/web/kh/etusivu/ naytaartikkeli/tunnus/hoi50044 (2010, accessed 1 January  2016).",Non-OADS,/arxiv_data1/oa_pdf/5c/42/10.1177_2050312116676033.PMC5117247.pdf
"Dementia, http://apps.who.int/iris/bitstream/10665/75263/1/9789241564458_eng.pdf (2012,  accessed 7 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/5c/42/10.1177_2050312116676033.PMC5117247.pdf
"National Institute for Health and Welfare, https://www.thl.",Non-OADS,/arxiv_data1/oa_pdf/5c/42/10.1177_2050312116676033.PMC5117247.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a2/64/10.1177_2331216516672186.PMC5117250.pdf
"Cycloserine – Capsules, USP, http://www.thechaocenter.",Non-OADS,/arxiv_data1/oa_pdf/22/d0/10.1177_1744806916678627.PMC5117251.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).T rends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a4/8d/10.1177_2331216516669329.PMC5117252.pdf
Keywords Whey permeate; Galacto-oligosaccharides (GOS); β-galactosidase; Prebiotics;  Transgalactosylation This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/90/emss-70446.PMC5117255.pdf
"The level of lactose was  also analyzed with the enzyme-based lactose biosensor Lactosens  (DirectSens GmbH,  Vienna, Austria; http://www.directsens.com ), which confirmed the concentration to be below  0.1 g L−1, which is the limit recommended for dairy products to be labelled as ‘lactose-free’ [49].",Non-OADS,/arxiv_data1/oa_pdf/30/90/emss-70446.PMC5117255.pdf
"Retrieved from http://www.cdc.gov/nchs/nhis/index.htm Cohen-Mansfield, J., Marx, M. S., & Guralnik, J. M. (2003).",OADS,/arxiv_data1/oa_pdf/5a/f9/10.1177_2333721416677399.PMC5117257.pdf
"Retrieved from http://www.cdc.gov/mmwr/pdf/ other/su6203.pdf Chadiha, L. A., Washington, O. G., Lichtenberg, P. A., Green,  C. R., Daniels, K. L., & Jackson, J. S. (2011).",OADS,/arxiv_data1/oa_pdf/da/a3/10.1177_2333721416677469.PMC5117259.pdf
"Retrieved from http://agingstats.gov/docs/ PastReports/2010/OA2010.pdf Ficker, L. C., Lysack, C. L., Hanna, M., & Lichtenberg, P.  (2014).",Non-OADS,/arxiv_data1/oa_pdf/da/a3/10.1177_2333721416677469.PMC5117259.pdf
"Stockholm, 2008 [cited 2009  2009-08-26]; available from: http://www.socialstyrelsen.se/NR/  rdonlyres/64AD2A81-FF9F-459F-B0CF-CA955B7E8513/  13410/200812516_rev2.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7a/be/JCB-3-16921.PMC5117532.pdf
References  1.http://www.cancer.org/Cancer/ProstateCancer/Overview  Guide/prostate-cancer-overview-key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/cc/96/JCB-3-16923.PMC5117534.pdf
"As previously described (13), physio - chemical analysis, including molecular weight, theoretical pI,  amino acid composition, instability index, aliphatic index and  the grand average of hydropathicity (GRAVY) of Per a 10 was  performed using the ProtParam tool (http://web.expasy.org/ protparam/)  (33).",OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
"As previously  described (13), the best homologous templates for Per a 10  were selected using the PSI-BLAST server (http://blast.ncbi.",OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
The  modeled protein structure of Per a 10 was built by SWISS- MODEL (http://swissmodel.expasy.org/).,OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
"As previ - ously described (13), 3 immunoinformatics tools, namely the DNAStar Protean system (38), bioinformatics predicted anti - genic peptides (BPAP) system (http://imed.med.ucm.es/Tools/ antigenic.pl) and the BepiPred 1.0 server (http://www.cbs.dtu.",OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
"As previously  described (13), for HLA-DR-based T  cell epitope prediction,  the artificial neural network-based alignment (NN-align)  method NetMHCIIpan-3.0 (http://www.cbs.dtu.dk/services/ NetMHCIIpan/) was applied (42).",OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
"For HLA-DQ alleles,  NetMHCII-2.2 (http://www.cbs.dtu.dk/services/NetMHCII/)  was used (43).",OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
1MBQ; https://www.ncbi.nlm.nih.gov/Structure/mmdb/ mmdbsrv.cgi?,OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
"Thus, we  optimized this modeled structure by Chiron (http://troll.med.",Non-OADS,/arxiv_data1/oa_pdf/02/d2/ijmm-38-06-1806.PMC5117736.pdf
The rat cDNA sequence  (GenBank  NM -012778; https://www.ncbi.nlm.nih.gov/ nuccore/NM_012778) was analyzed for potential small  interfering RNA (siRNA) target sequences for AQP -1.,OADS,/arxiv_data1/oa_pdf/3f/2b/ijmm-38-06-1752.PMC5117737.pdf
"The complete  amino acid sequence of the cloned Per a 9 gene was used as  query to search for homologous sequences through the Swiss- Prot/TrEMBL (Uniprot; http://www.uniprot.org/) and tBLASTn  in NCBI (blast.ncbi.nlm.nih.gov/Blast.cgi) (10,23 -25).",OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
"cs.ucl.ac.uk/psipred), which threads sequence segments  through Protein Data Bank (PDB) library (http://www.pdb.",OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
"In addition, the homologous templates suitable for  Per a 9 were selected using the PSI-BLAST server (http:// blast.ncbi.nlm.nih.gov/Blast.cgi) in the NCBI and Swiss-model  server (http://swissmodel.expasy.org/).",OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
The Der f 25 modeled protein structure  was built through Alignment Mode in SWISS -MODEL  (http://swissmodel.expasy.org/) using the complete amino  acid sequence.,OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
"Three immunoinfor - matics tools, including the DNASTAR  Protean system  (39),  Bioinformatics Predicted Antigenic Peptides (BPAP)  system (http://imed.med.ucm.es/Tools/antigenic.pl) and  the BepiPred 1.0 server (http://www.cbs.dtu.dk/services/ BepiPred/) were used to predict the B cell epitopes of Per a 9,  as previously described (40).",OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
"For  HLA-DQ alleles, NetMHCII-2.2  (http://www.cbs.dtu.",Non-OADS,/arxiv_data1/oa_pdf/45/98/ijmm-38-06-1795.PMC5117749.pdf
"Therefore, research to understand the mechanisms is urgently  necessary [Multidisciplinary European Low Dose Initiative,  Strategic Research Agenda  2015, http://www.melodi-online.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/ijmm-38-06-1623.PMC5117755.pdf
All the 22 exons with their adjacent intronic sequences of the  PHEX  gene were amplified by PCR with 21  pairs of sequencing  primers designed using Primer 3 software (http://bioinfo.ut.ee/ primer3-0.4.0/).,OADS,/arxiv_data1/oa_pdf/72/b2/ijmm-38-06-1703.PMC5117772.pdf
Mut at ions  were checked using Mutalyzer 2.0 (http://mutalyzer.nl/check).,OADS,/arxiv_data1/oa_pdf/72/b2/ijmm-38-06-1703.PMC5117772.pdf
"To predict the impact of missense  mutations on protein structure and function, Polymorphism  Phenotyping  v2 (PolyPhen-2; http://genetics.bwh.harvard.edu/ pph2) (22) and Sorting Tolerant from Intolerant (SIFT; http:// sift.jcvi.org) (23) were used based on sequence alignments.",OADS,/arxiv_data1/oa_pdf/72/b2/ijmm-38-06-1703.PMC5117772.pdf
Available at https://www.rcpath.org/asset/55DBFC41-F06A-4A71-BCC35A97821F8E8D/ (last accessed 11 July 2016).,OADS,/arxiv_data1/oa_pdf/56/b4/bjc2016259a.PMC5117779.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Characterisation of seven novel sarcoma cell lines 1068 www.bjcancer.com | DOI:10.1038/bjc.2016.259,Non-OADS,/arxiv_data1/oa_pdf/56/b4/bjc2016259a.PMC5117779.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Triple-negative breast cancer and node metastasis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.283 1031,Non-OADS,/arxiv_data1/oa_pdf/32/d7/bjc2016283a.PMC5117781.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Quality of life in biliary cancer 1038 www.bjcancer.com | DOI:10.1038/bjc.2016.284,Non-OADS,/arxiv_data1/oa_pdf/7c/87/bjc2016284a.PMC5117782.pdf
NASA Earthdata (2016) Available at http://giovanni.sci.gsfc.nasa.gov/ giovanni/ (accessed on 21 February 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/bf/bjc2016289a.PMC5117784.pdf
Available at https://www.ars.usda.gov/northeast-area/beltsville-md/beltsville-human-nutrition-research-center/nutrient-data-laboratory/docs/usda-national-nutrient-database-for-standard-reference/ (accessed on 04 January 2016).,Non-OADS,/arxiv_data1/oa_pdf/61/bf/bjc2016289a.PMC5117784.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Dairy foods, related nutrients and ovarian cancer 1130 www.bjcancer.com | DOI:10.1038/bjc.2016.289",Non-OADS,/arxiv_data1/oa_pdf/61/bf/bjc2016289a.PMC5117784.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Breast cancer and occupational radiation exposure 1112 www.bjcancer.com | DOI:10.1038/bjc.2016.292,Non-OADS,/arxiv_data1/oa_pdf/4a/b5/bjc2016292a.PMC5117787.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HSP90 inhibition delays resistance in NSCLC models BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.294 1077,Non-OADS,/arxiv_data1/oa_pdf/af/f6/bjc2016294a.PMC5117788.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Hepatic resection for intermediate-stage HCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.301 1047,Non-OADS,/arxiv_data1/oa_pdf/d9/b3/bjc2016301a.PMC5117793.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Survival in patients with relapsed neuroblastoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.302 1057,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/bjc2016302a.PMC5117794.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Serum metabolomic profiling of prostate cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.305 1095",Non-OADS,/arxiv_data1/oa_pdf/9b/5f/bjc2016305a.PMC5117796.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Corrigendum 2 www.bjcancer.com | DOI:10.1038/bjc.2016.306,Non-OADS,/arxiv_data1/oa_pdf/53/9a/bjc2016306a.PMC5117797.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Hypoxia-induced genes profile as a prognostic factor for STS patients 1104 www.bjcancer.com | DOI:10.1038/bjc.2016.310,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/bjc2016310a.PMC5117798.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 207–209Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 207 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S122820 Are another 5 years of adjuvant aromatase  inhibitor therapy needed?",Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
"It is possible that they underestimate the toxicity associated with another 5 years of letrozole therapy in the broader target population.Correspondence: Chang-Yuan Wei Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Hedi Road, No 71, Nanning 530021, People’s Republic of ChinaTel +86 771 533 0855Fax +86 771 531 2000Email weicy63@aliyun.comJournal name: Breast Cancer - Targets and Therapy Article Designation: LETTERY ear: 2016V olume: 8Running head verso: Mo et alRunning head recto: Adjuvant endocrine therapy for postmenopausal womenDOI: http://dx.doi.org/10.2147/BCTT.S122820",Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
Available  from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 209 Adjuvant endocrine therapy for postmenopausal women Authors’ reply Julieta Leone1 Bernardo Amadeo Leone1 José Pablo Leone2 1Department of Medical Oncology, Grupo Oncológico  Cooperativo del Sur, Neuquén, Argentina; 2Division of  Hematology-Oncology and Blood & Marrow Transplantation,   Department of Internal Medicine, University of Iowa Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA, USA Correspondence: José Pablo Leone Division of Hematology-Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C32 GH Iowa City, IA 52242-1081, USATel +1 319 356 7839Fax +1 319 353 8383Email jose-leone@uiowa.edu Dear editor We read the letter from Mo et al with great interest.",Non-OADS,/arxiv_data1/oa_pdf/01/e5/bctt-8-207.PMC5117802.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 211–221Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 211 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S119691 T umor suppressor ING4 inhibits estrogen  receptor activity in breast cancer cells Madeline M Keenen1 Suwon Kim1,2 1Department of Basic Medical  Sciences, University of Arizona  College of Medicine – Phoenix,  Phoenix, AZ,  2Division of Cancer and  Cell Biology, Translational Genomics Research Institute, Phoenix, AZ, USAAbstract: Resistance to antiestrogen therapy remains a significant problem in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
"5 Correspondence: Suwon Kim Department of Basic Medical Sciences, University of Arizona College of Medicine –   Phoenix, 425 North 5th Street, Phoenix, AZ 85004, USATel +1 602 343 8762Email suwon@email.arizona.edu Journal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Keenen and KimRunning head recto: ING4 inhibits ER in breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S119691",Non-OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 221 ING4 inhibits ER in breast cancer 32.,Non-OADS,/arxiv_data1/oa_pdf/a6/74/bctt-8-211.PMC5117803.pdf
"We also performed DAPC with the adegenet package (Jombart, 2008) implemented in R (https://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/3c/ce/hdy201641a.PMC5117837.pdf
", 2000) as implemented in Popart 1.7 (http://popart.otago.ac.nz).",Non-OADS,/arxiv_data1/oa_pdf/3c/ce/hdy201641a.PMC5117837.pdf
DATA ARCHIVING All data sets have been archived in PANGAEA https://doi.pangaea.de/ 10.1594/PANGAEA.860018.,OADS,/arxiv_data1/oa_pdf/3c/ce/hdy201641a.PMC5117837.pdf
"To view a copy of this license, visit http://creativeco mmons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Genetic diversity and hybridization in Ircinia fasciculata A Riesgo et al 439 Heredity",Non-OADS,/arxiv_data1/oa_pdf/3c/ce/hdy201641a.PMC5117837.pdf
"32(6) : 489-499 (2016) https://doi.org/10.5423/PPJ.FT.08.2016.0163 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Co-corresponding author.SM JungPhone) +82-63-238-6742, FAX) +82-63-238-6705E-mail) fizzfizz@korea.krYH KimPhone) +82-2-880-4675, FAX) +82-2-873-2317E-mail) yhokim@snu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/73/ppj-32-489.PMC5117857.pdf
*Compound classes from PubChem (https://pubchem.ncbi.nlm.nih.gov) and EMBL-EBI Ontology Lookup Service (http://www.ebi.ac.uk/ols/index).,OADS,/arxiv_data1/oa_pdf/dc/73/ppj-32-489.PMC5117857.pdf
32(6) : 500-507 (2016) https://doi.org/10.5423/PPJ.FT.10.2016.0216pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †These authors contributed equally to this work as first authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/98/ppj-32-500.PMC5117858.pdf
Motif identification was performed using MotifMaker  (https://github.com/PacificBiosciences/MotifMaker) and  in-house Python scripts with REBASE version 608 (ftp://ftp.neb.com/pub/rebase/allenz.txt).,OADS,/arxiv_data1/oa_pdf/4c/98/ppj-32-500.PMC5117858.pdf
"32(6) : 508-518 (2016) https://doi.org/10.5423/PPJ.OA.06.2015.0101pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +91-9983936683, FAX) +91-2962-260013E-mail) ppjambhulkar@gmail.com cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/60/ppj-32-508.PMC5117859.pdf
"32(6) : 519-527 (2016) https://doi.org/10.5423/PPJ.OA.02.2016.0034pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +91-9437684176, FAX) +91-674-2350652E-mail) rajkumar.joshi@yahoo.co.in cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/6a/ppj-32-519.PMC5117860.pdf
URL http://faostat3.fao.org/browse/Q/QC/E.,OADS,/arxiv_data1/oa_pdf/f2/6a/ppj-32-519.PMC5117860.pdf
URL  http://www.iihr.res.in/content/annual-reports-0 [March  2015].,Non-OADS,/arxiv_data1/oa_pdf/f2/6a/ppj-32-519.PMC5117860.pdf
"32(6) : 528-536 (2016) https://doi.org/10.5423/PPJ.OA.05.2016.0131 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †Current affiliation: Z Mersha, Lincoln University Cooperative  Extension, Jefferson City, MO 65101, USA; CH Huang, De-partment of Soil and Environmental Sciences, National Chung Hsing University, Taichung City, Taiwan 402, Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/c6/73/ppj-32-528.PMC5117861.pdf
URL http://edis.ifas.ufl.edu/pi046 [25 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/c6/73/ppj-32-528.PMC5117861.pdf
URL http://www.hos.ufl.edu/ProtectedAg/pdf/HS32100.pdf [25 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/c6/73/ppj-32-528.PMC5117861.pdf
"32(6) : 537-544 (2016) https://doi.org/10.5423/PPJ.OA.03.2016.0068 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-64-741-2584, FAX) +82-64-749-2066E-mail) doki7312@gmail.com cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/2b/ppj-32-537.PMC5117862.pdf
32(6) : 545-551 (2016) https://doi.org/10.5423/PPJ.OA.05.2016.0122pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/6e/19/ppj-32-545.PMC5117863.pdf
32(6) : 552-562 (2016) https://doi.org/10.5423/PPJ.OA.06.2016.0141pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Co-corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/01/ppj-32-552.PMC5117864.pdf
"Database searches were per - formed using Mascot (http://www.matrixscience.com) and ProteinProspector (http://prospector.ucsf.edu/pros- pector/mshome.htm) as described previously (Kim et al.,  2008a).",OADS,/arxiv_data1/oa_pdf/f6/01/ppj-32-552.PMC5117864.pdf
"32(6) : 563-569 (2016) https://doi.org/10.5423/PPJ.NT.04.2016.0112pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-54-530-1246, FAX) +82-54-530-1248E-mail) kiwoo@knu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/5b/ppj-32-563.PMC5117865.pdf
They produce a  dense black fungal coating on the leaves and stems from  summer to fall (https://www.clemson.edu/extension/hgic/pests/pdf/hgic2002.pdf).,Non-OADS,/arxiv_data1/oa_pdf/03/5b/ppj-32-563.PMC5117865.pdf
"32(6) : 570-574 (2016) https://doi.org/10.5423/PPJ.NT.05.2016.0114pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-33-250-6435, FAX) +82-33-259-5558E-mail) kims@kangwon.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/27/ppj-32-570.PMC5117866.pdf
"32(6) : 575-579 (2016) https://doi.org/10.5423/PPJ.NT.05.2016.0118 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-63-238-5131, FAX) +82-63-238-5118E-mail) nohtw831@korea.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/75/ppj-32-575.PMC5117867.pdf
"32(6) : 580-583 (2016) https://doi.org/10.5423/PPJ.NT.09.2015.0197pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +91-674-2367757, FAX) +91-671-2367663E-mail) titirtua@gmail.com cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/85/ppj-32-580.PMC5117868.pdf
The PCR products were se- quenced directly and translated with EXPASY Translate tool (http://web.expasy.org/translate) and the sequences aligned on www.phylogeny.fr after curation (removal of poorly aligned regions) with GBLOCKS (http://phylog-eny.lirmm.fr/phylo_cgi/one_task.cgi?task_type=gblocks).,OADS,/arxiv_data1/oa_pdf/d3/85/ppj-32-580.PMC5117868.pdf
"32(6) : 584-588 (2016) https://doi.org/10.5423/PPJ.NT.07.2016.0153pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-51-629-5617, FAX) +82-51-629-5610E-mail) choitj@pknu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/ab/ppj-32-584.PMC5117869.pdf
"Blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis showed that the isolated bacteria were B. cereus , B. pseudomycoides , and  Bacillus sp.",OADS,/arxiv_data1/oa_pdf/f6/ab/ppj-32-584.PMC5117869.pdf
"Prediction of open reading frames (ORFs) was carried out using the RAST server (http://rast.nmpdr.org/), and Blastp analysis of amino acid se-quences was performed using the NCBI database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).",OADS,/arxiv_data1/oa_pdf/f6/ab/ppj-32-584.PMC5117869.pdf
tRNA prediction was conducted using the tRNAscan-SE program (http://low-elab.ucsc.edu/tRNAscan-SE).,OADS,/arxiv_data1/oa_pdf/f6/ab/ppj-32-584.PMC5117869.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/dddt-10-3755.PMC5117872.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3755–3761Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3755Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11512 1 Oncolytic adenovirus expressing interleukin-18  improves antitumor activity of dacarbazine for  malignant melanoma chunhua Yang1,2 hang cao1 ning liu1 Kai Xu1 Meng Ding1 li-jun Mao1 1Department of Urinary surgery, The  affiliated hospital of Xuzhou Medical  University, 2Jiangsu Key laboratory  of Biological cancer Therapy, Xuzhou  Medical college, Xuzhou, People’s  republic of chinaAbstract:  Conditionally replicating adenoviruses have emerged as novel therapeutic agents  for cancer.",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/dddt-10-3755.PMC5117872.pdf
"correspondence: li-jun Mao Department of Urinary surgery,  The Affiliated Hospital of Xuzhou  Medical University, 99 West huai-hai   road, Xuzhou 221000, People’s  republic of china email mljmlj05@xzmc.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y ang et al Running head recto: Oncolytic adenovirus plus chemotherapy for melanoma DOI: http://dx.doi.org/10.2147/DDDT.S115121",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/dddt-10-3755.PMC5117872.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/fe/dddt-10-3755.PMC5117872.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/fe/dddt-10-3755.PMC5117872.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/29/dddt-10-3661.PMC5117873.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3661–3672Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3661Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10749 0 Sildenafil potentiates the antitumor activity of  cisplatin by induction of apoptosis and inhibition  of proliferation and angiogenesis Mona Mohamed el-naa1 Mohamed Othman2,3 sheren Y ounes4,5 1Faculty of Pharmacy, October  University for Modern Sciences and  arts (M sa), 6 October city, egypt;   2Preparatory Year College, University  of Hail, Hail, Kingdom of Saudi Arabia;   3Faculty of Biotechnology, October  University for Modern Science and  arts (M sa), 6 October city, egypt;   4Pathology Department, Faculty of  Medicine, Menoufia University, Shebin  El-Kom, Egypt; 5College of Medicine,   Princess Nora Bint Abdulrahman  University, Riyadh, Kingdom of  saudi arabiaAbstract:  Sildenafil is the first phosphodiesterase-5 inhibitor used for the treatment of erectile  dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/f5/29/dddt-10-3661.PMC5117873.pdf
"PDE-5, -6, and -9 are selective for cGMP and PDE-4, -7, and -8 are cAMP  selective, whereas PDE-1, -2, -3, -10, and -11 are dual substrate-degrading isozymes.2 Altered expression and/or activity of PDEs have been reported in various carci - nomas and hematological malignancies.1 PDE-5 has been shown to be overexpressed correspondence: Mona Mohamed el-naa Faculty of Pharmacy, October University  for Modern Sciences and Arts (MSA),  26 July Mehwar road intersection with  Wahat road, 6 October city, egypt Tel +20 2 0122 7310 837 Fax +20 2 3837 1543 email mona_elnaa@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: El-Naa et al Running head recto: Impact of sildenafil on the antitumor activity of cisplatin DOI: http://dx.doi.org/10.2147/DDDT.S107490",Non-OADS,/arxiv_data1/oa_pdf/f5/29/dddt-10-3661.PMC5117873.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f5/29/dddt-10-3661.PMC5117873.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/29/dddt-10-3661.PMC5117873.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/41/opth-10-2277.PMC5117874.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2277–2289Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2277Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11855 5 Clinical and imaging evaluation of the response  to intravenous steroids in patients with graves’  orbitopathy and analysis on who requires  additional therapy Theodora Tsirouki1 alexandra Bargiota2 stelios Tigas3 agathi Vasileiou2 eftichia Kapsalaki4 Zoe giotaki3 ioannis asproudis5 agathokles Tsatsoulis3 georgios Koukoulis2 evangelia e Tsironi1 1Department of Ophthalmology,   University hospital of larissa,   larissa, 2Department of  endocrinology, University hospital  of larissa, larissa,  3Department of  endocrinology, University hospital  of ioannina, ioannina, 4Department  of Diagnostic radiology, University  hospital of larissa, larissa,   5Department of Ophthalmology,   University hospital of ioannina,   ioannina, greeceObjective:  The aim of this study was to evaluate the safety and efficacy of an individualized  steroid regimen in patients with moderate-to-severe Graves’ orbitopathy (GO) by monitoring  clinical and imaging parameters.",Non-OADS,/arxiv_data1/oa_pdf/34/41/opth-10-2277.PMC5117874.pdf
"Keywords:  Graves’ orbitopathy, magnetic resonance imaging, MRI, glucocorticoids Introduction Graves’ orbitopathy (GO) is an autoimmune disorder of the orbit, which is closely  related to Graves’ disease (GD).1 Ophthalmic manifestations are present in 25%–50%  of patients with GD, and the majority of patients with GO have already presented or  are anticipated to experience Graves’ hyperthyroidism.1,2 GO has an annual incidence  rate of 16 women and 3 men per 100,000, principally affecting patients aged between  30 and 60 years old.1 Although it is a self-limiting disease, 5% of patients have sight- threatening disease manifestations.2 Clinical assessment and treatment of GO remain a riddle for physicians of varied  specialties.3–5 Several clinical studies, over the last 60 years, have attempted to identify Correspondence: Theodora Tsirouki Department of Ophthalmology,  University hospital of larissa, 6 iliodorou  street, 41222 larissa, greece Tel +30 6 944429964 email theod.tsi@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tsirouki et al Running head recto: Graves’ orbitopathy individualized treatment DOI: http://dx.doi.org/10.2147/OPTH.S118555",Non-OADS,/arxiv_data1/oa_pdf/34/41/opth-10-2277.PMC5117874.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/34/41/opth-10-2277.PMC5117874.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/41/opth-10-2277.PMC5117874.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2839–2850International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2839OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11872 4 Community-based exercise training for people  with chronic respiratory and chronic cardiac  disease: a mixed-methods evaluation renae J Mcn amara1,2 Zoe J McKeough3 laura r Mo3 Jamie T Dallimore4 sarah M Dennis3 1Physiotherapy Department,   2respiratory and sleep Medicine  Department, Prince of Wales hospital,   randwick, 3Discipline of Physiotherapy,   The University of sydney, lidcombe,   4eastern sydney Medicare local,   rosebery, nsW, australiaBackground:  Poor uptake and adherence are problematic for hospital-based pulmonary and  heart failure rehabilitation programs, often because of access difficulties.",Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
gov.auJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: McNamara et al Running head recto: Community-based exercise training DOI: http://dx.doi.org/10.2147/COPD.S118724,Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
"Available from: http://lungfoundation.com.au/wp- content/uploads/2015/02/Pre-Budget-Submision-Improving-Access- to-Pulmonary-Rehabiliatation-through-MBS-Rebate.pd f. Accessed  January 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
"Available from: http://www.qualres.org/ HomeSemi-3629.htm l. Accessed January 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
Available from: http://archive.ahrq.,OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
Available from http://www.heartmoves.,Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/81/copd-11-2839.PMC5117875.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/01/ott-9-7071.PMC5117876.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7071–7079OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7071Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11253 4 lrig1 is a positive prognostic marker in  hepatocellular carcinoma Bo Yang1,2 chen Dai1,2 rumeng Tan1,2 Bo Zhang1,2 Xiao Meng3 Jing Ye3 Xinqiang Wang1,2 lai Wei1,2 Fan he4 Zhishui chen1,2 1institute of Organ Transplantation,   Tongji hospital, Tongji Medical  college, huazhong University of  science and T echnology, Wuhan,   hubei, People’s republic of china;   2Key laboratory of Ministry of health  and Key laboratory of Ministry of  education, Wuhan, hubei, People’s  republic of china; 3Department  of Pathology, liaocheng People’s  hospital, liaocheng, shandong,   People’s republic of china;   4Department of nephrology, Tongji  hospital, T ongji Medical college,   huazhong University of science and  T echnology, Wuhan, hubei, People’s  republic of chinaBackground:  The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ab/01/ott-9-7071.PMC5117876.pdf
"The leucine-rich repeats and immunoglobulin-like domains (Lrig) family comprises three  paralogous genes, termed Lrig1 , Lrig2 , and Lrig3 , which are widely expressed in human correspondence: Zhishui chen institute of Organ Transplantation,  Tongji hospital, Tongji Medical college,  huazhong University of science and  Technology, no 1095 Jiefang avenue,  Wuhan, hubei Province 430030, People’s  republic of china Tel +86 136 0714 7899 email chenzhishui@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: Lrig1 is a positive prognostic marker in hepatocellular carcinoma DOI: http://dx.doi.org/10.2147/OTT.S112534",Non-OADS,/arxiv_data1/oa_pdf/ab/01/ott-9-7071.PMC5117876.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/01/ott-9-7071.PMC5117876.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/01/ott-9-7071.PMC5117876.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/e5/ott-9-7019.PMC5117877.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7019–7028OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7019CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11097 6 ERCC1  and XRCC1  but not XPA single nucleotide  polymorphisms correlate with response to  chemotherapy in endometrial carcinoma liang Chen1 Mei-Mei liu1 Hui liu1 Dan lu2 Xiao-Dan Zhao3 Xue-Jing Yang4 1Department of Gynecology and  Obstetrics, 2Department of Oncology,   3Department of Clinical laboratory,   The 2nd affiliated Hospital, Harbin  Medical University, 4nursing  Department, Harbin Chest Hospital,   Harbin, people’s republic of ChinaAbstract:  Our study aimed to investigate the correlation between single nucleotide polymorphisms  of ERCC1/XRCC1/XPA  genes and postoperative chemotherapy efficacy and prognosis of endo - metrial carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/2e/e5/ott-9-7019.PMC5117877.pdf
"Namely, exposure of the endometrium to high levels of estrogen and low progester - one contributes to the development of endometrial cell and further enhances the risk  of cancer.1 Interestingly, operation is the principal way for patients with endometrial  carcinoma, such as hysterectomy and bilateral salpingo-oophorectomy, followed by  other auxiliary treatments.3 In recent years, along with the improvement in molecular  biological fields, it has been found that DNA repair polymorphism participates in the  development of tumors, such as base excision repair (BER) and nucleotide excision Correspondence: liang Chen Department of Gynecology and  Obstetrics, The 2nd Affiliated Hospital,  Harbin Medical University, Xuefu road  no 246, nangang District, Harbin  150056, Heilongjiang province, people’s  republic of China Tel +86 0451 5569 3666 email acdfj18678@163.co m Journal name: OncoTargets and Therapy Article Designation: Clinical Trial Report Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: ERCC1/XRCC1  genes and chemotherapy efficacy DOI: http://dx.doi.org/10.2147/OTT.S110976",Non-OADS,/arxiv_data1/oa_pdf/2e/e5/ott-9-7019.PMC5117877.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2e/e5/ott-9-7019.PMC5117877.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/e5/ott-9-7019.PMC5117877.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/db/e8/cia-11-1661.PMC5117878.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1661–1674Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1661OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11530 4 Calf-raise senior: a new test for assessment  of plantar flexor muscle strength in older  adults: protocol, validity, and reliability helô-Isa André1 Filomena Carnide1 edgar Borja2 Fátima Ramalho1,2 Rita Santos-Rocha1,2 António P Veloso1 1Laboratory of Biomechanics  and Functional Morphology,   Interdisciplinary study Centre for  human Performance (CIP er), Faculty  of human Kinetics (FM h), University  of lisbon, Portugal; 2sports science  School of Rio Maior (ESDRM),   Polytechnic Institute of Santarém,   PortugalPurpose:  This study aimed to develop a new field test protocol with a standardized measurement  of strength and power in plantar flexor muscles targeted to functionally independent older adults,  the calf-raise senior (CRS) test, and also evaluate its reliability and validity.",Non-OADS,/arxiv_data1/oa_pdf/db/e8/cia-11-1661.PMC5117878.pdf
"Keywords:  elderly, heel-raise test, ankle, isometric, strength, functionality Introduction The aging process associated with a sedentary lifestyle can lead to the decline of some  physical capacities, including muscle strength and power,1–3 which is associated with  functional limitations in daily living activities4–6 and, therefore, to an increased risk  of falling.7,8 The identification of risk factors for falls is claimed to be critical to the  development of appropriate preventive intervention strategies aiming at reducing the  incidence of falling in the older population.9 Muscle weakness, gait, and balance deficits are considered as intrinsic risk factors  with the highest relative risk for falls.8,10 Neuromuscular changes of the ankle muscle– tendon complex appear to play a very important role in the prevention of falls in older Correspondence: helô Isa André Faculdade de Motricidade humana,  estrada da Costa, 1499-022 Cruz  Quebrada, Dafundo, Portugal Tel +351 214 149 204 email heloandre@fmh.ulisboa.p t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: André et al Running head recto: Calf-raise senior test DOI: http://dx.doi.org/10.2147/CIA.S115304",Non-OADS,/arxiv_data1/oa_pdf/db/e8/cia-11-1661.PMC5117878.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/db/e8/cia-11-1661.PMC5117878.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/db/e8/cia-11-1661.PMC5117878.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/37/ott-9-7047.PMC5117879.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7047–7057OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7047Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10723 5 Microrna-9 suppresses the growth, migration,  and invasion of malignant melanoma cells via  targeting nrP1 Dan Xu1 Xiaofeng chen2 Quanyong he1 chengqun luo1 1Department of Plastic surgery,   Third Xiangya hospital of central  south University, 2Department of  neurosurgery, Brain hospital of  hunan Province, changsha, hunan,   People’s republic of chinaAbstract:  MicroRNAs (miRs) are a class of small noncoding RNAs that negatively regulate the  gene expression by directly binding to the 3 ′ untranslated region of their target mRNA, thus result - ing in mRNA degradation or translational repression.",Non-OADS,/arxiv_data1/oa_pdf/26/37/ott-9-7047.PMC5117879.pdf
"Keywords:  malignant melanoma, microRNA, neuropilin1, proliferation, migration, invasion Introduction Malignant melanoma (MM) is a malignant tumor originating from melanocytes and  is a dangerous disease entity that is ranked as the seventh most common malignancy  in females and the fifth most common cancer in males globally.1,2 It is characterized  by a rapid progression and lymph node metastasis.3 Furthermore, the recurrence of  MM is common if not detected in the early stage, and thus has become the deadliest  skin cancer.3 Recently, the incidence of MM is estimated to have increased by 3.1% in  1 year, and thus has become a continuing threat to health.2 Recent studies have identi - fied some oncogenes and tumor suppressors involved in MM, which show promise to  serve as therapeutic targets for the treatment of MM.4–6 MicroRNAs (miRs) are a class of small noncoding RNAs that negatively regulate the  gene expression via directly binding to the 3 ′ untranslational region (UTR) of their target correspondence: Dan Xu Department of Plastic surgery, Third  Xiangya hospital of central south  University, no 138 Tongzipo road,  changsha, hunan 41013, People’s  republic of china Tel/fax +86 731 8861 8816 email doctorxudan2013@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xu et al Running head recto: miR-9 suppresses MM DOI: http://dx.doi.org/10.2147/OTT.S107235",Non-OADS,/arxiv_data1/oa_pdf/26/37/ott-9-7047.PMC5117879.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/37/ott-9-7047.PMC5117879.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/37/ott-9-7047.PMC5117879.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/d6/ott-9-7029.PMC5117880.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7029–7037OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7029Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11255 5 Predictive values of diffusion-weighted imaging   and perfusion-weighted imaging in evaluating  the efficacy of transcatheter arterial  chemoembolization for hepatocellular carcinoma Min lin1 Man-Man Tian1 Wei-Ping Zhang2 li Xu1 Ping Jin1 1Department of radiology,   2Department of Oncology, The  Third affiliated hospital of Zhejiang  chinese Medical University, hangzhou,   Zhejiang Province, People’s republic  of chinaAbstract:  This study explored the predictive values of diffusion-weighted imaging (DWI) and  perfusion-weighted imaging (PWI) in evaluating the efficacy of transcatheter arterial chemoem - bolization (TACE) for patients with hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/b1/d6/ott-9-7029.PMC5117880.pdf
"Keywords:  hepatocellular carcinoma, transcatheter arterial chemoembolization, diffusion- weighted imaging, perfusion-weighted imaging, efficacy Introduction Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide  for its high incidence and mortality, which seriously threatens human health and  life.1 In the People’s Republic of China, HCC is the second leading malignancy with  an annual incidence and mortality of ~360,000 and 350,000, respectively.2 Surgical  resection remains the first option for HCC patients, but a number of patients are diag - nosed after the optimal time for surgical resection has passed.3 Transcatheter arterial  chemoembolization (TACE) has been widely used in patients with unresectable HCC.4 correspondence: Min lin Department of radiology, The Third  Affiliated Hospital of Zhejiang Chinese  Medical University, no 219, Moganshan  road, Xihu District, hangzhou 310005,  Zhejiang Province, People’s republic of  china Tel +86 571 8839 3556 email linmin050@126.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lin et al Running head recto: DWI and PWI in evaluating the efficacy of TACE for HCC DOI: http://dx.doi.org/10.2147/OTT.S112555",Non-OADS,/arxiv_data1/oa_pdf/b1/d6/ott-9-7029.PMC5117880.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b1/d6/ott-9-7029.PMC5117880.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/d6/ott-9-7029.PMC5117880.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/31/dddt-10-3789.PMC5117881.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3789–3798Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3789Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11991 8 comparison of bile salt/phosphatidylcholine mixed  micelles in solubilization to sterols and stability Qin guo1,* Jie cai1,2,* Pengyu li1 Dongling Xu1 Xiaomin ni1 hui Wen3 Dan liu3 suizhen lin3 haiyan hu1 1school of Pharmaceutical sciences,   sun Yat-sen University, 2guangzhou  First People’s hospital, guangzhou  Medical University, 3guangzhou  cellprotek Pharmaceutical co., ltd.,   science Park, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Androst-3 β,5α,6β-triol (Triol) is a promising neuroprotective agent, but its poor  solubility restricts its development into parenteral preparations.",Non-OADS,/arxiv_data1/oa_pdf/c5/31/dddt-10-3789.PMC5117881.pdf
"In the BS/PC-MM system, the bile salts (BSs) interact with the  aqueous solvent through their hydrophilic surfaces and combine with the hydrophobic  tail of phosphatidylcholine (PC) via hydrophobic surfaces.9,10 Drugs were reported  to bind to BSs either in the palisade layer or in the micellar core.11 Although solubi - lizing capacity is a fundamental consideration for BS/PC-MM system, its stability correspondence: haiyan hu school of Pharmaceutical sciences, sun  Yat-sen University, 132 Waihuan east  road, University Town, guangzhou  510006, People’s republic of china Tel/fax +86 20 3933 6119 email lsshhy@mail.sysu.edu.c nJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Guo et al Running head recto: BS/PC mixed micelles for sterols: solubility and stability DOI: http://dx.doi.org/10.2147/DDDT.S119918",Non-OADS,/arxiv_data1/oa_pdf/c5/31/dddt-10-3789.PMC5117881.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c5/31/dddt-10-3789.PMC5117881.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/31/dddt-10-3789.PMC5117881.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fa/b0/opth-10-2291.PMC5117882.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2291–2296Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2291Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11566 0 amaurosis fugax – delay between symptoms and  surgery by specialty Pia Kvickström1 Bertil lindblom2,3 göran Bergström4,5 Madeleine Zetterberg2,3 1Department of Ophthalmology,   skaraborg hospital, skövde,   2Department of Clinical  neuroscience/Ophthalmology,   institute of neuroscience and  Physiology, The sahlgrenska academy  at University of gothenburg,   gothenburg, 3Department of  Ophthalmology, sahlgrenska  University hospital, Mölndal,   4Department of Molecular and  Clinical Medicine, The sahlgrenska  academy at University of gothenburg,   5Department of Clinical Physiology,   sahlgrenska University hospital,   gothenburg, swedenPurpose:  To describe the time course of management of patients with amaurosis fugax and  analyze differences in management by different specialties.",Non-OADS,/arxiv_data1/oa_pdf/fa/b0/opth-10-2291.PMC5117882.pdf
"This is the most effec - tive stroke prevention in symptomatic patients.7 The current recommendation is that  the patient should be operated within 2 weeks from the debut of symptoms or even Correspondence: Madeleine Zetterberg Department of Clinical neuroscience/ Ophthalmology, The sahlgrenska  academy at University of gothenburg,  sahlgrenska University hospital, se-431  80 Mölndal, sweden Tel +46 31 343 3255 Fax +46 31 412 904 email madeleine.zetterberg@gu.s e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kvickström et al Running head recto: Amaurosis fugax – management by different specialties DOI: http://dx.doi.org/10.2147/OPTH.S115660",Non-OADS,/arxiv_data1/oa_pdf/fa/b0/opth-10-2291.PMC5117882.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fa/b0/opth-10-2291.PMC5117882.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/b0/opth-10-2291.PMC5117882.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/dd/ijn-11-6079.PMC5117883.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6079–6088International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6079OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12082 8 Polyethyleneimine-coated quantum dots for  mirNa delivery and its enhanced suppression  in hepg2 cells gaofeng liang1 Yang li1 Wenpo Feng1 Xinshuai Wang2 aihua Jing1 Jinghua li1 Kaiwang Ma1 1Department of Biomedical engineering,  school of Medical Technology &  engineering, 2Department of Oncology,  The First affiliated hospital, henan  University of science & T echnology,  luoyang, People’s republic of chinaAbstract:  Quantum dots (QDs) have been intensively investigated for bioimaging, drug  delivery, and labeling probes because of their unique optical properties.",Non-OADS,/arxiv_data1/oa_pdf/cb/dd/ijn-11-6079.PMC5117883.pdf
"Meanwhile, our previous correspondence: Kaiwang Ma Department of Biomedical engineering,  school of Medical Technology &  engineering, henan University of  science & Technology, #263 Kaiyuan  avenue, luoyang 471023, henan  Province, People’s republic of china Tel +86 134 6100 7723 email kaiwang.ma@haust.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liang et al Running head recto: PEI-coated QDs for miRNA delivery in HepG2 cells DOI: http://dx.doi.org/10.2147/IJN.S120828",Non-OADS,/arxiv_data1/oa_pdf/cb/dd/ijn-11-6079.PMC5117883.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cb/dd/ijn-11-6079.PMC5117883.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/dd/ijn-11-6079.PMC5117883.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7059–7069OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7059Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11296 5 Meta-analysis of outcomes of patients with stage  iV colorectal cancer managed with chemotherapy/  radiochemotherapy with and without primary  tumor resection Ko-chao lee1 Yu-che Ou2 Wan-hsiang hu1 chia-cheng liu3 hong-hwa chen1 1Division of colorectal surgery,   Department of surgery, 2Department  of Obstetrics and gynecology,   chang gung Memorial hospital,   Kaohsiung Medical center, chang  gung University college of Medicine,   Kaohsiung, 3Department of surgery,   Pingtung christian hospital,   Pingtung, TaiwanBackground:  Colorectal cancer is the third leading cause of death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"Keywords:  chemotherapy, colorectal cancer, outcomes, tumor resection Introduction New cases of colorectal cancer (CRC) worldwide totaled 14.1 million in 2012, with  8.2 million deaths, making CRC the third leading cause of death worldwide after lung  and liver cancers.1 In the US, ~134,490 adults will be diagnosed with CRC in 2016 correspondence: Ko-chao lee;  hong-hwa chen Division of colorectal surgery,  Department of surgery, Kaohsiung chang  gung Memorial hospital, 123 Ta Pei  road, niao sung, Kaohsiung, Taiwan Tel +886 7 731 7123 Fax +886 7 731 8762 email kclee@adm.cgmh.org.t w;  kmch4329@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lee et al Running head recto: Primary tumor resection in advanced CRC DOI: http://dx.doi.org/10.2147/OTT.S112965",Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"Available from: http://www.cdc.gov/nchs/nhis/nhis_question - naires.ht m. Accessed March 25, 2016.",OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"Available from: http://www.cancer.org/cancer/colonandrectumcancer/ detailedguide/colorectal-cancer-key-statistic s. Accessed January 19,  2016.",Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/77/ott-9-7059.PMC5117884.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/38/dddt-10-3763.PMC5117885.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3763–3770Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3763Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12038 7 Pharmacokinetics, pharmacodynamics and safety  of cKD-519, a ceTP inhibitor, in healthy subjects choon Ok Kim1 eun sil Oh2 chungam choi1 Yeonjoo Kim3 sera lee4 semi Kim4 Min soo Park1,5 1Department of clinical Pharmacology,   severance hospital, Y onsei University  college of Medicine, seoul,   2Department of Pharmaceutical  Medicines and regulatory science,   colleges of Medicine and Pharmacy,   Y onsei University, incheon, 3chong  Kun Dang clinical research, chong  Kun Dang Pharmaceutical corp.,   4chong Kun Dang research institute,   chong Kun Dang Pharmaceutical  corp., 5Department of Pediatrics,   Y onsei University college of Medicine,   seoul, republic of KoreaAbstract:  CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor  being developed for the treatment of dyslipidemia to raise high-density lipoprotein cholesterol.",Non-OADS,/arxiv_data1/oa_pdf/3d/38/dddt-10-3763.PMC5117885.pdf
"The fibrates and correspondence: Min soo Park Department of clinical Pharmacology,  severance hospital, Yonsei University  college of Medicine, 50-1 Yonsei-ro,  seodaemun-gu, seoul 03722,   republic of Korea Tel +82 2 2228 0400 Fax +82 2 2227 7890 email minspark@yuhs.a c Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kim et al Running head recto: Pharmacokinetic and pharmacodynamics of new CETP inhibitor, CKD-519 DOI: http://dx.doi.org/10.2147/DDDT.S120387",Non-OADS,/arxiv_data1/oa_pdf/3d/38/dddt-10-3763.PMC5117885.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3d/38/dddt-10-3763.PMC5117885.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/38/dddt-10-3763.PMC5117885.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1653–1659Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1653OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12017 5 safety and effectiveness of daily teriparatide for  osteoporosis in patients with severe stages of  chronic kidney disease: post hoc analysis of a  postmarketing observational study Atsushi nishikawa1 Fumito Y oshiki2 Masanori Taketsuna2 Kenta Kajimoto2 hiroyuki enomoto2 1global Patient safety Japan, Quality  and Patient safety, eli lilly Japan K.K.,   2Medicines Development Unit Japan,   eli lilly Japan K.K., Kobe, JapanAbstract:  Teriparatide (recombinant 1–34 N-terminal sequence of human parathyroid  hormone) for the treatment of osteoporosis should be prescribed with caution in patients with  severe stages of chronic kidney disease (CKD).",Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
"In 2005, ∼13% of the Japanese adult population were estimated  to have CKD and this figure is likely to be even higher in the elderly.6,7 Osteoporosis Correspondence: hiroyuki enomoto Medical sciences, Medicines Development  Unit Japan, eli lilly Japan K.K.,  4-15-1-13F, Akasaka, Minoto-ku, Tokyo,  107-0052, Japan Tel +81 35 574 9143 Fax +81 35 574 9979 email enomoto_hiroyuki@lilly.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Nishikawa et al Running head recto: Daily teriparatide in stage 4/5 CKD DOI: http://dx.doi.org/10.2147/CIA.S120175",Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
"Available from: https://www.lilly.co.jp/_Assets/pdf/ lillyanswers /products/tenpu_for-kit600.pd f. Accessed September 30,  2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/67/cia-11-1653.PMC5117886.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/24/dddt-10-3779.PMC5117887.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3779–3787Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3779Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11814 5 increased localized delivery of piroxicam by  cationic nanoparticles after intra-articular injection sung rae Kim1 Myoung Jin ho2 sang hyun Kim1 ha ra cho2 han sol Kim2 Y ong seok choi2 Y oung Wook choi1 Myung Joo Kang2 1Division of Pharmaceutical sciences,   college of Pharmacy, chung- ang  University, seoul, 2college of  Pharmacy, Dankook University,   cheonan, chungnam, south KoreaAbstract:  Piroxicam (PRX), a potent nonsteroidal anti-inflammatory drug, is prescribed to  relieve postoperative and/or chronic joint pain.",Non-OADS,/arxiv_data1/oa_pdf/16/24/dddt-10-3779.PMC5117887.pdf
"It was reported that IA indomethacin showed  a short elimination half-life of 2.8 h in patients.5 Moreover, several low molecular  weight analgesics such as paracetamol, salicylate, and diclofenac exhibited only 1.1,  2.4, and 5.2 h elimination half-lives, respectively, in preclinical studies.6 There is an  emerging interest in the development of polymeric nano- and micro-particulate systems correspondence: Young Wook choi Division of Pharmaceutical sciences,  college of Pharmacy, chung-ang  University, 84 heukseok-ro, Dongjak-gu,  seoul 156-756, south Korea Tel +82 2 820 5609 Fax +82 2 826 3781 email ywchoi@cau.ac.k r Myung Joo Kang Division of Pharmaceutical sciences,  college of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  cheonan, chungnam 330-714,  south Korea Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kim et al Running head recto: Increased joint retention of piroxicam by polymeric nanoparticles DOI: http://dx.doi.org/10.2147/DDDT.S11814 5",Non-OADS,/arxiv_data1/oa_pdf/16/24/dddt-10-3779.PMC5117887.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/24/dddt-10-3779.PMC5117887.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/24/dddt-10-3779.PMC5117887.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3747–3754Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3747Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10353 4 Selexipag in the treatment of pulmonary arterial  hypertension: design, development, and therapy elizabeth Ashley Hardin1 Kelly M Chin2 1Department of internal Medicine,   Division of Cardiology, 2Department  of internal Medicine, Division  of Pulmonary and Critical Care  Medicine, University of Texas  Southwestern Medical Center,   Dallas, TX, USAAbstract:  Pulmonary arterial hypertension is characterized by abnormalities in the small  pulmonary arteries including increased vasoconstriction, vascular remodeling, proliferation  of smooth muscle cells, and in situ thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
"In animal stud - ies, mice with IP receptor knockout mutations develop much more severe PAH under  hypoxic conditions compared with wild-type mice.5 Furthermore, transfer of the human Correspondence: Kelly M Chin Division of Pulmonary and Critical  Care Medicine, University of Texas  Southwestern Medical Center, 5939  Harry Hines Boulevard, 6th Floor, Suite  600, Dallas, TX 75390-9253, USA Tel +1 214 645 5505 email kelly.chin@utsouthwestern.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Hardin and Chin Running head recto: Selexipag for the treatment of pulmonary arterial hypertension DOI: http://dx.doi.org/10.2147/DDDT.S103534",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
"Available from:  https://www.orenitram.com/pdf/Orenitram_Full_Prescribing_Informa - tion.pd f. Accessed July 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0190869 9.,Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2015/207947s000lbl.pd f. Accessed September 25,   2016.25.",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/f4/dddt-10-3747.PMC5117890.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 419–426International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 419 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S119965Multi-ethnic differences in HbA1c, blood pressure,  and low-density-lipid cholesterol control among  South Africans living with type 2 diabetes, after a  4-year follow-up Yacob Pinchevsky1 Varada J Shukla1 Neil Butkow1 T obias Chirwa2 Frederick Raal3 1Department of Pharmacy and  Pharmacology, School of Therapeutic  Sciences, 2Division of Epidemiology  and Biostatistics, School of Public Health,  3Carbohydrate and Lipid  Metabolism Research Unit, Division of Endocrinology and Metabolism,  Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,  South AfricaPurpose: Our study set out to examine if disparities in control of glycated hemoglobin (HbA1c),  blood pressure (BP), and low-density-lipoprotein cholesterol (LDL-C) existed among an urban  multi-ethnic cohort of South Africans, living with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
"5–10Correspondence: Yacob Pinchevsky Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South AfricaTel +27 82 837 4082Fax +27 11 026 4700Email jpinchevsky@gmail.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Pinchevsky et alRunning head recto: Multi-ethnic differences of risk factors in South African diabeticsDOI: http://dx.doi.org/10.2147/IJGM.S119965",Non-OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
Available from: https://www.statssa.gov.za/publications/P0302/P03022015.pdf.,OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 426 Pinchevsky et al  11.,Non-OADS,/arxiv_data1/oa_pdf/93/d7/ijgm-9-419.PMC5117891.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/08/ott-9-7095.PMC5117892.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7095–7103OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7095MeThO dOlOgyopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11850 2 A FISh-based method for assessment of HER-2   amplification status in breast cancer circulating  tumor cells following CellSearch isolation henrik Frithiof1 Kristina Aaltonen1 lisa Rydén2,3 1division of Oncology and Pathology,   2division of Surgery, department  of Clinical Sciences lund, lund  University, lund, 3department of  Surgery, Skåne University hospital,   Malmö, SwedenIntroduction:  Amplification of the HER-2/neu  (HER-2 ) proto-oncogene occurs in 10%–15%  of primary breast cancer, leading to an activated HER-2 receptor, augmenting growth of cancer  cells.",Non-OADS,/arxiv_data1/oa_pdf/f4/08/ott-9-7095.PMC5117892.pdf
"HER-2/neu  (HER-2 ) proto-oncogene amplification and the resultant protein overex - pression are present in ~10%–15% of primary invasive breast cancers, surmising an  overall more aggressive cancer phenotype, essentially imparting a worse prognosis and Correspondence: lisa Rydén division of Surgery, department of  Clinical Sciences lund, lund University,  Medicon Village, Se-223 81 lund, Sweden Tel +46 46 176 241 Fax +46 46 172 335 email lisa.ryden@med.lu.s e Journal name: OncoTargets and Therapy Article Designation: Methodology Y ear: 2016 Volume: 9 Running head verso: Frithiof et al Running head recto: Assessment of HER-2  amplification in CTCs DOI: http://dx.doi.org/10.2147/OTT.S118502",Non-OADS,/arxiv_data1/oa_pdf/f4/08/ott-9-7095.PMC5117892.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/08/ott-9-7095.PMC5117892.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/08/ott-9-7095.PMC5117892.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/70/96/ott-9-7011.PMC5117893.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7011–7017OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7011Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9971 7 cT -diagnosed severe skull base bone destruction  predicts distant bone metastasis in early n-stage  nasopharyngeal carcinoma Wei Yi,1,* Zhi-gang liu,2,3,*  Xian li,4 Jiao Tang,2,3 chang- Bin Jiang,1 Jing-Ye hu,5  Zi-Wei T u,5 hui Wang,2,3  Dao-li niu,1 Yun-Fei Xia5 1Department of radiotherapy, The  First affiliated hospital of guangzhou  Medical University, guangzhou,   2Department of radiotherapy, hunan  cancer hospital, The affiliated  cancer hospital of Xiangya school of  Medicine, central south University,   changsha, 3Key laboratory of  Translational radiation Oncology,   hunan Province, 4Department of  radiology, The First affiliated hospital  of guangzhou Medical University,   5state Key laboratory of Oncology  in southern china, Department of  radiotherapy, sun Yat- sen University  cancer center, guangzhou, People’s  republic of china *These authors contributed equally  to this workAbstract:  Bone metastasis is the most frequent type of distant metastasis in nasopharyngeal  carcinoma (NPC).",Non-OADS,/arxiv_data1/oa_pdf/70/96/ott-9-7011.PMC5117893.pdf
"cn Dao-li niu Department of radiotherapy, The First  Affiliated Hospital of Guangzhou Medical  University, 151 Yanjiang road,  guangzhou 510120, guangdong, People’s  republic of china Tel +86 20 3429 4221 email  daoli_niu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yi et al Running head recto: CT-diagnosed skull base bone destruction predicts distant bone metastasis DOI: http://dx.doi.org/10.2147/OTT.S99717",Non-OADS,/arxiv_data1/oa_pdf/70/96/ott-9-7011.PMC5117893.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/70/96/ott-9-7011.PMC5117893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/96/ott-9-7011.PMC5117893.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/53/ijn-11-5671.PMC5117895.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5671–5682International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5671OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11535 7 Noninvasive monitoring of early antiangiogenic  therapy response in human nasopharyngeal  carcinoma xenograft model using MrI with  rgD-conjugated ultrasmall superparamagnetic  iron oxide nanoparticles Yanfen cui1,* caiyuan Zhang1,* ran luo1 huanhuan liu1 Zhongyang Zhang1 Tianyong Xu2 Y ong Zhang2 Dengbin Wang1 1Department of radiology, Xinhua  hospital, shanghai Jiao T ong University  school of Medicine, 2Mr advanced  application and research center,   ge healthcare china, shanghai,   People’s republic of china *These authors contributed equally  to this workPurpose:  Arginine-glycine-aspartic acid (RGD)-based nanoprobes allow specific imaging of  integrin avβ3, a protein overexpressed during angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/c9/53/ijn-11-5671.PMC5117895.pdf
"Focus on angiogenesis factors,  antiangiogenic agents alone or in conjunction with chemoradiotherapy, has proved  to be an effective treatment in advanced NPC.3,4 However, not all patients would correspondence: Dengbin Wang Department of radiology, Xinhua  hospital, shanghai Jiao Tong University  school of Medicine, shanghai, 200092,  People’s republic of china Tel +86 21 2507 7030 email dbwang8@aliyun.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Cui et al Running head recto: Antiangiogenic treatment in human NPC xenograft model by using MRI DOI: http://dx.doi.org/10.2147/IJN.S115357",Non-OADS,/arxiv_data1/oa_pdf/c9/53/ijn-11-5671.PMC5117895.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/53/ijn-11-5671.PMC5117895.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/53/ijn-11-5671.PMC5117895.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/e2/dddt-10-3737.PMC5117896.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3737–3746Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3737Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8743 5 lentivirus-mediated knockdown of nlK inhibits  small-cell lung cancer growth and metastasis Mutian lv1 Yaming li1 Xin Tian2 shundong Dai3,4 Jing sun5 guojiang Jin6 shenyi Jiang7 1Department of n uclear Medicine,   2Molecular Oncology laboratory of  cancer research institute, The First  affiliated hospital of china Medical  University, 3Department of Pathology,   The First affiliated hospital, college  of Basic Medical sciences of china  Medical University, 4Department of  Pathology, institute of Pathology and  Pathophysiology, 5Department of  immunology and Biotherapy, liaoning  cancer hospital and institute,   6Department of laboratory Medicine,   7Department of rheumatology, The  First affiliated hospital of china  Medical University, shenyang, People’s  republic of chinaAbstract:  Nemo-like kinase (NLK), an evolutionarily conserved serine/threonine kinase, has  been recognized as a critical regulator of various cancers.",Non-OADS,/arxiv_data1/oa_pdf/29/e2/dddt-10-3737.PMC5117896.pdf
"NLK is known to be a tumor suppressor in various types  of cancer as a negative regulator of the canonical Wnt/ β-catenin signaling pathway,  which phosphorylates T-cell factor and lymphoid enhancer factor, promoting the correspondence: Yaming li Department of nuclear Medicine,  The First Affiliated Hospital of China  Medical University, 155 nanjing north  street, shenyang 110001, People’s  republic of china Tel +86 24 8328 2142 Fax +86 24 8328 2671 email ymli2001@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lv et al Running head recto: Lentivirus-mediated knockdown of NLK DOI: http://dx.doi.org/10.2147/DDDT.S87435",Non-OADS,/arxiv_data1/oa_pdf/29/e2/dddt-10-3737.PMC5117896.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/29/e2/dddt-10-3737.PMC5117896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/e2/dddt-10-3737.PMC5117896.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/67/ott-9-6999.PMC5117897.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6999–7009OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6999Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11650 9 Microrna-29a plays a suppressive role in non- small cell lung cancer cells via targeting lasP1 Zhaolan hu1,* Yanhui cui1,* Yanhui Zhou2 Kaiying Zhou3 Xiaoqing Qiao1 changqi li1 shuang Wang4 1Department of anatomy and  neurobiology, school of Basic Medical  science, central south University,   2XiangYa nursing school, central  south University, changsha,   3Department of Orthopaedics,   People’s hospital of lianyuan,   lianyuan, 4Medical research center  and clinical laboratory, Xiangya  hospital, central south University,   changsha, hunan, People’s republic  of china *These authors contributed equally  to this workAbstract:  MicroRNA (miR)-29a has been implicated in non-small cell lung cancer (NSCLC),  but the mechanism remains largely unclear.",Non-OADS,/arxiv_data1/oa_pdf/9f/67/ott-9-6999.PMC5117897.pdf
"correspondence: shuang Wang Medical research center and clinical  laboratory, Xiangya hospital, central  south University, 87 Xiangya road,  changsha, hunan 410008, People’s  republic of china Tel/fax +86 731 8975 3203 email csuwangshuang@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Hu et al Running head recto: miR-29a inhibits NSCLC DOI: http://dx.doi.org/10.2147/OTT.S116509",Non-OADS,/arxiv_data1/oa_pdf/9f/67/ott-9-6999.PMC5117897.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/67/ott-9-6999.PMC5117897.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/67/ott-9-6999.PMC5117897.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/ijn-11-6123.PMC5117898.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6123–6134International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6123OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11424 1 The effect of dexamethasone/cell-penetrating  peptide nanoparticles on gene delivery for inner  ear therapy Ji Y oung Y oon1 Keum-Jin Yang2 shi-Nae Park3 Dong-Kee Kim3 Jong-Duk Kim1 1Department of chemical and  Biomolecular engineering, BK 21  Plus Program, Korea advanced  Institute of science and T echnology,   guseong-Dong, Yuseong-gu, Daejeon,   2clinical research Institute, st Mary’s  hospital, Daejeon, 3Department of  Otolaryngology – head and Neck  surgery, college of Medicine, The  catholic University of Korea, seoul,   republic of KoreaAbstract:  Dexamethasone (Dex)-loaded PHEA-g-C18-Arg8 (PCA) nanoparticles (PCA/Dex)  were developed for the delivery of genes to determine the synergistic effect of Dex on gene  expression.",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/ijn-11-6123.PMC5117898.pdf
"Keywords:  cell-penetrating peptide, nanoparticle, dexamethasone, gene delivery, brain-derived  neurotrophic factor Introduction An inner ear delivery system for drugs (or genes) has been developed using viral or  non-viral vectors.1 Viral vectors have been used to deliver genes due to their high  transfection ability.2 However, non-viral vectors have been considered as potential  carriers due to problems with viral vectors, such as carcinogenesis, immunogenicity,  broad tropism, limited DNA packaging capacity, and production difficulty.1 A non- viral delivery system, a polymer nanoparticle carrier, has been investigated due to  its biocompatibility and high stability.3 Nanoparticles offer targeted drug delivery  to specific cells.3 Many kinds of nanoparticles including polymersomes,4 solid lipid  nanoparticles,5 and polylysine6 have been used as inner ear delivery carriers, and  the functionalization of peptide moieties on their surfaces has also been reported to  target the special cell populations of the inner ear, such as spiral ganglion neuron and correspondence: Dong-Kee Kim Department of Otolaryngology – head  and Neck surgery, college of Medicine,  The catholic University of Korea, 222,  Banpo-daero, seocho-gu, seoul (06591),  republic of Korea Tel +82 10 3296 5204 email cider12@catholic.ac.k r Jong-Duk Kim Department of chemical and  Biomolecular engineering, Korea  advanced Institute of science and  Technology, 291, Daehak-ro, Yuseong-gu,  Daejeon, republic of Korea Tel +82 10 9484 3921 email kjd@kaist.ac.k rJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y oon et al Running head recto: Effect of dexamethasone/CPP nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S114241",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/ijn-11-6123.PMC5117898.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1d/0a/ijn-11-6123.PMC5117898.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/0a/ijn-11-6123.PMC5117898.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d8/c9/dddt-10-3771.PMC5117900.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3771–3778Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3771Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11508 8 Dietary arginine silicate inositol complex inhibits  periodontal tissue loss in rats with ligature- induced periodontitis serkan Dundar1 abubekir eltas2 sema s hakki3 Sıddık Malkoc4 M Ozay Uslu2 Mehmet T uzcu5 James Komorowski6 I Hanifi Ozercan7 Fatih akdemir8 Kazim Sahin9 1Department of Periodontology,   Faculty of Dentistry, Firat University,   Elazig, 2Department of Periodontology,   Faculty of Dentistry, inonu  University, Malatya, 3Department  of Periodontology, Faculty of  Dentistry, Selcuk University, Konya,   4Department of Orthodontics, Faculty  of Dentistry, Inonu University, Malatya,   5Department of Biology, Faculty  of Science, Firat University, Elazig,   T urkey; 6research & Development,   Nutrition 21 Inc., Purchase, NY, USA;   7Department of Pathology, Faculty  of Medicine, 8Department of animal  nutrition, Faculty of Fisheries, inonu  University, Malatya, 9Department  of animal nutrition, Faculty of  Veterinary Medicine, Firat University,   Elazig, T urkeyAbstract:  The purpose of this study was to induce experimental periodontitis in rats previously  fed diets containing arginine silicate inositol (ASI) complex and examine the biochemical,  immunological, and radiological effects.",Non-OADS,/arxiv_data1/oa_pdf/d8/c9/dddt-10-3771.PMC5117900.pdf
"Arginine silicate inositol (ASI) complex is a novel, bioavailable source of argin - ine and silicon that could serve as an alternative agent for host modulation.11–14 The  effects of arginine and silicon on bone and connective tissue metabolism in mammals  are well documented, and the ASI complex has been shown to benefit bone and vas - cular health.15 Several clinical studies have demonstrated the safety of ASI complex Correspondence: Kazim Sahin Department of animal nutrition, Faculty  of Veterinary Medicine, Firat University,  Elazig 23119, Turkey Tel +90 532 747 35 06 email nsahinkm@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dundar et al Running head recto: Arginine silicate inositol complex and host modulation DOI: http://dx.doi.org/10.2147/DDDT.S115088",Non-OADS,/arxiv_data1/oa_pdf/d8/c9/dddt-10-3771.PMC5117900.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d8/c9/dddt-10-3771.PMC5117900.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/c9/dddt-10-3771.PMC5117900.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d7/71/ijn-11-5789.PMC5117901.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5789–5806International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5789OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10820 8 Biosynthesis, characterization, and evaluation  of bioactivities of leaf extract-mediated  biocompatible silver nanoparticles from an early  tracheophyte, Pteris tripartita sw. Xavierravi Baskaran1 antony Varuvel geo Vigila2 Thangaraj Parimelazhagan3 Doulathabad  Muralidhara-rao4 shouzhou Zhang1 1shenzhen Key laboratory of  southern subtropical Plant Diversity,   Fairy lake Botanical garden,   shenzhen and chinese academy  of sciences, shenzhen, People’s  republic of china; 2Department  of Zoology, st Xavier’s college,   Palayamkottai, 3Department of Botany,   Bioprospecting laboratory, Bharathiar  University, coimbatore, Tamil Nadu,   4Department of Biotechnology, sri  Krishnadevaraya University, anantapur,   andhra Pradesh, IndiaAbstract:  The objective of the study was to characterize silver nanoparticles (Ag-NPs) and  their bioactivities in early tracheophytes (Pteridophyta).",Non-OADS,/arxiv_data1/oa_pdf/d7/71/ijn-11-5789.PMC5117901.pdf
"In particular, silver compounds are widely used for healing purposes owing to their  antimicrobial properties.5,6 Historically, Alexander the Great also used silver vessels correspondence: shouzhou Zhang shenzhen Key laboratory of southern  subtropical Plant Diversity, Fairy lake  Botanical garden, shenzhen and chinese  academy of sciences, 165 Xianhu road,  shenzhen 518004, People’s republic of  china Tel +86 755 180 2539 1959 email shouzhouz@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Baskaran et al Running head recto: Biosynthesis of Ag-NPs using Pteris tripartita  Sw. DOI: http://dx.doi.org/10.2147/IJN.S108208",Non-OADS,/arxiv_data1/oa_pdf/d7/71/ijn-11-5789.PMC5117901.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d7/71/ijn-11-5789.PMC5117901.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/71/ijn-11-5789.PMC5117901.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 685–694ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  685 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S119971Patient-reported financial barriers to adherence  to treatment in neurology Lidia MVR Moura1  Eli L Schwamm1  Valdery Moura Junior1  Michael P Seitz1  Daniel B Hoch1  John Hsu2,3  Lee H Schwamm1 1Department of Neurology,   2Mongan Institute for Health Policy,   Massachusetts General Hospital,   3Department of Medicine and  Department of Health Care Policy,   Harvard Medical School, Boston,  MA, USAObjective: Many effective medical therapies are available for treating neurological diseases,  but these therapies tend to be expensive and adherence is critical to their effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"The resulting differences in out-of-pocket payments can be challenging for beneficiaries with limited Correspondence: Lidia MVR Moura  Department of Neurology, Wang 720 Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USATel +1 617 726 3311   Fax +1 617 724 6513Email lidia.moura@mgh.harvard.eduJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Moura et alRunning head recto: Patient-reported financial barriers to medication adherenceDOI: http://dx.doi.org/10.2147/CEOR.S119971",Non-OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 694 Moura et al Table S1  Characteristics of the eligible population by survey participation  Survey participation p-Value No, N  (Column %)Yes, N (Column %) Total, n=6075 3082 2992 Mean age (years ± SD) 57±19 56±18 0.0260 Gender 0.6676 Male, n=2781 1403 (45.52) 1387 (45.48) Female, n=3292 1679 (54.48) 1613 (53.93) Ethnicity 0.1357 Non-Hispanic, n=3354 1677 (88.92) 1677 (90.40) Hispanic, n=387 209 (11.08) 178 (9.60) Preferred language <0.0001 English, n=5624 2805 (90.98) 2819 (94.22) Non-English, n=451 278 (9.02) 173 (5.78) Insurance <0.0001 Medicare, Medicaid, and MassHealth, n =2391 1369 (44.40) 1022 (34.16) Private, n=3684 1714 (55.60) 1970 (65.84) Marital status 0.0069 Single, n=2510 1307 (45.70) 1203 (42.15) Married, partnered, n =3204 1553 (54.30) 1651 (57.85) Clinic type <0.0001 Ataxia, n=117 82 (2.66) 35 (1.17) Epilepsy, n=520 327 (10.61) 193 (6.45) General neurology, n=2489 1168 (37.89) 1321 (44.15) Memory, n=473 222 (7.20) 251 (8.39) Movement, n=1057 584 (18.94) 473 (15.81) Neuromuscular, n =291 232 (7.53) 59 (1.97) Neurobehavioral, n =376 202 (6.55) 174 (5.82) Sleep, n=224 0 (0) 224 (7.49) Stroke, n=528 266 (8.63) 262 (8.76) Notes: Two-sided t-tests were used to calculate p-values to compare the mean values of patient age between the groups.",Non-OADS,/arxiv_data1/oa_pdf/b9/c8/ceor-8-685.PMC5117903.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/75/ijn-11-6047.PMC5117904.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6047–6064International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6047OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11761 8 cationic Pegylated liposomes incorporating  an antimicrobial peptide tilapia hepcidin 2–3: an  adjuvant of epirubicin to overcome multidrug  resistance in cervical cancer cells Vivian Juang1 hsin-Pin lee2 anya Maan-Yuh lin1,3 Yu-li lo1 1Department and Institute of  Pharmacology, National Yang-Ming  University, 2Department of Biological  sciences and T echnology, National  University of Tainan, 3Department  of Medical research, Taipei Veterans  general hospital, Taipei, Taiwan,   republic of chinaAbstract:  Antimicrobial peptides (AMPs) have been recently evaluated as a new generation of  adjuvants in cancer chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/c6/75/ijn-11-6047.PMC5117904.pdf
"AMPs also exhibit anticancer activity by inducing cytolytic action  on tumor cells.1,2 Hepcidin, an AMP, was originally isolated from Oreochromis  mossambicus .3 There are three hepcidin isoforms, namely hepcidin 1-5, hepcidin 2-2, correspondence: Yu-li lo Department and Institute of  Pharmacology, National Yang-Ming  University, No 155, section 2, linong  street, Taipei 11221, Taiwan,  republic of china Tel +886 2 2826 7095 Fax +886 2 2826 4372 email yulilo@ym.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Juang et al Running head recto: Cationic PEGylated liposomes incorporating hepcidin 2–3 and epirubicin DOI: http://dx.doi.org/10.2147/IJN.S117618",Non-OADS,/arxiv_data1/oa_pdf/c6/75/ijn-11-6047.PMC5117904.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c6/75/ijn-11-6047.PMC5117904.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/75/ijn-11-6047.PMC5117904.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 191–198Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  191 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S106676A prospective, observational study comparing  the PK/PD relationships of generic Meropenem  (Mercide®) to the innovator brand in critically  ill patients Mervyn Mer1 Jacques Rene Snyman2 Constance Elizabeth Jansen  van Rensburg2 Jacob John van T onder3 Ilze Laurens2 1Department of Medicine, Divisions  of Critical Care and Pulmonology,   University of the Witwatersrand,  Johannesburg, South Africa;  2Office of  the Dean, Faculty of Health Sciences,  University of Pretoria, Pretoria, South Africa;  3Scientific Affairs Department,   Triclinium Clinical Development (Pty) Ltd, Centurion, South AfricaIntroduction: Clinicians’ skepticism, fueled by evidence of inferiority of some multisource  generic antimicrobial products, results in the underutilization of more cost-effective generics,  especially in critically ill patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
"Although bioequivalence testing and in vitro quality Correspondence: Ilze Laurens Department of Pharmacology, University of Pretoria, Basic Medical Sciences Building, 6th floor, 9 Bophelo Road, Prinshof Campus, 0001–0299, Pretoria, South AfricaTel +27 82 448 9153Email ilze@dermav.co.zaJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Mer et alRunning head recto: Observational PK/PD relationships between Meropenem brandsDOI: http://dx.doi.org/10.2147/CPAA.S106676",Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 198 Mer et al  4.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
Available from: http://r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
Available from: http://www.fda.gov/down-loads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM182288.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/UCM134846.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/f3/cpaa-8-191.PMC5117905.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/64/ijn-11-6065.PMC5117906.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6065–6077International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6065OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11944 6 synthesis of three-arm block copolymer  poly(lactic- co-glycolic acid)–poly(ethylene  glycol) with oxalyl chloride and its application  in hydrophobic drug delivery Xiaowei Zhu* chao liu* Jianwei Duan Xiaoyu liang Xuanling li hongfan sun Deling Kong Jing Yang Tianjin Key laboratory of Biomaterial  research, Institute of Biomedical  engineering, chinese academy of  Medical science and Peking Union  Medical college, Tianjin, People’s  republic of china *These authors contributed equally  to this workPurpose:  Synthesis of star-shaped block copolymer with oxalyl chloride and preparation of  micelles to assess the prospect for drug-carrier applications.",Non-OADS,/arxiv_data1/oa_pdf/07/64/ijn-11-6065.PMC5117906.pdf
"It is estimated that 40% or more of new chemical entities are  poorly water-soluble and thereby suffer from low bioavailability or erratic absorption.1  Formulations of these substances pose a significant challenge for the development of  viable dosage forms during early stages of drug development.correspondence: Jing Yang Tianjin Key laboratory of Biomaterial  research, Institute of Biomedical  engineering, chinese academy of  Medical science and Peking Union  Medical college, 236 Baidi road,  Nankai, Tianjin 300192, People’s  republic of china Tel +86 22 8789 0153 Fax +86 22 8789 0153 email yangjing37@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhu et al Running head recto: Synthesis of star copolymer with oxalyl chloride DOI: http://dx.doi.org/10.2147/IJN.S119446",Non-OADS,/arxiv_data1/oa_pdf/07/64/ijn-11-6065.PMC5117906.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/07/64/ijn-11-6065.PMC5117906.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/64/ijn-11-6065.PMC5117906.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/60/ott-9-6935.PMC5117909.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6935–6943OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6935Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11422 9 Paxillin functions as an oncogene in human  gliomas by promoting cell migration and invasion Bing chen lei Xia chang-song Xu Feng Xiao Yan-feng Wang Department of neurology, huai’an  First People’s hospital, nanjing  Medical University, huai’an, People’s  republic of chinaBackground:  Paxillin is implicated in tumorigenesis, progression and aggressive phenotypes  of various malignancies, highlighting its functions in cellular adhesion, migration and survival.",Non-OADS,/arxiv_data1/oa_pdf/cb/60/ott-9-6935.PMC5117909.pdf
"Paxillin, together with Hic-5 and leupaxin, belongs to the paxillin family of intra - cellular scaffold proteins, which play important roles in coordinating these signaling correspondence: Yan-feng Wang Department of neurology, The First  Hospital of Huai’an City Affiliated  to nanjing Medical University, #6  Beijing West road, huaiyin District,  huai’an, Jiangsu 223300, People’s  republic of china Tel +86 135 1524 8180 email 758565376@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Paxillin in glioma DOI: http://dx.doi.org/10.2147/OTT.S114229",Non-OADS,/arxiv_data1/oa_pdf/cb/60/ott-9-6935.PMC5117909.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cb/60/ott-9-6935.PMC5117909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/60/ott-9-6935.PMC5117909.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 115–118Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 115 CAse RepOR t open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S114689 portal hypertension: an uncommon clinical  manifestation of takayasu arteritis in a  9-year -old child Cristina N Herrera Javier e tomala-Haz Department of p ediatric  Rheumatology, Dr Roberto  Gilbert Children’s Hospital,   Guayaquil,  ecuadorAbstract:  Takayasu arteritis (TA) is the third most common childhood vasculitis and its clini- cal manifestations depend on the arteries involved.",Non-OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
"A control body angio-CT scan performed at our hos-pital showed enlargement of aneurysms when compared with the first scan; therefore, pulse therapy with methylprednisolone at a dose of 30 mg/kg/day for 3 consecutive  Correspondence: Cristina N Herrera  Roberto Gilbert Children’s Hospital, Av Roberto Gilbert y Nicasio saafadi, Guayaquil 090514, ecuadoremail cristinaherrera227@gmail.comJournal name: Open Access Rheumatology: Research and Reviews Article Designation: CAse RepORTY ear: 2016V olume: 8Running head verso: Herrera and Tomala-HazRunning head recto: p ortal hypertension as a manifestation of Takayasu arteritis DOI: http://dx.doi.org/10.2147/OARRR.s114689",Non-OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: p athology,  pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 118 Herrera and tomala-Haz  11.,Non-OADS,/arxiv_data1/oa_pdf/1a/77/oarrr-8-115.PMC5117910.pdf
"8–10While not eliminating the need to control access to sensitive or identi ﬁable data, our aim is to expand the c u r r e n t l yb i n a r yo p e n / c o n t r o l l e d approach to protect the privacy of participants and patients and at the same time further the research to which they are contributing their data in a more proportionate manner.We are also focused on responding to the needs of the Global Alliance ‘Demonstration Projects ’, scienti ﬁc initiatives that are beingaccelerated to demonstrate the v alue of data sharing, namely: the Beacon Project (http://www.ga 4gh.org/#/beacon), Matchmaker Exchange 11and the BRCA Challenge (http ://brcaexchange.org).",Non-OADS,/arxiv_data1/oa_pdf/86/aa/ejhg2016115a.PMC5117919.pdf
"These include the Asthma Gene Database, MedGene and PharmGKB, 12projects parti- cipating in the Matchmaker Exchange project such as DECIPHER13 and PhenomeCentral14and, more recently, the Simons Foundation Autism Research Initiative (https://www.nextcode.com/ssc/).",Non-OADS,/arxiv_data1/oa_pdf/86/aa/ejhg2016115a.PMC5117919.pdf
"26For example, at the outset, the HapMap database used an open source data access policy in Table 2 Proposed registered access criteria General criteria (for Authorization) Information required (for example) Competence Applicants are bona ﬁderesearchers/clinical care professionals1a The applicant ’s name, title, position, af ﬁliation, email address, institutional website and mailing address (for Authentication) 1b Any additional information required for authorization of researcher/clinical care professional bona ﬁdes 1c‘Ia ma bona ﬁderesearcher/clinical care professional …’(with a de ﬁnition) Ethics IRB/REC requirements have been met 2a ‘I will comply with all ethical and legal regulatory requirements applicable in my institution and country/region in my use of the data ’ Respect GA4GH data sharing framework 2b ‘My use of the data will be consistent with the GA4GH Framework for Responsible Sharing of Genomic and Health-Related Data (https://genomicsandhealth.org) ’ Adhesion to consent restrictions on the scope of data use2c‘I will only use the data for the purposes allowed by the provider.",Non-OADS,/arxiv_data1/oa_pdf/86/aa/ejhg2016115a.PMC5117919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Characteristics of this Registered Access Model SOM Dyke et al 1680 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/86/aa/ejhg2016115a.PMC5117919.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/31/ijn-11-6103.PMC5117944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6103–6121International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6103OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11243 2 Improved proliferation of antigen-specific cytolytic  T lymphocytes using a multimodal nanovaccine Bo li1,2 Michael Siuta1 Vanessa Bright1,2 Dmitry Koktysh3,4 Brittany K Matlock5 Megan e Dumas1 Meiying Zhu1 alex holt1 Donald stec3,6 Shenglou Deng7 Paul B savage7 Sebastian Joyce8,9 Wellington Pham1,2,6,10–12 1Institute of Imaging science,   Vanderbilt University School  of Medicine, 2Department of  Radiology and Radiological Sciences,   3Department of Chemistry, Vanderbilt  University, 4Vanderbilt Institute of  Nanoscale science and engineering,   5Vanderbilt Flow Cytometry Shared  Resource, Vanderbilt University,   6Vanderbilt Institute of Chemical  Biology, 7Department of Chemistry  and Biochemistry, Brigham Young  University, 8Department of Pathology,   Microbiology and Immunology,   Vanderbilt University, 9Veterans  Administration Tennessee Valley  Healthcare System, 10Department of  Biomedical engineering, 11Vanderbilt  Ingram cancer center, 12Vanderbilt  Brain Institute, Vanderbilt University,   Nashville, TN, USAAbstract:  The present study investigated the immunoenhancing property of our newly designed  nanovaccine, that is, its ability to induce antigen-specific immunity.",Non-OADS,/arxiv_data1/oa_pdf/36/31/ijn-11-6103.PMC5117944.pdf
"Further, in order to  realize minimal toxicity and maximal therapeutic benefit, encapsulation of the antigens Correspondence: Wellington Pham Institute of Imaging science, Vanderbilt  University School of Medicine,  1161, 21st Avenue South, Nashville,  TN 37232-2310, Usa Tel +1 615 936 7621 email wellington.pham@vanderbilt.ed uJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: NanoVac, a multimodal nanovaccine  DOI: http://dx.doi.org/10.2147/IJN.S112432",Non-OADS,/arxiv_data1/oa_pdf/36/31/ijn-11-6103.PMC5117944.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/36/31/ijn-11-6103.PMC5117944.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/31/ijn-11-6103.PMC5117944.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/44/opth-10-2297.PMC5117946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2297–2302Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2297Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12252 0 Preoperative optical coherence tomography  visualization of epiretinal membranes enhances  surgical strategies norihiro suzuki Y oshio hirano Miyu ichida Taneto T omiyasu Yuya esaki Tsutomu Yasukawa Yuichiro Ogura Department of Ophthalmology and  Visual science, nagoya City University  graduate school of Medical sciences,   nagoya, JapanPurpose:  The aim of this study was to evaluate the usefulness of preoperative optical coherence  tomography (OCT) findings in patients with macular epiretinal membrane (ERM) for the  planning of surgical strategy.",Non-OADS,/arxiv_data1/oa_pdf/b1/44/opth-10-2297.PMC5117946.pdf
"Surgical planning would be facilitated if the detailed  structures of the ERM could be determined preoperatively, as information regarding Correspondence: Yoshio hirano Department of Ophthalmology and  Visual science, nagoya City University  graduate school of Medical sciences,  1-Kawasumi, Mizuho-cho, Mizuho-ku,  nagoya 467-0001, Japan Tel +81 52 853 8251 Fax +81 52 841 9490 email yoshio.hirano@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Suzuki et al Running head recto: Preoperative OCT findings in epiretinal membrane DOI: http://dx.doi.org/10.2147/OPTH.S122520",Non-OADS,/arxiv_data1/oa_pdf/b1/44/opth-10-2297.PMC5117946.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b1/44/opth-10-2297.PMC5117946.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/44/opth-10-2297.PMC5117946.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 675–683ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  675 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S112252Evaluating increased resource use in fibromyalgia  using electronic health records Jay M Margolis1 Elizabeth T Masters2 Joseph C Cappelleri3 David M Smith1 Steven Faulkner4 1Truven Health Analytics, Life Sciences,   Outcomes Research, Bethesda, MD,   2Pfizer Inc, Outcomes & Evidence,   New Y ork, NY, 3Pfizer Inc, Statistics,   Groton, CT, 4Pfizer Inc, North  American Medical Affairs, Medical  Outcomes Specialists, St Louis,    MO, USAObjective: The management of fibromyalgia (FM), a chronic musculoskeletal disease, remains  challenging, and patients with FM are often characterized by high health care resource utilization.",Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
"Keywords: fibromyalgia, electronic health records, health care resource utilization Introduction Fibromyalgia (FM) is a chronic musculoskeletal disease with evidence suggesting that  it results from a dysfunction of central pain processing pathways.1,2 The clinical char - acteristics of FM include the hallmark symptom of chronic widespread pain, which is a key feature required for diagnosis, 3 as well as a constellation of other symptoms such  as sleep disturbances, headaches, fatigue, reduced function, anxiety, and depression.4  The prevalence of FM in the US has been estimated to be between ~2% and 6%,5,6  with middle-aged women disproportionately affected.7Correspondence: Jay M Margolis  Truven Health Analytics, 332 Bryn Mawr Avenue, Bala Cynwyd, PA 19004, USATel +1 610 667 4718Fax +1 610 667 4718Email jay.margolis@truvenhealth.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Margolis et alRunning head recto: Increased resource use in fibromyalgiaDOI: http://dx.doi.org/10.2147/CEOR.S112252",Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
Available from: http://fmguidelines.ca/?page_id= 21.,Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 683 Increased resource use in fibromyalgia,Non-OADS,/arxiv_data1/oa_pdf/74/6a/ceor-8-675.PMC5117947.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/9b/cia-11-1687.PMC5117948.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1687–1695Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1687OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11619 4 Transcranial direct current stimulation improves  the QT variability index and autonomic cardiac  control in healthy subjects older than 60 years gianfranco Piccirillo1 Cristina Ottaviani2 Claudia Fiorucci1 nicola Petrocchi2 Federica Moscucci1 Claudia Di Iorio1 Fabiola Mastropietri1 Ilaria Parrotta1 Matteo Pascucci1 Damiano Magrì3 1Department of Cardiovascular,   respiratory, nephrological,   Anestesiological and geriatric  sciences, “ sapienza” University,   2neuroimaging laboratory, I rCCs  santa lucia Foundation, 3Department  of Clinical and Molecular Medicine,   University of rome “ sapienza”,   rome,  ItalyBackground:  Noninvasive brain stimulation technique is an interesting tool to investigate the  causal relation between cortical functioning and autonomic nervous system (ANS) responses.",Non-OADS,/arxiv_data1/oa_pdf/8d/9b/cia-11-1687.PMC5117948.pdf
"The right insula is considered as the site  where both sympathetic hyperactivity and left ventricular repolarization dispersion  originate during acute stroke or transient ischemic attacks.5–8 Other studies indicated  that the left IC intervenes in baroreflex and parasympathetic control.6,7,9,10Correspondence: gianfranco Piccirillo Department of Cardiovascular,  respiratory, nephrological,  Anesthesiological and geriatric sciences,  “sapienza” University of rome,  00185 rome, Italy Tel +39 06 4667 0118 email gianfranco.piccirillo@uniroma1.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Piccirillo et al Running head recto: Transcranial direct current stimulation DOI: http://dx.doi.org/10.2147/CIA.S116194",Non-OADS,/arxiv_data1/oa_pdf/8d/9b/cia-11-1687.PMC5117948.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/9b/cia-11-1687.PMC5117948.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/9b/cia-11-1687.PMC5117948.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/17/ijn-11-6089.PMC5117954.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 6089–6101International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6089OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11866 1 Nanoparticle-based strategy for personalized  B-cell lymphoma therapy Nicola M Martucci1,* Nunzia Migliaccio1,* Immacolata ruggiero1,* Francesco albano2 gaetano calì3 simona romano1 Monica T erracciano4 Ilaria rea4 Paolo arcari1 annalisa lamberti1 1Department of Molecular Medicine  and Medical Biotechnology, University  Federico II of Naples, Naples,   2Department of experimental and  clinical Medicine, University of  catanzaro “Magna graecia”, catanzaro,   3Institute of endocrinology and  Molecular Oncology, 4Institute for  Microelectronics and Microsystems,   National research council,   Naples, Italy *These authors contributed equally  to this workAbstract:  B-cell lymphoma is associated with incomplete response to treatment, and the  development of effective strategies targeting this disease remains challenging.",Non-OADS,/arxiv_data1/oa_pdf/49/17/ijn-11-6089.PMC5117954.pdf
"A wide range of nanomaterials have been explored for siRNA delivery, and, among  them, inorganic systems based on silica are the most attractive bio-interfaces, since correspondence: annalisa lamberti Department of Molecular Medicine  and Medical Biotechnology, University  Federico II of Naples, via sergio Pansini 5,  80131 Naples, Italy Tel +39 81 746 3119 Fax +39 81 746 3653 email annalisa.lamberti@unina.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Martucci et al Running head recto: Nanoparticle targeting of B-cell lymphoma DOI: http://dx.doi.org/10.2147/IJN.S118661",Non-OADS,/arxiv_data1/oa_pdf/49/17/ijn-11-6089.PMC5117954.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/49/17/ijn-11-6089.PMC5117954.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/17/ijn-11-6089.PMC5117954.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/a9/ott-9-7039.PMC5117955.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7039–7045OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7039Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11005 5 Identification of lncRNA FAM83H-AS1  as a  novel prognostic marker in luminal subtype  breast cancer Fan Yang shi-Xu lv lin lv Ye-huan liu si-Yang Dong Zhi-han Yao Xuan-xuan Dai Xiao-hua Zhang Ou-chen Wang Department of Surgical Oncology, The  First Affiliated Hospital of Wenzhou  Medical University, Wenzhou,   Zhejiang,  People’s Republic of ChinaBackground:  Luminal subtype breast cancer accounts for a predominant number of breast  cancers.",Non-OADS,/arxiv_data1/oa_pdf/16/a9/ott-9-7039.PMC5117955.pdf
"Similar therapeutic strate - gies could evoke diverse responses within luminal subtype patients.3,4 Therefore,  it is urgent to develop novel biomarkers to improve risk stratification and optimize  therapy choice.correspondence: Xiao-hua Zhang;  Ou-chen Wang Department of Surgical Oncology, The  First Affiliated Hospital of Wenzhou  Medical University, Nan Bai Xiang Street,  Ouhai District, Wenzhou, Zhejiang  32500, People’s Republic of China email xiaohuazhang2015@sina.co m;  woconcology2000@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: FAM83H-AS1  and breast cancer DOI: http://dx.doi.org/10.2147/OTT.S110055",Non-OADS,/arxiv_data1/oa_pdf/16/a9/ott-9-7039.PMC5117955.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/a9/ott-9-7039.PMC5117955.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/a9/ott-9-7039.PMC5117955.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/16/dddt-10-3699.PMC5117956.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3699–3706Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3699Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11872 3 effects of resveratrol on P-glycoprotein and   cytochrome P450 3a in vitro and on  pharmacokinetics of oral saquinavir in rats Jiapeng li1,2 Yang liu2 Jingru Zhang1,2 Xiaotong Yu1,2 Xiaoling Wang1 libo Zhao1 1Department of Pharmacy, Beijing  children’s hospital, capital Medical  University, 2Department of Pharmacy  administration and clinical Pharmacy,   school of Pharmaceutical sciences,   Peking University, Beijing, People’s  republic of chinaBackground:  The intestinal cytochrome P450 3A (CYP 3A) and P-glycoprotein (P-gp) present  a barrier to the oral absorption of saquinavir (SQV).",Non-OADS,/arxiv_data1/oa_pdf/7e/16/dddt-10-3699.PMC5117956.pdf
"Although  SQV is highly effective in blocking HIV -1 infection, SQV efficacy in clinical practice  is limited, mainly due to its low and highly variable oral bioavailability, which is ~4%  with a coefficient of variation (CV) .100%.2,3 Multiple factors contribute to the low  oral bioavailability of SQV, including poor solubility characteristics, extensive first correspondence: Xiaoling Wang;  libo Zhao Department of Pharmacy, Beijing  children’s hospital, capital Medical  University, 56 nanlishi road, Xicheng  District, Beijing 100045, People’s  republic of china Tel +86 10 5961 6380; +86 10 5961 6379 Fax +86 10 5961 6380 email eyjdb6380@163.co m;  lb.zhao@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Resveratrol on P-glycoprotein and cytochrome P450 3A DOI: http://dx.doi.org/10.2147/DDDT.S118723",Non-OADS,/arxiv_data1/oa_pdf/7e/16/dddt-10-3699.PMC5117956.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7e/16/dddt-10-3699.PMC5117956.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/16/dddt-10-3699.PMC5117956.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/48/cia-11-1675.PMC5117993.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1675–1686Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1675OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11328 7 Efficacy of L-carnitine supplementation on frailty  status and its biomarkers, nutritional status, and  physical and cognitive function among prefrail  older adults: a double-blind, randomized, placebo- controlled clinical trial M Badrasawi1,2 Suzana Shahar1 AM Zahara1 r nor Fadilah3 Devinder Kaur Ajit singh4 1Dietetic Programme, school of  healthcare sciences, Universiti  Kebangsaan Malaysia, Kuala Lumpur,   Malaysia; 2Nutrition Program, Faulty  of Applied sciences, Palestine  Polytechnic University, Hebron,   Palestine; 3Biomedical Programme,   school of healthcare sciences,   Universiti Kebangsaan Malaysia, Kuala  Lumpur, Malaysia; 4Physiotherapy  Programme, school of rehabilitation  sciences, Universiti Kebangsaan  Malaysia, Kuala Lumpur, MalaysiaBackground:  Frailty is a biological syndrome of decreased reserve and resistance to stressors  due to decline in multiple physiological systems.",Non-OADS,/arxiv_data1/oa_pdf/df/48/cia-11-1675.PMC5117993.pdf
"Keywords:  frailty, Fried criteria, Frailty Index accumulation of deficit, L-carnitine supple - mentation, prefrail elderly, physical function, frailty biomarkers, randomized controlled  clinical trial Background Aging is associated with functional decline, loss of autonomy, and a wide spectrum  of adverse outcomes as mooted in literature.1 Due to a global rise in life expectancy,  maintaining physical function and preventing disability in advanced age are among  the major clinical and public health priorities.2,3 Frailty is one of the main factors that  suppresses successful aging and leads to adverse health consequences, mainly falls  and delirium after minor stressor.4Correspondence: Suzana Shahar Dietetics Programme, school of  Healthcare Sciences, Faculty of Health  Sciences, Universiti Kebangsaan Malaysia,  Jalan Raja Muda Abdul Aziz, 50300 Kuala  Lumpur, Malaysia Tel +60 3 9289 7194 Fax +60 3 2693 8717 email suzana.shahar@ukm.edu.m y Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Badrasawi et al Running head recto: Efficacy of L-carnitine supplementation in prefrail older adults DOI: http://dx.doi.org/10.2147/CIA.S113287",Non-OADS,/arxiv_data1/oa_pdf/df/48/cia-11-1675.PMC5117993.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/df/48/cia-11-1675.PMC5117993.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/df/48/cia-11-1675.PMC5117993.pdf
"Next, we selected puta - tive miRNA target genes using microRNA.org (August, 2010 release, http://www.microrna.org) databases.",OADS,/arxiv_data1/oa_pdf/55/27/ijo-49-06-2255.PMC5117997.pdf
"The Screening Committee of Anticancer  Drugs (SCADS) compound library, containing 324 compounds in four 96-well microplates (http://gantoku-shien.jfcr.or.jp/), was kindly provided by Grant-in-Aid for Scientific Research on the Priority Area ‘Cancer’ from the Ministry of Education, Culture, Sports, Science and Technology of Japan.",Non-OADS,/arxiv_data1/oa_pdf/f7/74/ijo-49-06-2275.PMC5117998.pdf
"The mutational profiles of known  driver oncogenes such as KRAS  mutation, EGFR  mutation,  BRAF  mutation, ALK, RET  or ROS1  fusion, MAP2K1, NRAS   or HRAS  mutation, MET  exon 14 skipping mutation, MET   amplification, ERBB2  mutation, ERBB2  amplification, RIT1  mutation, and NF1 loss, for 230 lung adenocarcinomas were  based on the previously published report (17) and the gene expression profiles of these samples were extracted from the Cancer Genome Atlas (TCGA) data portal (https://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp).",OADS,/arxiv_data1/oa_pdf/f7/64/ijo-49-06-2236.PMC5118002.pdf
"For the pathway analyses, genes involved in each specific pathway were extracted from the REACTOME database (http://www.reactome.org/).",OADS,/arxiv_data1/oa_pdf/f7/64/ijo-49-06-2236.PMC5118002.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 161–167Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 161 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S119361 Characteristics of social drinkers with and  without a hangover after heavy alcohol  consumption A Hogewoning1,*  AJAE Van de Loo1,*  M Mackus1  SJ Raasveld1  R De Zeeuw1  ER Bosma1  NH Bouwmeester1  KA Brookhuis2  J Garssen1,3  JC Verster1,4 1Division of Pharmacology, Utrecht  University, Utrecht, 2Faculty of  Behavioral and Social Sciences,   Groningen University, Groningen,   3Nutricia Research, Utrecht, the  Netherlands; 4Centre for Human  Psychopharmacology, Swinburne University, Melbourne, VIC, Australia *These authors contributed equally to  this workBackground: A number of social drinkers claim that they do not experience next-day hang- overs despite consuming large quantities of alcohol.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
"The analysis revealed that alcohol hangover is associated with increased anxiety and fatigue, decreased alertness and arousal, physical discomfort, and emotional disturbance.Correspondence: JC Verster Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584CG Utrecht, the Netherlands   Tel +31 30 253 6909   Fax +31 30 253 7900   Email j.c.verster@uu.nlJournal name: Substance Abuse and Rehabilitation Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Hogewoning et alRunning head recto: Alcohol hangover immunityDOI: http://dx.doi.org/10.2147/SAR.S119361",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 167 Alcohol hangover immunity Acknowledgment This work was supported by Utrecht University.,Non-OADS,/arxiv_data1/oa_pdf/3f/1f/sar-7-161.PMC5118016.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/8a/ppa-10-2351.PMC5118017.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2351–2356Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2351OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12237 7 Validity of the control Preferences scale in  patients with emotional disorders carlos De las cuevas1 Wenceslao Peñate2 1Department of internal Medicine,   Dermatology and Psychiatry,   2Department of Personality,   Assessment and Psychological  Treatments, University of la  laguna,  san cristóbal de la  laguna,  canary islands, spainBackground:  The Control Preferences Scale (CPS) is the most frequently used measure of  patients’ preferred roles in treatment decisions.",Non-OADS,/arxiv_data1/oa_pdf/d0/8a/ppa-10-2351.PMC5118017.pdf
"This agreement stems from  political ideas, ethical thinking, and research in health care.1 Since psychiatric practice  is characterized by clinical situations in which more than one reasonable possibility  of therapeutic intervention is available with no evidence that any of the options is  better than another, it has been suggested that it should be the patients’ preferences  that guide final selection of treatment.2 Moreover, psychiatric patient participation  in decision-making meets the ethical principle of patient autonomy and the legal  requirement of informed consent and has also been associated to better patients’  outcome measures.3,4 Depression and anxiety disorders are among the most common illnesses in the  community of western countries with estimated lifetime prevalence rates of up to 29%  for anxiety disorders and 19% for depressive disorders.5 Many patients with depres - sion often have significant symptoms of anxiety disorders,6 and those with anxiety correspondence: carlos De las cuevas Departamento de Medicina interna,  Dermatología y Psiquiatría, Facultad de  ciencias de la salud – sección Medicina,  Universidad de la laguna, campus de  Ofra s/n, 38071 san cristóbal de la  laguna, spain Tel +34 922 60 952 1405 Fax +34 922 31 9353 email cdelascuevas@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: De las Cuevas and Peñate Running head recto: Control Preferences Scale validity DOI: http://dx.doi.org/10.2147/PPA.S122377",Non-OADS,/arxiv_data1/oa_pdf/d0/8a/ppa-10-2351.PMC5118017.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d0/8a/ppa-10-2351.PMC5118017.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 305–314Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  305 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S117392Effects of tai chi chuan on anxiety and sleep  quality in young adults: lessons from a randomized  controlled feasibility study Karen L Caldwell1 Shawn M Bergman2 Scott R Collier3 N Travis Triplett3 Rebecca Quin4 John Bergquist5 Carl F Pieper6 1Department of Human Development  and Psychological Counseling,   2Department of Psychology,   3Department of Health and Exercise  Science, 4Department of Theatre and  Dance, 5Department of Psychology,   Appalachian State University, Boone,   6Department of Biostatistics and  Bioinformatics, Duke University  Medical Center, Durham, NC,  USAObjective: To determine feasibility and estimate the effect of a 10-week tai chi chuan (TCC)  intervention on anxiety and sleep quality in young adults.",Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
"6 Correspondence: Karen L Caldwell Department of Human Development and Psychological Counseling, Appalachian State University, 151 College Street, Boone, NC 28608, USAEmail caldwellkaren@appstate.edu Journal name: Nature and Science of Sleep Article Designation: CLINICAL TRIAL REPORTY ear: 2016V olume: 8Running head verso: Caldwell et alRunning head recto: Effects of tai chi chuan on anxiety and sleep quality in young adultsDOI: http://dx.doi.org/10.2147/NSS.S117392",Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
Available from: http://www.acha-ncha.org/docs/NCHA-II_WEB_SPRING_2015_REFERENCE_GROUP_EXECUTIVE_SUMMAR Y .pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
Available from: http://bmccomple-mentalternmed.biomedcentral.com/articles/10.1186/1472-6882-10-23.,Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
Available from http://ijbnpa.biomed-central.com/articles/10.1186/1479-5868-9-78.,Non-OADS,/arxiv_data1/oa_pdf/1a/2b/nss-8-305.PMC5118018.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/34/ijwh-8-663.PMC5118019.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 663–667International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  663OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12278 1 success rate in preterm uterine contraction  inhibition with tocolytic agents in a tertiary  care center correspondence: Jadsada Thinkhamrop Department of Obstetrics and  gynecology, Faculty of Medicine,  Khon Kaen University, 123 Mittraphap  Highway, Muang Khon Kaen,  Khon Kaen 40002, Thailand Tel +66 43 202 489 Fax +66 43 348 395 email jadsada@kku.ac.t h Duangsamorn Kiatsuda Jadsada Thinkhamrop Witoon Prasertcharoensuk Department of Obstetrics and  gynecology, Faculty of Medicine,   Khon Kaen University, Khon Kaen,   ThailandObjective:  This study aims to assess the success rate of inhibiting preterm uterine contraction with  tocolytic agents to delay delivery for at least 48 hours and risk factors of failure inhibition.",Non-OADS,/arxiv_data1/oa_pdf/59/34/ijwh-8-663.PMC5118019.pdf
"Antenatal administration of corticosteroids to women who were expected to give  preterm birth was associated with a significant reduction of neonatal morbidity and  mortality, respiratory distress syndrome, intraventricular hemorrhage, and necrotizing Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Kiatsuda et al Running head recto: Success rate in preterm uterine contraction inhibition DOI: http://dx.doi.org/10.2147/IJWH.S122781",Non-OADS,/arxiv_data1/oa_pdf/59/34/ijwh-8-663.PMC5118019.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/59/34/ijwh-8-663.PMC5118019.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/34/ijwh-8-663.PMC5118019.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 161–166Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 161 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S119388Single-leg squats can predict leg alignment  in dancers performing ballet movements in  “turnout” Luke S Hopper1 Nahoko Sato2 Andries L Weidemann1 1Western Australian Academy of  Performing Arts, Edith Cowan  University, Mt Lawley, WA, Australia;   2Department of Physical Therapy,   Nagoya Gakuin University, Seto, JapanAbstract: The physical assessments used in dance injury surveillance programs are often  adapted from the sports and exercise domain.",Non-OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
"14–19 No studies have examined whether the single-leg squat Correspondence: Luke S Hopper Western Australian Academy of Performing Arts, Edith Cowan University, 2 Bradford St, Mt Lawley, WA 6050, AustraliaTel +61 8 6304 8234Fax +61 8 6304 6444Email l.hopper@ecu.edu.auJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Hopper et alRunning head recto: Single-leg squat assessment of leg alignment in dancersDOI: http://dx.doi.org/10.2147/OAJSM.S119388",Non-OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/91/oajsm-7-161.PMC5118020.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/af/c4/prbm-9-309.PMC5118021.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/af/c4/prbm-9-309.PMC5118021.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 309–315Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 309 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S110705 Effectiveness of social work intervention with a  systematic approach to improve general health in  opioid addicts in addiction treatment centers Ghoncheh Raheb1,2  Esmat Khaleghi1  Amir Moghanibashi- Mansourieh1  Ali Farhoudian2  Robab T eymouri3 1Department of Social Work,   University of Social Welfare and  Rehabilitation Sciences, T ehran, Iran;   2Substance Abuse and Dependence  Research Center, University of Social Welfare and Rehabilitation Sciences, T ehran, Iran;  3Pediatric  Neurorehabilitation Research Center,  University of Social Welfare and Rehabilitation Sciences, T ehran, IranPurpose: This study takes a systematic approach to investigate the effect of social work inter - vention aimed at increasing general health among opioid addicts in addiction treatment centers.",Non-OADS,/arxiv_data1/oa_pdf/af/c4/prbm-9-309.PMC5118021.pdf
"13Correspondence: Robab Teymouri   Pediatric Neurorehabilitation Research  Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Avenue, Daneshjoo Boulevard, Evin, Tehran 1985713834, Iran   Tel +98 21 2218 0099   Fax +98 21 2218 0095   Email robab.teymouri@yahoo.comJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Raheb et alRunning head recto: Effectiveness of social work intervention with a systematic approachDOI: http://dx.doi.org/10.2147/PRBM.S110705",Non-OADS,/arxiv_data1/oa_pdf/af/c4/prbm-9-309.PMC5118021.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/af/c4/prbm-9-309.PMC5118021.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1049–1056Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1049 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115065The psychological profile of women presenting to  a multidisciplinary clinic for chronic pelvic pain:   high levels of psychological dysfunction  and implications for practice Christina Bryant1,2 Rebecca Cockburn1 Anne-Florence Plante3 Angela Chia4 1Centre for Women’s Mental Health,   Royal Women’s Hospital, Parkville,   2Melbourne School of Psychological  Sciences, University of Melbourne,   3Department of Physiotherapy,   4Department of Anaesthesia, Royal  Women’s Hospital, Parkville, VIC,   AustraliaObjective: Chronic pelvic pain (CPP) is widely acknowledged as a common problem with  significant consequences for those diagnosed with this condition.",Non-OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
"Definitions Correspondence: Christina Bryant The Royal Women’s Hospital, Locked   Bag 300, Cnr Grattan St and   Flemington Rd, Parkville VIC 3052, AustraliaEmail christina.bryant@thewomens.org.auJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Bryant et alRunning head recto: Psychological profile of women presenting with chronic pelvic painDOI: http://dx.doi.org/10.2147/JPR.S115065",Non-OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1056 Bryant et al 31.,Non-OADS,/arxiv_data1/oa_pdf/77/1d/jpr-9-1049.PMC5118022.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1039–1048Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1039 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121415Effects of fentanyl on pain and motor behaviors  following a collagenase-induced intracerebral  hemorrhage in rats Laurence Saine1 Pierre Hélie2 Pascal Vachon1 1Department of Veterinary  Biomedicine, Faculty of Veterinary  Medicine, 2Department of Pathology  and Microbiology, Faculty of Veterinary Medicine, University of Montreal, Saint-Hyacinthe, Quebec,  CanadaPurpose: Intracerebral hemorrhage (IH) and cephalalgia are common consequences of traumatic  brain injury.",Non-OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
"One nonnegligible aspect is the pain associated with TBI and Correspondence: Pascal Vachon Department of Veterinary Biomedicine, Faculty of Veterinary Medicine, University of Montréal, 3200 Sicotte, St-Hyacinthe, QC J2S 7C6, CanadaTel: +1 450 773 8521 ext 8294Email pascal.vachon@umontreal.caJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Saine et alRunning head recto: Fentanyl and intracerebral hemorrhageDOI: http://dx.doi.org/10.2147/JPR.S121415",Non-OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1048 Saine et al  23.,Non-OADS,/arxiv_data1/oa_pdf/bd/6c/jpr-9-1039.PMC5118023.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 453–470Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  453 ReView open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S90383Advances in the management of heart failure: the  role of ivabradine Ursula Müller-w erdan1,2 Georg Stöckl3 Karl werdan4 1Charité – Universitätsmedizin  Berlin, 2Protestant Geriatric Centre,   Berlin, 3Department of Medical  Affairs, Servier Deutschland  GmbH, Munich, 4Department of  Medicine iii, University Hospital Halle (Saale), Martin-Luther-University Halle-wittenberg, Halle (Saale),  GermanyAbstract:  A high resting heart rate (≥70–75 b.p.m.)",Non-OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
"40, D-06120 Halle(Saale), GermanyTel +49 345 511 5773Fax +49 345 511 5774email karl.werdan@medizin.uni-halle.deJournal name: Vascular Health and Risk Management  Article Designation: ReviewY ear: 2016V olume: 12Running head verso: Müller-Werdan et alRunning head recto: Advances in the management of heart failureDOI: http://dx.doi.org/10.2147/VHRM.S90383",Non-OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 470 Müller-w erdan et al 115.,Non-OADS,/arxiv_data1/oa_pdf/f6/df/vhrm-12-453.PMC5118024.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/0e/ppa-10-2357.PMC5118025.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2357–2367Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2357OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11700 6 Adherence, satisfaction and preferences for  treatment in patients with psoriasis in the  european Union: a systematic review of the  literature i Belinchón1 r rivera2 c Blanch3 M comellas4 l lizán4,5 1Department of Dermatology,   hospital general Universitario de  Alicante, Alicante, 2Department of  Dermatology, hospital Universitario  12 de Octubre, Madrid, 3novartis  Farmacéutica s.A., Barcelona,   4Outcomes’10, castellón, spain;   5Medical Department, University  Jaime i, castellón, spainBackground and objective:  Adherence to treatment in patients with psoriasis is often poor.",Non-OADS,/arxiv_data1/oa_pdf/69/0e/ppa-10-2357.PMC5118025.pdf
"Keywords:  psoriasis, patient preference, adherence, satisfaction, systematic review, patient- reported outcomes, European Union Introduction Psoriasis is a common chronic inflammatory disease of the skin and joints that is  typically characterized by erythematous papules and plaques.1–3 Estimates of the  worldwide prevalence of psoriasis range from 1% to 3%4–6 and it affects ~2% of the correspondence: l lizán Outcomes’10, espaitec 2, Universitat  Jaume i, castellón de la Plana,  castellón, spain Tel +34 964 83 19 98 email lizan@outcomes10.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Belinchón et al Running head recto: Adherence, satisfaction and preference in European psoriatic patients DOI: http://dx.doi.org/10.2147/PPA.S117006",Non-OADS,/arxiv_data1/oa_pdf/69/0e/ppa-10-2357.PMC5118025.pdf
Available from: http://www.cebm.net/?o =1025.,Non-OADS,/arxiv_data1/oa_pdf/69/0e/ppa-10-2357.PMC5118025.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/69/0e/ppa-10-2357.PMC5118025.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2016:3 69–76Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 69 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S106072 Profile of tivantinib and its potential in the  treatment of hepatocellular carcinoma: the  evidence to date Daniel Pievsky1  Nikolaos Pyrsopoulos2 1Department of Internal Medicine,   2Division of Gastroenterology and  Hepatology, Rutgers New Jersey  Medical School, University Hospital,  Newark, NJ, USAAbstract: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related death  in the United States and carries a very poor prognosis, with a median survival time of < 50%  at 1 year for advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
"9,10 While sorafenib  represents a major advancement in the treatment of HCC, its effects are modest, with the SHARP trial demonstrating an increase in overall survival from 7.9 months to 10.7 months and an increase from 2.8 months to 5.5 months in the median time to Correspondence: Nikolaos Pyrsopoulos Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, University Hospital, 185 South Orange Avenue, MSB H Rm – 536, Newark, NJ 07101-1709, USA Tel +1 973 972 5252   Fax +1 973 972 3144   Email pyrsopni@njms.rutgers.eduJournal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEWY ear: 2016V olume: 3Running head verso: Pievsky and PyrsopoulosRunning head recto: Tivantinib and its potential in the treatment of HCCDOI: http://dx.doi.org/10.2147/JHC.S106072",Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
Available from: http://files.shareholder.com/downloads/ARQL/2313700819x0x882287/84DDD033-9DCA-46B6-9556-D4E90448754B/METIV -HCC_Interim_Analysis_Press_Release__cs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
"Journal of Hepatocellular Carcinoma 2016:3submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 76 Pievsky and Pyrsopoulos  52.,Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
Available from: http://investors.arqule.com/releasedetail.cfm?ReleaseID= 819847.,Non-OADS,/arxiv_data1/oa_pdf/54/49/jhc-3-069.PMC5118026.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2016:7 183–193Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 183 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S116987 Refinement of the Long-T erm Conditions  Questionnaire (LTCQ): patient and expert  stakeholder opinion Laura Kelly1 Caroline M Potter1 Cheryl Hunter2 Elizabeth Gibbons1 Ray Fitzpatrick1 Crispin Jenkinson1 Michele Peters1 1Health Services Research Unit,   Nuffield Department of Population  Health, University of Oxford, Oxford,   2Academic Unit of Primary Care,   Leeds Institute of Health Sciences,  University of Leeds, Leeds, UKPurpose: It is a key UK government priority to assess and improve outcomes in people with  long-term conditions (LTCs).",Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
"10 In the  absence of an appropriate instrument, this paper reports one stage of work to refine Correspondence: Laura Kelly   Health Services Research Unit, Nuffield  Department of Population Health, New Richards Building, Old Road Campus, Headington, Oxford OX3 7LF, UK   Tel +44 1865 289 425   Email laura.kelly@dph.ox.ac.ukJournal name: Patient Related Outcome Measures Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Kelly et alRunning head recto: LTCQ refinement: patient and expert opinionDOI: http://dx.doi.org/10.2147/PROM.S116987",Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
Available from:  http://content.digital.nhs.uk/qof.,Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
"Patient Related Outcome Measures 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/87/prom-7-183.PMC5118027.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare Dovepress Original research open access to scientific and medical research Open Access Full T ext Article Journal of Multidisciplinary healthcare 2016:9 623–630submit your manuscript | www.dovepress.com Dovepress 623 http: //dx.doi.org/10.2147/JMDH.S121788health provider experiences with galactagogues  to support breastfeeding: a cross-sectional survey alessandra n Bazzano1 lisa littrell1 amelia Brandt1 shelley Thibeau2 Kamala Thriemer3 Katherine P Theall1 1Department of global community  health and Behavioral sciences, T ulane  University school of Public health and  Tropical Medicine, 2Ochsner health  system, new Orleans, la, Usa; 3MlT  epiconsult, Jingili, nT, australiaBackground: Exclusive breastfeeding for infants up to 6 months is widely recommended, yet  breastfeeding rates are relatively low in the US.",Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"7,8correspondence: alessandra n Bazzano Department of global community health and Behavioral sciences, Tulane University school of Public health and Tropical Medicine, 1440 canal st, new Orleans, la 70112, Usa Tel +1 504 988 2338email abazzano@tulane.eduJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGIn AL RESEARcH Y ear: 2016V olume: 9Running head verso: Bazzano et alRunning head recto: Health providers experiences with galactagogues to support breastfeedingDOI: http://dx.doi.org/10.2147/JMDH.S121788",Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
Available from: http://www.who.int/nutrition/ publications/infantfeeding/WHO_nHD_01.09/en/.,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
Available from: http://www.who.int/about/agenda/health_development/events/innocenti_declaration_1990.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"Journal of Multidisciplinary healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 630 Bazzano et al  11. chung M, Raman G, Trikalinos T, Lau J, Ip S. Interventions in  primary care to promote breastfeeding: an evidence review for the  U.S. Preventive Services Task Force.",Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugclass/ucm173886.htm.,Non-OADS,/arxiv_data1/oa_pdf/0d/6a/jmdh-9-623.PMC5118028.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2963–2971Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2963Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11672 1 ADHD and Present Hedonism: time perspective  as a potential diagnostic and therapeutic tool S weissenberger1 M Klicperova-Baker2 P Zimbardo3 K Schonova1 D Akotia1 J Kostal2 M Goetz4 J Raboch1 R Ptacek1 1First Medical Faculty, Charles  University, 2institute of Psychology,   Academy of Sciences of the Czech  Republic, Praha, Czech Republic;   3Department of Psychology, Stanford  University, Stanford, CA, USA; 4Second  Faculty of Medicine, Department of  Child Psychiatry, Charles University,   Motol University Hospital, Praha,   Czech RepublicAbstract:  The article draws primarily from the behavioral findings (mainly psychiatric and  psychological observations) and points out the important relationships between attention-deficit/ hyperactivity disorder (ADHD) symptoms and time orientation.",Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
"Fayyad et al  report that the prevalence of ADHD is around 5.3% in the pediatric population and Correspondence: R Ptacek First Medical Faculty, Charles University,  Katerinska 1660/32, 121 08 Praha 2,  Czech Republic email ptacek@neuro.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Weissenberger et al Running head recto: ADHD and Present Hedonism DOI: http://dx.doi.org/10.2147/NDT.S116721",Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
Available from: http://www.medicalnewstoday.,Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/94/ndt-12-2963.PMC5118029.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 69–76Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  69 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S117042Influence of curcumin on the pharmacodynamics  and pharmacokinetics of gliclazide in animal  models Leela Krishna Vatsavai1 Eswar Kumar Kilari2 1Department of Pharmaceutical  Sciences, Jawaharlal Nehru  T echnological University, Hyderabad,  T elangana,  2Pharmacology Division, AU  College of Pharmaceutical Sciences,  Andhra University, Visakhapatnam,  Andhra Pradesh, IndiaPurpose: Patients suffering from obesity-related diseases use multiple prescription drugs to  control their condition, and it is therefore essential to determine the safety and efficacy of any  combination.",Non-OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
"These therapeutic combinations may be toxic at the  Correspondence: Leela Krishna Vatsavai Gayatri Nivas, Flat No G3, Plot No 169/c, Road No 5, Addagutta Society, Kukatpally, Hyderabad 500072, Telangana, IndiaTel +91 99 6369 2345Email leelakrishna.vatsavai@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Vatsavai and KilariRunning head recto: Herb–drug interaction of curcumin with gliclazideDOI: http://dx.doi.org/10.2147/JEP .S117042",Non-OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/ed/jep-8-069.PMC5118030.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 369–371International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 369 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S122553Excellent response of infantile orbital hemangioma   to propranolol Fandresena A Sendrasoa Irina M Ranaivo Naina H Razanakoto Malalaniaina AndrianarisonLala S RamarozatovoF Rapelanoro Rabenja Department of Dermatology,   University Hospital Joseph Raseta Befelatanana, Antananarivo,  MadagascarAbstract:  Infantile hemangiomas are the most common vascular neoplasm that present in  infancy, with more than half affecting the head and neck region.",Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
"However, Correspondence: Fandresena A  SendrasoaDepartment of Dermatology, University Hospital Joseph Raseta Befelatanana, Rue Dr Davioud Jacques, Antananarivo 101, MadagascarTel +261 330 471 344Email nasendrefa@yahoo.frJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Sendrasoa et alRunning head recto: Propranolol for infantile orbital hemangiomaDOI: http://dx.doi.org/10.2147/IMCRJ.S122553 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
Or use: http://youtu.be/pDI3qDR8bFM,Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 371 Propranolol for infantile orbital hemangioma tumor regression occurs before age 4 years.,Non-OADS,/arxiv_data1/oa_pdf/22/fa/imcrj-9-369.PMC5118031.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 1057–1066Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1057 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S119212Words that describe chronic musculoskeletal  pain: implications for assessing pain quality across  cultures Saurab Sharma1  Anupa Pathak2  Mark P Jensen3 1Department of Physiotherapy,   Kathmandu University School  of Medical Sciences, Dhulikhel Hospital Kathmandu University Hospital, Dhulikhel,  2Department of  Physiotherapy, Kathmandu University School of Medical Sciences, Dhulikhel,  Kavre, Nepal;  3Department of  Rehabilitation Medicine, University of Washington, Seattle, WA, USABackground: People from different cultures who speak different languages may experience  pain differently.",Non-OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
"11008, Nepal   Tel +977 98 4163 4043   Fax +977 11 490 707   Email saurabsharma1@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Sharma et alRunning head recto: Cross-cultural pain descriptionDOI: http://dx.doi.org/10.2147/JPR.S119212",Non-OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1066 Sharma et al  18.,Non-OADS,/arxiv_data1/oa_pdf/e8/a5/jpr-9-1057.PMC5118033.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2973–2980Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2973OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12297 9 Factors associated with vitamin D status of low- income, hospitalized psychiatric patients: results  of a retrospective study alessandra N Bazzano1 lisa littrell1 stephen lambert2 cody roi2 1Department of global community  health and Behavioral sciences,   Tulane University school of Public  health and Tropical Medicine, Tulane  University, 2Department of Psychiatry,   louisiana state University health  sciences center, louisiana state  University, New Orleans, la, UsaBackground:  Recent evidence has indicated a potential role of vitamin D3 in a range of  neuropsychiatric outcomes, as well as on cognitive function, but conflicting data have left that  role uncertain.",Non-OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
"Technically a steroid  hormone, vitamin D3 and its receptor VDR (vitamin D receptor) have become more  widely implicated in various health and disease states beyond osteomalacia, or rickets,  as information on their function in the body has emerged over the past three decades.1  Deficiency of vitamin D3 (also known as cholecalciferol) has arisen as a possible risk  factor for a range of mental health conditions.2,3 Preclinical studies and epidemiologi - cal research support the contention that prenatal deficiency of vitamin D impairs fetal  neurodevelopment potentially contributing to developmental disability in childhood  or psychiatric conditions such as schizophrenia in adulthood.4,5 Similar findings have  been identified in animal models.6,7 Numerous clinical studies have also shown that  low levels of vitamin D are directly or indirectly linked to adult psychiatric conditions  including depression and cognitive impairment.8–10 Clinical studies11,12 have implied  a relationship between low vitamin D levels and conditions such as depression,13,14  substance abuse,15 schizophrenia,16,17 delirium,18 and suicidal ideation.19correspondence: alessandra N Bazzano Department of global community  health and Behavioral sciences, Tulane  University school of Public health and  Tropical Medicine, Tulane University,  1440 canal st, New Orleans,   la 70112, Usa email abazzano@tulane.ed uJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Bazzano et al Running head recto: Vitamin D status of low-income, hospitalized psychiatric patients DOI: http://dx.doi.org/10.2147/NDT.S122979",Non-OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
"Available from: http://www.cdc.gov/nchs/data/ databriefs/db59.pd f. Accessed August 25, 2016.",OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/e7/ndt-12-2973.PMC5118036.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 443–451Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  443 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S91020Combination therapy with lercanidipine and  enalapril in the management of the hypertensive  patient: an update of the evidence Christina Antza1  Stella Stabouli2  Vasilios Kotsis1 1Hypertension Center, Third  Department of Medicine,   Papageorgiou Hospital, 2First  Department of Pediatrics,  Hippokration Hospital, Aristotle University of Thessaloniki,  Thessaloniki, GreeceAbstract:  Hypertension is an important risk factor for premature death as it increases the prob- ability of stroke, myocardial infarction, and heart failure.",Non-OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
"These physiological mechanisms are Correspondence: Vasilios Kotsis   Third Department of Internal Medicine,  Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece Tel +30 69 7474 8860   Email vkotsis@auth.grJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: Antza et alRunning head recto: Combination therapies for hypertensive patientsDOI: http://dx.doi.org/10.2147/VHRM.S91020",Non-OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 451 Combination therapies for hypertensive patients,Non-OADS,/arxiv_data1/oa_pdf/6e/48/vhrm-12-443.PMC5118038.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 209–219Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 209 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S121233 Fc gamma receptors: glycobiology and therapeutic  prospects Jerrard M Hayes1  Mark R Wormald2  Pauline M Rudd3  Gavin P Davey1 1School of Biochemistry and  Immunology, Trinity Biomedical  Sciences Institute, Trinity College,  Dublin, Ireland;  2Department of  Biochemistry, Oxford Glycobiology Institute, University of Oxford,  Oxford, UK;  3NIBRT Glycoscience  Group, National Institute for Bioprocessing, Research and Training,  Dublin, IrelandAbstract:  Therapeutic antibodies hold great promise for the treatment of cancer and autoim- mune diseases, and developments in antibody–drug conjugates and bispecific antibodies continue  to enhance treatment options for patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"1,2 Mab therapy  was born in the 1970s with the major discoveries of the IgG structure by Edelman et al3 Correspondence: Jerrard M Hayes School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland Tel +353 1 96 3527   Email jehayes@tcd.ieJournal name: Journal of Inflammation Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Hayes et alRunning head recto: Fc gamma receptors, glycosylation and therapeutic prospectsDOI: http://dx.doi.org/10.2147/JIR.S121233",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"The glycan compositions modeled onto each N-glycosylation site for each FcγR are named according to the Oxford  notation (https://glycobase.nibrt.ie/glycobase/show_nibrt.action)86 and are as follows: FcγRI: Asn 59 (Man 5), Asn 78 (FA2G2S1), Asn 152 (FA2GN2S2), Asn 159 (Man 6),  Asn 163 (FA2G2), Asn 195 (FA2G1GN1), Asn 240 (FA2BG2).",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"The glycan compositions modeled onto each N-glycosylation site for each FcγR are named according to the oxford notation  (see https://glycobase.nibrt.ie/glycobase/show_nibrt.action)86 and are as follows: FcgRI: Asn 59 (Man 5), Asn 78 (FA2G2S1), Asn 152 (FA2GN2S2), Asn 159 (Man 6), Asn 163  (FA2G2), Asn 195 (FA2G1GN1), Asn 240 (FA2BG2).",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"The glycan compositions modeled onto each N-glycosylation site for each FcγR are named according to the  oxford notation (see https://glycobase.nibrt.ie/glycobase/show_nibrt.action)86 and are as follows: FcgRI: Asn 59 (Man 5), Asn 78 (FA2G2S1), Asn 152 (FA2GN2S2), Asn 159  (Man 6), Asn 163 (FA2G2), Asn 195 (FA2G1GN1), Asn 240 (FA2BG2).",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
"Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 219 Fc gamma receptors, glycosylation and therapeutic prospects 74.",Non-OADS,/arxiv_data1/oa_pdf/ac/52/jir-9-209.PMC5118039.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 253–260Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 253 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S89724 Impact of a medical university on laparoscopic  surgery in a service-oriented public hospital in  the Caribbean Shamir O Cawich1  Suresh Pooran2  Barbara Amow2  Ernest Ali2  Fawwaz Mohammed1  Marlon Mencia1  Samuel Ramsewak1  Seetharaman Hariharan1  Vijay Naraynsingh1 1Department of Clinical Surgical  Sciences, University of the West  Indies, St Augustine, 2North West  Regional Health Authority, Port of Spain General Hospital, Port of Spain,  Trinidad and T obagoIntroduction: The Caribbean lags behind global trends for volume and complexity of lapa- roscopic operations.",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
"3 A similar situation existed in most Caribbean  countries, with many offering no laparoscopy at all.4Correspondence: Shamir O Cawich Department of Clinical Surgical Sciences, University of the West Indies, St Augustine, Trinidad and Tobago   Tel +1 868 622 9909   Email socawich@hotmail.comJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Cawich et alRunning head recto: LaparoscopyDOI: http://dx.doi.org/10.2147/RMHP .S89724",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 260 Cawich et al  6.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
Available from: https://www.cags-accg.ca/docs/Taylor_-_CAGS_report_2000.DOC.,OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
Available from: http://www.prb.org/Publications/Data sheets/2012/world-population-data-sheet/fact-sheet-world-population.aspx.,OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
Available from: http://www.planning.gov.tt/sites/default/files/content/mediacentre/documents/Trinidad-and-Tobago-Demographic-Report-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
Available from: http://www.hrsa.gov/healthit/meaningfuluse/meaningfuluseprimer.pdf.,OADS,/arxiv_data1/oa_pdf/b5/dd/rmhp-9-253.PMC5118042.pdf
"Available at http://data.bls.gov/timeseries/CUUR0000SAM?output_view=pct_12mths Accessed August 25, 2015.",OADS,/arxiv_data1/oa_pdf/b2/ad/JGS-64-2288.PMC5118096.pdf
"Available at http://www.dart- mouthatlas.org/ Accessed August 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/ad/JGS-64-2288.PMC5118096.pdf
- Korean J Orthod 2016;46:290-300 https://doi.org/10.4041/kjod.2016.46.6.343343www.e-kjo.orgpIssN 2234-7518 eIssN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-343.PMC5118212.pdf
"www.e-kjo.org https://doi.org/10.4041/kjod.2016.46.6.343This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Replied by  Yoon-Ah Kook Department of Orthodontics, Seoul St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, Seoul, Korea",Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-343.PMC5118212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.345",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 346 https://doi.org/10.4041/kjod.2016.46.6.345 INTRODUCTION   Anteroposterior as well as transverse skeletal problems  may co-exist in malocclusion patients.,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
"Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 347 https://doi.org/10.4041/kjod.2016.46.6.345 assessment of the midpalatal suture, hand-wrist and  cephalometric radiographs for bone age, and panoramic radiographs for dental age.",OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 348 https://doi.org/10.4041/kjod.2016.46.6.345 that the horizontal line of the cursor would intersect the  middle of the palate in the sagittal plane (Figure 1C).,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 349 https://doi.org/10.4041/kjod.2016.46.6.345 the midpalatal suture was reconfirmed on a horizontal  cross-sectional image by additionally investigating its morphology and fusion on a coronal cross-sectional planar view and on volume-rendered images.,OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 350 https://doi.org/10.4041/kjod.2016.46.6.345 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 351 https://doi.org/10.4041/kjod.2016.46.6.345 performed by using gamma ( γ) and Kendall’s tau-b ( τ- b) as association measures.,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 352 https://doi.org/10.4041/kjod.2016.46.6.345 surgical procedures are necessary to expand the maxilla.,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
"Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 353 https://doi.org/10.4041/kjod.2016.46.6.345   Angelieri et al.10 reported that stage A was observed  mostly in the early childhood period from 5 to 11 years  of age (four of five subjects), and stage B was observed mostly up to 13 years of age (50 of 57 subjects).",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 354 https://doi.org/10.4041/kjod.2016.46.6.345 between the maturation stage of the midpalatal suture  and developmental age indices.,OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
Jang et al • Maturation and morphology of palatal suture www.e-kjo.org 355 https://doi.org/10.4041/kjod.2016.46.6.345 review of the literature.,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/kjod-46-345.PMC5118213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.356",Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
Cho et al • Additional arch length required for leveling www.e-kjo.org 357 https://doi.org/10.4041/kjod.2016.46.6.356 INTRODUCTION   The curve of Spee (COS) is an important characteristic  of the mandibular arch.1 Most dentists believe that the  COS comprises the occlusal surfaces of the molars and incisal edges.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
"Cho et al • Additional arch length required for leveling www.e-kjo.org 358 https://doi.org/10.4041/kjod.2016.46.6.356   In addition, the AALL can be measured for an indivi- dual tooth by subtracting the 2D tooth width from the 3D tooth width.",Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
"Cho et al • Additional arch length required for leveling www.e-kjo.org 359 https://doi.org/10.4041/kjod.2016.46.6.356 is more frequently used than the sum of the right side  and left side COS depths3,9,18,19 and compatible with the  rule of thumb.10,11    In each setup, even marginal ridge relationships bet - ween adjacent teeth were maintained.",Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
"Cho et al • Additional arch length required for leveling www.e-kjo.org 360 https://doi.org/10.4041/kjod.2016.46.6.356 RESULTS   As the average of the right side and left side COS  depths increased from 0 mm to 4.7 mm, the 2D arch circumference decreased by 6.0 mm in the cusp tip measurements, and by 3.4 mm in the proximal maximum convexity measurements (Tables 2 and 3, Figure 3 ).",OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
Cho et al • Additional arch length required for leveling www.e-kjo.org 361 https://doi.org/10.4041/kjod.2016.46.6.356 AALL disclosed that the value was highest between the  first and second molars for the cusp tip measurements (0.27 mm) and at the mandibular second molar for the proximal maximum convexity measurements (0.32 mm).,OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
Cho et al • Additional arch length required for leveling www.e-kjo.org 362 https://doi.org/10.4041/kjod.2016.46.6.356 to make room for distal uprighting of the mandibular  second molars and to facilitate uprighting of the mandibular second molar with the accelerated regional phenomenon.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
Cho et al • Additional arch length required for leveling www.e-kjo.org 363 https://doi.org/10.4041/kjod.2016.46.6.356 alignment of the dentition is developed in the future.,Non-OADS,/arxiv_data1/oa_pdf/15/7d/kjod-46-356.PMC5118214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.364",Non-OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
Lee et al • Bonding strengths of LED curing units www.e-kjo.org 365 https://doi.org/10.4041/kjod.2016.46.6.364 INTRODUCTION   There have been many developments in dental bonding  materials in order to improve the efficiency of the bonding procedure and to assure long-term stability.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
"Lee et al • Bonding strengths of LED curing units www.e-kjo.org 366 https://doi.org/10.4041/kjod.2016.46.6.364 either VALO® (Ultradent Products Inc.) or an Ortholux  luminous curing light (3M Unitek, Monrovia, CA, USA).",OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
Lee et al • Bonding strengths of LED curing units www.e-kjo.org 367 https://doi.org/10.4041/kjod.2016.46.6.364 measured as a Newton when the bracket debonded from  the tooth surface (Figure 1).,OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
"Lee et al • Bonding strengths of LED curing units www.e-kjo.org 368 https://doi.org/10.4041/kjod.2016.46.6.364 RESULTS Measurements of shear bond strength    Generally, the shear bond strengths of the metal  bracket groups were significantly lower than the bond strengths of the ceramic bracket groups except for when the plasma emulation mode was used (Figure 2).",OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
"Lee et al • Bonding strengths of LED curing units www.e-kjo.org 369 https://doi.org/10.4041/kjod.2016.46.6.364 ARI measurements   The ARI scores were based on the images acquired with  the scanning electron microscope (Figure 3, Table 7).",OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
"Lee et al • Bonding strengths of LED curing units www.e-kjo.org 370 https://doi.org/10.4041/kjod.2016.46.6.364 preserving the enamel from possible damage.3 However,  in the present study, no significant differences in the ARI  scores were observed among the groups (Table 8).",Non-OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
Lee et al • Bonding strengths of LED curing units www.e-kjo.org 371 https://doi.org/10.4041/kjod.2016.46.6.364 during orthodontic bonding.,OADS,/arxiv_data1/oa_pdf/88/ee/kjod-46-364.PMC5118215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.372",Non-OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 373 https://doi.org/10.4041/kjod.2016.46.6.372 INTRODUCTION   Postoperative skeletal relapse after mandibular  setback surgery has already been reported by many investigators.,Non-OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 374 https://doi.org/10.4041/kjod.2016.46.6.372 mini-plates.,OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
"Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 375 https://doi.org/10.4041/kjod.2016.46.6.372 good, with mean ICCs of 0.965 (95% confidence interval  [CI], 0.800–0.999) and 0.892 (95% CI, 0.802–0.941), respectively.",OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
"Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 376 https://doi.org/10.4041/kjod.2016.46.6.372 or Euclidean distances, except along the Y-axis for the  left condylion.",OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 377 https://doi.org/10.4041/kjod.2016.46.6.372 coronoid process showed postoperative postero-medio- inferior movement.,OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
Kim et al • Postoperative change in the segments according to fixation methods www.e-kjo.org 378 https://doi.org/10.4041/kjod.2016.46.6.372 fixation: a systematic review.,OADS,/arxiv_data1/oa_pdf/55/b0/kjod-46-372.PMC5118216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.379",Non-OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"Kwon et al • Effect of slow forced eruption www.e-kjo.org 380 https://doi.org/10.4041/kjod.2016.46.6.379 INTRODUCTION   Advanced periodontal disease is characterized by  severe attachment loss, reduction of bony support, and increased tooth mobility, often resulting in pathologic tooth migration and flaring.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"Kwon et al • Effect of slow forced eruption www.e-kjo.org 381 https://doi.org/10.4041/kjod.2016.46.6.379 Friedy, Chicago, IL, USA), and the readings were rounded  up to the nearest 1 mm.",OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"Kwon et al • Effect of slow forced eruption www.e-kjo.org 382 https://doi.org/10.4041/kjod.2016.46.6.379 interproximal bone height, the papilla level, and  the alveolar ridge width were performed using the Kolmogorov-Smirnov test.",OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"Kwon et al • Effect of slow forced eruption www.e-kjo.org 383 https://doi.org/10.4041/kjod.2016.46.6.379 the cementoenamel junction remains unchanged,  the eruption of teeth gives rise to an increase in the interproximal alveolar bone level.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"Kwon et al • Effect of slow forced eruption www.e-kjo.org 384 https://doi.org/10.4041/kjod.2016.46.6.379 CONCLUSION   This prospective study demonstrated that the levels  of the interproximal alveolar bone and papilla were significantly increased by 1.36 mm and 1.09 mm, respectively, in the vertical direction through the application of the forced eruption technique.",Non-OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
Kwon et al • Effect of slow forced eruption www.e-kjo.org 385 https://doi.org/10.4041/kjod.2016.46.6.379 Orthop 1997;112:187-93.,OADS,/arxiv_data1/oa_pdf/33/34/kjod-46-379.PMC5118217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.386",Non-OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 387 https://doi.org/10.4041/kjod.2016.46.6.386 INTRODUCTION   Orthodontic mini-implants (OMIs) have been widely  used with a high rate of success as a form of skeletal anchorage in orthodontic treatment.,Non-OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 388 https://doi.org/10.4041/kjod.2016.46.6.386 Jeju National University in compliance with the  Management Policy of animal laboratories, and with the approval of the Animal Ethics Committee of the Jeju National University (approval number 2010-0047).",Non-OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 389 https://doi.org/10.4041/kjod.2016.46.6.386 a dose of 30,000 IU/kg once a day via subcutaneous  injections in addition to dressing on the surgical area using a chlorhexidine solution.",Non-OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 390 https://doi.org/10.4041/kjod.2016.46.6.386 between the cortical bone and threads using an optical  microscope under ×100 magnification to calculate BIC and BA (Figure 4).,OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 391 https://doi.org/10.4041/kjod.2016.46.6.386 were detected in the hybrid group only, based on the  EDS surface analysis.",OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 392 https://doi.org/10.4041/kjod.2016.46.6.386 Comparison of osseointegration Comparison of removal torque in experimental animals   The method of measuring removal torque introduced  by Carlsson et al.23 was applied to evaluate the levels of osseointegration of OMIs in this study.9,12   A high removal torque implies good osseointegration.",OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 393 https://doi.org/10.4041/kjod.2016.46.6.386 Histomorphometric analysis   There are two histomorphometric measurements used  to evaluate the osseointegration level of dental implants: percentage of BIC, and percentage of BA.",OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
Kim and Kim • Bone cutting capacity and osseointegration www.e-kjo.org 394 https://doi.org/10.4041/kjod.2016.46.6.386 implants.,OADS,/arxiv_data1/oa_pdf/a0/6d/kjod-46-386.PMC5118218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSCase Report pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2016.46.6.395",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 396 https://doi.org/10.4041/kjod.2016.46.6.395 INTRODUCTION   In patients with mandibular retrognathism, it is  difficult to establish a satisfactory esthetic profile,1,2 improve the respiratory function,3,4 and achieve stable  treatment outcomes2,5 with orthodontic treatment alone.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 397 https://doi.org/10.4041/kjod.2016.46.6.395 is generally required for effective treatment,6 and both  osteotomy techniques have exhibited equal effectiveness  and good outcomes.7   However, progressive condylar resorption (PCR) sometimes occurs as a serious complication of surgical mandibular advancement.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 398 https://doi.org/10.4041/kjod.2016.46.6.395 septal defect.,OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 399 https://doi.org/10.4041/kjod.2016.46.6.395 mandibular body was short compared with the Japanese  norms.12 The mandibular plane (Mp) angle was steep  and the ramus plane (Rp) was rotated clockwise (Mp–Frankfort [FH] plane, 39.0 o; Rp–FH, 90.5o).",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 400 https://doi.org/10.4041/kjod.2016.46.6.395 TREATMENT OBJECTIVES   The treatment objectives in the second phase were  as follows: correction of the retrognathic facial profile from esthetic and functional perspectives, correction of the anterior open bite and excessive overjet, and achievement of an acceptable occlusion.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 401 https://doi.org/10.4041/kjod.2016.46.6.395 TREATMENT ALTERNATIVES   To achieve the abovementioned treatment objectives,  surgical orthodontic treatment with double-jaw surgery (Le Fort I intrusion osteotomy and mandibular ramus osteotomy) was considered necessary to advance the mandible.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 402 https://doi.org/10.4041/kjod.2016.46.6.395 Therefore, Le Fort I intrusion osteotomy was performed  with advancement genioplasty and extraction of the maxillary second molar.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 403 https://doi.org/10.4041/kjod.2016.46.6.395 overbite (Figure 15).,OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 404 https://doi.org/10.4041/kjod.2016.46.6.395 Fort osteotomy and two genioplasty procedures,  thus eliminating the need for surgical mandibular advancement.",Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 405 https://doi.org/10.4041/kjod.2016.46.6.395 osteotomies in patients with an anterior open bite.,Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 406 https://doi.org/10.4041/kjod.2016.46.6.395 changes in the condylar morphology were observed at  24 months after surgery.,OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 407 https://doi.org/10.4041/kjod.2016.46.6.395 displacement of the tongue.,Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
Nakamura et al • Severe retrognathism with condylar deformity www.e-kjo.org 408 https://doi.org/10.4041/kjod.2016.46.6.395 osteotomies in patients with anterior open bite.,Non-OADS,/arxiv_data1/oa_pdf/cf/ee/kjod-46-395.PMC5118219.pdf
"Fields, United States Hakan Turkkahraman, Turkey Hande Gorucu Coskuner, Turkey Hatice Gokalp, Turkey Hee-Moon Kyung, Korea Heon Jae Cho, Korea Hoi-Jeong Lim, Korea Hooman Zarif Najafi,  Iran Hyo-Sang Park, Korea Hyo-Won Ahn, Korea Il-Hyung Y ang, Korea Il-Sik Cho, Korea Insan Jang, Korea J. Martin Palomo, United States Jae Hyun Park, United StatesJaehoon Lee, Korea Jae-Woo Park, Korea Jaewook Nam, Korea Janghoon Ahn, Korea Jeong-Chae Lee, Korea JH Calderó, Mexico Jianhua Hou, China Jin Hyoung Cho, Korea Jin-Hyoung Cho, Korea Jiuxiang Lin, China Ji-Y eon Lee, Korea Joe Antoun, New Zealand Jong-Moon Chae, Korea Jong-Wan Kim, Korea Joon Row, Korea Jung-Yul Cha, Korea Junji Sugawara, Japan Kee-Joon Lee, Korea Khalid H. Zawawi, Saudi Arabia Ki Beom Kim, United States Ki-Ho Park, Korea Kwang-Mahn Kim, Korea Kyung Hwa Kang, Korea Kyung Min Lee, Korea Kyung-Ho Kim, Korea Leopold Wagner, Poland LJ Lo, Taiwan LM Galantucci, Italy Lorenzo Franchi, Italy M. Ali Darendeliler, Australia Manuel Lagravere, Canada Masaru Y amaguchi, Japan MG Woods, Australia Min-Ho Jung, Korea Minji Kim, Korea Mohammad Khursheed Alam, Malaysia Mohd Masood, Malaysia Nam-Ki Lee, Korea Nasrin Farhadian, Iran Na-young Chang, Korea Neslihan Ebru Şışık, Turkey Rafael Scaf de Molon, BrazilRavindra Nanda, United States Renato Bigliazzi, Brazil RF Viecilli, United States S Sood, India Sang Jin Sung, Korea Sang-Min Lee, Korea Seniz Karacay, Turkey Seong Sik Kim, Korea Seong-Hun Kim, Korea Seung-Hak Baek, Korea Seung-Y oup Lee, Korea Siti Adibah Othman, Malaysia Spyridon N. Papageorgiou, Germany Sug-Joon Ahn, Korea Su-Jung Kim, Korea Sung Jin Kim, Korea Sung-Hoon Lim, Korea Sunghwan Choi, Korea Sung-Nam Gang, Korea Sung-Seo Mo, Korea SW Herring, United States Tae Hyun Choi, Korea Tae-Woo Kim, Korea Tancan Uysal, Turkey Tarek H EL-Bialy, Canada Tian-Min Xu, China Visnja Katic, Croatia Wey Mang Chek, Malaya Won Hee Lim, Korea Woo-Sung Son, Korea Xiaowei Li, China Y anheng Zhou, China Y ong-Il Kim, Korea Y oon Jeong Choi, Korea Y oon-Ah Kook, Korea Y oon-Goo Kang, Korea Y oon-Ji Kim, Korea Y oonji Kim, Korea Y oung Ho Kim, Korea Y oung-Guk Park, Korea Yu-lou Tian, ChinapIssN 2234-7518 eIssN 2005-372X https://doi.org/10.4041/kjod.2016.46.6.409409www.e-kjo.org",Non-OADS,/arxiv_data1/oa_pdf/30/f1/kjod-46-409.PMC5118220.pdf
"HbA 1cdeclined by mean of 9.7 mmol/mol (95% CI 8.5–10.9) (0.89%) 14–90 days after starting dapagliﬂozin, 10.2 mmol/mol (95% CI 8.9–11.5) (0.93%) after 91–180 days andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C885F0604F94A707 .",Non-OADS,/arxiv_data1/oa_pdf/e5/44/13300_2016_Article_193.PMC5118232.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e5/44/13300_2016_Article_193.PMC5118232.pdf
Sensitivity analyses demonstrate the robustness of these results.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E295F06048D26213 .,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2008. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071624.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2015.https://eunethta.fedimbo.belgium.be/sites/5026.fedimbo.belgium.be/ﬁles/2015-04-29-ECO-GL_Final %20version_0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2004. https://sundhedsstyrelsen.dk/da/medicin/tilskud/ generelle-tilskud/ansoegning/sundhedsoekonomiske-analyser/erfaringer-med-sundhedsoekonomiskeanalyser-i-ansoegninger-om-generelt-tilskud-til-laeg emidler .,OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2010. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2016. http://www.medicinpriser.,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2016. http://www.nomeco.dk/en .,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
"DSI Institut for Sundhedsvæsen, 2003. http://docplayer.dk/ 1323732-International-sammenligning-af-akut-ambulancetjeneste.html .",Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2015. http://dst.dk/da/Statistik/emner/forbrugerpriser/forbrugerprisindeks .,OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2016. http://sundhedsdatastyrelsen.dk/-/media/ sds/ﬁler/ﬁnansiering-og-afregning/takster/2016/ambulante-dags-takster-2016.xlsx .,OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
2016. http://www.laeger.dk/portal/page/portal/ LAEGERDK/Laegerdk/P_L_O/Overenskomster/Hono rartabel/Honorartabel%2001-10-2015/Honorartabel%2001-10-2015%20dagtid/%C2%A7%2050%20Grundydelser .,Non-OADS,/arxiv_data1/oa_pdf/7c/63/13300_2016_Article_195.PMC5118233.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7e/83/13300_2016_Article_196.PMC5118234.pdf
"We have also begun measuring meaningful outcomes, such as disease-free life span, survival rates, and time to important events such as stroke, myocardial infarction and heart failure, instead of relying on surrogate markers.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0E76F0602BE61B31 .",Non-OADS,/arxiv_data1/oa_pdf/f5/a0/13300_2016_Article_197.PMC5118235.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f5/a0/13300_2016_Article_197.PMC5118235.pdf
"There was even decreased risk of pancreatic cancer within groups paralleled by incretin-matched placebos (RR =0.55, 95% CIEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2FD6F0603A66AFFE .",Non-OADS,/arxiv_data1/oa_pdf/08/a2/13300_2016_Article_198.PMC5118236.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/08/a2/13300_2016_Article_198.PMC5118236.pdf
2000. http://clinicaltrials.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/08/a2/13300_2016_Article_198.PMC5118236.pdf
"March, 2011. http://handbook.cochrane.",Non-OADS,/arxiv_data1/oa_pdf/08/a2/13300_2016_Article_198.PMC5118236.pdf
Funding : Novo Nordisk.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B0E6F0606980ACBA .,Non-OADS,/arxiv_data1/oa_pdf/d0/b2/13300_2016_Article_199.PMC5118237.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d0/b2/13300_2016_Article_199.PMC5118237.pdf
2012. http://www.idf.org/ global-guideline-type-2-diabetes-2012 .,Non-OADS,/arxiv_data1/oa_pdf/d0/b2/13300_2016_Article_199.PMC5118237.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 12E6F06005FA780C .,Non-OADS,/arxiv_data1/oa_pdf/19/9c/13300_2016_Article_200.PMC5118238.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.Diabetes Ther (2016) 7:743–753 751",Non-OADS,/arxiv_data1/oa_pdf/19/9c/13300_2016_Article_200.PMC5118238.pdf
"Funding : Janssen Global Services, LLC.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 44E6F060333FA026 .",Non-OADS,/arxiv_data1/oa_pdf/50/7e/13300_2016_Article_201.PMC5118239.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.676 Diabetes Ther (2016) 7:659–678",Non-OADS,/arxiv_data1/oa_pdf/50/7e/13300_2016_Article_201.PMC5118239.pdf
http://www.fda.gov/Drugs/DrugSafety/ ucm500965.htm .,Non-OADS,/arxiv_data1/oa_pdf/50/7e/13300_2016_Article_201.PMC5118239.pdf
Patients with a high adherence to medication had anEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8FE6F0602ACF776E .,Non-OADS,/arxiv_data1/oa_pdf/5b/51/13300_2016_Article_203.PMC5118241.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/13300_2016_Article_203.PMC5118241.pdf
2014. https://m.tempo.co/read/news/2014/ 02/07/092552083/sebanyak-54-7-persen-penduduk-terpusat-di-jawa .,Non-OADS,/arxiv_data1/oa_pdf/5b/51/13300_2016_Article_203.PMC5118241.pdf
In 12.8% and 2.8% of patients the frequency of administration of insulinEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5E07F060511683EE .,Non-OADS,/arxiv_data1/oa_pdf/89/92/13300_2016_Article_204.PMC5118242.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/92/13300_2016_Article_204.PMC5118242.pdf
2015. http://www.idf.org/ membership/sea/india .,Non-OADS,/arxiv_data1/oa_pdf/89/92/13300_2016_Article_204.PMC5118242.pdf
"Classically, progressive loss of beta cell function in CFEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1F07F06021932850 .",Non-OADS,/arxiv_data1/oa_pdf/cd/f9/13300_2016_Article_205.PMC5118243.pdf
2016; http://dx.doi.org/10.1016/S0140-6736(16)00576-6 .,OADS,/arxiv_data1/oa_pdf/cd/f9/13300_2016_Article_205.PMC5118243.pdf
http:// www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/checking-your-blood-glucose.html?referrer=https://www.google.co.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/f9/13300_2016_Article_205.PMC5118243.pdf
https://www.diabetes.org.uk/About_us/What- we-say/Specialist-care-for-children-and-adults-and- complications/Glycaemic-management-during-the-inpatient-enteral-feeding- of-stroke-patients-with- diabetes/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/f9/13300_2016_Article_205.PMC5118243.pdf
"Results : Compared with baseline proﬁles of patients, combination therapies withEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A017F060797F273D .",Non-OADS,/arxiv_data1/oa_pdf/e3/7e/13300_2016_Article_206.PMC5118244.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e3/7e/13300_2016_Article_206.PMC5118244.pdf
2015. https://www.nice.org.uk/ guidance/ng28 .,Non-OADS,/arxiv_data1/oa_pdf/e3/7e/13300_2016_Article_206.PMC5118244.pdf
2013. http://www.hscic.gov.uk/catalogue/ PUB12421/nati-diab-audi-11-12-care-proc-rep.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e3/7e/13300_2016_Article_206.PMC5118244.pdf
Lixisenatide was generally well tolerated.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2017F0602F399121 .,Non-OADS,/arxiv_data1/oa_pdf/25/36/13300_2016_Article_207.PMC5118245.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/25/36/13300_2016_Article_207.PMC5118245.pdf
http://www.idf.org/diabetesatlas/5e/the- global-burden .,Non-OADS,/arxiv_data1/oa_pdf/25/36/13300_2016_Article_207.PMC5118245.pdf
"In those failing metformin, triple oral therapy by adding a non-metformin SPC such as empagliﬂozin/linagliptin or pioglitazone/Enhanced Content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0217F060488512AE .",Non-OADS,/arxiv_data1/oa_pdf/12/e8/13300_2016_Article_208.PMC5118246.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/12/e8/13300_2016_Article_208.PMC5118246.pdf
2002. https://www.kidney.org/sites/default/ﬁles/docs/ckd_ evaluation_classiﬁcation_stratiﬁcation.pdf .A c c e s s e d 25 Aug 2015.,Non-OADS,/arxiv_data1/oa_pdf/12/e8/13300_2016_Article_208.PMC5118246.pdf
http://www.fda.gov/Drugs/DrugSafety/ ucm459579.htm .,Non-OADS,/arxiv_data1/oa_pdf/12/e8/13300_2016_Article_208.PMC5118246.pdf
2015. http://www.fda.gov/ Drugs/DrugSafety/ucm446845.htm .,Non-OADS,/arxiv_data1/oa_pdf/12/e8/13300_2016_Article_208.PMC5118246.pdf
A smallEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 3317F0600150A08D .,Non-OADS,/arxiv_data1/oa_pdf/62/36/13300_2016_Article_209.PMC5118247.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/62/36/13300_2016_Article_209.PMC5118247.pdf
Revised: November 2015. http://www.diabetes.org.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/62/36/13300_2016_Article_209.PMC5118247.pdf
2015. http://www.nice.or g.uk/guidance/ng28 .,Non-OADS,/arxiv_data1/oa_pdf/62/36/13300_2016_Article_209.PMC5118247.pdf
"dynamics, and insulin release during perfusion under 3 or 11 mM glucose.Enhanced content The online video ﬁles are available to view at http://www.medengine.com/Redeem/ 6317F060735F7A3B .",Non-OADS,/arxiv_data1/oa_pdf/6b/39/13300_2016_Article_210.PMC5118248.pdf
"Animals and Pancreatic Islet Extraction and Preparation The protocol followed the Guide for the Care and Use of Laboratory Animals, eighth edition (2011) ( http://grants.nih.gov/grants/ olaw/guide-for-the-care- and-use-of-laboratory- animals.pdf ), and was compliant with local and national laws.",Non-OADS,/arxiv_data1/oa_pdf/6b/39/13300_2016_Article_210.PMC5118248.pdf
"The protocol followed the Guide for the Care and Use of Laboratory Animals, eighth edition (2011) ( http://grants.nih.gov/grants/ olaw/guide-for-the-care- and-use-of-laboratory- animals.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/6b/39/13300_2016_Article_210.PMC5118248.pdf
"The protocol followed the Guide for the care and use of laboratory animals, Eighth edition (2011) ( http://grants.nih.gov/grants/ olaw/guide-for-the-care- and-use-of-laboratory- animals.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/6b/39/13300_2016_Article_210.PMC5118248.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6b/39/13300_2016_Article_210.PMC5118248.pdf
"Toronto, Canada.http://ehealthinnovation.org/wp- content/uploads/ Patient-Order- Sets_Report_OHTAC_UHNHHF_Feb_10_Final.pdf .",Non-OADS,/arxiv_data1/oa_pdf/64/fc/198_2016_Article_3669.PMC5118409.pdf
http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php?type=2&file=/I_8/I8_A.html .,OADS,/arxiv_data1/oa_pdf/64/fc/198_2016_Article_3669.PMC5118409.pdf
"Thereare key arguments for and against all these models,as well as commonalities among models (http://tinyurl.com/zkzza9x).",Non-OADS,/arxiv_data1/oa_pdf/c9/24/bjsports-2015-095422.PMC5118437.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Cook JL, et al.Br J Sports Med 2016; 50:1187 –1191.",Non-OADS,/arxiv_data1/oa_pdf/c9/24/bjsports-2015-095422.PMC5118437.pdf
"425 https://doi.org/10.3345/kjp.2016.59.11.425Korean J Pediatr 2016;59(11):425-431 Waist-to-height ratio as a screening tool for  obesity and cardiometabolic risk Eun-Gyong Yoo, MD, PhD Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam, Korea The waist-to-height ratio (WHtR), calculated by dividing the waist circumference (WC) by height, has  recently gained attention as an anthropometric index for central adiposity.",Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
"Both BMI and WC are highly age­dependent in Corresponding author: Eun-Gyong Yoo, MD, PhD Department of Pediatrics, CHA Bundang Medical  Center, CHA University, 59 Yatap-ro, Bundang-gu,  Seongnam 13496, Korea Tel: +82-31-780-1999 Fax: +82-31-780-5239 E-mail: pedyoo@cha.ac.kr Received: 29 February, 2016 Revised: 6 June, 2016 Accepted: 7 June, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2016;59(11):425-431 https://doi.org/10.3345/kjp.2016.59.11.425 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
"https://doi.org/10.3345/kjp.2016.59.11.425Yoo EG  • Waist-to-height ratio as a screening tool for obesity 426children and adolescents, and clinicians must refer to tables to  determine gender­ and age­dependent cutoffs8).",Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
427 https://doi.org/10.3345/kjp.2016.59.11.425Korean J Pediatr 2016;59(11):425-431 Validity of WHtR for predicting cardiometabolic  risks 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
https://doi.org/10.3345/kjp.2016.59.11.425Yoo EG  • Waist-to-height ratio as a screening tool for obesity 428Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
"429 https://doi.org/10.3345/kjp.2016.59.11.425Korean J Pediatr 2016;59(11):425-431 New Zealand children aged 5–14 years, although a WHtR>0.5  was more common in Pacific and Maori children than in those of  other ethnicities and ethnicity influenced the relationship  between BMI and WHtR, the differences were clinically insignifi ­ cant and WHtR values for a given BMI were similar (WHtR of  0.47 in Maori, 0.46 in Pacific, and 0.48 in European boys at the  85th percentile)41).",Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
https://doi.org/10.3345/kjp.2016.59.11.425Yoo EG  • Waist-to-height ratio as a screening tool for obesity 430for identifying children and adolescents with increased cardio ­ metabolic risk related to central adiposity.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
431 https://doi.org/10.3345/kjp.2016.59.11.425Korean J Pediatr 2016;59(11):425-431 the Korean population: the Korean National Health and Nutrition  Examination Survey 2008­2011.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/kjped-59-425.PMC5118501.pdf
"https://doi.org/10.3345/kjp.2016.59.11.432Song DJ  • Rhinovirus and childhood asthma 432 Rhinovirus and childhood asthma: an update Dae Jin Song, MD, PhD1,2 1Department of Pediatrics, Korea University College of Medicine, Seoul, 2Environmental Health Center for Childhood Asthma, Korea University Anam Hospital, Seoul,  Korea Asthma is recognized as a complex disease resulting from interactions between multiple genetic and  environmental factors.",Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
"A greater understanding of the relationship between HRV  infections, allergic inflammation, and asthma could lead to new strategies to prevent and  treat childhood asthma.Corresponding author: Dae Jin Song, MD, PhD Departments of Pediatrics, Korea University Guro  Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308,  Korea Tel: +82-2-2626-3158 Fax: +82-2-2626-1249 E-mail: djsong506@korea.ac.kr  Received: 25 August, 2015 Revised: 18 October, 2015 Accepted: 23 October, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2016;59(11):432-439 https://doi.org/10.3345/kjp.2016.59.11.432 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
"433 https://doi.org/10.3345/kjp.2016.59.11.432Korean J Pediatr 2016;59(11):432-439 HRV and host innate immune responses  HRVs, members of the family Picornaviridae , are positive- sense, single-stranded RNA viruses with a genome of approxima - tely 7.2 kb.",Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
https://doi.org/10.3345/kjp.2016.59.11.432Song DJ  • Rhinovirus and childhood asthma 434asthma in vivo .,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
435 https://doi.org/10.3345/kjp.2016.59.11.432Korean J Pediatr 2016;59(11):432-439 additional environmental factors that modify the risk for asthma  following early life HRV infection and the mechanisms that  underlie the interactions between HRV infection and these  factors.,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
https://doi.org/10.3345/kjp.2016.59.11.432Song DJ  • Rhinovirus and childhood asthma 436not correlate with the severity of symptoms68).,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
437 https://doi.org/10.3345/kjp.2016.59.11.432Korean J Pediatr 2016;59(11):432-439 Conclusion The advent of molecular diagnostics to detect respiratory  viruses has led to new insights into the role of HRV infections in  the development and acute exacerbation of asthma in children.,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
https://doi.org/10.3345/kjp.2016.59.11.432Song DJ  • Rhinovirus and childhood asthma 438111:66-71.,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
439 https://doi.org/10.3345/kjp.2016.59.11.432Korean J Pediatr 2016;59(11):432-439 bronchial asthma.,Non-OADS,/arxiv_data1/oa_pdf/6c/4e/kjped-59-432.PMC5118502.pdf
"https://doi.org/10.3345/kjp.2016.59.11.440Seo SY, et al.",OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
"The prognostic significance of  many other risk factors is equivocal and may reflect differences in data collection, classi -Corresponding author: Su Jeong You, MD, PhD Department of Pediatrics, Inje University Sanggye  Paik Hospital, Inje University College of Medicine,  1342 Dongil-ro, Nowon-gu, Seoul 01757, Korea Tel: + 82-2-950-1080 Fax: +82-2-951-1246 E-mail: sjyou@paik.ac.kr Received: 5 August, 2016 Revised: 6 October, 2016 Accepted: 11 October, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(11):440-445 https://doi.org/10.3345/kjp.2016.59.11.440 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
"441 https://doi.org/10.3345/kjp.2016.59.11.440Korean J Pediatr 2016;59(11):440-445 fication, and analysis.",OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
"https://doi.org/10.3345/kjp.2016.59.11.440Seo SY, et al.",OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
443 https://doi.org/10.3345/kjp.2016.59.11.440Korean J Pediatr 2016;59(11):440-445 quences of HIE found that 14.5% of these infants developed CP2).,Non-OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
"https://doi.org/10.3345/kjp.2016.59.11.440Seo SY, et al.",OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
445 https://doi.org/10.3345/kjp.2016.59.11.440Korean J Pediatr 2016;59(11):440-445 References  1.,Non-OADS,/arxiv_data1/oa_pdf/05/c3/kjped-59-440.PMC5118503.pdf
"https://doi.org/10.3345/kjp.2016.59.11.446Hwang TW, et al.",OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
"Therefore, we aimed to analyze the impact of Corresponding author: Sang­Yun Lee, MD Department of Pediatrics, Sejong General Hospital,  28, Hohyeon­ro 489beon­gil, Bucheon 14754,  Korea Tel: +82­32­340­1121 Fax: +82­32­340­1236 E­mail: saeng123@hanmail.net Received: 7 August, 2016 Revised: 6 September, 2016 Accepted: 12 September, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(11):446-450 https://doi.org/10.3345/kjp.2016.59.11.446 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
447 https://doi.org/10.3345/kjp.2016.59.11.446Korean J Pediatr 2016;59(11):446-450 postoperative duration of aspirin use on longevity of biopro ­ sthetic pulmonary valve in patients who underwent congenital  heart disease repair.,Non-OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
"https://doi.org/10.3345/kjp.2016.59.11.446Hwang TW, et al.",OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
449 https://doi.org/10.3345/kjp.2016.59.11.446Korean J Pediatr 2016;59(11):446-450 mg to 100 mg per day is rea  sonable in all patients with a bio ­ prosthetic aortic or mitral valve for long term8).,Non-OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
"https://doi.org/10.3345/kjp.2016.59.11.446Hwang TW, et al.",OADS,/arxiv_data1/oa_pdf/48/38/kjped-59-446.PMC5118504.pdf
"451 https://doi.org/10.3345/kjp.2016.59.11.451Korean J Pediatr 2016;59(11):451-455 P wave dispersion on 12-lead electrocardio- graphy in adolescents with neurocardiogenic  syncope Dong-Hyuk Lee, MD1, Kyung-Min Lee, MD1, Jung-Min Yoon MD1, Jae-Woo Lim, MD1, Kyung-Ok Kho, MD, PhD1, Hong-Ryang Kil,  MD, PhD2, Eun-Jung Cheon, MD1 1Department of Pediatrics, Konyang University College of Medicine, Daejeon, 2Department of Pediatrics, Chungnam National University College of Medicine, Daejeon,  Korea Purpose: Neurocardiogenic syncope (NCS) is the most frequent cause of fainting during adolescence.",Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
"PWD has proven Corresponding author: Eun Jung Cheon, MD Department of Pediatrics, Konyang University Col - lege of Medicine, 158 Gwanjeodong-ro, Seo-gu,  Daejeon 35365, Korea  Tel: +82-42-600-9230 Fax: +82-42-600-9090 E-mail:ejcheon000@kyuh.ac.kr Received: 29 April, 2016 Revised: 27 September, 2016 Accepted: 29 September, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(11):451-455 https://doi.org/10.3345/kjp.2016.59.11.451 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
https://doi.org/10.3345/kjp.2016.59.11.451Lee DH  • P wave dispersion in neurocardiogenic syncope 452to be a sensitive and specific ECG predictor in the assessment of  the risk for atrial fibrillation in patients without apparent heart  disease.,Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
"453 https://doi.org/10.3345/kjp.2016.59.11.451Korean J Pediatr 2016;59(11):451-455 (53%) of the patients experienced syncope for the first time, the  second episodes in 16 patients (29%), the third episodes in three  patients, and the fourth episodes in only 1 patient, respectively.",Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
https://doi.org/10.3345/kjp.2016.59.11.451Lee DH  • P wave dispersion in neurocardiogenic syncope 454Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
"455 https://doi.org/10.3345/kjp.2016.59.11.451Korean J Pediatr 2016;59(11):451-455 report from the American Society of Echocardiography's Guide ­ lines and Standards Committee and the Chamber Quantification  Writing Group, developed in conjunction with the European Asso ­ ciation of Echocardiography, a branch of the European Society of  Cardiology.",Non-OADS,/arxiv_data1/oa_pdf/14/10/kjped-59-451.PMC5118505.pdf
"https://doi.org/10.3345/kjp.2016.59.11.456Vahedi M, et al.",OADS,/arxiv_data1/oa_pdf/63/0e/kjped-59-456.PMC5118506.pdf
"5, 2nd St, Niloufar St, Apadana  St, Tehran 1533853911, Iran Tel & Fax: +9809126082162 E-mail: Shfathi7@gmail.com Received: 25 February, 2016 Revised: 9 August, 2016 Accepted: 12 August, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2016;59(11):456-459 https://doi.org/10.3345/kjp.2016.59.11.456 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/63/0e/kjped-59-456.PMC5118506.pdf
457 https://doi.org/10.3345/kjp.2016.59.11.456Korean J Pediatr 2016;59(11):456-459 properly and suffered from his appearance.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/kjped-59-456.PMC5118506.pdf
"https://doi.org/10.3345/kjp.2016.59.11.456Vahedi M, et al.",OADS,/arxiv_data1/oa_pdf/63/0e/kjped-59-456.PMC5118506.pdf
459 https://doi.org/10.3345/kjp.2016.59.11.456Korean J Pediatr 2016;59(11):456-459 suffered from similar symptoms3).,Non-OADS,/arxiv_data1/oa_pdf/63/0e/kjped-59-456.PMC5118506.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: West syndromeHemophilia AACTHCoagulopathy 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/20/main.PMC5118558.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.007 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/20/main.PMC5118558.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/20/main.PMC5118558.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: SeizureHigh-frequency oscillation Epileptiform spikes with high-frequency oscillationsEEGHuman temporal lobe epilepsyEpilepsy surgery 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/2d/main.PMC5118559.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.006 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/2d/main.PMC5118559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/2d/main.PMC5118559.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Endometriosis FSHRLHRGATA4/6INSL3Ovarian- like differentiation 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.11.002 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"360 (3) 268 –279, http://dx.doi.org/ 10.1056/NEJMra0804690 (PubMed PMID: 19144942).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"10 (5) 261 –275, http://dx.doi.org/10.1038/ nrendo.2013.255 (PubMed PMID: 24366116).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"2013 859619, http://dx.doi.org/10.1155/2013/859619 (PubMed PMID: 23766765; PubMed Central PMCID: PMC3677669).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"29 (3) 400 –412, http://dx.doi.org/10.1093/humrep/det457 (PubMed PMID: 24435778).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"21 (5) 551 –583, http://dx.doi.org/10.1210/edrv.21.5.0409 (PubMed PMID: 11041448).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"363 (17) 1621 –1630, http://dx.doi.org/10.1056/NEJMoa1001283 (PubMed PMID: 20961245).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"BMC Cancer 13 246, http://dx.doi.org/10.1186/1471-2407-13-246 (PubMed PMID: 23688201; PubMed Central PMCID: PMC3663659).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"89 (5) 1069 –1072, http://dx.doi.org/10.1016/j.fertnstert.2007.05.011 (PubMed PMID: 17681338).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"102 (7) 1352 –1359, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"5 6, http://dx.doi.org/10.3389/fendo.2014.00006 (PubMed PMID: 24478759; PubMed Central PMCID: PMC3902607).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"Gene 513 (1) 1 –13,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
2010. http://dx.doi.org/10.1155/2010/486164 (PubMed PMID: 20706654; PubMed Central PMCID: PMC2913851).,OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"111 (3) 496 –501, http://dx.doi.org/10.1016/ j.ygyno.2008.08.018 (PubMed PMID: 18829089).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"22 (4) 781 –798, http://dx.doi.org/10.1210/me.2007-0513 (PubMed PMID: 18174356; PubMed Central PMCID: PMC2276466).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"Endocrinology 138 (11) 4748 –4756, http://dx.doi.org/10.1210/endo.",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"91 (3) 74, http://dx.doi.org/10.1095/biolreprod.114.118562 (PubMed PMID: 25100706).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"34 (1) 12,http://dx.doi.org/10.1186/s13046-015-0128-7 (PubMed PMID: 25652007; PubMed Central PMCID: PMC4321709).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"73 (2) 256 –260, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"269 (1 –2) 51 –60, http://dx.doi.org/10.1016/j.mce.2006.08.016 (PubMed PMID: 17367919).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"23 (7) 885 –891, http://dx.doi.org/10.1177/1933719115623647 (PubMed PMID: 26704526).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"jc20161014, http://dx.doi.org/10.1210/jc.2016 – 1014 (PubMed PMID: 27224263).",OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"Cancer 107 (4) 513 –519, http://dx.doi.org/10.1002/ijc.11424 (PubMed PMID: 14520686).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
"Endocrinology 153 (5) 2474 –2485, http://dx.doi.org/10.1210/en.2011-1969 (PubMed PMID: 22434075; PubMed Cen- tral PMCID: PMC3339651).",Non-OADS,/arxiv_data1/oa_pdf/b2/97/main.PMC5118588.pdf
http://dx.doi.org/10.1016/j.idcr.2016.09.010 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/9f/a7/main.PMC5118589.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  97–99 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/9f/a7/main.PMC5118589.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/cd/main.PMC5118590.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.007 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/bf/cd/main.PMC5118590.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  100 –103 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/bf/cd/main.PMC5118590.pdf
"N  Engl  J  Med  2015(October 14),  doi:http://dx.doi.org/10.1056/NEJMoa1511410 .",OADS,/arxiv_data1/oa_pdf/bf/cd/main.PMC5118590.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.005 2214-2509/ ã  2016  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/e3/eb/main.PMC5118591.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  104–105 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/e3/eb/main.PMC5118591.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.10.003 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
Receiver Operating Curves were gener- ated and analyzed using MedCalc software ( https://www.medcalc.org/ index.php ).,OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
"Odds ratios comparing the numbers of participants with HTN and DM as a function of BMI, WC and WHtR group were calculatedby Fisher's Exact test with Yates continuity correction using GraphPad InStat version 3.05 http://www.graphpad.com/scienti ﬁc-software/ instat/ .",OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
"The AUCs of all three measurements were poor (0.6 –0.7,http://gim.unmc.edu/dxtests/roc3.htm ) indicating that none of these are able to predict HTN without considering otherfactors.",OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
Diabetes Care Retrieved from: http://care.diabetesjournals.org/content/38/Supplement_1/S8.,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.org/10.1097/MD.0000000000003902 .,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.org/10.1007/s00394-012-0390-9 .,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
"Health Care Poor Under-served 26 (2 Suppl):16 –35.http://dx.doi.org/10.1353/hpu.2015.0061 .International Diabetes Foundation, 2006.",Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
99 (3):292 –299  .http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.org/10.1016/j.ypmed.2014.04.010 .,OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.org/10.4239/wjd.v6.i4.543 .,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
http://dx.doi.org/10.1016/j.maturitas.2009.12.,OADS,/arxiv_data1/oa_pdf/64/ab/main.PMC5118592.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/bd/main.PMC5118610.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.078 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/01/bd/main.PMC5118610.pdf
"Available  online:  http://www.cancerresearchuk.org/ cancer-info/cancerstats ,  2013.",Non-OADS,/arxiv_data1/oa_pdf/01/bd/main.PMC5118610.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Child Metabolic syndrome XMuscle strengthSchools 1.,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.11.004 2211-3355/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
http://dx.doi.org/10.1371/journal.pone.0093150 .,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
2. http://dx.doi.org/10.1186/1758-5996-2-8 .,Non-OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
http://dx.doi.org/10.1016/j.jpeds.,OADS,/arxiv_data1/oa_pdf/04/4b/main.PMC5118611.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.11.007 2213-0071/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/80/33/main.PMC5118614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 22 e24,Non-OADS,/arxiv_data1/oa_pdf/80/33/main.PMC5118614.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/6d/main.PMC5118615.pdf
The adhesions  were  lysed  and  the  Appendix  identiﬁed  and  removed http://dx.doi.org/10.1016/j.ijscr.2016.10.074 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5d/6d/main.PMC5118615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.007,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1016/j.ejca.2014.05.019 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1056/NEJMoa043330 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1200/JCO.2005.03.7689 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1038/onc.2008.74 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1016/j.cellsig.2011.01.019 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1210/en.2009-1116 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.3892/or.2015.4422 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.3892/ijo.2014.2523 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1371/journal.pone.0132072 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0387 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1016/j.ccr.2006.03.003 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1038/nrc2602 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1371/journal.pone.0123736 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
"Mol Cancer Res 13,2 9–40.http://dx.doi.org/10.1158/1541-7786.MCR-14-0163 .",Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1002/stem.1322 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1371/journal.pone.0137703 .,Non-OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.18632/oncotarget.4358 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
"Cell Cycle 10, 579–583.http://dx.doi.org/10.4161/cc.10.4.14850 .",OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1016/j.ccr.2013.04.008 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.12.006 .,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
http://dx.doi.org/10.1111/j.1365 –2990.2010.01132.x .556 Cyclin-dependent kinase 2 and glioblastoma Wang et al.,OADS,/arxiv_data1/oa_pdf/45/14/main.PMC5118617.pdf
"1521-0103/359/3/482 –490$25.00 http://dx.doi.org/10.1124/jpet.116.236067 THEJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 359:482 –490, December 2016 Copyright ª2016 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/4a/b5/jpet.116.236067.PMC5118642.pdf
0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).,OADS,/arxiv_data1/oa_pdf/00/20/cro-0009-0593.PMC5118684.pdf
"Additional Information Supplementary information accompanies this paper at http://www.nature.com/srep Competing financial interests: The authors declare no competing financial interests.Data and materials availability: Additional data and materials are available.How to cite this article: Stoupin, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/32/af/srep37440.PMC5118721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/32/af/srep37440.PMC5118721.pdf
"   Case Rep Oncol 2016;9:661 –665  DOI: 10.1159/000450596   Published online: October 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC  BY-NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/af/0d/cro-0009-0661.PMC5118823.pdf
"http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf (accessed September 18,  2015).",Non-OADS,/arxiv_data1/oa_pdf/af/0d/cro-0009-0661.PMC5118823.pdf
"   Case Rep Oncol 2016;9:666 –671  DOI: 10.1159/000449126   Published online: November 1, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is license d under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/26/1e/cro-0009-0666.PMC5118824.pdf
"   Case Rep Oncol 2016;9:586 –592  DOI: 10.1159/000449448   Published online: October 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/74/d7/cro-0009-0586.PMC5118826.pdf
"   Case Rep Oncol 2016;9:574 –579  DOI: 10.1159/000450597   Published online: October 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Se rvices/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a1/af/cro-0009-0574.PMC5118827.pdf
"   Case Rep Oncol 2016;9:599 –609  DOI: 10.1159/000450598   Published online: October 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.",Non-OADS,/arxiv_data1/oa_pdf/69/e6/cro-0009-0599.PMC5118828.pdf
"   Case Rep Oncol 2016;9:650 –654  DOI: 10.1159/000450940   Published online: October 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This arti cle is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e1/99/cro-0009-0650.PMC5118829.pdf
"April 23, 2005.  https://www.legifrance.gouv.fr/eli/loi/2005/4/22/SANX0407815L/jo/texte.",Non-OADS,/arxiv_data1/oa_pdf/e1/99/cro-0009-0650.PMC5118829.pdf
"February 2, 2016.  https://www.legifrance.gouv.fr/eli/loi/2016/2/2/AFSX1507642L/jo/texte.",Non-OADS,/arxiv_data1/oa_pdf/e1/99/cro-0009-0650.PMC5118829.pdf
"   Case Rep Oncol 2016;9:568 –573  DOI: 10.1159/000449406   Published online: October 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons At tribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/21/fc/cro-0009-0568.PMC5118830.pdf
"   Case Rep Oncol 2016;9:644 –649  DOI: 10.1159/000450974   Published online: October 17, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccess License).",Non-OADS,/arxiv_data1/oa_pdf/ac/1f/cro-0009-0644.PMC5118831.pdf
"   Case Rep Oncol 2016;9:610 –628  DOI: 10.1159/000448705   Published online: October 17, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creati ve Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/90/57/cro-0009-0610.PMC5118832.pdf
"   Case Rep Oncol 2016;9:580 –585  DOI: 10.1159/000449127   Published online: October 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Com mons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/ca/f8/cro-0009-0580.PMC5118833.pdf
"2015.  http://seer.cancer.gov/archive/csr/1975_2012/results_merged/topic_surv ival.pdf (accessed June 15,  2016).",OADS,/arxiv_data1/oa_pdf/ca/f8/cro-0009-0580.PMC5118833.pdf
"2009.  http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2 010-06-14_QuickReference_8.5x11.pdf (accessed  June 15, 2016).",OADS,/arxiv_data1/oa_pdf/ca/f8/cro-0009-0580.PMC5118833.pdf
"   Case Rep Oncol 2016;9:629 –632  DOI: 10.1159/000450544   Published online: October 17, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creat ive Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/45/55/cro-0009-0629.PMC5118834.pdf
"   Case Rep Oncol 2016;9:655 –660  DOI: 10.1159/000452147   Published online: October 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1a/19/cro-0009-0655.PMC5118835.pdf
"   Case Rep Oncol 2016;9:639 –643  DOI: 10.1159/000450545   Published online: October 17, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c5/49/cro-0009-0639.PMC5118836.pdf
"   Case Rep Oncol 2016;9:672 –678  DOI: 10.1159/000452329   Published online: November 1, 2016  © 2016The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License  (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/1c/66/cro-0009-0672.PMC5118837.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/76/iranjradiol-13-04-37978.PMC5118842.pdf
Available from: http://www.psy.unsw.edu.au/Groups/Dass /.,Non-OADS,/arxiv_data1/oa_pdf/0a/76/iranjradiol-13-04-37978.PMC5118842.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/iranjradiol-13-04-38016.PMC5118843.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/44/iranjradiol-13-04-34016.PMC5118844.pdf
"   Case Rep Oncol 2016;9:633 –638  DOI: 10.1159/000449462   Published online: October 17, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d2/62/cro-0009-0633.PMC5118864.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/8b/iranjradiol-13-04-37265.PMC5118874.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdProgesterone receptor-positive  meningioma in CAHT O’Shea and others Growth of a progesterone receptor-positive  meningioma in a female patient with  congenital adrenal hyperplasia T O’Shea1, R K Crowley1, M Farrell2, S MacNally3, P Govender4, J Feeney4, J Gibney1  and M Sherlock1 1Department of Endocrinology, Adelaide and Meath Hospitals, incorporating the National Children’s  Hospital, Tallaght, Dublin, Ireland, Departments of 2Neuropathology, 3Neurosurgery, National  Neurosciences Centre, Beaumont Hospital, Beaumont, Dublin, Ireland, and 4Department of Radiology,  Adelaide and Meath Hospitals, incorporating the National Children’s Hospital, Tallaght, Dublin, IrelandID: 16-0054; November 2016 DOI: 10.1530/EDM-16-005410.1530/EDM-16-0054ID: 15-0028; XXX 2016 Correspondence  should be addressed  to M Sherlock  Email  mark.sherlock@amnch.ie Summary Meningioma growth has been previously described in patients receiving oestrogen/progestogen therapy.",Non-OADS,/arxiv_data1/oa_pdf/01/1a/edmcr-2016-160054.PMC5118966.pdf
"PROOF ONLY T O’Shea and others Progesterone receptor-positive  meningioma in CAHID: 16-0054; November 2016 DOI: 10.1530/EDM-16-0054 http://www.edmcasereports.com  2ACTH promotes the production of pregnenolone from  cholesterol, which is then converted to progesterone and  17-hydroxyprogesterone (17OHP) and cortisol.",Non-OADS,/arxiv_data1/oa_pdf/01/1a/edmcr-2016-160054.PMC5118966.pdf
PROOF ONLY T O’Shea and othersID: 16-0054; November 2016 DOI: 10.1530/EDM-16-0054 Progesterone receptor-positive  meningioma in CAH http://www.edmcasereports.com  3of detection of the assay at >180 nmol/L (reference range  <6.5 nmol/L).,Non-OADS,/arxiv_data1/oa_pdf/01/1a/edmcr-2016-160054.PMC5118966.pdf
"PROOF ONLY T O’Shea and others Progesterone receptor-positive  meningioma in CAHID: 16-0054; November 2016 DOI: 10.1530/EDM-16-0054 http://www.edmcasereports.com  4congenital adrenal hyperplasia ( 3, 4).",Non-OADS,/arxiv_data1/oa_pdf/01/1a/edmcr-2016-160054.PMC5118966.pdf
"PROOF ONLY T O’Shea and othersID: 16-0054; November 2016 DOI: 10.1530/EDM-16-0054 Progesterone receptor-positive  meningioma in CAH http://www.edmcasereports.com  5 7 Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR & Caritis SN  2007 Comparison of progesterone and glucocorticoid receptor  binding and stimulation of gene expression by progesterone, 17-alpha  hydroxyprogesterone caproate, and related progestins.",Non-OADS,/arxiv_data1/oa_pdf/01/1a/edmcr-2016-160054.PMC5118966.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdAcromegaly and somatostatin  withdrawalC Alvarez-Escola and   J Cardenas-Salas Active postoperative acromegaly: sustained  remission after discontinuation of  somatostatin analogues Cristina Alvarez-Escola  and Jersy Cardenas-Salas Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain Summary In patients with active acromegaly after pituitary surgery, somatostatin analogues are effective in controlling the disease  and can even be curative in some cases.",Non-OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
"PROOF ONLY C Alvarez-Escola and   J Cardenas-SalasAcromegaly and somatostatin  withdrawalID: 16-0092; November 2016 DOI: 10.1530/EDM- 16-0092 http://www.edmcasereports.com  2in inducing biochemical remission and shrinking the  tumour, thereby reducing the clinical influence of the  disease ( 3).",Non-OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
"PROOF ONLY C Alvarez-Escola and   J Cardenas-SalasID: 16-0092; November 2016 DOI: 10.1530/EDM- 16-0092 Acromegaly and somatostatin  withdrawal http://www.edmcasereports.com  3A pituitary MRI performed in June 2012 showed  postsurgical changes, including only minimal remains of  the gland, retraction of the optic chiasm ( Figs 1  and 2)  and no evidence of any remaining residual tumour.",Non-OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
"PROOF ONLY C Alvarez-Escola and   J Cardenas-SalasAcromegaly and somatostatin  withdrawalID: 16-0092; November 2016 DOI: 10.1530/EDM- 16-0092 http://www.edmcasereports.com  4(March  2016), random GH levels and IGF1 values were  0.72 and 146  ng/mL respectively (normal values for IGF1  range from 64 to 188  ng/mL).",OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
PROOF ONLY C Alvarez-Escola and   J Cardenas-SalasID: 16-0092; November 2016 DOI: 10.1530/EDM- 16-0092 Acromegaly and somatostatin  withdrawal http://www.edmcasereports.com  5with IGF1 normalization ( 15).,Non-OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
PROOF ONLY C Alvarez-Escola and   J Cardenas-SalasAcromegaly and somatostatin  withdrawalID: 16-0092; November 2016 DOI: 10.1530/EDM- 16-0092 http://www.edmcasereports.com  6Patient consent Written patient consent has been obtained from the patient.,Non-OADS,/arxiv_data1/oa_pdf/dd/8d/edmcr-2016-160092.PMC5118967.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0111; November 2016 DOI: 10.1530/EDM-16-0111Brown tumor in MEN1 A Casteràs and others Brown tumor of the jaw after pregnancy and  lactation in a MEN1 patient Anna Casteràs1, Lídia Darder2, Carles Zafon1, Juan Antonio Hueto2,  Margarita Alberola4, Enric Caubet3 and Jordi Mesa1 1Department of Endocrinology, 2Department of Maxilofacial Surgery, 3Department of Pathology and  4Department of Endocrine Surgery, University Hospital Vall d’Hebron, Barcelona, Spain Summary Skeletal manifestations of primary hyperparathyroidism (pHPT) include brown tumors (BT), which are osteoclastic  focal lesions often localized in the jaws.",Non-OADS,/arxiv_data1/oa_pdf/4f/58/edmcr-2016-160111.PMC5118968.pdf
"PROOF ONLY A Casteràs and others Brown tumor in MEN1 ID: 16-0111; November 2016 DOI: 10.1530/EDM-16-0111 http://www.edmcasereports.com  2found/associated in/with brown tumors, which have  also been reported in secondary HPT, parathyroid  carcinoma as well as paraneoplastic syndrome (PTHrP)  (2).",Non-OADS,/arxiv_data1/oa_pdf/4f/58/edmcr-2016-160111.PMC5118968.pdf
PROOF ONLY A Casteràs and others  ID: 16-0111; November 2016 DOI: 10.1530/EDM-16-0111Brown tumor in MEN1 http://www.edmcasereports.com  3150 IU/L (n.v. 30–120) ( Table 1 ) .,Non-OADS,/arxiv_data1/oa_pdf/4f/58/edmcr-2016-160111.PMC5118968.pdf
"PROOF ONLY A Casteràs and others Brown tumor in MEN1 ID: 16-0111; November 2016 DOI: 10.1530/EDM-16-0111 http://www.edmcasereports.com  4reparative giant cell granuloma, cherubism, aneurysmal  bone cyst or true giant cell tumors.",Non-OADS,/arxiv_data1/oa_pdf/4f/58/edmcr-2016-160111.PMC5118968.pdf
"PROOF ONLY A Casteràs and others  ID: 16-0111; November 2016 DOI: 10.1530/EDM-16-0111Brown tumor in MEN1 http://www.edmcasereports.com  5low; therefore, we attribute the development of BT to an  acute bone mineral and vitamin depletion in gestation  and breastfeeding.",Non-OADS,/arxiv_data1/oa_pdf/4f/58/edmcr-2016-160111.PMC5118968.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdGestational thyrotoxicosis and  myocardial infarctionV B Nannaka and D Lvovsky A rare case of gestational thyrotoxicosis as a  cause of acute myocardial infarction Varalaxmi Bhavani Nannaka  and Dmitry Lvovsky Division of Pulmonary and Critical Care Medicine, Bronx Lebanon Hospital Center, Bronx, New York, USA Summary Angina pectoris in pregnancy is unusual and Prinzmetal’s angina is much rarer.",Non-OADS,/arxiv_data1/oa_pdf/1e/1e/edmcr-2016-160063.PMC5118969.pdf
"PROOF ONLY V B Nannaka and D Lvovsky Gestational thyrotoxicosis and  myocardial infarctionID: 16-0063; November 2016 DOI: 10.1530/EDM-16-0063 http://www.edmcasereports.com  2Case presentation A 27-year-old 9-week pregnant woman presented to  emergency room with the complaint of 3  weeks of  generalized weakness, nausea and vomiting.",Non-OADS,/arxiv_data1/oa_pdf/1e/1e/edmcr-2016-160063.PMC5118969.pdf
"PROOF ONLY V B Nannaka and D LvovskyID: 16-0063; November 2016 DOI: 10.1530/EDM-16-0063 Gestational thyrotoxicosis and  myocardial infarction http://www.edmcasereports.com  3underwent coronary angiography, which showed  severe right coronary artery spasm ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/1e/1e/edmcr-2016-160063.PMC5118969.pdf
PROOF ONLY V B Nannaka and D Lvovsky Gestational thyrotoxicosis and  myocardial infarctionID: 16-0063; November 2016 DOI: 10.1530/EDM-16-0063 http://www.edmcasereports.com  4undetectable serum TSH level in the absence of TSH  receptor antibody.,Non-OADS,/arxiv_data1/oa_pdf/1e/1e/edmcr-2016-160063.PMC5118969.pdf
"PROOF ONLY V B Nannaka and D LvovskyID: 16-0063; November 2016 DOI: 10.1530/EDM-16-0063 Gestational thyrotoxicosis and  myocardial infarction http://www.edmcasereports.com  5cardiac arrest with death, ventricular arrhythmias  and pulmonary vasospasm mimicking pulmonary  embolism.",Non-OADS,/arxiv_data1/oa_pdf/1e/1e/edmcr-2016-160063.PMC5118969.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097HCAO controlled by pulse  steroid therapyN Miyamura and others A case of hepatitis C-associated osteosclerosis:  accelerated bone turnover controlled by pulse  steroid therapy Nobuhiro Miyamura1, Shuhei Nishida1, Mina Itasaka1, Hirofumi Matsuda1,  Takeshi Ohtou2, Yasuhiro Yamaguchi3, Daisuke Inaba4, Sadahiro Tamiya5 and  Tetsuo Nakano4 1Departments of Diabetes and Endocrinology, 2Gastroenterology, 3Neurology, and 4Orthopedic Surgery,  Tamana Central Hospital, Tamana, Japan, and 5Department of General and Community Medicine,  Kumamoto University Hospital, Kumamoto, Japan Summary Hepatitis C-associated osteosclerosis (HCAO), a very rare disorder in which an extremely rapid bone turnover occurs  and results in osteosclerosis, was acknowledged in 1990s as a new clinical entity with the unique bone disorder and  definite link to chronic type C hepatitis, although the pathogenesis still remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
"PROOF ONLY N Miyamura and others HCAO controlled by pulse  steroid therapy ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 http://www.edmcasereports.com  2Background Hepatitis C-associated osteosclerosis (HCAO) is a very  rare disorder in which an extremely rapid bone turnover  occurs, resulting in generalized osteosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
"PROOF ONLY N Miyamura and others  ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 HCAO controlled by pulse  steroid therapy http://www.edmcasereports.com  3excretion by phosphorus absorption, which did not seem  effective ( Fig.",OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
PROOF ONLY N Miyamura and others HCAO controlled by pulse  steroid therapy ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 http://www.edmcasereports.com  4formation marker of BAP during infusion periods ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
PROOF ONLY N Miyamura and others  ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 HCAO controlled by pulse  steroid therapy http://www.edmcasereports.com  5DXA evaluations revealed sustained increase of BMD  and bone mineral content (BMC) despite decreasing  levels of bone markers.,OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
"PROOF ONLY N Miyamura and others HCAO controlled by pulse  steroid therapy ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 http://www.edmcasereports.com  6least five patients were ineffective, whereas symptomatic  treatments may provide some benefit ( 1).",Non-OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
PROOF ONLY N Miyamura and others  ID: 16-0097; November 2016 DOI: 10.1530/EDM-16-0097 HCAO controlled by pulse  steroid therapy http://www.edmcasereports.com  7osteosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/5f/9c/edmcr-2016-160097.PMC5118973.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0079; November 2016 DOI: 10.1530/EDM-16-0079Insulin antibodies to   insulin analogC-T Su and Y-C Lin Hyperinsulinemic hypoglycemia associated  with insulin antibodies caused by exogenous  insulin analog Chih-Ting Su1 and Yi-Chun Lin1,2 1Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan and 2Department of Medicine,  Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan Summary Insulin antibodies (IA) associated with exogenous insulin administration seldom caused hypoglycemia and had different  characteristics from insulin autoantibodies (IAA) found in insulin autoimmune syndrome (IAS), which was first described  by Dr Hirata in 1970.",Non-OADS,/arxiv_data1/oa_pdf/40/ff/edmcr-2016-160079.PMC5118974.pdf
"PROOF ONLY C-T Su and Y-C Lin Insulin antibodies to   insulin analog ID: 16-0079; November 2016 DOI: 10.1530/EDM-16-0079 http://www.edmcasereports.com  2hypoglycemia, should be considered after excluding  insulinoma and nesidioblastosis ( 1, 2, 3).",Non-OADS,/arxiv_data1/oa_pdf/40/ff/edmcr-2016-160079.PMC5118974.pdf
PROOF ONLY C-T Su and Y-C Lin  ID: 16-0079; November 2016 DOI: 10.1530/EDM-16-0079 Insulin antibodies to   insulin analog http://www.edmcasereports.com  3hypoglycemia events did not improve.,Non-OADS,/arxiv_data1/oa_pdf/40/ff/edmcr-2016-160079.PMC5118974.pdf
PROOF ONLY C-T Su and Y-C Lin Insulin antibodies to   insulin analog ID: 16-0079; November 2016 DOI: 10.1530/EDM-16-0079 http://www.edmcasereports.com  4the insulin autoimmune syndrome (IAS) after insulin  treatment being changed from human insulin to analog  insulin was published in 2009 ( 3).,Non-OADS,/arxiv_data1/oa_pdf/40/ff/edmcr-2016-160079.PMC5118974.pdf
"PROOF ONLY C-T Su and Y-C Lin  ID: 16-0079; November 2016 DOI: 10.1530/EDM-16-0079 Insulin antibodies to   insulin analog http://www.edmcasereports.com  5References  1 Cavaco B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L &  Leite V 2001 Hypoglycaemia due to insulin autoimmune syndrome:  report of two cases with characterisation of HLA alleles and insulin  autoantibodies.",Non-OADS,/arxiv_data1/oa_pdf/40/ff/edmcr-2016-160079.PMC5118974.pdf
"PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081Phenotype mutation in the  glucagon receptorE Larger , N J Wewer Albrechtsen,   L H Hansen and others Pancreatic α-cell hyperplasia and  hyperglucagonemia due to a glucagon  receptor splice mutation Etienne Larger1,*, Nicolai J Wewer Albrechtsen2,3,*, Lars H Hansen4,*,  Richard W Gelling5, Jacqueline Capeau6,7, Carolyn F Deacon2,3, Ole D Madsen8,  Fumiatsu Yakushiji9,10, Pierre De Meyts8, Jens J Holst2,3 and Erica Nishimura11 1Department of Diabetology, Hôpital Bichat and University Paris Denis Diderot, Paris, France,  2Department of Biomedical Sciences, and 3Novo Nordisk Foundation Center for Basic Metabolic  Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark,  4Department of Molecular Signaling, Hagedorn Research Institute, Gentofte, Denmark, 5Department of  Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore,   6Inserm UMR_S 938, Centre de Recherche Saint-Antoine, Paris, France, 7Sorbonne University, UPMC,  University of Paris 6, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France, 8Global Research  External Affairs, Novo Nordisk A/S, 2760 Måløv, Denmark, 9Department of Internal Medicine,  Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan, 10Department of Education Planning and  Development, Faculty of Medicine, Toho University, Tokyo, Japan, and 11Metabolic Disease Research,  Novo Nordisk A/S, Måløv, Denmark *(E Larger, N J Wewer Albrechtsen and L H Hansen contributed equally to this work) Summary Glucagon stimulates hepatic glucose production by activating specific glucagon receptors in the liver, which in turn  increase hepatic glycogenolysis as well as gluconeogenesis and ureagenesis from amino acids.",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"PROOF ONLY E Larger , N J Wewer Albrechtsen,   L H Hansen and othersPhenotype mutation in the  glucagon receptorID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081 http://www.edmcasereports.com  2Background We present a patient who, despite having many-fold  (~100) elevated glucagon levels, showed no apparent  manifestations of a gluco-regulatory defect, nor any  symptoms of a glucagonoma syndrome.",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"PROOF ONLY E Larger , N J Wewer Albrechtsen,   L H Hansen and othersID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081 Phenotype mutation in the  glucagon receptor http://www.edmcasereports.com  3Investigation Six months after surgery, a physical examination indicated  no abnormalities (including a CT scan) despite the  presence of extremely high plasma glucagon levels.",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"PROOF ONLY E Larger , N J Wewer Albrechtsen,   L H Hansen and othersPhenotype mutation in the  glucagon receptorID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081 http://www.edmcasereports.com  4membranes and with cells transfected with the mutated  receptor confirmed that this mutation results in a receptor  that is unable to bind glucagon or signal in response to  glucagon in terms of cAMP accumulation.",OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"PROOF ONLY E Larger , N J Wewer Albrechtsen,   L H Hansen and othersID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081 Phenotype mutation in the  glucagon receptor http://www.edmcasereports.com  5is due to a liver-derived factor ( 8).",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"PROOF ONLY E Larger , N J Wewer Albrechtsen,   L H Hansen and othersPhenotype mutation in the  glucagon receptorID: 16-0081; November 2016 DOI: 10.1530/EDM-16-0081 http://www.edmcasereports.com  6Heterogeneity of glucagonomas due to differential processing of  proglucagon-derived peptides.",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/edmcr-2016-160081.PMC5118975.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/24/iranjradiol-13-04-41066.PMC5118976.pdf
"11,12 Given these dual effects, it is not surprising  *Correspondence to: Naihan Xu; Email: xu.naihan@sz.tsinghua.edu.cn; Hongxi Xu; Email: xuhongxi88@gmail.com Submitted: 05/21/2013; Revised: 01/28/2014; Accepted: 01/29/2014http://dx.doi.org/10.4161/auto.28034The natural compound oblongifolin C inhibits  autophagic flux and enhances antitumor efficacy  of nutrient deprivation Yuanzhi Lao,1,† Gang Wan,2,3,† Zhenyan Liu,1,† Xiaoyu Wang,1 Ping Ruan,4 Wei Xu,2,3 Danqing Xu,1,5 Weidong Xie,2 Yaou Zhang,2  hongxi Xu,1,* and Naihan Xu2,* 1school of Pharmacy; s hanghai University of Traditional c hinese Medicine; s hanghai, c hina; 2Key Lab in h ealthy s cience and Technology; Division of Life s cience;   Graduate s chool at s henzhen; Tsinghua University; s henzhen, china; 3school of Life s ciences; Tsinghua University; Beijing, c hina; 4Department of Pathology; Ruikang h ospital  Affiliated to Guangxi University of c hinese Medicine; Nanning, c hina; 5Department of Discovery Technologies; Roche R&D c enter ( china) Ltd; s hanghai, c hina †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nat Cell Biol  2007; 9:1102-9;  PMID:17909521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Cell 2011; 146:682-95; PMID:21884931 ;  http://dx.doi.org/10.1016/j.cell.2011.07.030 3.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nature 2008; 451:1069-75; PMID:18305538 ;  http://dx.doi.org/10.1038/nature06639 5.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nat Rev Cancer 2007; 7:961- 7; PMID:17972889 ; http://dx.doi.org/10.1038/ nrc22547.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Cell Death Differ 2009; 16:87-93; PMID:18806760 ;  http://dx.doi.org/10.1038/cdd.2008.131 8.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nature 2007; 446:745-7;  PMID:17429391 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Proc Natl Acad Sci U S A 2003; 100:15077- 82; PMID:14657337 ; http://dx.doi.org/10.1073/ pnas.2436255100 10.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nat Cell Biol 2007; 9:1142-51; PMID:17891140 ;  http://dx.doi.org/10.1038/ncb1634 11.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nature 1999; 402:672-6;  PMID:10604474 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Mol  Cancer Ther 2011; 10:1533-41; PMID:21878654 ;  http://dx.doi.org/10.1158/1535-7163.MCT-11-0047 14.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Proc Natl Acad Sci U S A  2007; 104:19023-8;  PMID:18024584 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Cell 2010; 140:313-26; PMID:20144757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Autophagy 2012; 8:445-544; PMID:22966490 ; http://dx.doi.org/10.4161/ auto.19496 20.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
J Cell Biol 2005; 171:603-14; PMID:16286508 ; http://dx.doi.org/10.1083/ jcb.200507002 21.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Curr Med Chem 2009;  16:3775-96;  PMID:19747141 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Pharm Biol 2012;  50:78-91;  PMID:22196584 ; http://dx.doi.org/10.31 09/13880209.2011.636176 24.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Cancer Res  2008; 68:1843-50;  PMID:18339865 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Anticancer Agents Med Chem 2012;  12:994-1000;  PMID:22339063 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Angew Chem Int Ed Engl 2012; 51:4536-61; PMID :22461155 ; http://dx.doi.org/10.1002/ anie.201103873 27.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Int J Cancer  2012; 131:1445-54;  PMID:22116711 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Int J Cancer 2013; 132:707- 16; PMID:22733377 ; http://dx.doi.org/10.1002/ ijc.27694 30.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Chem Biodivers 2008; 5:2710-7;  PMID:19089829 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
J Nat Prod 2012; 75:1459-64; PMID:22871217 ;  http://dx.doi.org/10.1021/np3003639 33.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Autophagy 2011; 7:572-83; PMID:21325881 ;  http://dx.doi.org/10.4161/auto.7.6.14943 34.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
J Cell Mol Med 2010; 14:2448-59;  PMID :19583815 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Invest Ophthalmol Vis Sci  2010; 51:6030-7;  PMID:20574031 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Methods Enzymol 2009; 452:85-95;  PMID:19200877 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Biochim Biophys Acta 2012; 1824:44-50;  PMID:21640203 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Dev Cell 2004; 6:463-77;  PMID:15068787 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Biomed  Pharmacother 2003; 57:203-8; PMID:12888255 ;  http://dx.doi.org/10.1016/S0753-3322(03)00048-9 42.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Pharm Res 2012; 29:2249-63; PMID:22538436 ;  http://dx.doi.org/10.1007/s11095-012-0753-1 43.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Genes Dev 2007; 21:1621- 35; PMID:17606641 ; http://dx.doi.org/10.1101/ gad.1565707 47.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
J Biol Chem  2011; 286:6602-13;  PMID:21148553 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Autophagy 2013; 9:714-29; PMID:23519090 ;  http://dx.doi.org/10.4161/auto.23997 50.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Autophagy 2012; 8:338-49; PMID:22302005 ;  http://dx.doi.org/10.4161/auto.18721 51.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Nat Cell Biol  2011; 13:453-60;  PMID:21394080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Science 2011; 332:1429- 33; PMID:21617040 ; http://dx.doi.org/10.1126/ science.1204592 53.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Autophagy 2012; 8:200-12; PMID:22252008 ; http://dx.doi.org/10.4161/ auto.8.2.18554 56.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Expert Opin Ther Targets 2013; 17:281-91; PMID:23293836 ; http://dx.doi.org/10.1517/147282 22.2013.740461 57.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
"Frlan R, Gobec S. Inhibitors of cathepsin B. Curr  Med Chem 2006; 13:2309-27; PMID:16918357 ;  http://dx.doi.org/10.2174/092986706777935122 59.",Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
Cancer Res  2012; 72:1199-209;  PMID:22266111 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/32/dc/kaup-10-05-10928034.PMC5119057.pdf
"4 However, even if autophagy is  a predominantly cytoprotective process, a nonphysiological exacerbated autophagic stimulus may trigger autophagosomal clustering and accumulation leading to an autophagy-dependent  *Correspondence to: Francesca Belleudi; Email: francesca.belleudi@uniroma1.it Submitted: 05/24/2013; Revised: 02/04/2014; Accepted: 02/07/2014http://dx.doi.org/10.4161/auto.28145FGF7/KGF regulates autophagy in keratinocytes A novel dual role in the induction of both assembly   and turnover of autophagosomes Francesca Belleudi,1,* Valeria Purpura,1 silvia c aputo,1 and Maria Rosaria Torrisi1,2 1istituto Pasteur-Fondazione c enci Bolognetti; Dipartimento di Medicina c linica e Molecolare; s apienza Università di Roma; Rome, i taly;   2azienda Ospedaliera s .",Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Physiol Rev 2010;  90:1383-435;  PMID:20959619 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Cell 2011 ; 146:682-95; PMID:21884931 ;  http://dx.doi.org/10.1016/j.cell.2011.07.030 3.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Dev Cell  2008 ; 15:344-57;  PMID:18804433 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Curr  Opin Cell Biol 2010 ; 22:124-31; PMID:20034776 ;  http://dx.doi.org/10.1016/j.ceb.2009.11.014 5.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Nat Rev Mol Cell Biol 2007 ; 8:741- 52; PMID:17717517 ; http://dx.doi.org/10.1038/ nrm2239 6.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Int J Biol  Sci 2011 ; 7:1114 -21; PMID:21927580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Eur J Cell Biol 2009 ; 88:117- 30; PMID:19013662 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Biol Chem 2009 ;  284:20398 -407; PMID:19509289 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Proc Natl Acad Sci U S A 1990 ; 87:2466 - 70; PMID:2138778 ; http://dx.doi.org/10.1073/ pnas.87.7.2466 12.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Cell Signal  2010 ; 22:914-25; PMID:20114074 ;  http://dx.doi.org/10.1016/j.cellsig.2010.01.015 14.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Mol Cell  2007 ; 25:193- 205; PMID:17244528 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Biol Chem 2008 ;  283:15370 -80; PMID:18356160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Cell Physiol 1990 ; 144:326-32;  PMID:1696274 ; http://dx.doi.org/10.1002/ jcp.1041440219 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Clin Invest 1995 ; 96:2026 -33; PMID:7560096 ;  http://dx.doi.org/10.1172/JCI11825019.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Invest Dermatol   2004 ; 123:207-12; PMID :15191562 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J  Cell Physiol  2007 ; 212:633-42; PMID:17458890 ;  http://dx.doi.org/10.1002/jcp.21056 21.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Exp Cell Res 2007 ; 313:1758 -77; PMID:17449030 ;  http://dx.doi.org/10.1016/j.yexcr.2007.03.013 22.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
PLoS One  2011 ; 6:e29159 ;  PMID:22195012 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Proc Natl Acad Sci U S A 1989 ; 86:802- 6; PMID :2915979 ; http://dx.doi.org/10.1073/ pnas.86.3.802 24.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Proc Natl Acad Sci U S A 1992 ; 89:246- 50; PMID:1309608 ; http://dx.doi.org/10.1073/ pnas.89.1.246 25.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Development  2003 ; 130:5493 - 501; PMID:14530295 ; http://dx.doi.org/10.1242/ dev.00788 26.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
EMBO J  2007 ; 26:1268 -78; PMID:17304214 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Cell Biol 2010 ; 188:935- 52; PMID:20308431 ; http://dx.doi.org/10.1083/ jcb.200910126 28.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
PLoS One   2011 ; 6:e24194 ; PMID:21957444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
FASEB  J 2011 ; 25:170-81; PMID:20844240 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Cell Biol  1988 ; 106:761-71; PMID:2450098 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
EMBO J 2000 ; 19:5720 -8;  PMID:11060023 ; http://dx.doi.org/10.1093/ emboj/19.21.5720 33.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Biochem Biophys Res  Commun  2006 ; 339:437-42; PMID:16300744 ;  http://dx.doi.org/10.1016/j.bbrc.2005.10.21134.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Pathol  2010 ; 221:117-24; PMID:20225337 ;  http://dx.doi.org/10.1002/path.2694 38.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
Autophagy   2013 ; 9:1407- 17; PMID:23800949 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Biol Chem  2000 ; 275:992-8; PMID:10625637 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Biol Chem 2007 ;  282:6763 -72; PMID:17192262 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Immunol  2011 ; 186:1248 -58;  PMID:21160040 ; http://dx.doi.org/10.4049/ jimmunol.1001954 44.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Invest Dermatol  2013 ; 133:2416 - 24; PMID:23558403 ; http://dx.doi.org/10.1038/ jid.2013.165 45.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
J Invest Dermatol  2005 ;  125:1190 -9; PMID:16354189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/da/kaup-10-05-10928145.PMC5119059.pdf
"10-12 The consequences of  such manipulations can be analyzed by established techniques.13  Over the years, various pathways including those linked to DNA instability and maintenance, 14-16 copper homeostasis,17,18 and ROS  *Correspondence to: Heinz D Osiewacz; Email: osiewacz@bio.uni-frankfurt.de Submitted: 07/16/2013; Revised: 02/07/2014; Accepted: 02/07/2014http://dx.doi.org/10.4161/auto.28148Identification of autophagy as a longevity- assurance mechanism in the aging model  Podospora anserina Laura Knuppertz,1 Andrea h amann,1 Francesco Pampaloni,2 ernst s telzer,2 and h einz D Osiewacz1,* 1institute of Molecular Biosciences and c luster of e xcellence Frankfurt Macromolecular c omplexes; Department of Biosciences; J W Goethe University; Frankfurt, Germany;  2Physical Biology Group; Buchmann i nstitute of Molecular Life s ciences; c luster of e xcellence Frankfurt Macromolecular c omplexes; Frankfurt, Germany Keywords:  aging, autophagy, ATG1, ATG8, Podospora anserina Abbreviations:  Atg, autophagy-related gene; Ble , phleomycin resistance gene; BMM, Biomalt Maize Medium; bp, base pairs;   CM, complete medium; DIC, differential interference contrast; GFP, green fluorescent protein; PaGLO1, P. anserina glyoxalase 1;  Hyg, hygromycin-resistance gene; kDa, kilodalton; LC3, microtubule-associated protein 1A/1B-light chain 3; mDSLM, monolithic  digitally scanned light sheet-based fluorescence microscope; PCR, polymerase chain reaction; PE, phosphatidylethanolamine;  PaPRE3, P. anserina proteasome core particle subunit β 1; ROS, reactive oxygen species; PaSOD, P. anserina superoxide dismutase;  TOR, target of rapamycin kinase; wt, wild type The filamentous ascomycete Podospora anserina  is a well-established aging model in which a variety of different  pathways, including those involved in the control of respiration, RO s generation and scavenging, DNA maintenance,  proteostasis, mitochondrial dynamics, and programmed cell death have previously been demonstrated to affect aging  and life span.",Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
"The spacing between the slices was 0.4 µ m. The image stacks were first deconvolved  by employing the parallel iterative deconvolution  plugin of the  freeware image software Fiji (http://fiji.sc/Fiji), by choosing the WPL algorithm and performing 5 iterations.",OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Gerontol 1956; 11:298- 300;  PMID:13332224 ; http://dx.doi.org/10.1093/ geronj/11.3.298 2.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Free Radic Biol Med  2002; 32:1084-9;  PMID:12031893 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Int J Biochem Cell Biol 2002; 34:1401- 14; PMID:12200035 ; http://dx.doi.org/10.1016/ S1357-2725(02)00053-5 4.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nature 2000;  408:239-47;  PMID:11089981 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Mutat Res  2002; 509:127-51;  PMID:12427535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Trends Biochem Sci 2012; 37:284-92; PMID:22410198 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Appl Microbiol Biotechnol 1991; 35:38-45; PMID:1367277 ; http://dx.doi.org/10.1007/ BF0018063312.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Methods Mol Biol 2013;  965:439-62;  PMID:23296676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Mech Ageing Dev 2009; 130:487-96; PMID:19486911 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Curr Genet 1985; 10:59-67; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Int J Biochem Cell Biol 2002; 34:1355- 71; PMID:12200031 ; http://dx.doi.org/10.1016/ S1357-2725(02)00078-X 18.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Biogerontology 2002; 3:143-53; PMID:12075133 ;  http://dx.doi.org/10.1023/A:101569640472320.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Exp Gerontol 2010; 45:525- 32; PMID:20080171 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nat Cell Biol 2009; 11:852-8; PMID:19543272 ;  http://dx.doi.org/10.1038/ncb1893 23.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nat Commun 2013; 4:1397;  PMID:23360988 ; http://dx.doi.org/10.1038/ ncomms2397 25.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell Cycle 2011; 10:4280-90; PMID:22134244 ; http://dx.doi.org/10.4161/ cc.10.24.18560 26.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Mol Microbiol 2007; 65:948-58; PMID:17627766 ;  http://dx.doi.org/10.1111/j.1365-2958.2007.05839.x 27.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Aging Cell 2010;  9:761-75;  PMID:20626725 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Curr Genet 2010; 56:225-35; PMID:20306265 ;  http://dx.doi.org/10.1007/s00294-010-0295-1,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
PLoS Comput Biol 2012; 8:e1002576; PMID :22761564 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Bioessays  2013; 35:314-22;  PMID:23359437 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nat Cell Biol 2007; 9:99-105; PMID:17173038; http://dx.doi.org/10.1038/ ncb1524 32.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Exp Gerontol  2006; 41:439-47;  PMID:16530367 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Mol Microbiol 2003;  47:321-33;  PMID:12519185 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Semin  Cancer Biol 2007; 17:101-11; PMID:17204431 ;  http://dx.doi.org/10.1016/j.semcancer.2006.11.009 36.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
FEBS Lett 1993; 333:169-74; PMID:8224160 ;  http://dx.doi.org/10.1016/0014-5793(93)80398-E 37.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Science 2000; 290:1717- 21; PMID:11099404 ; http://dx.doi.org/10.1126/ science.290.5497.1717 39.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2002; 277:763-73; PMID:11675395 ;  http://dx.doi.org/10.1074/jbc.M109134200 40.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Methods Mol Biol 2008; 445:89-109;  PMID:18425444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Autophagy 2013; 9:1024-43; PMID :23722157 ;  http://dx.doi.org/10.4161/auto.24483 42.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2008;  283:32386-93;  PMID:18818209 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Autophagy 2009; 5:1186-9; PMID:19806021 ;  http://dx.doi.org/10.4161/auto.5.8.985444.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
PLoS One 2012; 7:e46720; PMID:23056421 ;  http://dx.doi.org/10.1371/journal.pone.0046720 45.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Dev Cell 2004; 7:167-78;  PMID :15296714 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
PLoS  Genet 2008; 4:e24;  PMID:18282106 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Biochem J 2013; 454:459-66; PMID:23805866 ;  http://dx.doi.org/10.1042/BJ20121907 50.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
"Nat Cell Biol 2008; 10:602- 10; PMID:18391941 ; http://dx.doi.org/10.1038/ ncb1723 51. van der Klei IJ, Yurimoto H, Sakai Y, Veenhuis M.  The significance of peroxisomes in methanol metabo - lism in methylotrophic yeast.",OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Autophagy  2005; 1:131-40;  PMID:16874025 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell 2011; 146:682-95; PMID:21884931 ;  http://dx.doi.org/10.1016/j.cell.2011.07.030 55.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Immunity 2007; 27:11- 21; PMID:17663981 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell 2008; 132:27-42; PMID:18191218 ;  http://dx.doi.org/10.1016/j.cell.2007.12.018 58.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nat Cell Biol  2010; 12:823-30;  PMID:20811354 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Trends Microbiol 2008; 16:276-83;  PMID:18440231 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nat Rev Mol Cell Biol 2007; 8:741- 52; PMID:17717517 ; http://dx.doi.org/10.1038/ nrm223961.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell Death Differ 2009; 16:3-11; PMID:18846107 ;  http://dx.doi.org/10.1038/cdd.2008.150 62.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Eukaryot Cell 2007; 6:997- 1005;  PMID:17416896 ; http://dx.doi.org/10.1128/ EC.00011-07 63.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Eukaryot Cell  2006; 5:1328-36;  PMID:16896216 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Eukaryot Cell  2007; 6:2437-47;  PMID:17921348 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Fungal Genet Biol  2009; 46:531-42;  PMID :19351563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Microbiol Res 2014; 169:128- 38; PMID:23953726 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Fungal Genet Biol 2009; 46:1- 8; PMID:19010432 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Gerontology 2013; 59:413-20;  PMID :23615432 ;  http://dx.doi.org/10.1159/000348662 71.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Science 2003; 301:1387-91; PMID:12958363 ;  http://dx.doi.org/10.1126/science.1087782 72.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Mol Biol Cell 1998; 9:1995-2010; PMID:9693362 ;  http://dx.doi.org/10.1091/mbc.9.8.1995 77.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
EMBO J 2006; 25:5396- 404; PMID:17082767 ; http://dx.doi.org/10.1038/ sj.emboj.7601409 78.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Am J Physiol  Cell Physiol 2006; 291:C445-55; PMID:16611735 ;  http://dx.doi.org/10.1152/ajpcell.00505.2005 79.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Physiol Rev 2010;  90:1383-435;  PMID:20959619 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell Biochem Biophys 2013; 67:3- 13; PMID:23709310 ; http://dx.doi.org/10.1007/ s12013-013-9623-7 82.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
FEBS Lett 2010; 584:1393-8;  PMID:20040365 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Free Radic Biol Med 2005; 38:226-34;  PMID :15607905 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Neurochem  2003; 86:489-97;  PMID :12871590 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2005; 280:40282-92;  PMID:16192271 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Int J Biochem Cell Biol 2004; 36:2551- 62; PMID:15325592 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Neurobiol Dis 2008; 32:16-25; PMID:18640276 ;  http://dx.doi.org/10.1016/j.nbd.2008.06.00390.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nature 2007; 447:859- 63; PMID:17568747 ; http://dx.doi.org/10.1038/ nature05853 91.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Biochem J  2012; 443:213-22;  PMID:22188542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Curr Opin Cell Biol  2010; 22:157-68;  PMID:20006481 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2005; 280 :31582-6 ;  PMID:16027116 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Exp Gerontol 2013; 48:1107-19; PMID:23337777 ;  http://dx.doi.org/10.1016/j.exger.2013.01.006 96.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Geriatr  Gerontol Int 2010; 10:110-2;  PMID:20102391 ;  http://dx.doi.org/10.1111/j.1447-0594.2009.00569.x 99.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Cell Metab 2010; 11:35-46; PMID:20074526 ;  http://dx.doi.org/10.1016/j.cmet.2009.11.010 101.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Curr Opin Cell Biol  2005; 17:596-603;  PMID:16226444 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
PLoS One 2013; 8:e83109; PMID:24376646 ;  http://dx.doi.org/10.1371/journal.pone.0083109 103.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2000; 275:31505-13;  PMID:10806201 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Biol Chem 2006;  281:14474-85;  PMID:16522639 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
EMBO Rep 2012; 13:258- 65; PMID:22249165 ; http://dx.doi.org/10.1038/ embor.2011.260 107.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Proc Natl Acad Sci U S A  2010; 107:14164-9;  PMID:20660724 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
J Gerontol A Biol Sci Med Sci  1999; 54:B318-23;  PMID:10496537 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
EMBO J 2009; 28:889-901;  PMID:19229298 ; http://dx.doi.org/10.1038/ emboj.2009.29 110.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Aging Cell  2010; 9:433-47;  PMID:20346072 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Exp Gerontol  2013; 48:191-201;  PMID:23247094 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Biochem Soc Trans  2011; 39:1488-92;  PMID:21936839 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Curr Genet 1994; 26:87- 90; PMID:7954902 ; http://dx.doi.org/10.1007/ BF00326309 117.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Eukaryot Cell 2004; 3:200- 11; PMID:14871950 ; http://dx.doi.org/10.1128/ EC.3.1.200-211.2004 118.,Non-OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Nucleic Acids  Res 2000; 28:E97; PMID:11071951 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
Aging Cell  2008; 7:651-62;  PMID:18616635 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/59/kaup-10-05-10928148.PMC5119060.pdf
"*Correspondence to: Kazuyuki Kuchitsu; Email: kuchitsu@rs.noda.tus.ac.jp Submitted: 10/10/2013; Revised: 02/12/2014; Accepted: 02/18/2014http://dx.doi.org/10.4161/auto.28279OsATG7 is required for autophagy-dependent  lipid metabolism in rice postmeiotic anther  development Takamitsu Kurusu,1,2,3,† Tomoko Koyano,1,† shigeru hanamata,1,† Takahiko Kubo,4 Yuhei Noguchi,1 chikako Yagi,1   Noriko Nagata,5 Takashi Yamamoto,1 Takayuki Ohnishi,6 Yozo Okazaki,7 Nobutaka Kitahata,1 Daichi Ando,1 Masaya i shikawa,8  shinya Wada,9 Akio Miyao,10 hirohiko h irochika,10 hiroaki shimada,2,11 Amane Makino,9 Kazuki s aito,7,12 hiroyuki i shida,9   Tetsu Kinoshita,6 Nori Kurata,4 and Kazuyuki Kuchitsu1,2,* 1Department of Applied Biological s cience; Tokyo University of s cience; Noda, c hiba Japan; 2Research i nstitute for s cience and Technology; Tokyo University of s cience;   Noda, c hiba Japan; 3school of Bioscience and Biotechnology; Tokyo University of Technology; h achioji, Tokyo Japan; 4Plant Genetics Laboratory;   National i nstitute of Genetics; Mishima, s hizuoka Japan; 5Department of c hemical Biological s cience; Faculty of s cience; Japan Women’s University; Bunkyo-ku, Tokyo Japan;  6Faculty of Bioscience; Nagahama i nstitute of Bio- science and Technology; s higa, Japan; 7Metabolomic Function Research Group; R iKeN center for s ustainable Resource  science; Yokohama, Kanagawa Japan; 8environmental s tress Research Unit; Division of Plant s ciences; National i nstitute of Agrobiological s ciences; Tsukuba, i baraki Japan;  9Department of Applied Plant s cience; Graduate s chool of Agricultural s ciences; Tohoku University; s endai, Miyagi, Japan; 10Agrogenomics Research c enter;   National i nstitute of Agrobiological s ciences; Tsukuba, i baraki Japan; 11Department of Biological s cience and Technology; Tokyo University of s cience;   Katsushika, Tokyo Japan; 12Graduate s chool of Pharmaceutical s ciences; c hiba University; c hiba, c hiba Japan †These authors contributed equally to this work Keywords:  anther, autophagy, male sterility, pollen development, rice Abbreviations:  DAGs, diacylglycerols; GFP, green fluorescent protein; NB, Nipponbare ; OsC6, anther specific protein 6;   PCD, programmed cell death; PCs, phosphatidylcholines; PtdIns3K, phosphatidylinositol 3-kinase; TAGs, triacylglycerols;   TEM, transmission electron microscopy in flowering plants, the tapetum, the innermost layer of the anther, provides both nutrient and lipid components  to developing microspores, pollen grains, and the pollen coat.",OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
"We also consulted the  microarray-expression database (Rice XPro; http://ricexpro.dna.affrc.go.jp/GGEP/index.html), which showed OsATG7   expression throughout several developmental stages.",OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Annu Rev Plant Biol 2011; 62:437- 60; PMID:21275644 ; http://dx.doi.org/10.1146/ annurev-arplant-042809-112312 2.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Protoplasma   2012 ; 249:541-85; PMID:22002710 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Mol Plant  2008 ; 1:667- 74; PMID:19825571 ; http://dx.doi.org/10.1093/mp/ ssn027 5.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant  Physiol  2009 ; 149:694-707; PMID:19091874 ;  http://dx.doi.org/10.1104/pp.108.131128 6.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Protoplasma  2012 ; 249:285- 99; PMID:21660427 ; http://dx.doi.org/10.1007/ s00709-011-0296-z 9.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Signal Behav   2012 ; 8:e22510 ; PMID:23123450 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant  Cell Physiol  2012 ; 53:1355 -65; PMID:22764279 ;  http://dx.doi.org/10.1093/pcp/pcs099 11.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Trends Endocrinol Metab  2011 ; 22:234- 40; PMID:21419642 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Cell Death Differ  2013 ; 20:3-11; PMID:22595754 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Cell 2011 ; 147:728-41;  PMID:22078875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Physiol  2009 ; 149:220-34; PMID:18790996 ;  http://dx.doi.org/10.1104/pp.108.126714 17.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant J  2008 ;  55:1010 -24; PMID:18547393 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Physiol  2007 ; 143:1132 - 9; PMID:17259285 ; http://dx.doi.org/10.1104/ pp.106.093864 20.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Curr  Opin Plant Biol 2001 ; 4:118-22; PMID:11228433 ;  http://dx.doi.org/10.1016/S1369-5266(00)00146-1 22.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Trends Plant Sci 2012 ; 17:526-37; PMID:22694835 ;  http://dx.doi.org/10.1016/j.tplants.2012.05.006 23.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Cell 2007 ; 130: 165- 78; PMID:17632063 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell   2004 ; 16:2967 -83; PMID :15494556 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
J Biol Chem 2002 ;  277:33105 -14; PMID:12070171 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Physiol  2005 ; 138:2097 - 110; PMID:16040659 ; http://dx.doi.org/10.1104/ pp.105.060673 27.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Ann  Bot 1999 ; 84:501-6; http://dx.doi.org/10.1006/ anbo.1999.0943 28.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Mol Biol Cell  2000 ; 11:255- 68; PMID:10637306 ; http://dx.doi.org/10.1091/ mbc.11.1.255 29.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
J Biol Chem 2002 ; 277:22677 -84;  PMID:11929861 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell  2009 ; 21:3885 -901;  PMID:20040537 ; http://dx.doi.org/10.1105/ tpc.109.071795 32.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell  2012 ;  24:4652 -69;  PMID:23150634 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell   2012 ; 24:288-303; PMID:22253227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Front Plant Sci  2012 ; 3:3;  PMID:22645564 ; http://dx.doi.org/10.3389/ fpls.2012.00003 36.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Nat Cell Biol 2004 ; 6:1221 - 8; PMID:15558033 ; http://dx.doi.org/10.1038/ ncb1192,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Cell Death Differ  2005 ; 12(Suppl 2 ):1528 -34; PMID:16247500 ;  http://dx.doi.org/10.1038/sj.cdd.4401777 38.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Trends Cell Biol 2011 ;  21:387-92; PMID :21561772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Development  2008 ; 135:2347 -60; PMID:18567846 ;  http://dx.doi.org/10.1242/dev.016105 40.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Mol Biol   2009 ; 70:341-57; PMID:19277876 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Physiol Plant  1962 ; 15:473-92; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Protoplasma  1993 ; 174:79-81; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell Physiol 2002 ; 43:1096 -105;  PMID:12407188 ; http://dx.doi.org/10.1093/pcp/ pcf15644.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant J  2000 ; 22:561-70; PMID:10886776 ;  http://dx.doi.org/10.1046/j.1365-313x.2000.00767.x 45.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant J   2006 ; 45:123-32; PMID:16367959 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant J   1994 ; 6:271-82; PMID:7920717 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Cell Physiol 2004 ; 45:693-702;  PMID :15215504 ; http://dx.doi.org/10.1093/pcp/ pch08249.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Physiol  2010 ; 153:678-92; PMID:20357140 ;  http://dx.doi.org/10.1104/pp.109.151852 50.,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
DNA Res  2011 ; 18:363-77; PMID:21795261 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Biochem Biophys Res Commun   2006 ; 345:646-51; PMID:16690022 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Plant Biotechnol   2001 ; 18:219-22; http://dx.doi.org/10.5511/ plantbiotechnology.18.219,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/kaup-10-05-10928279.PMC5119067.pdf
Autophagy 2013; 9:1201-13;  PMID:23819996 ; http://dx.doi.org/10.4161/ auto.24811 2.,Non-OADS,/arxiv_data1/oa_pdf/6f/87/kaup-10-08-10929717.PMC5119268.pdf
"Autophagy 2014; 10:453-67; PMID:24419107 ; http://dx.doi.org/10.4161/auto.27442 *Correspondence to: Björn Stork; Email: bjoern.stork@uni-duesseldorf.de Submitted: 06/20/2014; Accepted: 06/20/2014; Published Online: 06/24/2014http://dx.doi.org/10.4161/auto.29717Erratum to: Alers S, Wesselborg S, Stork B.  ATG13: Just a companion, or an executor of the  autophagic program?",Non-OADS,/arxiv_data1/oa_pdf/6f/87/kaup-10-08-10929717.PMC5119268.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/eb/num-08-05-39581.PMC5119430.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf .,OADS,/arxiv_data1/oa_pdf/49/eb/num-08-05-39581.PMC5119430.pdf
Available from: http://www.uptodate.com/contents/evaluation-of-the-adult- patient-with-hypokalemia .15.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/num-08-05-39581.PMC5119430.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1247562Treatment of displaced midshaft clavicle fractures remains  controversial despite several randomized trials and a recent meta-analysis (McKee et al.,Non-OADS,/arxiv_data1/oa_pdf/6a/31/iort-87-539.PMC5119433.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1191275Background and purpose —  The best treatment for displaced  clavicle fractures has been debated for decades.,Non-OADS,/arxiv_data1/oa_pdf/3d/f2/iort-87-541.PMC5119434.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1222804Background and purpose —  According to previous Nordic  Arthroplasty Register Association (NARA) data, the 10-year  implant survival of cemented total hip arthroplasties (THAs) is  94% in patients aged 65–74 and 96% in patients aged 75 or more.",OADS,/arxiv_data1/oa_pdf/a1/51/iort-87-546.PMC5119435.pdf
"Annual Report 2015. https://aoanjrr.sahmri.com/ Annaratone G, Surace F M, Salerno P, Regis G F. Survival analysis of the  cemented SP II stem.",Non-OADS,/arxiv_data1/oa_pdf/a1/51/iort-87-546.PMC5119435.pdf
http://www.njrcentre.,Non-OADS,/arxiv_data1/oa_pdf/a1/51/iort-87-546.PMC5119435.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1246316Background and purpose —  In a previous registry report, short- term implant survival of hip resurfacing arthroplasty (HRA) in  Finland was found to be comparable to that of total hip arthro- plasty (THA).",OADS,/arxiv_data1/oa_pdf/33/4e/iort-87-554.PMC5119436.pdf
"http://www.suomenartroplas- tiayhdistys.ﬁ   Gross T P, Liu F. Hip resurfacing with the Biomet Hybrid ReCap-Magnum  system: 7-year results.",OADS,/arxiv_data1/oa_pdf/33/4e/iort-87-554.PMC5119436.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1234869Background and purpose —  Early postoperative mortality is  relatively high after total hip arthroplasty (THA) that has been  performed due to femoral neck fracture.,Non-OADS,/arxiv_data1/oa_pdf/5b/19/iort-87-560.PMC5119437.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1225649Background and purpose —  Patient-reported outcome (PRO) is  recognized as an important tool for evaluating the outcome and satisfaction after total hip arthroplasty (THA).,Non-OADS,/arxiv_data1/oa_pdf/ac/96/iort-87-567.PMC5119438.pdf
The subscale score can be calculated if at least 50% of the items on the subscale have been answered (HOOS scoring instructions are available at http://www.koos.nu/index.html).,Non-OADS,/arxiv_data1/oa_pdf/ac/96/iort-87-567.PMC5119438.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1244958Background and purpose —  Short-term experimental stud- ies have conﬁ  rmed that there is superior ﬁ  xation of cementless  implants inserted with compaction compared to broaching of the cancellous bone.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/iort-87-575.PMC5119439.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1237439Background and purpose —  The acetabular component has  remained the weakest link in hip arthroplasty for achievement of long-term survival.,Non-OADS,/arxiv_data1/oa_pdf/0b/6f/iort-87-583.PMC5119440.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1231008Background and purpose —  Acute kidney injury is a known com- plication of antibiotic use.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/iort-87-589.PMC5119441.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1244884Background and purpose —  The long-term effects of computer- assisted surgery in total knee replacement (CAS) compared to  conventionally operated knee replacement (CON) are still not  clear.,Non-OADS,/arxiv_data1/oa_pdf/ad/7a/iort-87-592.PMC5119442.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1237440Background and purpose —  Functional limitations after total  knee arthroplasty (TKA) are common.,Non-OADS,/arxiv_data1/oa_pdf/d5/10/iort-87-600.PMC5119443.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1233654Background and purpose —  Backside wear of the polyethylene  insert in total knee arthroplasty (TKA) can produce clinically signiﬁ  cant levels of polyethylene debris, which can lead to loosen- ing of the tibial component.",Non-OADS,/arxiv_data1/oa_pdf/26/df/iort-87-607.PMC5119444.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1228411Background and purpose —  Patients’ expectations of outcomes  following arthroscopic meniscus surgery are largely unknown.,Non-OADS,/arxiv_data1/oa_pdf/c9/07/iort-87-615.PMC5119445.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1210533Background and purpose —  The association between mortality  and lower extremity fractures (other than hip fractures in older  individuals) is unclear.,Non-OADS,/arxiv_data1/oa_pdf/66/9f/iort-87-622.PMC5119446.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1198883Background and purpose —  Bone fragility is determined by  bone mass, bone architecture, and the material properties of  bone.",Non-OADS,/arxiv_data1/oa_pdf/b4/a6/iort-87-626.PMC5119447.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1228413Background and purpose —  The burden of road trafﬁ  c injuries  globally is rising rapidly, and has a huge effect on health systems  and development in low- and middle-income countries.",Non-OADS,/arxiv_data1/oa_pdf/51/16/iort-87-632.PMC5119448.pdf
Available from: http://dx.doi.org/10.1186/s40064-016-2050-7,Non-OADS,/arxiv_data1/oa_pdf/51/16/iort-87-632.PMC5119448.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1237423Background and purpose —  The use of uncemented revision  stems is an established option in 2-stage procedures in patients with periprosthetic joint infection (PJI) after total hip arthro-plasty (THA).,Non-OADS,/arxiv_data1/oa_pdf/4e/8b/iort-87-637.PMC5119449.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2016.1246795Background and purpose —  Antibiotic treatment of patients  before specimen collection reduces the ability to detect organisms  by culture.,Non-OADS,/arxiv_data1/oa_pdf/1d/50/iort-87-644.PMC5119450.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1236322Sir,—I read with great interest the recent paper by Peters et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/26/iort-87-651.PMC5119451.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0)DOI 10.1080/17453674.2016.1247561Sir,— We read with interest the paper by Mukka et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/4a/iort-87-653.PMC5119452.pdf
Available at: https://www.nsf.gov/pubs/reports/sbes_ﬁnal_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/0b/i1552-5783-57-14-6287.PMC5119490.pdf
"Results Protein prediction by computational analysis TheuspF gene (435 bp) encodes a predicted protein of 168 amino acids, but the signal peptide was notdetected by analysis with the SignalP 4.1 server (http://www.cbs.dtu.dk/services/SignalP/).",OADS,/arxiv_data1/oa_pdf/43/4b/PRO-25-2142.PMC5119564.pdf
"Search of orthologs sequences werecarried out using BLASTP, available at the NationalCenter of Biotechnology Information server (http://www.ncbi.nlm.nih.gov/BLAST) and ClustalW (www.ebi.ac.uk/clustalw/).",OADS,/arxiv_data1/oa_pdf/43/4b/PRO-25-2142.PMC5119564.pdf
"Prediction of signal peptide andtransmembrane sequences were determined withSignalP and DAS programs, respectively (http://www.cbs.dtu.dk/services/SignalP/) and (http://www.sbc.su.se/~miklos/DAS/).",OADS,/arxiv_data1/oa_pdf/43/4b/PRO-25-2142.PMC5119564.pdf
Protein parameters of UspFwere calculated applying programs available at theExpasy Bioinformatics Portal (http://www.expasy.org/).,OADS,/arxiv_data1/oa_pdf/43/4b/PRO-25-2142.PMC5119564.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ott-9-7123.PMC5119620.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7123–7131OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11591 1 Deferred radiotherapy and upfront procarbazine– acnU–vincristine administration for 1p19q  codeleted oligodendroglial tumors are associated  with favorable outcome without compromising  patient performance, regardless of WhO grade nobuhiro hata1,2 Koji Y oshimoto1 ryusuke hatae1 Daisuke Kuga1 Y ojiro akagi1 satoshi O suzuki3 T oru iwaki3 Tadahisa shono1,4 Masahiro Mizoguchi1,5 Koji iihara1 1Department of n eurosurgery,   graduate school of Medical sciences,   Kyushu University, 2Department of  neurosurgery, clinical research  institute, national hospital  Organization Kyushu Medical center,   3Department of n europathology,   graduate school of Medical sciences,   Kyushu University, 4Department  of neurosurgery, harasanshin  hospital, Fukuoka, 5Department of  neurosurgery, Kitakyushu Municipal  Medical center, Kitakyushu, JapanAbstract:  Recently updated phase III trials revealed the favorable effect of add-on  procarbazine-lomustine-vincristine chemotherapy (CT) to radiotherapy (RT) in treating  anaplastic oligodendrogliomas with 1p19q codeletion (codel).",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ott-9-7123.PMC5119620.pdf
"However, since the efficacy of procarbazine +lomustine +  vincristine (PCV) chemotherapy (CT) for these tumors was reported,1 PCV with or  without radiotherapy (RT) had become the most common therapeutic approach.2 There - after, temozolomide (TMZ) replaced PCV overwhelmingly,3 and this substitution was  accelerated by the interval reports of phase III trials, RTOG 9402 and EORTC 26951,  which reported that PCV as an add-on treatment to RT showed no improvement in the  overall survival (OS) of patients with anaplastic oligodendrogliomas.4,5 The benefit of  TMZ in treating oligodendroglial tumors is presently being evaluated by 2 large ongoing correspondence: nobuhiro hata Department of neurosurgery, clinical  research institute, national hospital  Organization Kyushu Medical center,  1-8-1 Jigyohama, chuo-ku,   Fukuoka 810-8563, Japan Tel +81 92 852 0700 Fax +81 92 846 8485 email hatanobu@kyumed.j p Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Hata et al Running head recto: Upfront PAV for 1p19q codeleted oligodendroglioma DOI: http://dx.doi.org/10.2147/OTT.S115911",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ott-9-7123.PMC5119620.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ott-9-7123.PMC5119620.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/e9/ott-9-7123.PMC5119620.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/a9/ott-9-6945.PMC5119621.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6945–6951OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6945Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11119 8 Comparison of internal target volumes defined  on 3-dimensional, 4-dimensonal, and cone-beam  cT images of non-small-cell lung cancer Fengxiang li1 Jianbin li1 Zhifang Ma1 Yingjie Zhang1 Jun Xing1 huanpeng Qi1 Dongping shang2 1Department of radiation Oncology,   2Department of Big Bore cT room,   shandong cancer hospital affiliated  to shandong University, shandong  academy of Medical sciences, Jinan,   shandong, People’s republic of chinaPurpose:  The purpose of this study was to compare the positional and volumetric differences  of internal target volumes defined on three-dimensional computed tomography (3DCT),  four-dimensional CT (4DCT), and cone-beam CT (CBCT) images of non-small-cell lung  cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/72/a9/ott-9-6945.PMC5119621.pdf
"For conventional treatment planning based on three-dimensional computed  tomography (3DCT), a population-based margin is used to estimate tumor motion, correspondence: Jianbin li Department of radiation Oncology  (chest section), shandong cancer  Hospital Affiliated to Shandong  University, shandong academy of  Medical sciences, road Jiyan 440,  Jinan 250117, People’s republic of china Tel +86 531 6762 6130 Fax +86 531 6762 6130 email lijianbin@msn.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Comparison of ITVs based on 3D, 4D and CBCT DOI: http://dx.doi.org/10.2147/OTT.S111198",Non-OADS,/arxiv_data1/oa_pdf/72/a9/ott-9-6945.PMC5119621.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/72/a9/ott-9-6945.PMC5119621.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/a9/ott-9-6945.PMC5119621.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7105–7114OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7105Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11505 3 human papillomavirus as a potential risk  factor for gastric cancer: a meta-analysis of  1,917 cases Zhi-ming Zeng1 Fei-fei luo2 lin-xia Zou3 rong-quan he1 Deng-hua Pan2 Xin chen2 Ting-ting Xie2 Yuan-qing li2 Zhi-gang Peng1 gang chen2 1Department of Medical Oncology,   2Department of Pathology, The First  affiliated hospital of guangxi Medical  University, 3Department of children  rehabilitation Medicine, guangxi  Maternal and child health hospital,   nanning, chinaBackground:  Human papillomaviruses (HPVs) are causally associated with the tumorigenesis  of several classes of cancers.",Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
"HPV16 and HPV18 are the most common cancer-causing HPV subtypes correspondence: gang chen Department of Pathology, The First  Affiliated Hospital of Guangxi Medical  University, 6 shuangyong road, nanning  530021, guangxi Zhuang autonomous  region, china email chen_gang_triones@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zeng et al Running head recto: Prevalence of HPVs in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S115053",Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_ cancer.as px.,Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/14/ott-9-7105.PMC5119622.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/09/ott-9-7115.PMC5119623.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7115–7122OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7115Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11638 7 Methotrexate induces Dna damage and  inhibits homologous recombination repair  in choriocarcinoma cells lisha Xie1,* Tiancen Zhao1,2,* Jing cai1 Y ou su1 Zehua Wang1 Weihong Dong1 1Department of Obstetrics and  gynecology, Union hospital,   Tongji Medical college, huazhong  University of science and T echnology,   2Department of Obstetrics and  gynecology, central hospital of  Wuhan, Wuhan, china *These authors contributed equally  to this workObjective:  The objective of this study was to investigate the mechanism of sensitivity to  methotrexate (MTX) in human choriocarcinoma cells regarding DNA damage response.",Non-OADS,/arxiv_data1/oa_pdf/31/09/ott-9-7115.PMC5119623.pdf
"Methotrexate (MTX) is a common chemotherapeutic drug used in treating multiple  cancers, such as human leukemia, non-small-cell lung cancer and choriocarcinoma.3  Single-agent MTX chemotherapy and MTX combined with other cytotoxic drugs  (eg, EMA/CO [etoposide, MTX, actinomycin D, cyclophosphamide and vincristine])  were recommended as the first-line treatments for low- and high-risk choriocarcinoma,  respectively, which achieve a high survival rate ( .90%).4,5correspondence: Weihong Dong Department of Obstetrics and  gynecology, Union hospital, Tongji  Medical college, huazhong University  of science and Technology, 1277 Jiefang  avenue, Wuhan 430022, china Tel/fax +86 27 8535 1649 email rubydwh@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xie et al Running head recto: MTX-induced DSB with repressed HR in choriocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S116387",Non-OADS,/arxiv_data1/oa_pdf/31/09/ott-9-7115.PMC5119623.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/31/09/ott-9-7115.PMC5119623.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/09/ott-9-7115.PMC5119623.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 7081–7093OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  7081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11524 5 Efficacy and safety of talimogene laherparepvec  versus granulocyte-macrophage colony- stimulating factor in patients with stage iiiB/c  and iVM1a melanoma: subanalysis of the Phase iii  OPTiM trial Kevin J harrington1 robert hi andtbacka2 Frances collichio3 gerald Downey4 lisa chen5 Zsolt szabo6 howard l Kaufman7 1The institute of cancer research/ The royal Marsden hospital nihr  Biomedical research centre, london,   UK; 2huntsman cancer institute,   University of Utah, salt lake city, UT,   Usa; 3Division of hematology and  Oncology, The University of north  carolina at chapel hill, chapel hill,   nc, Usa; 4amgen ltd, cambridge,   UK; 5amgen inc, Thousand Oaks, ca,   Usa; 6amgen gmbh, Zug, switzerland;   7rutgers cancer institute of new  Jersey, new Brunswick, nJ, UsaObjectives:  Talimogene laherparepvec is the first oncolytic immunotherapy to receive  approval in Europe, the USA and Australia.",Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
"Keywords:  benefit–risk, clinical trial, durable response rate, immunotherapy, oncolytic virus,  talimogene laherparepvec Introduction Oncolytic viruses, with natural or engineered effects on the immune system, are novel  anti-cancer therapies.1 These oncolytic immunotherapies are designed to replicate in and  kill tumor cells without harming normal tissues and increase host immune cell recognition  of tumor and viral antigens exposed during oncolysis.2 Talimogene laherparepvec is the  first oncolytic immunotherapy to show an improved response in a Phase III randomized  clinical trial and recently became the first oncolytic immunotherapy to be approved by  the European Commission following approval of the product by the US Food and Drug correspondence: Kevin J harrington The institute of cancer research/ The royal Marsden hospital nihr  Biomedical research centre,  london sW3 6JB, UK Tel +44 20 7153 5157 Fax +44 20 7808 2235 email kevin.harrington@icr.ac.u k Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Harrington et al Running head recto: Talimogene laherparepvec versus GM-CSF in stage IIIB–IVM1a melanoma DOI: http://dx.doi.org/10.2147/OTT.S115245",Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Summary_of_opinion_-_Initial_authorisation/human/002771/ WC500195907.pd f. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/ae/ott-9-7081.PMC5119624.pdf
"For RCTs, the Cochrane risk of bias table (http://tech.cochrane.org/revman/download) was used, and forthe CCSs, the checklists of methodological issues onnon-randomised studies 26and the Newcastle–Ottawa Scale (NOS) were used.27In order to facilitate the study evaluation with respect to the management of con-founding, n¼8 potential confounders were prespeciﬁed, including age, gender, smoker, diabetes, history of stroke, history of AMI, reduced left ventricular ejectionfraction and acute or early PCI during AMI.",OADS,/arxiv_data1/oa_pdf/89/e7/10.1177_2047487316671181.PMC5119625.pdf
(1) c. –Event rate (% CR þ/no CR) Endpoint 1 after 1 y:Propensity-based matching: 2.2/5.3 Regression modelling: 4.8/10.9Endpoint 1 after 5 y:Propensity-based matching: 16.3/24.6 Regression modelling: 28.1/38.0 p<0.0001 for all– Description of CR is limited to the ‘use ofCR services defined by Medicare reimbursement for at least 1 CRsession within 1 y offollow-up’ – CR content is not reported in publicationbut known asmulti-component through official Medicare sites:www.massgeneral.org; http://www.massgeneral.org/ heartcenter/cardiac_rehab_program.aspx (continued)Rauch et al.,Non-OADS,/arxiv_data1/oa_pdf/89/e7/10.1177_2047487316671181.PMC5119625.pdf
"Translational Medical Sciences,University of Naples Federico II, Italy –Heinz Vo ¨ller, Centre of Rehabilitation Research, University of Potsdam, Germany Systematic review registration PROSPERO international prospective register of systematic reviews: http://www.crd.york.ac.uk/prospero/review_print.",Non-OADS,/arxiv_data1/oa_pdf/89/e7/10.1177_2047487316671181.PMC5119625.pdf
The  group  that  received  cyclophosphamide DOI of original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.06.004 .,OADS,/arxiv_data1/oa_pdf/39/b6/main.PMC5119658.pdf
"The  resources  required  to  collect  and  store http://dx.doi.org/10.1016/j.bjhh.2016.07.006 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/39/b6/main.PMC5119658.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/b6/main.PMC5119658.pdf
DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.06.002 .,OADS,/arxiv_data1/oa_pdf/cb/22/main.PMC5119659.pdf
"Even  more  importantly,  these patients present  signiﬁcantly  better  survival  and  lower  risk of  progression  to  AML.11,12Together,  these  data  supported  a signiﬁcant change in  the  revised  WHO  classiﬁcation  of  MDS in  2016, which  established  that,  in  the  presence  of  a  SF3B1 mutation,  a  diagnosis  of  MDS-RS  may  be  deﬁned  with  RS  in as few  as  5%  of  nucleated  erythroid  cells,  with  the  former threshold  of  15%  RS  reserved  for  cases  lacking  a  demon- strable  SF3B1  mutation.13These  patients  will  be  classiﬁed http://dx.doi.org/10.1016/j.bjhh.2016.08.003 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/cb/22/main.PMC5119659.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/22/main.PMC5119659.pdf
"She  also http://dx.doi.org/10.1016/j.bjhh.2016.05.003 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/4e/f4/main.PMC5119660.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/f4/main.PMC5119660.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.07.001 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ca/0d/main.PMC5119661.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/0d/main.PMC5119661.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/0d/main.PMC5119661.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.07.004 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a3/20/main.PMC5119662.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/20/main.PMC5119662.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/20/main.PMC5119662.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/main.PMC5119663.pdf
"It  is  believed  that  this  structural  diversity results from environment  pressure  and  plays  an  impor- tant  role in  the  symbiosis,  commensalism  and  parasitism continuum.2,5 Evidence supports  the  proposition  that  ABO,  H,  Lewis and  secretor  histo-blood  group  carbohydrates  are  related http://dx.doi.org/10.1016/j.bjhh.2016.07.005 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/9d/9a/main.PMC5119663.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/main.PMC5119663.pdf
Knowing  the structural variability of  their  carbohydrate  antigens  allows  us to  understand  the  evolutionary  importance  and  biological  role especially in  terms  of  diseases.2 The  International  Society  for  Blood  Transfusion  (ISBT) Working  Party  on  Red  Cell  Immunogenetics  and  Blood  Group Terminology identiﬁes each  blood  group  system  according  to its discovery  (http://www.isbtweb.org/working-parties/red- cell-immunogenetics-and-blood-group-terminology/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/main.PMC5119663.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.09.005 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ac/53/main.PMC5119664.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/53/main.PMC5119664.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/cf/main.PMC5119665.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.08.002 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/43/cf/main.PMC5119665.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/cf/main.PMC5119665.pdf
Available  from:  http://evs.nci.nih.gov/ftp1/ CTCAE/CTCAE 4.03  2010-06-14  QuickReference  8.5x11.pdf 17.,OADS,/arxiv_data1/oa_pdf/43/cf/main.PMC5119665.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/09/main.PMC5119666.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.06.005 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/20/09/main.PMC5119666.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/09/main.PMC5119666.pdf
These clones  were  retrieved  from  the  human  genome  high  reso- lution  BAC  re-arrayed  clone  set  available  in  a  web  format (http://bacpac.chori.org )  and  selected  according  to  physical and  genetic  mapping  data  reported  on  Ensembl  Browser  web- site (http://www.ensembl.org ).,OADS,/arxiv_data1/oa_pdf/20/09/main.PMC5119666.pdf
DOI of original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.04.005 .,OADS,/arxiv_data1/oa_pdf/8e/c1/main.PMC5119667.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.09.001 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/8e/c1/main.PMC5119667.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/c1/main.PMC5119667.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/1e/main.PMC5119668.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.07.003 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/65/1e/main.PMC5119668.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/1e/main.PMC5119668.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/66/main.PMC5119669.pdf
"The  common  event  in  both  situa- tions  is  the  reduction  of  iron  availability  for  erythropoiesis, http://dx.doi.org/10.1016/j.bjhh.2016.05.009 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/2f/66/main.PMC5119669.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/66/main.PMC5119669.pdf
"An  elevated  number  of  immature  circulat- ing platelets is observed  in  thrombocytopenia  of  peripheral origin  caused  by  excessive  consumption  of  platelets,  while DOI of original  article:  http://dx.doi.org/10.1016/j.bjhh.2016.07.001 .",Non-OADS,/arxiv_data1/oa_pdf/bc/0f/main.PMC5119670.pdf
"Initially,  it was possible to  subdivide  the  reticulocyte  population  in  dif- ferent  degrees  of  maturity  according  to  the  content  of  RNA inside  the  cell:  more  immature  reticulocytes  have  a  higher http://dx.doi.org/10.1016/j.bjhh.2016.08.001 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/bc/0f/main.PMC5119670.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/0f/main.PMC5119670.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/e7/main.PMC5119671.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.06.002 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/88/e7/main.PMC5119671.pdf
